Use of PP2A phosphatase modulators in the treatment of mental disorders

ABSTRACT

The invention relates to the use of PP2A/Bγ and to the use of a PP2A phosphatase comprising the PP2A/Bγ subunit for screening for modulators thereof. The use of these modulators for treating mental disorders such as bipolar disorder, schizophrenia and depression, and drugs comprising these modulators are further disclosed. The present invention further provides novel PP2A/Bγ subunits generated by alternative splicing events. The invention also discloses biallelic markers located in the gene encoding PP2A/Bγ and their use for diagnosing mental disorders.

CROSS-REFERENCE TO RELATED APPLICATIONS

[0001] This application is a continuation-in-part of PCT/EP03/50247, filed Jun. 20, 2003, which claims the benefit of U.S. Provisional 60/391,359, filed Jun. 25, 2002. Each of these applications is hereby incorporated by reference in their entireties, including all figures, tables, formulae, amino acid sequences, and nucleic acid sequences.

FIELD OF THE INVENTION

[0002] The present invention is in the filed of mental disorders such as bipolar disorder, schizophrenia, depression and other mood disorders. More specifically, the present invention provides novel PP2A/Bγ subunits generated by alternative splicing events. The invention further relates to the use of a PP2A/Bγ subunit or of a PP2A phosphatase comprising the PP2A/Bγ subunit for screening for modulators, and to the use of said modulators for treating said mental disorders. The invention also relates to the use of biallelic markers located in the gene encoding the PP2A/Bγ subunit for diagnosing said mental disorders.

BACKGROUND

[0003] 1. The PP2A phosphatase

[0004] The Protein Phosphatase 2A (PP2A) is one of the major intracellular serine/threonine protein phosphatases, and accounts for a large portion of the total phosphatase activity of some cells. In addition of its serine/threonine protein phosphatase activity, PP2A also exhibits low but detectable phosphotyrosine phosphatase activity. Although the precise functions of PP2A in vivo have not yet been determined, evidences suggest that PP2A plays a role in metabolism, DNA replication, cell proliferation, cell cycle and viral transformation. Moreover, PP2A deregulation has been suggested contribute to carcinogenesis and to the development of taupathies such as Alzheimer's disease (see, e.g., Janssens and Goris (2001) Biochem J. 353:417-439). Accordingly, PP2A plays a pivotal role in a wide variety of cellular processes.

[0005] PP2A is constituted by two or three subunits. PP2A phosphatases comprise of catalytic subunit (PP2A/C), a scaffolding subunit (PP2A/A) and eventually a regulatory subunit (PP2A/B) (see, e.g., Janssens and Goris (2001) Biochem J. 353:417-439). Two striking features of the B subunits are their diversity, stemming from the existence of entire subunit families, and the total lack of sequence similarity between the gene families, even though they recognize similar segments of the A subunit. As a consequence, at least 75 different dimeric and trimeric PP2A isoforms can be generated through combinational associations of different A, B and C subunits.

[0006] The existence of multiple families and isoforms of the PP2A/B subunits raises the possibility that different physiological functions are carried out by different isoforms. Indeed, biochemical characterization has demonstrated that subunit composition and specific complex formation play important roles in modulating the substrate specificity and catalytic activity of PP2A (see, e.g., Usui et al. (1988) J Biol. Chem. 263:3752-3761). Regulatory subunits are also thought to confer tissue specificity, subcellular localization and developmental regulation to PP2A.

[0007] PP2A/Bγ is one of the alternative B subunits. PP2A/Bγ is encoded by the PPP2R2C gene that was mapped to human chromosome 4p16 between markers D4S2925 and D4S3007 (Hu et al., Genomics., 2000, 67:83-6). Only one variant of the PP2A/Bγ subunit has been characterised until now (see, e.g., SwissProt Accession No. Q9Y2T4). Strack et al. showed that in rats, the PP2A/Bγ subunit can only be detected in brain. Furthermore, PP2A/Bγ is enriched in the cytosqueletal fraction of the cell and is developmentally regulated (Strack et al. (1998) J Comp Neurol. 1998 392:515-527). This article further shows that compartmentalization of brain PP2A is regulated by different B subunits, the PP2A/Bγ subunit anchoring PP2A to cytoskeletal structures. Based on the localization of the enzyme and on the postnatal increase of PPP2R2C expression, which coincides with synapse formation, Strack et al. hypothesized that PP2A phosphatases comprising the PP2A/Bγ subunit may be involved in synaptic plasticity and in neurological disorders.

[0008] Although PP2A being a major phosphatase, the precise physiological role of most of the different PP2A isoforms is still unknown. Additional data on the specific B subunits and on the processes in which they are specifically involved would very likely lead to the discovery of new therapeutic agents.

[0009] 2. KCNQ Potassium Channels

[0010] Malfunction in ion channels, due to mutations in genes encoding channel proteins or the presence of autoantibodies, are increasingly being implicated in causing disease conditions, termed channelopathies. For instance, dysfunction of potassium channels has been associated with the pathophysiology of a number of neurological disorders both affecting the central and peripheral nervous system (e.g., episodic ataxia, epilepsy, neuromyotonia, Parkinson's disease, congenital deafness, long QT syndrome). Potassium channels, which demonstrate a high degree of diversity and ubiquity, are fundamental in the control of membrane depolarisation and cell excitability. A common feature of potassium channelopathies is a reduction or loss of membrane potential repolarisation. Marketed potassium channels openers include for example flupirtine, an analgesic drug used for treating pain.

[0011] KCNQ polypeptides belong to the potassium channel family. KCNQ polypeptides associate to form homomeric or heteromeric potassium channels, each polypeptide corresponding to a subunit of the channel. Currently, five different members of the KCNQ family are known: KCNQ1, KCNQ2, KCNQ3, KCNQ4 and KCNQ5. Heteromeric KCNQ potassium channels can be comprised either of different members of the KCNQ family, or of KCNQ polypeptides associated with other members of the potassium channel family. Some of the KCNQ potassium channels, including KCNQ2 and KCNQ3, underlie the M-current, an important regulator of neuronal excitability. Both their amino-terminal and their carboxyl-terminal extremities are located on the intracellular side of the membrane. These extremities play an important role both in interactions with other proteins and in modulation of the channel's activity.

[0012] The activity of KCNQ channels has been shown to be modulated by the Protein kinase A (PKA) and by the c-Src tyrosine kinase (Src). Schroeder et al. showed that currents generated by heteromeric KCNQ2/KCNQ3 channels can be increased by intracellular cyclic AMP, and that this effect is mediated by the PKA kinase. PKA stimulated current intensity by 66% (Schroeder et al. (2000) Epilepsia (2000) 41:1068-1069). Gamper et al. showed that coexpression of Src with KCNQ2/KCNQ3 heteromeric channels resulted in a 4.5-fold reduction of current density and a 2-fold slowing of activation kinetics at 0 mV. However, Src had no effect on currents generated by KCNQ2 homomeric channels (Gamper et al. (2003) J Neurosci. 23:84-95). Accordingly, modulation of the phosphorylation state of KCNQ channels, which represents a balance between the activities of kinases and phosphatases, is believed to be important for control of neuronal excitability.

[0013] 3. Mental Disorders

[0014] Mental disorders encompass a wide range of CNS disorders. Mental disorders include, e.g., mood disorders, psychotic disorders, anxiety disorders, childhood disorders, eating disorders and personality disorders, all these terms being defined according to the DSM-IV classification (Diagnosis and Statistical Manual of Mental Disorders, Fourth Edition, American Psychiatric Association, Washington D.C., 1994). Mood Disorders encompass bipolar I disorder (mania with or without major depression), bipolar II disorder (hypomania with major depression), cyclothymic disorder (numerous brief episodes of hypomania and minor depression), dysthymic disorder (prolonged minor depression without mania/hypomania) and major depressive disorder (major depression without mania). Psychotic disorders encompass schizophrenia, schizoaffective disorder, schizophreniform disorder, brief psychotic disorder, delusional disorder and shared psychotic disorder. Bipolar disorder, schizophrenia and depression are three particularly serious and widespread mental disorders.

[0015] 3.1. Bipolar Disorder

[0016] Bipolar disorders are relatively common disorders, occurring in about 1.3% of the population, and have been reported to constitute about half of the mood disorders seen in psychiatric clinics with severe and potentially disabling effects. Bipolar disorders have been found to vary with gender depending of the type of disorder; for example, bipolar disorder I is found equally among men and women, while bipolar disorder II is reportedly more common in women. The age of onset of bipolar disorders is typically in the teenage years and diagnosis is typically made in the patient's early twenties. Bipolar disorders also occur among the elderly, generally as a result of a neurological disorder or other medical conditions. In addition to the severe effects on patients' social development, suicide completion rates among bipolar patients are reported to be about 15%.

[0017] Bipolar disorders are characterized by phases of excitement and often depression; the excitement phases, referred to as mania or hypomania, and depressive phases can alternate or occur in various admixtures, and can occur to different degrees of severity and over varying duration. Since bipolar disorders can exist in different forms and display different symptoms, the classification of bipolar disorder has been the subject of extensive studies resulting in the definition of bipolar disorder subtypes and widening of the overall concept to include patients previously thought to be suffering from different disorders. Bipolar disorders often share certain clinical signs, symptoms, treatments and neurobiological features with psychotic illnesses in general and therefore present a challenge to the psychiatrist to make an accurate diagnosis. Furthermore, because the course of bipolar disorders and various mood and psychotic disorders can differ greatly, it is critical to characterize the illness as early as possible in order to offer means to manage the illness over a long term.

[0018] The mania associated with the disease impairs performance and causes psychosis, and often results in hospitalization. This disease places a heavy burden on the patient's family and relatives, both in terms of the direct and indirect costs involved and the social stigma associated with the illness, sometimes over generations. Such stigma often leads to isolation and neglect. Furthermore, the earlier the onset, the more severe are the effects of interrupted education and social development.

[0019] The DSM-IV classification of bipolar disorder distinguishes among four types of disorders based on the degree and duration of mania or hypomania as well as two types of disorders which are evident typically with medical conditions or their treatments, or to substance abuse. Mania is recognized by elevated, expansive or irritable mood as well as by distractability, impulsive behavior, increased activity, grandiosity, elation, racing thoughts, and pressured speech. Of the four types of bipolar disorder characterized by the particular degree and duration of mania, DSM-IV includes:

[0020] bipolar disorder I, including patients displaying mania for at least one week;

[0021] bipolar disorder II, including patients displaying hypomania for at least 4 days, characterized by milder symptoms of excitement than mania, who have not previously displayed mania, and have previously suffered from episodes of major depression;

[0022] bipolar disorder not otherwise specified (NOS), including patients otherwise displaying features of bipolar disorder II but not meeting the 4 day duration for the excitement phase, or who display hypomania without an episode of major depression; and

[0023] cyclothymia, including patients who show numerous manic and depressive symptoms that do not meet the criteria for hypomania or major depression, but which are displayed for over two years without a symptom-free interval of more than two months.

[0024] The remaining two types of bipolar disorder as classified in DSM-VI are disorders evident or caused by various medical disorder and their treatments, and disorders involving or related to substance abuse. Medical disorders which can cause bipolar disorders typically include endocrine disorders and cerebrovascular injuries, and medical treatments causing bipolar disorder are known to include glucocorticoids and the abuse of stimulants. The disorder associated with the use or abuse of a substance is referred to as “substance induced mood disorder with manic or mixed features”.

[0025] Evidence from twin and adoption studies, and the lack of variation in incidence worldwide, indicate that bipolar disorder is primarily a genetic condition, although environmental risk factors are also involved at some level as necessary, sufficient, or interactive causes. Aggregation of bipolar disorder and schizophrenia in families suggests that these two distinct disorders share some common genetic susceptibility. Several linkage studies of bipolar disorder have been reported, and several susceptibility regions have been identified. The regions that are associated with bipolar disorder include 1q31-q32, 4p16, 7q31, 12q23-q24, 13q32, 18p11.2, 21q22 and 22q11-q13 (Detera-Wadleigh et al. (1999) Proc Natl Acad Sci USA A96(10):5604-9). Some of these regions, like 4p16, 12q24, 18p11, 21 q21 and 22q 11 have been repeatedly implicated by independent investigators. Furthermore, some regions that are linked to bipolar disorder such as, e.g., 13q32 and 18p11.2, are also implicated in genome scans of schizophrenia, confirming that these two distinct disorders share some common genetic susceptibility. However, the genes underlying bipolar disorder and/or schizophrenia have not yet been identified.

[0026] 3.2. Schizophrenia

[0027] There are an estimated 45 million people with schizophrenia in the world, with more than 33 million of them in the developing countries. In developed countries schizophrenia occurs in approximately 1% of the adult population at some point during their lives. If there is one grandparent with schizophrenia, the risk of getting the illness increases to about 3%; one parent with Schizophrenia, to about 10%. When both parents have schizophrenia, the risk rises to approximately 40%. Most schizophrenia patients are never able to work. Standardized mortality ratios (SMRs) for schizophrenic patients are estimated to be two to four times higher than the general population and their life expectancy overall is 20% shorter than for the general population. The most common cause of death among schizophrenic patients is suicide (in 10% of patients) which represents a 20 times higher risk than for the general population. Deaths from heart disease and from diseases of the respiratory and digestive system are also increased among schizophrenic patients.

[0028] Schizophrenia comprises a group of psychoses with either ‘positive’ or ‘negative’ symptoms. Positive symptoms consist of hallucinations, delusions and disorders of thought; negative symptoms include emotional flattening, lack of volition and a decrease in motor activity.

[0029] A number of biochemical abnormalities have been identified and, in consequence, several neurotransmitter based hypotheses have been advanced over recent years; the most popular one has been “the dopamine hypothesis,” one variant of which states that there is over-activity of the mesolimbic dopamine pathways at the level of the D₂ receptor. However, researchers have been unable to consistently find an association between various receptors of the dopaminergic system and schizophrenia.

[0030] 3.3. Depression

[0031] Depression is a serious medical illness that affects 340 million people worldwide. In contrast to the normal emotional experiences of sadness, loss, or passing mood states, clinical depression is persistent and can interfere significantly with an individual's ability to function. As a result, depression is the leading cause of disability throughout the world.

[0032] Symptoms of depression include depressed mood, diminished interest or pleasure in activities, change in appetite or weight, insomnia or hypersomnia, psycho-motor agitation or retardation, fatigue or loss of energy, feelings of worthlessness or excessive guilt, anxiety, inability to concentrate or act decisively, and recurrent thoughts of death or suicide. A diagnosis of unipolar major depression (or major depressive disorder) is made if a person has five or more of these symptoms and impairment in usual functioning nearly every day during the same two-week period. The onset of depression generally begins in late adolescence or early adult life; however, recent evidence suggests depression may be occurring earlier in life in people born in the past thirty years.

[0033] The World Health Organization predicts that by the year 2020 depression will be the greatest burden of ill-health to people in the developing world, and that by then depression will be the second largest cause of death and disability. Beyond the almost unbearable misery it causes, the big risk in major depression is suicide. Within five years of suffering a major depression, an estimated 25% of sufferers try to kill themselves. In addition, depression is a frequent and serious complication of heart attack, stroke, diabetes, and cancer. According to one recent study that covered a 13-year period, individuals with a history of major depression were four times as likely to suffer a heart attack compared to people without such a history. Depression may also be a feature in up to 50% of patients with mental disorders such as Parkinson's disease and Alzheimer's disease.

[0034] 3.4. Treatment

[0035] There are currently no cures for mental disorders such as bipolar disorder, schizophrenia, depression and other mood disorders, so the objective of treatment is to reduce the severity of the symptoms, if possible to the point of remission. Due to the similarities in symptoms, schizophrenia, depression and bipolar disorder are often treated with some of the same medicaments.

[0036] 3.4.1. Treatment of Bipolar Disorder

[0037] Depressive episodes may be treated like depression. However, most antidepressants can cause swings from depression to hypomania or mania and sometimes cause rapid cycling between them. Therefore, these drugs are used for only short periods, and their effect on mood is closely monitored. At the first sign of a swing to hypomania or mania, the antidepressant is stopped. Most people with manic-depressive disorder are given drugs with a mood-stabilizing effect such as lithium, carbamazepine and divalproex.

[0038] Lithium has no effect on normal mood but reduces the tendency toward mood swings in about 70% of the people with manic-depressive illness. A doctor monitors the level of lithium in the blood with blood tests. Possible adverse effects of lithium include tremor, muscle twitching, nausea, vomiting, diarrhea, thirst, excessive urination, and weight gain. Lithium can make acne or psoriasis worse, can cause the blood levels of thyroid hormone to fall, and rarely can cause excessive urination. A very high level of lithium in the blood can cause a persistent headache, mental confusion, drowsiness, seizures, and abnormal heart rhythms. Adverse effects are more likely to occur in the elderly. Women who are trying to become pregnant must stop taking lithium, because lithium may cause heart defects in a developing fetus.

[0039] Newer drug treatments have evolved over the past several years. These include the carbamazepine and divalproex. However, carbamazepine can seriously reduce the number of red and white blood cells, and divalproex can cause liver damage (primarily in children). With careful monitoring by a doctor, these problems are rare, and carbamazepine and divalproex are useful alternatives to lithium, especially for people with the mixed or rapid cycling form of manic-depressive illness who haven't responded to other treatments.

[0040] 3.4.2. Treatment of Schizophrenia

[0041] For schizophrenia, antipsychotic medications are the most common and most valuable treatments. There are four main classes of antipsychotic drugs which are commonly prescribed for schizophrenia. The first, neuroleptics, exemplified by chlorpromazine (Thorazine), has revolutionized the treatment of schizophrenic patients by reducing positive (psychotic) symptoms and preventing their recurrence. Patients receiving chlorpromazine have been able to leave mental hospitals and live in community programs or their own homes. But these drugs are far from ideal. Some 20% to 30% of patients do not respond to them at all, and others eventually relapse. These drugs were named neuroleptics because they produce serious neurological side effects, including rigidity and tremors in the arms and legs, muscle spasms, abnormal body movements, and akathisia (restless pacing and fidgeting). These side effects are so troublesome that many patients simply refuse to take the drugs. Besides, neuroleptics do not improve the so-called negative symptoms of schizophrenia and the side effects may even exacerbate these symptoms. Thus, despite the clear beneficial effects of neuroleptics, even some patients who have a good short-term response will ultimately deteriorate in overall functioning.

[0042] The well known deficiencies in the standard neuroleptics have stimulated a search for new treatments and have led to a new class of drugs termed a typical neuroleptics. The first a typical neuroleptic, Clozapine, is effective for about one third of patients who do not respond to standard neuroleptics. It seems to reduce negative as well as positive symptoms, or at least exacerbates negative symptoms less than standard neuroleptics do. Moreover, it has beneficial effects on overall functioning and may reduce the chance of suicide in schizophrenic patients. It does not produce the troubling neurological symptoms of the standard neuroleptics, or raise blood levels of the hormone prolactin, excess of which may cause menstrual irregularities and infertility in women, impotence or breast enlargement in men. Many patients who cannot tolerate standard neuroleptics have been able to take clozapine. However, clozapine has serious limitations. It was originally withdrawn from the market because it can cause agranulocytosis, a potentially lethal inability to produce white blood cells. Agranulocytosis remains a threat that requires careful monitoring and periodic blood tests. Clozapine can also cause seizures and other disturbing side effects (e.g., drowsiness, lowered blood pressure, drooling, bed-wetting, and weight gain). Thus only patients who do not respond to other drugs usually take Clozapine.

[0043] Researchers have developed a third class of antipsychotic drugs that have the virtues of clozapine without its defects. One of these drugs is risperidone (Risperdal). Early studies suggest that it is as effective as standard neuroleptic drugs for positive symptoms and may be somewhat more effective for negative symptoms. It produces more neurological side effects than clozapine but fewer than standard neuroleptics. However, it raises prolactin levels. Risperidone is now prescribed for a broad range of psychotic patients, and many clinicians seem to use it before clozapine for patients who do not respond to standard drugs, because they regard it as safer. Another new drug is Olanzapine (Zyprexa) which is at least as effective as standard drugs for positive symptoms and more effective for negative symptoms. It has few neurological side effects at ordinary clinical doses, and it does not significantly raise prolactin levels. Although it does not produce most of clozapine's most troubling side effects, including agranulocytosis, some patients taking olanzapine may become sedated or dizzy, develop dry mouth, or gain weight. In rare cases, liver function tests become transiently abnormal.

[0044] 3.4.3. Treatment of Depression

[0045] Several types of antidepressants are available. These antidepressants belong to four main categories: tricyclic antidepressants, selective serotonin reuptake inhibitors, monoamine oxidase inhibitors and psychostimulants. Tricyclic antidepressants include, e.g., Amitriptyline, Amoxapine, Bupropion, Clomipramine, Desipramine, Doxepin, Imipramine, Maprotiline, Nefazodone, Nortriptyline, Protriptyline, Trazodone, Trimipramine and Venlafaxine. Selective serotonin reuptake inhibitors include, e.g., Fluoxetine, Fluvoxamine, Paroxetine and Sertraline. Monoamine oxidase inhibitors include, e.g., Isocarboxazid, Pargyline, Phenelzine and Tranylcypromine. Psychostimulants include, e.g., Dextroamphetamine and Methylphenidate.

[0046] All these antidepressants must be taken regularly for at least several weeks before they begin to work. The chances that any given antidepressant will work for a particular person are about 65%. However, most of these drugs have side effects varying with each type of drug. For example, the tricyclic antidepressants often cause sedation and lead to weight gain. They can also be associated with side effects such as an increased heart rate, a decrease in blood pressure when the person stands or blurred vision.

[0047] Thus, for mental disorders such as bipolar disorder, schizophrenia, depression and other mood disorders, known molecules used for the treatment have side effects and act only against the symptoms of the disease. Consequently, there is a strong need for new molecules without associated side effects that are specifically directed against targets which are involved in the causal mechanisms of such mental disorders. Therefore, there is a need to identify proteins involved in bipolar disorder and schizophrenia. Providing new targets involved in bipolar disorder and schizophrenia will allow new screenings for drugs, resulting in new drugs that are efficient in treatment of these serious mental disorders.

[0048] Furthermore, there is also a need for diagnostic tools. There is increasing evidence that leaving schizophrenia untreated for long periods early in course of the illness may negatively affect the outcome. However, the use of drugs is often delayed for patients experiencing a first episode of the illness. The patients may not realize that they are ill, or they may be afraid to seek help; family members sometimes hope the problem will simply disappear or cannot persuade the patient to seek treatment; clinicians may hesitate to prescribe antipsychotic medications when the diagnosis is uncertain because of potential side effects. Indeed, at the first manifestation of the disease, schizophrenia or bipolar disorder is difficult to distinguish from, e.g., drug-related disorders and stress-related disorders. Accordingly, there is a need for new methods for detecting a susceptibility to mental disorders such as bipolar disorder, schizophrenia, and depression.

SUMMARY OF THE INVENTION

[0049] In the frame of the present invention, novel splice variants of the PP2A/Bγ subunit have been found.

[0050] Therefore, a first aspect of the present invention is directed to an isolated PP2A/Bγ subunit selected from the group consisting of:

[0051] a) a polypeptide comprising SEQ ID NO: 49;

[0052] b) a polypeptide comprising SEQ ID NO: 51;

[0053] c) a polypeptide comprising SEQ ID NO: 53;

[0054] d) a polypeptide comprising SEQ ID NO: 55;

[0055] e) a polypeptide comprising SEQ ID NO: 57;

[0056] f) a polypeptide comprising SEQ ID NO: 61;

[0057] g) a polypeptide comprising SEQ ID NO: 63;

[0058] h) a polypeptide comprising amino acids 25 to 47 of SEQ ID NO: 51;

[0059] i) a mutein of any of (a) to (h), wherein the amino acid sequence has at least 60% or 70% or 80% or 90% or 95% or 99% identity to at least one of the sequences in (a) to (h);

[0060] j) a mutein of any of (a) to (h) which is encoded by a DNA sequence which hybridizes to the complement of the DNA sequence encoding any of (a) to (h) under moderately stringent conditions or under highly stringent conditions; and

[0061] k) a mutein of any of (a) to (h) wherein any changes in the amino acid sequence are conservative amino acid substitutions to the amino acid sequences in (a) to (h).

[0062] A second aspect of the present invention relates to a purified PP2A/Bγ polynucleotide encoding a PP2A/Bγ subunit according to the present invention.

[0063] A third aspect of the present invention relates to an expression vector comprising a PP2A/Bγ polynucleotide according to the present invention.

[0064] A host cell comprising an expression vector according to the present invention is a fourth aspect of the present invention.

[0065] Further, a fifth aspect of the present invention pertains to a method of making a PP2A/Bγ subunit according to the present invention, said method comprising the steps of culturing a host cell according to the present invention conditions suitable for the production of said PP2A/Bγ subunit within said host cell.

[0066] A sixth aspect of the present invention relates to an antibody that specifically binds to a PP2A/Bγ subunit according to the present invention.

[0067] The present invention is further based on the finding that the PPP2R2C gene encoding PP2A/Bγ subunits is associated with the onset and the development of mental disorders.

[0068] Accordingly, a seventh aspect of the present invention is directed to the use of a PP2A/Bγ subunit as a target for screening candidate modulators.

[0069] An eight aspect of the present invention is directed to the use of a PP2A phosphatase comprising a PP2A/Bγ subunit as a target for screening candidate modulators.

[0070] In a ninth aspect, the invention relates to the use of modulator of a PP2A phosphatase comprising a PP2A/Bγ subunit for preparing a medicament for the treatment of a mental disorder, and to the use of a gene therapy vector comprising a polynucleotide encoding a PP2A/Bγ subunit for preparing a medicament for the treatment of a mental disorder.

[0071] The use of a PP2A/Bγ subunit as a target for screening for natural binding partners is a tenth aspect of the present invention.

[0072] An eleventh aspect of the invention pertains to a method of assessing the efficiency of a modulator of a PP2A phosphatase comprising a PP2A/Bγ subunit for the treatment of a mental disorder, said method comprising administering said modulator to an animal model for said mental disorder; wherein a determination that said modulator ameliorates a representative characteristic of said mental disorder in said animal model indicates that said agonist is a drug for the treatment of said mental disorder.

[0073] In the frame of the present invention, biallelic markers located in the gene encoding PP2A/Bγ have been identified.

[0074] Therefore, a twelfth aspect of the invention relates to the use of at least one PP2A/Bγ-related biallelic marker for diagnosing whether an individual suffers from or is at risk of suffering from a mental disorder.

[0075] In a thirteenth aspect, the invention encompasses the use of at least one PP2A/Bγ-related biallelic marker for determining whether there is a significant association between said marker and a mental disorder.

[0076] In a fourteenth aspect, the invention relates to a method of genotyping comprising the step of determining the identity of a nucleotide at a PP2A/Bγ-related biallelic marker or the complement thereof in a biological sample.

[0077] A fifteenth aspect of the present invention pertains to a method of diagnosing a mental disorder in an individual comprising the step of genotyping at least one PP2A/Bγ-related biallelic marker according to the method of any of claims 29 to 33.

[0078] In a sixtenth aspect, the invention pertains to the use of a polynucleotide comprising a contiguous span of at least 12 nucleotides of SEQ ID NO: 37 or a polynucleotide complementary thereto in a microsequencing assay for determining the identity of the nucleotide at a PP2A/Bγ-related biallelic marker, wherein the 3′ end of said polynucleotide is located 1 nucleotide upstream of said PP2A/Bγ-related biallelic marker in said sequence.

BRIEF DESCRIPTION OF THE FIGURES

[0079]FIGS. 1A and 1B show an alignment between the full-length KCNQ2 polypeptide (KCNQ2-fl, SEQ ID NO: 7), KCNQ2-15bx (SEQ ID NO: 2), KCNQ2-15by (SEQ ID NO: 4) and KCNQ2-15bz (SEQ ID NO: 6). The box shows highlights the amino acids that are unique to KCNQ2-15bx, KCNQ2-15by and KCNQ2-15bz compared to KCNQ2-fl.

[0080]FIG. 2 shows a sheme of the structure of the KCNQ2-15bx, KCNQ2-15by and KCNQ2-15bz cDNAs.

[0081]FIG. 3 shows the results of a mating test between PP2A/Bγ and different KCNQ2 polypeptides, as described in detail in Example 3.

[0082]FIG. 4 shows the results of a mating test between different KCNQ2 polypeptides, as described in detail in Example 3.

[0083]FIG. 5 compares the intensity of the currents generated by homotetrameric potassium channels comprised of KCNQ2-15bx, KCNQ2-15by, KCNQ2-15bz or KCNQ2-fl subunits respectively.

[0084]FIG. 6A shows the voltage clamp traces of the current generated by a homotetrameric potassium channels comprised of KCNQ2-15bx subunits.

[0085]FIG. 6B shows the voltage clamp traces of the current generated by a homotetrameric potassium channels comprised of KCNQ2-15by subunits.

[0086]FIGS. 7A and 7B show an alignment between the wild-type PP2A/Bγ subunit and the novel splice variants of the type PP2A/Bγ subunit.

BRIEF DESCRIPTION OF THE SEQUENCES OF THE SEQUENCE LISTING

[0087] SEQ ID NO: 1 corresponds to a polynucleotide consisting of the CDS of KCNQ2-15bx

[0088] SEQ ID NO: 2 corresponds to the KCNQ2-15bx polypeptide.

[0089] SEQ ID NO: 3 corresponds to a polynucleotide consisting of the CDS of KCNQ2-15by

[0090] SEQ ID NO: 4 corresponds to the KCNQ2-15by polypeptide.

[0091] SEQ ID NO: 5 corresponds to a polynucleotide consisting of the CDS of KCNQ2-15bz

[0092] SEQ ID NO: 6 corresponds to the KCNQ2-15bz polypeptide.

[0093] SEQ ID NO: 7 corresponds to the KCNQ2-fl polypeptide.

[0094] SEQ ID Nos. 8 to 36 correspond to primers and probes used in Examples 1 to 4.

[0095] SEQ ID NO: 37 corresponds to the PPP2R2C gene which encodes the PP2A/Bγ subunit, on which PP2A/Bγ-related biallelic markers are indicated.

[0096] SEQ ID NO: 38 corresponds to the wild-type PP2A/Bγ subunit.

[0097] SEQ ID Nos. 39 to 41 correspond to primers used for microsequencing some of the PP2A/Bγ-related biallelic markers.

[0098] SEQ ID Nos. 42 to 47 correspond to regions of the KCNQ2 gene, on which KCNQ2-related biallelic markers are indicated.

[0099] SEQ ID Nos. 48, 50, 52, 54, 56, 58, 60 and 62 correspond to cDNAs encoding splice variants of the PP2A/Bγ subunit.

[0100] SEQ ID Nos. 49, 51, 53, 55, 57, 59, 61 and 63 correspond to splice variants of the PP2A/Bγ subunit.

[0101] SEQ ID Nos. 64 to 69 correspond to primers used for sequencing the cDNAs encoding splice variants of the PP2A/Bγ subunit.

BRIEF DESCRIPTION OF THE TABLES

[0102] Table 0 presents the structure of the wild-type PP2A/Bγ subunit and the novel splice variants of the type PP2A/Bγ subunit.

[0103] Table 1 presents the structure of KCNQ2-fl, KCNQ2-15bx KCNQ2-15by and KCNQ2-15bz.

[0104] Tables 2A and 2B present the location of the primers used for amplification of genomic DNA by PCR in the PPP2R2C and in the KCNQ2 gene respectively

[0105] Table 3A and 3B present biallelic markers located in PP2R2C and in the KCNQ2 gene respectively.

[0106] Tables 4A and 4B present the the primers used for microsequencing biallelic markers located in PP2R2C and in the KCNQ2 gene respectively.

[0107] Tables 5A and 5B present the p-values for biallelic markers located in PPP2R2C and in the KCNQ2 gene respectively.

[0108] Tables 6A and 6B present the genotypic odds ratios for biallelic markers located in PPP2R2C and in the KCNQ2 gene respectively.

[0109] Tables 7A and 7B present the risk haplotypes for two sets of biallelic markers located in PPP2R2C.

DETAILED DESCRIPTION OF THE INVENTION

[0110] The present invention stems from association studies between the gene encoding PP2A/Bγ (PPP2R2C) and bipolar disorder. As shown in example 15, PPP2R2C is strongly associated with bipolar disorder in two different populations. Novel splice variants of the PP2A/Bγ subunit are provided. Novel validated biallelic markers located in PPP2R2C and associated with bipolar disorder are further provided. In the frame of the present invention, it was further demonstrated that PP2A/Bγ interacts with novel splice variants of the KCNQ2 potassium channel, and that the KCNQ2 gene is also associated with bipolar disorder. Moreover, it was shown that (i) PP2A dephosphorylates the novel KCNQ2 splice variants; and (ii) GSK3β and PKA phosphorylate the novel KCNQ2 splice variants. In addition, phosphorylation of the novel KCNQ2 splice variants is inhibited in the presence of lithium, a known mood-stabilizing agent.

[0111] Accordingly, the present invention provides means to identify compounds useful in the treatment of mental disorders such as bipolar disorder, schizophrenia, depression and other mood disorders. The invention further relates to the use of PP2A/Bγ or to the use of a PP2A phosphatase comprising PP2A/Bγ as a target for screening for modulators thereof, and to the use of said modulators for treating mental disorders. The invention also relates to the use of biallelic markers located in PPP2R2C gene for diagnosing mental disorders.

[0112] 1. Definitions

[0113] The term “treat” or “treating” as used herein is meant to ameliorate, alleviate symptoms, eliminate the causation of the symptoms either on a temporary or permanent basis, or to prevent or slow the appearance of symptoms of the named disorder or condition. The term “treatment” as used herein also encompasses the term “prevention of the disorder”, which is, e.g., manifested by delaying the onset of the symptoms of the disorder to a medically significant extent. Treatment of the disorder is, e.g., manifested by a decrease in the symptoms associated with the disorder or an amelioration of the reoccurrence of the symptoms of the disorder.

[0114] The term “mental disorder” refers to diseases characterized as mood disorders, psychotic disorders, anxiety disorders, childhood disorders, eating disorders, personality disorders, adjustment disorder, autistic disorder, delirium, dementia, multi-infarct dementia and Tourette's disorder in the DSM-IV classification (Diagnosis and Statistical Manual of Mental Disorders, Fourth Edition, American Psychiatric Association, Washington D.C., 1994).

[0115] The term “schizophrenia” refers to a condition characterized as schizophrenia in the DSM-IV classification (Diagnosis and Statistical Manual of Mental Disorders, Fourth Edition, American Psychiatric Association, Washington D.C., 1994).

[0116] The term “bipolar disorder” as used herein refers to a condition characterized as a Bipolar Disorder in the DSM-IV. Bipolar disorder may be bipolar I and bipolar disorder II as described in the DSM-IV. The term further includes cyclothymic disorder. Cyclothymic disorder refers to an alternation of depressive symptoms and hypomanic symptoms. The skilled artisan will recognize that there are alternative nomenclatures, posologies, and classification systems for pathologic psychological conditions and that these systems evolve with medical scientific progress.

[0117] The terms “comprising”, “consisting of”, or “consisting essentially of” have distinct meanings. However, each term may be substituted for another herein to change the scope of the invention.

[0118] As used interchangeably herein, the term “oligonucleotides”, and “polynucleotides” include RNA, DNA, or RNA/DNA hybrid sequences of more than one nucleotide in either single chain or duplex form. The term “nucleotide” as used herein as an adjective to describe compounds comprising RNA, DNA, or RNA/DNA hybrid sequences of any length in single-stranded or duplex form. The term “nucleotide” is also used herein as a noun to refer to individual nucleotides or varieties of nucleotides, meaning a compound, or individual unit in a larger nucleic acid compound, comprising a purine or pyrimidine, a ribose or deoxyribose sugar moiety, and a phosphate group, or phosphodiester linkage in the case of nucleotides within an oligonucleotide or polynucleotide. Although the term “nucleotide” is also used herein to encompass “modified nucleotides” which comprise at least one modifications (a) an alternative linking group, (b) an analogous form of purine, (c) an analogous form of pyrimidine, or (d) an analogous sugar, for examples of analogous linking groups, purine, pyrimidines, and sugars see for example PCT publication No. WO 95/04064, the disclosure of which is incorporated herein by reference. However, the polynucleotides of the invention are preferably comprised of greater than 50% conventional deoxyribose nucleotides, and most preferably greater than 90% conventional deoxyribose nucleotides. The polynucleotide sequences of the invention may be prepared by any known method, including synthetic, recombinant, ex vivo generation, or a combination thereof, as well as utilizing any purification methods known in the art.

[0119] The term “isolated” requires that the material be removed from its original environment (e.g., the natural environment if it is naturally occurring). For example, a naturally-occurring polynucleotide or polypeptide present in a living animal is not isolated, but the same polynucleotide or DNA or polypeptide, separated from some or all of the coexisting materials in the natural system, is isolated. Such polynucleotide could be part of a vector and/or such polynucleotide or polypeptide could be part of a composition, and still be isolated in that the vector or composition is not part of its natural environment.

[0120] The term “primer” denotes a specific oligonucleotide sequence which is complementary to a target nucleotide sequence and used to hybridize to the target nucleotide sequence. A primer serves as an initiation point for nucleotide polymerization catalyzed by either DNA polymerase, RNA polymerase or reverse transcriptase.

[0121] The term “probe” denotes a defined nucleic acid segment (or nucleotide analog segment, e.g., polynucleotide as defined herein) which can be used to identify a specific polynucleotide sequence present in samples, said nucleic acid segment comprising a nucleotide sequence complementary of the specific polynucleotide sequence to be identified.

[0122] The terms “complementary” or “complement thereof” are used herein to refer to the sequences of polynucleotides which are capable of forming Watson & Crick base pairing with another specified polynucleotide throughout the entirety of the complementary region. This term is applied to pairs of polynucleotides based solely upon their sequences and not any particular set of conditions under which the two polynucleotides would actually bind.

[0123] The term “polypeptide” refers to a polymer of amino acids without regard to the length of the polymer; thus, peptides, oligopeptides, and proteins are included within the definition of polypeptide. This term also does not specify or exclude prost-expression modifications of polypeptides, for example, polypeptides which include the covalent attachment of glycosyl groups, acetyl groups, phosphate groups, lipid groups and the like are expressly encompassed by the term polypeptide. Also included within the definition are polypeptides which contain one or more analogs of an amino acid (including, for example, non-naturally occurring amino acids, amino acids which only occur naturally in an unrelated biological system, modified amino acids from mammalian systems etc.), polypeptides with substituted linkages, as well as other modifications known in the art, both naturally occurring and non-naturally occurring.

[0124] As used herein, the term “exon” refers as well to the portion of a DNA that codes for portion of spliced mRNA as to the amino acids encoded by said part of a DNA.

[0125] As used herein, “splice variants” refer to different mRNAs produced by alternative splicing events and translated from the same gene. The term splice variant refers as well to the mRNA as to the corresponding polypeptide.

[0126] As used herein, the term “non-human animal” refers to any non-human vertebrate, birds and more usually mammals, preferably primates, farm animals such as swine, goats, sheep, donkeys, and horses, rabbits or rodents, more preferably rats or mice. As used herein, the term “animal” is used to refer to any vertebrate, preferable a mammal. Both the terms “animal” and “mammal” expressly embrace human subjects unless preceded with the term “non-human”.

[0127] The terms “trait” and “phenotype” are used interchangeably herein and refer to any clinically distinguishable, detectable or otherwise measurable property of an organism such as symptoms of, or susceptibility to a disease for example. Typically the terms “trait” or “phenotype” are used herein to refer to symptoms of, or susceptibility to bipolar disorder; or to refer to an individual's response to an agent acting on bipolar disorder; or to refer to symptoms of, or susceptibility to side effects to an agent acting on bipolar disorder.

[0128] As used herein, the term “allele” refers to one of the variant forms of a biallelic marker, differing from other forms in its nucleotide sequence. Typically the first identified allele is designated as the original allele whereas other alleles are designated as alternative alleles. Diploid organisms may be homozygous or heterozygous for an allelic form.

[0129] The term “polymorphism” as used herein refers to the occurrence of two or more alternative genomic sequences or alleles between or among different genomes or individuals. “Polymorphic” refers to the condition in which two or more variants of a specific genomic sequence can be found in a population. A “polymorphic site” is the locus at which the variation occurs. A polymorphism may comprise a substitution, deletion or insertion of one or more nucleotides. A single nucleotide polymorphism is a single base pair change. Typically a single nucleotide polymorphism is the replacement of one nucleotide by another nucleotide at the polymorphic site. A “single nucleotide polymorphism” (SNP) refers to a sequence polymorphism differing in a single base pair.

[0130] 2. PP2A/Bγ Subunits of the Present Invention

[0131] The term “PP2A/Bγ subunit” is used herein to embrace all of the polypeptides of the present invention. As used herein, the term “PP2A/Bγ subunit” is used interchangeably with “PP2A/Bγ” and refers to a polypeptide encoded by the PPP2R2C gene (SEQ ID NO: 37). Thus the term PP2A/Bγ encompasses all variants that are encoded by PPP2R2C corresponding to, e.g., alternative splice variants, or polypeptides translated from alternative start methionines.

[0132] In one embodiment, the PP2A/Bγ subunit is a polypeptide comprising or consisting of SEQ ID NO: 38. As used herein, a “wild-type PP2A/Bγ subunit” refers to a PP2A/Bγ subunit of SEQ ID NO: 38.

[0133] In the frame of the present invention, eight novel splice variants of PP2A/Bγ were found (see Example1). Accordingly, one embodiment is directed to a PP2A/Bγ subunit selected from the group consisting of:

[0134] a) a polypeptide comprising SEQ ID NO: 49;

[0135] b) a polypeptide comprising SEQ ID NO: 51;

[0136] c) a polypeptide comprising SEQ ID NO: 53;

[0137] d) a polypeptide comprising SEQ ID NO: 55;

[0138] e) a polypeptide comprising SEQ ID NO: 57;

[0139] f) a polypeptide comprising SEQ ID NO: 61;

[0140] g) a polypeptide comprising SEQ ID NO: 63;

[0141] h) a polypeptide comprising amino acids 25 to 47 of SEQ ID NO: 51;

[0142] i) a mutein of any of (a) to (h), wherein the amino acid sequence has at least 50% or 60% or 70% or 80% or 90% or 95% or 99% identity to at least one of the sequences in (a) to (h);

[0143] j) a mutein of any of (a) to (h) which is encoded by a DNA sequence which hybridizes to the complement of the DNA sequence encoding any of (a) to (hi) under moderately stringent conditions or under highly stringent conditions; and

[0144] k) a mutein of any of (a) to (h) wherein any changes in the amino acid sequence are conservative amino acid substitutions to the amino acid sequences in (a) to (h).

[0145] As shown in examples 4 and 6, a PP2A/Bγ subunit of SEQ ID NO: 38 is capable of binding to KCNQ2 polypeptides in vitro. Both the gene encoding PP2A/Bγ and the gene encoding KCNQ2 polypeptides are associated with bipolar disorder (see Example 15).

[0146] In a preferred embodiment, PP2A/Bγ subunits are capable of binding to KCNQ2 polypeptides. Preferably, said PP2A/Bγ subunits are capable of binding to KCNQ2-15b polypeptides. In another preferred embodiment, PP2A/Bγ subunits are capable of binding other subunits of the PP2A phosphatase such as a catalytic or a scaffolding subunit. The capacity of PP2A/Bγ to bind KCNQ2 polypeptides or to bind other subunits of the PP2A phosphatase may be assessed by several assays well known by those of skill in the art including, e.g., the yeast mating test described in example 4 and the solid phase overlay assay described in example 6. Testing whether PP2A/Bγ subunits are capable of binding a polypeptide may be tested by any suitable assay such as, e.g., the yeast mating test described in example 9 and the solid phase overlay assay described in example 6.

[0147] In further preferred embodiments, PP2A/Bγ subunits comprise the novel exon 5bis. The term “exon 5bis” refers to the amino acids at position 25 to 47 of SEQ ID NO: 51, which are encoded by nucleotides 124705 to 124802 of SEQ ID NO: 37. PP2A/Bγ subunits may comprise any combination of exons of the PPP2R2C gene.

[0148] The present invention is also directed to fragments of at least 10, 20, 30, 40, 50, 60, 70, 80, 90, 100, 110, 120, 130, 140, 150, 160, 170, 180, 190, 200, 210, 220, 230, 240, 250, 260, 270, 280, 290, 300, 310, 320, 330, 340, 350, 360, 370, 380, 390, 400, 410, 420, 430, 440, 450, 460, 470, 480, 490, 500, 510, 520, 530, 540, 550, 560, 570, 580, 590, 600 or 610 amino acids of PP2A/Bγ consisting of SEQ ID Nos. 49, 51, 53, 55, 57, 59, 61 or 63.

[0149] Further embodiments are directed to muteins. As used herein the term “muteins” refers to analogs of PP2A/Bγ, in which one or more of the amino acid residues of a natural PP2A/Bγ subunit are replaced by different amino acid residues, or are deleted, or one or more amino acid residues are added to the natural sequence of PP2A/Bγ subunit, without lowering considerably the activity of the resulting products as compared with the wild-type PP2A/Bγ subunit. These muteins are prepared by known synthesis and/or by site-directed mutagenesis techniques, or any other known technique suitable therefore.

[0150] Muteins of PP2A/Bγ subunits, which can be used in accordance with the present invention, or nucleic acid coding thereof, include a finite set of substantially corresponding sequences as substitution peptides or polynucleotides which can be routinely obtained by one of ordinary skill in the art, without undue experimentation, based on the teachings and guidance presented herein.

[0151] PP2A/Bγ subunits in accordance with the present invention include proteins encoded by a nucleic acid, such as DNA or RNA, which hybridizes to DNA or RNA, which encodes a PP2A/Bγ subunit of SEQ ID NO: 49, 51, 53, 55, 57, 59, 61 or 63, in accordance with the present invention, under moderately or highly stringent conditions. The term “stringent conditions” refers to hybridization and subsequent washing conditions, which those of ordinary skill in the art conventionally refer to as “stringent”. See Ausubel et al., Current Protocols in Molecular Biology, supra, Interscience, N.Y., §§6.3 and 6.4 (1987, 1992), and Sambrook et al. (Sambrook, J. C., Fritsch, E. F., and Maniatis, T. (1989) Molecular Cloning: A Laboratory Manual, Cold Spring Harbor Laboratory Press, Cold Spring Harbor, N.Y.). Without limitation, examples of stringent conditions include washing conditions 12-20° C. below the calculated Tm of the hybrid under study in, e.g., 2×SSC and 0.5% SDS for 5 minutes, 2×SSC and 0.1% SDS for 15 minutes; 0.1×SSC and 0.5% SDS at 37° C. for 30-60 minutes and then, a 0.1×SSC and 0.5% SDS at 68° C. for 30-60 minutes. Those of ordinary skill in this art understand that stringency conditions also depend on the length of the DNA sequences, oligonucleotide probes (such as 10-40 bases) or mixed oligonucleotide probes. If mixed probes are used, it is preferable to use tetramethyl ammonium chloride (TMAC) instead of SSC.

[0152] The polypeptides of the present invention include muteins having an amino acid sequence at least 50% identical, more preferably at least 60% identical, and still more preferably 70%, 80%, 90%, 95%, 96%, 97%, 98% or 99% identical to a PP2A/Bγ subunit of the present invention. By a polypeptide having an amino acid sequence at least, for example, 95% “identical” to a query amino acid sequence of the present invention, it is intended that the amino acid sequence of the subject polypeptide is identical to the query sequence except that the subject polypeptide sequence may include up to five amino acid alterations per each 100 amino acids of the query amino acid sequence. In other words, to obtain a polypeptide having an amino acid sequence at least 95% identical to a query amino acid sequence, up to 5% (5 of 100) of the amino acid residues in the subject sequence may be inserted, deleted, or substituted with another amino acid.

[0153] For sequences where there is not an exact correspondence, a “% identity” may be determined. In general, the two sequences to be compared are aligned to give a maximum correlation between the sequences. This may include inserting “gaps” in either one or both sequences, to enhance the degree of alignment. A % identity may be determined over the whole length of each of the sequences being compared (so-called global alignment), that is particularly suitable for sequences of the same or very similar length, or over shorter, defined lengths (so-called local alignment), that is more suitable for sequences of unequal length. Methods for comparing the identity and homology of two or more sequences are well known in the art. Thus for instance, programs available in the Wisconsin Sequence Analysis Package, version 9.1 (Devereux J et al., 1984), for example the programs BESTFIT and GAP, may be used to determine the % identity between two polynucleotides and the % identity and the % homology between two polypeptide sequences. BESTFIT uses the “local homology” algorithm of Smith and Waterman (1981) and finds the best single region of similarity between two sequences. Other programs for determining identity and/or similarity between sequences are also known in the art, for instance the BLAST family of programs (Altschul S F et al, 1990, Altschul S F et al, 1997, accessible through the home page of the NCBI at world wide web site ncbi.nlm.nih.gov) and FASTA (Pearson W R, 1990; Pearson 1988).

[0154] Preferred changes for muteins in accordance with the present invention are what are known as “conservative” substitutions. Conservative amino acid substitutions of PP2A/Bγ subunits may include synonymous amino acids within a group which have sufficiently similar physicochemical properties that substitution between members of the group will preserve the biological function of the molecule (Grantham, 1974). It is clear that insertions and deletions of amino acids may also be made in the above-defined sequences without altering their function, particularly if the insertions or deletions only involve a few amino acids, e.g. under thirty, and preferably under ten, and do not remove or displace amino acids which are critical to a functional conformation, e.g. cysteine residues. Proteins and muteins produced by such deletions and/or insertions come within the purview of the present invention.

[0155] Preferably, the synonymous amino acid groups are those defined in Table I. More preferably, the synonymous amino acid groups are those defined in Table II; and most preferably the synonymous amino acid groups are those defined in Table III. TABLE I Preferred Groups of Synonymous Amino Acids Amino Acid Synonymous Group Ser Ser, Thr, Gly, Asn Arg Arg, Gln, Lys, Glu, His Leu Ile, Phe, Tyr, Met, Val, Leu Pro Gly, Ala, Thr, Pro Thr Pro, Ser, Ala, Gly, His, Gln, Thr Ala Gly, Thr, Pro, Ala Val Met, Tyr, Phe, Ile, Leu, Val Gly Ala, Thr, Pro, Ser, Gly Ile Met, Tyr, Phe, Val, Leu, Ile Phe Trp, Met, Tyr, Ile, Val, Leu, Phe Tyr Trp, Met, Phe, Ile, Val, Leu, Tyr Cys Ser, Thr, Cys His Glu, Lys, Gln, Thr, Arg, His Gln Glu, Lys, Asn, His, Thr, Arg, Gln Asn Gln, Asp, Ser, Asn Lys Glu, Gln, His, Arg, Lys Asp Glu, Asn, Asp Glu Asp, Lys, Asn, Gln, His, Arg, Glu Met Phe, Ile, Val, Leu, Met Trp Trp

[0156] TABLE II More Preferred Groups of Synonymous Amino Acids Amino Acid Synonymous Group Ser Ser Arg His, Lys, Arg Leu Leu, Ile, Phe, Met Pro Ala, Pro Thr Thr Ala Pro, Ala Val Val, Met, Ile Gly Gly Ile Ile, Met, Phe, Val, Leu Phe Met, Tyr, Ile, Leu, Phe Tyr Phe, Tyr Cys Cys, Ser His His, Gln, Arg Gln Glu, Gln, His Asn Asp, Asn Lys Lys, Arg Asp Asp, Asn Glu Glu, Gln Met Met, Phe, Ile, Val, Leu Trp Trp

[0157] TABLE III Most Preferred Groups of Synonymous Amino Acids Amino Acid Synonymous Group Ser Ser Arg Arg Leu Leu, Ile, Met Pro Pro Thr Thr Ala Ala Val Val Gly Gly Ile Ile, Met, Leu Phe Phe Tyr Tyr Cys Cys, Ser His His Gln Gln Asn Asn Lys Lys Asp Asp Glu Glu Met Met, Ile, Leu Trp Met

[0158] Examples of production of amino acid substitutions in proteins which can be used for obtaining muteins of PP2A/Bγ subunits, polypeptides for use in the present invention include any known method steps, such as presented in U.S. Pat. Nos. 4,959,314, 4,588,585 and 4,737,462, to Mark et al; 5,116,943 to Koths et al., 4,965,195 to Namen et al; 4,879,111 to Chong et al; and 5,017,691 to Lee et al; and lysine substituted proteins presented in U.S. Pat. No. 4,904,584 (Shaw et al).

[0159] Preferably, the muteins of the present invention exhibit substantially the same biological activity as the PP2A/Bγ subunit to which it corresponds.

[0160] In some embodiments, PP2A/Bγ subunits and muteins or fragments thereof have biological activity or binding activity as defined above. In other embodiments, PP2A/Bγ subunits and muteins or fragments thereof do not have activity as defined above. Other uses of the polypeptides of the present invention include, inter alia, as epitope tags, in epitope mapping, and as molecular weight markers on SDS-PAGE gels or on molecular sieve gel filtration columns using methods known to those of skill in the art. Such polypeptides can be used to raise polyclonal and monoclonal antibodies, which are useful in assays for detecting PP2A/Bγ expression, or for purifying PP2A/Bγ subunits. As a matter of example, a further specific use for PP2A/Bγ subunits is the use of such subunits the yeast two-hybrid system to capture PP2A/Bγ subunits binding proteins, which are candidate modulators according to the present invention, as further detailed below.

[0161] 3. PP2A/Bγ Polynucleotides of the Present Invention

[0162] The present invention is further directed to PP2A/Bγ polynucleotides encoding any of the PP2A/Bγ subunits described above, and to sequences complementary thereto.

[0163] In a preferred embodiment, said polynucleotide is selected from the group consisting of:

[0164] a) a polynucleotide comprising SEQ ID NO: 48;

[0165] b) a polynucleotide comprising SEQ ID NO: 50;

[0166] c) a polynucleotide comprising SEQ ID NO: 52;

[0167] d) a polynucleotide comprising SEQ ID NO: 54;

[0168] e) a polynucleotide comprising SEQ ID NO: 56;

[0169] f) a polynucleotide comprising SEQ ID NO: 58;

[0170] g) a polynucleotide comprising SEQ ID NO: 60;

[0171] h) a polynucleotide comprising SEQ ID NO: 62;

[0172] i) a polynucleotide complementary to any of the polynucleotides of (a) to (h); and

[0173] j) a polynucleotide hybridizing to any of the polynucleotides of (a) to (h) under moderately stringent conditions or under highly stringent conditions.

[0174] The invention encompasses a purified, isolated and/or recombinant nucleic acid comprising a nucleotide sequence selected from the group consisting of polynucleotides encoding a PP2A/Bγ subunit, including splice variants as well as allelic variants, and fragments of a sequence of SEQ ID Nos. 48, 50, 52, 54, 56, 58, 60 or 62.

[0175] Preferred PP2A/Bγ polynucleotides of the invention include isolated and/or recombinant polynucleotides comprising a contiguous span of at least 8, 12, 15, 18, 20, 25, 30, 35, 40, 45, 50, 60, 70, 80, 90, 100, 200, 300, 400, 500, 600, 700, 800, 900, 1000, 1100, 1200, 1300, 1400, 1500, 1600, 1700 or 1800 nucleotides of SEQ ID Nos. 48, 50, 52, 54, 56, 58, 60 or 62, or sequences complementery thereto.

[0176] In a further preferred embodiment, the purified PP2A/Bγ polynucleotide has at least 70, 80, 85, 90, 95, 96, 97, 98 or 99% nucleotide identity with a polynucleotide selected from the group consisting of 48, 50, 52, 54, 56, 58, 60 and 62, sequences complementery thereto and fragments thereof.

[0177] Most preferred PP2A/Bγ polynucleotides of the invention include polynucleotides encoding PP2A/Bγ subunit of SEQ ID NO: 49, 51, 53, 55, 57, 59, 61 or 63.

[0178] In some embodiments, said PP2A/Bγ polynucleotide comprises or consists of the coding sequence (CDS) encoding a PP2A/Bγ subunit. In other embodiments, said PP2A/Bγ polynucleotide comprises or consists of the messenger RNA (mRNA) encoding a PP2A/Bγ subunit. In further embodiments, said PP2A/Bγ polynucleotide comprises or consists of the complementary DNA (cDNA) encoding a PP2A/Bγ sununit.

[0179] The present invention also encompasses fragments of PP2A/Bγ polynucleotides for use as primers and probes. Such primers are useful in order to detect the presence of at least a copy of a PP2A/Bγ polynucleotide, complement, or variant thereof in a test sample. The probes of the present invention are useful for a number of purposes. They can notably be used in Southern hybridization to genomic DNA. The probes can also be used to detect PCR amplification products. They may also be used to detect mismatches in the PP2A/Bγ mRNAs using other techniques. They may further be used for in situ hybridization.

[0180] Preferred probes are those which specifically detect one PP2A/Bγ subunit according to the present invention. For example, such a probe may specifically detect PP2A/Bγ subunits comprising exon 5bis. Alternatively, such a probe may specifically detect PP2A/Bγ subunits lacking exons. For example, a probe that specifically detects PP2A/Bγ subunits lacking exons 2 to 5 can easily be generated by constructing a probe comprising a polynucleotide fragment comprising the end of exon 1 and the beginning of exon 6.

[0181] Any of the polynucleotides, primers and probes of the present invention can be conveniently immobilized on a solid substrate, such as, e.g., a microarray. A substrate comprising a plurality of oligonucleotide primers or probes of the invention may be used either for detecting or amplifying targeted sequences in the PPP2R2C gene, may be used for detecting mutations in the coding or in the non-coding sequences of the PP2A/Bγ mRNAs, and may also be used to determine expression of PP2A/Bγ mRNAs in different contexts such as in different tissues, at different stages of a process (embryo development, disease treatment), and in patients versus healthy individuals.

[0182] Methods of cloning or constructing PP2A/Bγ polynucleotides are well known by those of skill in the art. For example, the methods described in the examples may be used to clone or construct the PP2A/Bγ polynucleotides of the present invention.

[0183] 4. Vectors, Host Cells and Host Organisms of the Present Invention

[0184] The present invention also relates to vectors comprising the PP2A/Bγ polynucleotides of the present invention. More particularly, the present invention relates to expression vectors which comprise a PP2A/Bγ polynucleotide.

[0185] Preferably, the expression vector comprises a polynucleotide encoding a polypeptide selected from the group consisting of:

[0186] a) a polypeptide comprising SEQ ID NO: 49;

[0187] b) a polypeptide comprising SEQ ID NO: 51;

[0188] c) a polypeptide comprising SEQ ID NO: 53;

[0189] d) a polypeptide comprising SEQ ID NO: 55;

[0190] e) a polypeptide comprising SEQ ID NO: 57;

[0191] f) a polypeptide comprising SEQ ID NO: 61;

[0192] g) a polypeptide comprising SEQ ID NO: 63;

[0193] h) a polypeptide comprising amino acids 25 to 47 of SEQ ID NO: 51;

[0194] i) a mutein of any of (a) to (h), wherein the amino acid sequence has at least 50% or 60% or 70% or 80% or 90% or 95% or 99% identity to at least one of the sequences in (a) to (h);

[0195] j) a mutein of any of (a) to (h) which is encoded by a DNA sequence which hybridizes to the complement of the DNA sequence encoding any of (a) to (h) under moderately stringent conditions or under highly stringent conditions; and

[0196] k) a mutein of any of (a) to (h) wherein any changes in the amino acid sequence are conservative amino acid substitutions to the amino acid sequences in (a) to (h).

[0197] Most preferably, the expression vector comprises a polynucleotide selected from the group consisting of:

[0198] a) a polynucleotide comprising SEQ ID NO: 48;

[0199] b) a polynucleotide comprising SEQ ID NO: 50;

[0200] c) a polynucleotide comprising SEQ ID NO: 52;

[0201] d) a polynucleotide comprising SEQ ID NO: 54;

[0202] e) a polynucleotide comprising SEQ ID NO: 56;

[0203] f) a polynucleotide comprising SEQ ID NO: 58;

[0204] g) a polynucleotide comprising SEQ ID NO: 60;

[0205] h) a polynucleotide comprising SEQ ID NO: 62; and

[0206] i) a polynucleotide complementary to the polynucleotides of (a) to (h).

[0207] The term “vector” is used herein to designate either a circular or a linear DNA or RNA compound, which is either double-stranded or single-stranded, and which comprise at least one polynucleotide of the present invention to be transferred in a cell host or in a unicellular or multicellular host organism. An “expression vector” comprises appropriate signals in the vectors, said signals including various regulatory elements, such as enhancers/promoters from both viral and mammalian sources that drive expression of the inserted polynucleotide in host cells. Selectable markers for establishing permanent, stable cell clones expressing the products such as, e.g., a dominant drug selection, are generally included in the expression vectors of the invention, as they are elements that link expression of the drug selection markers to expression of the polypeptide.

[0208] Additionally, the expression vector may be a fusion vector driving the expression of a fusion polypeptide between a PP2A/Bγ subunit and a heterologous polypeptide. For example, the heterologous polypeptide may be a selectable marker such as, e.g, a luminescent protein, or a polypeptide allowing the purification of the fusion polypeptide.

[0209] The polynucleotides of the present invention may be used to, e.g., express the encoded polypeptide in a host cell for producing the encoded polypeptide. The polynucleotides of the present invention may further be used to express the encoded polypeptide in a host cell for screening assays. Screenings assays are of particular interest for identifying modulators and/or binding partners of PP2A/Bγ subunits as further detailed below. The polynucleotides of the present invention may also be used to express the encoded polypeptide in a host organism for producing a beneficial effect. In such procedures, the encoded protein may be transiently expressed in the host organism or stably expressed in the host organism. The encoded polypeptide may have any of the properties described herein. The encoded polypeptide may be a protein which the host organism lacks or, alternatively, the encoded protein may augment the existing levels of the protein in the host organism.

[0210] In one embodiment, the expression vector is a gene therapy vector. Viral vector systems that have application in gene therapy have been derived from, e.g., herpes virus, vaccinia virus, and several RNA viruses. In particular, herpes virus vectors may provide a unique strategy for persistence of inserted gene expression in cells of the central nervous system and ocular tissue.

[0211] Another object of the invention comprises a host cell that has been transformed, transfected or transduced with a polynucleotide encoding a PP2A/Bγ subunit. Also included are host cells that are transformed, transfected or transduced with a recombinant vector such as one of those described above. The cell hosts of the present invention can comprise any of the polynucleotides of the present invention.

[0212] Any host cell known by one of skill in the art may be used. Preferred host cells used as recipients for the polynucleotides and expression vectors of the invention include:

[0213] a) Prokaryotic host cells: Escherichia coli strains (I.E.DH5-α strain), Bacillus subtilis, Salmonella typhimurium, and strains from species like Pseudomonas, Streptomyces and Staphylococcus.

[0214] b) Eukaryotic host cells: CHO (ATCC No. CCL-61), HeLa cells (ATCC No. CCL2; No. CCL2.1; No. CCL2.2), Cv 1 cells (ATCC No. CCL70), COS cells (ATCC No. CRL1650; No. CRL1651), Sf-9 cells (ATCC No. CRL1711), C127 cells (ATCC No. CRL-1804), 3T3 (ATCC No. CRL-6361), human kidney 293. (ATCC No. 45504; No. CRL-1573), HEK293-H cells (Invitrogen), BHK (ECACC No. 84100501; No. 84111301), Saccharomyces cerevisiae strains such as AH109 and Y184, and Aspergillus niger strains.

[0215] Another object of the invention comprises methods of making the above vectors and host cells by recombinant techniques. Any well-known technique for constructing an expression vector and for delivering it to a cell may be used for construction and delivering the vectors of the present invention. Such techniques include but are not limited to the techniques detailed in the examples.

[0216] Another object of the present invention is a transgenic animal which includes within a plurality of its cells a cloned recombinant PP2A/Bγ polynucleotide. The terms “transgenic animals” or “host animals” are used herein to designate animals that have their genome genetically and artificially manipulated so as to include one of the nucleic acids according to the invention. The cells affected may be somatic, germ cells, or both. Preferred animals are non-human mammals and include those belonging to a genus selected from Mus (e.g. mice), Rattus (e.g. rats) and Oryctogalus (e.g. rabbits) which have their genome artificially and genetically altered by the insertion of a nucleic acid according to the invention. In one embodiment, the invention encompasses non-human host mammals and animals comprising a recombinant vector of the invention or a PP2A/Bγ polynucleotide disrupted by homologous recombination with a knock out vector.

[0217] In a preferred embodiment, these transgenic animals may be good experimental models in order to study diverse pathologies related to PP2A/Bγ function. In particular, a transgenic animal wherein (i) an antisense mRNA binding to naturally occurring PP2A/Bγ mRNAs is transcribed; or (ii) an mRNA expressing a PP2A/Bγ subunit; may be a good animal model for bipolar disorders and/or other mood-disorders.

[0218] 5. Methods of Making the Polypeptides of the Present Invention

[0219] The present invention also relates to methods of making a PP2A/Bγ subunit.

[0220] Preferably, said PP2A/Bγ subunit is a polypeptide selected from the group consiting of

[0221] a) a polypeptide comprising SEQ ID NO: 49;

[0222] b) a polypeptide comprising SEQ ID NO: 51;

[0223] c) a polypeptide comprising SEQ ID NO: 53;

[0224] d) a polypeptide comprising SEQ ID NO: 55;

[0225] e) a polypeptide comprising SEQ ID NO: 57;

[0226] f) a polypeptide comprising SEQ ID NO: 61;

[0227] g) a polypeptide comprising SEQ ID NO: 63;

[0228] h) a polypeptide comprising amino acids 25 to 47 of SEQ ID NO: 51;

[0229] i) a mutein of any of (a) to (h), wherein the amino acid sequence has at least 50% or 60% or 70% or 80% or 90% or 95% or 99% identity to at least one of the sequences in (a) to (h);

[0230] j) a mutein of any of (a) to (h) which is encoded by a DNA sequence which hybridizes to the complement of the DNA sequence encoding any of (a) to (h) under moderately stringent conditions or under highly stringent conditions; and

[0231] k) a mutein of any of (a) to (h) wherein any changes in the amino acid sequence are conservative amino acid substitutions to the amino acid sequences in (a) to (h).

[0232] In one embodiment, the PP2A/Bγ subunits of the present invention are isolated from natural sources, including tissues and cells, whether directly isolated or cultured cells, of humans or non-human animals. Methods for extracting and purifying natural proteins are known in the art, and include the use of detergents or chaotropic agents to disrupt particles followed by, e.g., differential extraction and separation of the polypeptides by ion exchange chromatography, affinity chromatography, sedimentation according to density, and gel electrophoresis. The method described in Example 4 may for example be used. Polypeptides of the invention also can be purified from natural sources using, e.g., antibodies directed against the polypeptides of the invention such as those described herein, in methods which are well known in the art of protein purification.

[0233] In a preferred embodiment, the PP2A/Bγ subunits of the invention are recombinantly produced using routine expression methods known in the art. The polynucleotide encoding the desired polypeptide is operably linked to a promoter into an expression vector suitable for any convenient host. Both eukaryotic and prokaryotic host systems may be used in forming recombinant polypeptides. The polypeptide is then isolated from lysed cells or, if a soluble form is produced, from the culture medium and purified to the extent needed for its intended use.

[0234] Consequently, a further embodiment of the present invention is a method of making a polypeptide of the present invention, said method comprising the steps of:

[0235] a) obtaining a polynucleotide encoding a PP2A/Bγ subunit;

[0236] inserting said polynucleotide in an expression vector such that the polynucleotide is operably linked to a promoter; and

[0237] introducing said expression vector into a host cell whereby said host cell produces said polypeptide.

[0238] In a preferred embodiment, the method further comprises the step of isolating the polypeptide. The skilled person will appreciate that any step of this method may be carried out separately. The product of each step may be transferred to another step in order to carry out the subsequent step.

[0239] In further embodiments, said polynucleotide consists of a coding sequence (CDS). In another aspect of this embodiment, said polynucleotide is a polynucleotide consisting of SEQ ID NO: 49, 51, 53, 55, 57, 59, 61 or 63, or a fragment thereof.

[0240] A further aspect of the invention relates to a method of making a polypeptide, said method comprising the steps of culturing a host cell comprising an expression vector comprising a PP21A/Bγ polynucleotide under conditions suitable for the production of a PP21A/Bγ subunit within said host cell. In a preferred embodiment, the method further comprises the step of purifying said polypeptide from the culture.

[0241] In another embodiment, it is often advantageous to add to the recombinant polynucleotide encoding a PP21A/Bγ subunit additional nucleotide sequence which codes for secretory or leader sequences, pro-sequences, sequences which aid in purification, such as multiple histidine residues or GST tags, or an additional sequence for stability during recombinant production. Soluble portions of the PP21A/Bγ subunit polypeptide may be, e.g., linked to an Ig-Fc part in order to generate stable soluble variants.

[0242] A polypeptide of this invention can be recovered and purified from recombinant cell cultures by well-known methods including but not limited to differential extraction, ammonium sulfate or ethanol precipitation, acid extraction, anion or cation exchange chromatography, high performance liquid chromatography, phosphocellulose chromatography, hydrophobic interaction chromatography, affinity chromatography, hydroxylapatite chromatography, immunochromatography and lectin chromatography.

[0243] The expressed PP21A/Bγ subunit may be purified using any standard immunochromatography techniques. In such procedures, a solution containing the polypeptide of interest, such as the culture medium or a cell extract, is applied to a column having antibodies against the polypeptide attached to the chromatography matrix. The recombinant protein is allowed to bind the immunochromatography column. Thereafter, the column is washed to remove non-specifically bound proteins. The specifically bound secreted protein is then released from the column and recovered using standard techniques.

[0244] 6. Antibodies of the Present Invention

[0245] The present invention further relates to antibodies that specifically bind the PP21A/Bγ subunits of the present invention. More specifically, said antibodies bind to epitopes of the PP21A/Bγ subunits of the present invention. Preferably, said antibodies specifically bind PP2A/Bγ subunit selected from the group consisting of:

[0246] a) a polypeptide comprising SEQ ID NO: 49;

[0247] b) a polypeptide comprising SEQ ID NO: 51;

[0248] c) a polypeptide comprising SEQ ID NO: 53;

[0249] d) a polypeptide comprising SEQ ID NO: 55;

[0250] e) a polypeptide comprising SEQ ID NO: 57;

[0251] f) a polypeptide comprising SEQ ID NO: 61;

[0252] g) a polypeptide comprising SEQ ID NO: 63;

[0253] h) a polypeptide comprising amino acids 25 to 47 of SEQ ID NO: 51;

[0254] i) a mutein of any of (a) to (h), wherein the amino acid sequence has at least 50% or 60% or 70% or 80% or 90% or 95% or 99% identity to at least one of the sequences in (a) to (h);

[0255] j) a mutein of any of (a) to (h) which is encoded by a DNA sequence which hybridizes to the complement of the DNA sequence encoding any of (a) to (h) under moderately stringent conditions or under highly stringent conditions; and

[0256] k) a mutein of any of (a) to (h) wherein any changes in the amino acid sequence are conservative amino acid substitutions to the amino acid sequences in (a) to (h).

[0257] The antibodies of the present invention include IgG (including IgG1, IgG2, IgG3, and IgG4), IgA (including IgA1 and IgA2), IgD, IgE, or IgM, and IgY. The term “antibody” (Ab) refers to a polypeptide or group of polypeptides which are comprised of at least one binding domain, where a binding domain is formed from the folding of variable domains of an antibody compound to form three-dimensional binding spaces with an internal surface shape and charge distribution complementary to the features of an antigenic determinant of an antigen, which allows an immunological reaction with the antigen. As used herein, the term “antibody” is meant to include whole antibodies, including single-chain whole antibodies, and antigen binding fragments thereof. In a preferred embodiment the antibodies are human antigen binding antibody fragments of the present invention include, but are not limited to, Fab, Fab′ F(ab)2 and F(ab′)2, Fd, single-chain Fvs (scFv), single-chain antibodies, disulfide-linked Fvs (sdFv) and fragments comprising either a V_(L) or V_(H) domain. The antibodies may be from any animal origin including birds and mammals. Preferably, the antibodies are from human, mouse, rabbit, goat, guinea pig, camel, horse or chicken. The present invention further includes chimeric, humanized, and human monoclonal and polyclonal antibodies, which specifically bind the PP2A/Bγ subunits of the present invention.

[0258] A preferred embodiment of the invention is a method of specifically binding an antibody of the present invention to a PP2A/Bγ subunit. This method comprises the step of contacting the antibody of the present invention with a PP2A/Bγ subunit polypeptide under conditions in which said antibody can specifically bind to said polypeptide. Such conditions are well known to those skilled in the art. This method may be used to, e.g., detect, purify, or activate or inhibit the activity of PP2A/Bγ subunits.

[0259] The invention further relates to antibodies that act as modulators of the polypeptides of the present invention. Preferred antibodies are modulators that enhance the binding activity or the biological activity of the PP2A/Bγ subunit to which they bind. These antibodies may act as modulators for either all or less than all of the biological properties of the PP2A/Bγ subunit.

[0260] 7. Uses of PP2A/Bγ and PP2A Phosphatases Comprising a PP2A/Bγ Subunit.

[0261] The present invention is directed to uses of the PP2A/Bγ subunit and of PP2A phosphatases comprising a PP2A/Bγ subunit for treating or diagnosing mental disorders.

[0262] A first aspect of the present invention is directed to the use of a PP2A/Bγ subunit as a target for screening candidate modulators.

[0263] In one embodiment, said PP2A/Bγ subunit is a polypeptide comprising SEQ ID NO: 38. Preferably, said polypeptide is a wild-type PP2A/Bγ subunit consisting of SEQ ID NO: 38.

[0264] In another embodiment, said PP2A/Bγ subunit is selected from the group consisting of:

[0265] a) a polypeptide comprising SEQ ID NO: 49;

[0266] b) a polypeptide comprising SEQ ID NO: 51;

[0267] c) a polypeptide comprising SEQ ID NO: 53;

[0268] d) a polypeptide comprising SEQ ID NO: 55;

[0269] e) a polypeptide comprising SEQ ID NO: 57;

[0270] f) a polypeptide comprising SEQ ID NO: 61;

[0271] g) a polypeptide comprising SEQ ID NO: 63;

[0272] h) a polypeptide comprising amino acids 25 to 47 of SEQ ID NO: 51;

[0273] i) a mutein of any of (a) to (h), wherein the amino acid sequence has at least 50% or 60% or 70% or 80% or 90% or 95% or 99% identity to at least one of the sequences in (a) to (h);

[0274] j) a mutein of any of (a) to (h) which is encoded by a DNA sequence which hybridizes to the complement of the DNA sequence encoding any of (a) to (h) under moderately stringent conditions or under highly stringent conditions; and

[0275] k) a mutein of any of (a) to (h) wherein any changes in the amino acid sequence are conservative amino acid substitutions to the amino acid sequences in (a) to (h).

[0276] As used herein, a “PP2A/Bγ modulator” refers to a compound that increases or decreases the activity of a PP2A/Bγ polypeptide and/or to a compound that increases or decreases the transcription level of the PP2A/Bγ mRNA encoding said polypeptide. The term “modulator” encompasses both agonists and antagonists.

[0277] In one embodiment of the present invention, the PP2A/Bγ modulator is a PP2A/Bγ antagonist. As used herein, a “PP2A/Bγ antagonist” refers to a compound that decreases the activity of a PP2A/Bγ polypeptide and/or to a compound that decreases the expression level of the PP2A/Bγ mRNA encoding said polypeptide. The terms “antagonist” and “inhibitor” are considered to be synonymous and can be used interchangeably throughout the disclosure.

[0278] In one embodiment of the present invention, the PP2A/Bγ modulator is a PP2A/Bγ agonist. As used herein, a “PP2A/Bγ agonist” refers to a compound that increases the activity of a PP2A/Bγ polypeptide and/or to a compound that increases the expression level of the PP2A/Bγ mRNA encoding said polypeptide. The terms “agonist” and “activator” are considered to be synonymous and can be used interchangeably throughout the disclosure.

[0279] Methods that can be used for testing modulators for their ability to increase or decrease the activity of a PP2A/Bγ polypeptide or to increase or decrease the expression of a PP2A/Bγ mRNA are well known in the art and further detailed below.

[0280] As shown in examples 4 and 6, a PP2A/Bγ subunit is capable of binding to KCNQ2 polypeptides in vitro. As used herein, the term “KCNQ2 polypeptide” refers to any polypeptide encoded by the KCNQ2 gene. Thus the term “KCNQ2 polypeptide” encompasses all alternative splice variants encoded by the KCNQ2 gene, such as, e.g., a polypeptide of SEQ ID NO: 2, a polypeptide of SEQ ID NO: 4, a polypeptide of SEQ ID NO: 6, a polypeptide of SEQ ID NO: 7 and other previously described isoforms (see, e.g., SwissProt Accession No. 043526). Polypeptides comprising exon 15b as depicted in Example 2, such as polypeptides of SEQ ID Nos. 2, 4 and 6, are further defined as “KCNQ2-15b polypeptides”.

[0281] The term “PP2A/Bγ activity” as used herein may refer to the capacity of PP2A/Bγ to bind to KCNQ2 polypeptides. Preferably, PP2A/Bγ refers to the capacity of PP2A/Bγ to bind KCNQ2-15b polypeptides. Alternatively, the term “PP2A/Bγ activity” may refer to the capacity of PP2A/Bγ to bind to other subunits of the PP2A phosphatase such as a catalytic or a scaffolding subunit. The capacity of PP2A/Bγ to bind KCNQ2 polypeptides or to bind other subunits of the PP2A phosphatase may be assessed by several assays well known by those of skill in the art including, e.g., the yeast mating test described in example 4 and the solid phase overlay assay described in example 6.

[0282] A second aspect of the present invention is directed to the use of a PP2A phosphatase comprising a PP2A/Bγ subunit as a target for screening candidate modulators. As used herein, the term “modulator of a PP2A phosphatase comprising a PP2A/Bγ subunit” refers to a to a compound that increases or decreases any of the activities of a PP2A phosphatase comprising a PP2A/Bγ subunit. In one embodiment, the modulator is an agonist, i.e., a compound that increases the activity of a PP2A phosphatase comprising a PP2A/Bγ subunit. In one embodiment, the modulator is an antagonist, i.e., a compound that decreases the activity of a PP2A phosphatase comprising a PP2A/Bγ subunit. A PP2A/Bγ modulator is believed to modulate the activity of a PP2A phosphatase comprising a PP2A/Bγ subunit. Accordingly, as used herein, the term “modulator of a PP2A phosphatase comprising a PP2A/Bγ subunit” encompasses the term “PP2A/Bγ modulator”.

[0283] The term “activity of a PP2A phosphatase comprising a PP2A/Bγ subunit” as used herein refers to the enzymatic activity of such a PP2A isoform. The activity of PP2A refers both to the serine/threonine protein phosphatase activity and to the phosphotyrosine phosphatase activity. The activity of a PP2A phosphatase comprising a PP2A/Bγ subunit may be assessed by several assays well known by those of skill in the art including, e.g., the dephosphorylation assay described in Example 7.

[0284] In all aspects and embodiments of the present invention, the modulator preferably specifically modulates a PP2A phosphatase comprising the PP2A/Bγ subunit. In other words, the modulator (i) increases or decreases the activity of a PP2A phosphatase comprising a PP2A/Bγ subunit; and (ii) has no or significantly less effect on the activity of a PP2A phosphatase that does not comprise said PP2A/Bγ subunit.

[0285] The assays for measuring the activity of PP2A/Bγ or of a PP2A phosphatase comprising a PP2A/Bγ subunit when screening for a modulator may be performed either in vitro or in vivo, as further detailed below.

[0286] Candidate compounds according to the present invention include naturally occurring and synthetic compounds. Such compounds include, e.g., natural ligands, small molecules, antisense mRNAs, antibodies, aptamers and short interfering RNAs. As used herein, the term “natural liqand” refers to any signaling molecule that binds to a phosphatase comprising PP2A/Bγ in vivo and includes molecules such as, e.g., lipids, nucleotides, polynucleotides, amino acids, peptides, polypeptides, proteins, carbohydrates and inorganic molecules. As used herein, the term “small molecule” refers to an organic compound. As used herein, the term “antibody” refers to a protein produced by cells of the immune system or to a fragment thereof that binds to an antigen. As used herein, the term “antisense mRNA” refers an RNA molecule complementary to the strand normally processed into mRNA and translated, or complementary to a region thereof. As used herein, the term “aptamer” refers to an artificial nucleic acid ligand (see, e.g., Ellington and Szostak (1990) Nature 346:818-822). As used herein, the term “short interfering RNA” refers to a double-stranded RNA inducing sequence-specific posttranscriptional gene silencing (see, e.g., Elbashir et al. (2001) Genes Dev. 15:188-200).

[0287] Such candidate compounds can be obtained using any of the numerous approaches in combinatorial library methods known in the art, including, e.g., biological libraries, spatially addressable parallel solid phase or solution phase libraries, and synthetic library methods using affinity chromatography selection. The biological library approach is generally used with peptide libraries, while the other four approaches are applicable to peptide, non-peptide oligomers, or small molecule libraries of compounds.

[0288] One example of a method that may be used for screening candidate compounds for a modulator is a method comprising the steps of:

[0289] a) contacting PP2A/Bγ or a PP2A phosphatase comprising a PP2A/Bγ subunit with the candidate compound; and

[0290] b) testing the activity of PP2A/Bγ or of the PP2A phosphatase comprising a PP2A/Bγ subunit in the presence of said candidate compound,

[0291] wherein a difference in the activity of PP2A/Bγ or of the PP2A phosphatase comprising a PP2A/Bγ subunit in the presence of said compound in comparison to the activity in the absence of said compound indicates that the compound is a modulator of PP2A/Bγ or of the PP2A phosphatase comprising a PP2A/Bγ subunit.

[0292] Alternatively, the assay may be a cell-based assay comprising the steps of:

[0293] a) contacting a cell expressing PP2A/Bγ or a PP2A phosphatase comprising a PP2A/Bγ subunit with the candidate compound; and

[0294] b) testing the activity of PP2A/Bγ or of the PP2A phosphatase comprising a PP2A/Bγ subunit polypeptide in the presence of said candidate compound,

[0295] wherein a difference in the activity of PP2A/Bγ or of the PP2A phosphatase comprising a PP2A/Bγ subunit in the presence of said compound in comparison to the activity in the absence of said compound indicates that the compound is a modulator of said KCNQ2 polypeptide.

[0296] The modulator may modulate any activity of said PP2A/Bγ or of said PP2A phosphatase comprising a PP2A/Bγ subunit. The modulator may for example modulate PP2A/Bγ mRNA expression within a cell, or modulate the binding of PP2A/Bγ to KCNQ2 polypeptides or to other subunits of PP2A. Further activities that may be measured include the serine/threonine protein phosphatase activity and the phosphotyrosine phosphatase activity of a PP2A phosphatase comprising a PP2A/Bγ subunit.

[0297] In a preferred embodiment, the activity of a PP2A phosphatase comprising a PP2A/Bγ subunit is assessed by measuring its serine/threonine protein phosphatase activity. This activity may be measured as described in Example 7. Several other methods for measuring the serine/threonine protein phosphatase activity of PP2A are well known in the art. Such methods include, e.g., the phosophatase assays described by Price et al. (Biochemistry. (2000) 39:11312-11318) and by Kamibayashi et al. (J Biol. Chem. (1994) 269:20139-20148). Any known PP2A substrate may be used in such assays. In one embodiment, said substrate is KCNQ2 polypeptides.

[0298] In another preferred embodiment, the activity of a PP2A phosphatase comprising a PP2A/Bγ subunit is assessed by measuring its phosphotyrosine phosphatase activity. This activity may for example be measured as described by Agostinis et al. (Eur J Biochem. (1996) 236:548-557).

[0299] In a further preferred embodiment, the activity of PP2A/Bγ is assessed by measuring the binding of PP2A/Bγ to KCNQ2 polypeptides. The binding of PP2A/Bγ to KCNQ2 polypeptides can for example be measured by the yeast mating test as described in example 3 or by the solid phase overlay assay as described in example 6.

[0300] In a further preferred embodiment, the activity of PP2A/Bγ is assessed by measuring the binding of PP2A/Bγ to other the catalytic subunit of PP2A or to the scaffolding subunit of PP2A. This assay may also be performed using, e.g., the yeast mating test or the solid phase overlay assay described in examples 3 and 6.

[0301] In a further preferred embodiment, the activity of PP2A/Bγ is assessed by measuring the levels of PP2A/Bγ mRNA within a cell. In this embodiment, the activity can for example be measured using Northern blots, RT-PCR, quantitative RT-PCR with primers and probes specific for PP2A/Bγ mRNAs. The term “PP2A/B± mRNA” as used herein encompasses all alternative variants and splice variants translated from the PPP2R2C gene which encodes PP2A/Bγ. The primers and probes may detect one specific PP2A/Bγ splice variant or detect all alternative splice variants translated from PPP2R2C. Alternatively, the expression of the PP2A/Bγ mRNA is measured at the polypeptide level, by using labeled antibodies that specifically bind to PP2A/Bγ in immunoassays such as ELISA assays, RIA assays, Western blots or immunohistochemical assays.

[0302] As shown in Example 15, deregulation of PP2A phosphatases comprising the PP2A/Bγ regulatory subunit contributes to the onset and to the development of bipolar disease. Accordingly, modulators of PP2A/Bγ or of a PP2A phosphatase comprising PP2A/Bγ which may be found, e.g., by any of the above screenings, are candidate drugs for the treatment of a mental disorder.

[0303] As used throughout the disclosures of the present specification, the term “mental disorder” is used as defined in the DSM-IV classification (Diagnosis and Statistical Manual of Mental Disorders, Fourth Edition, American Psychiatric Association, Washington D.C., 1994). In all aspects and embodiments of the present invention, the term “mental disorder” preferably refers to a mental disorder selected from the group consisting of bipolar disorder, schizophrenia and depression. In all aspects and embodiments, the term “mental disorder” most preferably refers to bipolar disorder.

[0304] A further aspect of the present invention is the use of modulator of a PP2A phosphatase comprising a PP2A/Bγ subunit for preparing a medicament for the treatment of a mental disorder. Such a medicament comprises said modulator of a KCNQ2 polypeptide in combination with any physiologically acceptable carrier. Physiologically acceptable carriers can be prepared by any method known by those skilled in the art. Physiologically acceptable carriers include but are not limited to those described in Remington's Pharmaceutical Sciences (Mack Publishing Company, Easton, USA 1985). Pharmaceutical compositions comprising a modulator of a PP2A phosphatase comprising a PP2A/Bγ subunit and a physiologically acceptable carrier can be for, e.g., intravenous, topical, rectal, local, inhalant, subcutaneous, intradermal, intramuscular, oral, intrathecal and intracerebral use. The compositions can be in liquid (e.g., solutions, suspensions), solid (e.g., pills, tablets, suppositories) or semisolid (e.g., creams, gels) form. Dosages to be administered depend on individual needs, on the desired effect and the chosen route of administration.

[0305] If an increase of the activity of a PP2A phosphatase comprising a PP2A/Bγ subunit is sought in a patient, a particularly efficacious medicament is a gene therapy vector comprising a polynucleotide encoding PP2A/Bγ. Upon administration to a patient, such a vector will cause the active agent to be expressed in vivo, preferably specifically in the appropriate cells or tissues. Thus another aspect of the present invention is the use of a gene therapy vector comprising a polynucleotide encoding a PP2A/Bγ subunit for preparing a medicament for the treatment of a mental disorder.

[0306] Expression vectors that may be used for gene therapy are well known in the art, and they comprise further elements serving for expression of the gene of interest. They may comprise regulatory sequence, such as promoter and enhancer sequences, selection marker sequences, origins of multiplication, and the like. Advantageously, the expression of PP2A/Bγ will then be in situ, e.g., restricted to brain or to some regions of brain.

[0307] In a preferred embodiment, the expression vector is a lentiviral derived vector. Lentiviral vectors have been shown to be very efficient in the transfer of genes, in particular within the CNS. Other well established viral vectors, such as adenoviral derived vectors, may also be used according to the invention.

[0308] In a preferred embodiment of the invention, the expression vector may be administered by intramuscular injection.

[0309] The use of a vector for inducing and/or enhancing the endogenous production of PP2A/Bγ in a cell normally silent for expression of PP2A/Bγ, or which expresses amounts of PP2A/Bγ which are not sufficient, are also contemplated according to the invention. The vector may comprise regulatory sequences functional in the cells desired to express PP2A/Bγ. Such regulatory sequences may be promoters or enhancers, for example. The regulatory sequence may then be introduced into the appropriate locus of the genome by homologous recombination, thus PP2A/Bγ linking the regulatory sequence with the gene, the expression of which is required to be induced or enhanced. The technology is usually referred to as “endogenous gene activation” (EGA), and it is described e.g. in WO 91/09955.

[0310] Such medicaments comprising either a modulator of a PP2A phosphatase comprising a PP2A/Bγ subunit or a gene therapy vector comprising a polynucleotide encoding a PP2A/Bγ subunit may be administered in combination with any known drug for the treatment of a mental disorder. The modulator may for example be administered in combination with a mood-stabilizing drug used for treating bipolar disorder such as, e.g., lithium, carbamazepine or divalproex. The modulator may also be administered in combination with an antidepressant such as, e.g., a tricyclic antidepressant, a selective serotonin reuptake inhibitor, a monoamine oxidase inhibitor or a psychostimulant. When treating schizophrenia and other psychotic disorders, the modulator may for example be administered in combination with an antipsychotic drugs such as, e.g., chlorpromazine, clozapine, risperidone or olanzapine.

[0311] Another aspect is the use of a PP2A/Bγ subunit as a target for screening for natural binding partners. Methods for screening for natural binding partners include, e.g., the yeast two-hybrid screening that is described in Example 1. Using a PP2A/Bγ as a target has a utility for the identification of proteins involved in bipolar disorder and for providing new intervention points in the treatment of bipolar disorder and other mental disorders.

[0312] A method of assessing the efficiency of a modulator of a PP2A phosphatase comprising a PP2A/Bγ subunit for the treatment of a mental disorder, said method comprising administering said modulator to an animal model for said mental disorder; wherein a determination that said modulator ameliorates a representative characteristic of said mental disorder in said animal model indicates that said agonist is a drug for the treatment of said mental disorder is also contemplated according to the invention.

[0313] Animal models for mental disorders and assays for determining whether a compound ameliorates a representative characteristic of said mental disorder in said animal model are currently used and described in scientific and patent literature. For example, animal models that may be used in the above method include but are not limited to the conditioned avoidance behaviour model in rats, which is a standard behavioural test predictive of antipsychotic activity, the behavioral activity assessment of mice and rats in the Omnitech Digiscan animal activity monitors, the purpose of which is to evaluate compounds for antipsychotic-like CNS effects and a variety of other behavioral effects generally associated with CNS activity, the blockade of amphetamine-stimulated locomotion in rat, the protocol for the prepulse inhibition of acoustic startle model in rats, the inhibition of apomorphine-induced climbing behaviour and the inhibition of DOI-induced head twitches and scratches. A preferred animal model is the STOP−/− mice with synaptic defects and severe behavioral disorders described by Andrieux et al. (2002, Genes Dev., 16:2350-2364).

[0314] 8. PP2A/Bγ-Related Biallelic Markers

[0315] The present invention is directed to the use of at least one PP2A/Bγ-related biallelic marker for diagnosing whether an individual suffers from or is at risk of suffering from a mental disorder. As used herein, the term “PP2A/Bγ-related biallelic marker” refers to a biallelic marker located in an exon of PPP2R2C, in an intron of PPP2R2C, or in the regulatory regions of PPP2R2C, PPP2R2C being the gene encoding the PP2A/Bγ subunit. PP2A/Bγ-related biallelic markers encompass the biallelic markers shown in table 3A in Example 12.

[0316] In one embodiment, a single biallelic marker is used for diagnosing whether an individual suffers from or is at risk of suffering from a mental disorder by determining the genotype of an individual. In another embodiment, a combination of several biallelic markers may be used for diagnosing whether an individual suffers from or is at risk of suffering from a mental disorder by determining the haplotype of an individual. For example, a two-markers haplotype, a three-markers haplotype or a four-markers haplotype may be determined.

[0317] As used herein, the term “biallelic marker” refers to a polymorphism having two alleles at a fairly high frequency in the population, preferably a single nucleotide polymorphism. Typically the frequency of the less common allele of the biallelic markers of the present invention has been validated to be greater than 1%, preferably the frequency is greater than 10%, more preferably the frequency is at least 20% (i.e. heterozygosity rate of at least 0.32), even more preferably the frequency is at least 30% (i.e. heterozygosity rate of at least 0.42). In the present specification, the term “biallelic marker” is used to refer both to the polymorphism and to the locus carrying the polymorphism.

[0318] As used herein, the term “genotype” refers to the identity of the alleles present in an individual or a sample. The term “genotype” preferably refers to the description of both copies of a single biallelic marker that are present in the genome of an individual. The individual is homozygous if the two alleles of the biallelic marker present in the genome are identical. The individual is heterozygous if the two alleles of the biallelic marker present in the genome are different.

[0319] The term “genotyping” a sample or an individual for a biallelic marker involves determining the specific alleles or the specific nucleotides carried by an individual at a biallelic marker.

[0320] As used herein, the term “haplotype” refers to a set of alleles of closely linked biallelic markers present on one chromosome and which tend to be inherited together.

[0321] Methods for determining the alleles, genotypes or haplotypes carried by an individual are well known by those of skill in the art and further detailed below.

[0322] In all aspect and embodiments, preferred “mental disorders” include bipolar disorder, schizophrenia and depression. Most preferred mental disorder is bipolar disorder.

[0323] In the context of the present invention, the individual is generally understood to be human.

[0324] In the frame of the present invention, four validated PP2A/Bγ-related biallelic markers are provided. These four markers, 99-24169/139, 24-257/320, 99-24175/218 and 24-247/216, are described in table 3A in Example 12. Thus a preferred embodiment is the use of a PP2A/Bγ-related biallelic marker selected from the group consisting of 99-24169/139, 24-257/320, 99-24175/218 and 24-247/216 for diagnosing whether an individual suffers from or is at risk of suffering from a mental disorder. The alternative alleles of these four biallelic markers are indicated in table 3A. Positions of these biallelic markers on PPP2R2C (corresponding to SEQ ID NO: 37) are also indicated in table 3B. Other preferred embodiments are directed to the use of biallelic markers complementary to 99-24169/139, 24-257/320, 99-24175/218 and 24-247/216, i.e., the corresponding alternative alleles that are located on the complementary strand of DNA.

[0325] As shown in table 5A in Example 15, association studies were performed for these four biallelic markers. All these four PP2A/Bγ-related biallelic markers were found to be bipolar disorder-associated markers. A preferred embodiment of the present invention is thus directed to the use of a PP2A/Bγ-related biallelic marker selected from the group consisting of 99-24169/139, 24-257/320, 99-24175/218, 24-247/216 and the complements thereof for diagnosing whether an individual suffers from or is at risk of suffering from a mental disorder.

[0326] The individual may be of any ethnic origin. In one embodiment the individual is an individual of Caucasian origin.

[0327] The risk alleles for biallelic markers 99-24169/139, 24-257/320 and 99-24175/218 are indicated in Example 15. As used herein, “risk allele” means that the probability of having bipolar disorder is higher for an individual carrying the risk allele of a biallelic marker than for an individual carrying the other allele. The risk allele for 99-24169/139, 24-257/320 and 99-24175/218 is “A”. Thus a preferred embodiment of the present invention is the use of any of biallelic markers 99-24169/139, 24-257/320, 99-24175/218 or the complement thereof for diagnosing whether an individual suffers from or is at risk of suffering from a mental disorder, wherein the presence of the allele “A” at any of biallelic markers biallelic markers 99-24169/139, 24-257/320 or 99-24175/218 is indicative of said individual suffering from or being at risk of suffering from said mental disorder.

[0328] The risk genotype for biallelic marker 99-24169/139 is indicated in table 6A in Example 15. As used herein, “risk genotype” means that the probability of having bipolar disorder is higher for an individual carrying the risk genotype than for an individual carrying another genotype. The risk genotype for biallelic marker 99-24169/139 is “AA”. Thus a preferred embodiment of the present invention is the use of biallelic marker 99-24169/139 or the complement thereof for diagnosing whether an individual suffers from or is at risk of suffering from a mental disorder, wherein the presence of a genotype “AA” at biallelic marker 99-24169/139 is indicative of said individual suffering from or being at risk of suffering from said mental disorder.

[0329] A haplotype frequency analysis was carried out for the four PP2A/Bγ-related biallelic markers 99-24169/139, 24-257/320, 99-24175/218 and 24-247/216 (Example 15). More specifically, the risk haplotype for biallelic markers 99-24169/139 and 24-247/216 and for biallelic markers 24-257/320 and 99-24175/218 were determined. As used herein, “risk haplotype” means that the probability of having bipolar disorder is higher for an individual carrying the risk haplotype than for an individual carrying another haplotype. The risk haplotype for biallelic markers 99-24169/139 and 24-247/216 is “AG”. Thus a preferred embodiment of the present invention is the use of biallelic markers 99-24169/139 and 24-247/216 or the complement thereof for diagnosing whether an individual suffers from or is at risk of suffering from a mental disorder, wherein the presence a haplotype “AG” at biallelic markers 99-24169/139 and 24-247/216 is indicative of said individual suffering from or being at risk of suffering from said mental disorder. The risk haplotype for biallelic markers 24-257/320 and 99-24175/218 is “AA”. Thus another preferred embodiment of the present invention is the use of biallelic markers 24-257/320 and 99-24175/218 or the complement thereof for diagnosing whether an individual suffers from or is at risk of suffering from a mental disorder, wherein presence of a haplotype “AA” at biallelic markers 24-257/320 and 99-24175/218 is indicative of said individual suffering from or being at risk of suffering from said mental disorder.

[0330] In all aspects and embodiments of the present invention, the term “PP2A/Bγ-related biallelic markers” encompasses biallelic markers 99-24169/139, 24-257/320, 99-24175/218, 24-247/216 and the complements thereof. Preferred PP2A/Bγ-related biallelic markers are 99-24169/139, 24-257/320, 99-24175/218 and the complements thereof are. Biallelic marker 99-24169/139 and the complement thereof are most preferred PP2A/Bγ-related biallelic markers.

[0331] A further aspect of the present invention pertains to the use of at least one PP2A/Bγ-related biallelic marker for determining whether there is a significant association between said marker and a mental disorder. Such determination may for example be performed using methods described in examples 10 to 15 below, but using populations that are different from the UCL and the Labimo populations, e.g., populations having different ethnic origins. The determination may also be performed for a trait that is not bipolar disorder but, e.g., schizophrenia or another mood or psychotic disorder. In this aspect of the invention, the PP2A/Bγ-related biallelic marker may be selected from the group consisting of 99-24169/139, 24-257/320, 99-24175/218, 24-247/216 and the complements thereof. Alternatively, the PP2A/Bγ-related biallelic marker may be a marker that is not specifically disclosed in the present specification.

[0332] The present invention is further directed to a method of genotyping comprising the step of determining the identity of a nucleotide at a PP2A/Bγ-related biallelic marker or the complement thereof in a biological sample. Preferably, said biological sample is derived from a single subject. It is preferred that the identity of the nucleotides at said biallelic marker is determined for both copies of said biallelic marker present in said individual's genome. In a preferred embodiment, the identity of the nucleotide at said biallelic marker is determined by a microsequencing assay. Preferably, a portion of a sequence comprising the biallelic marker is amplified prior to the determination of the identity of the nucleotide. The amplification may preferably be performed by PCR. Such a method of genotyping may for example be performed using any of the protocols described in examples 10 to 14 of the present specification. Further methods of genotyping are well known by those of skill in the art and any other known protocol may be used.

[0333] Methods well-known to those skilled in the art that may be used for genotyping in order to detect biallelic polymorphisms include methods such as, e.g., conventional dot blot analyzes, single strand conformational polymorphism analysis (SSCP) (Orita et al. (1989) Proc Natl Acad Sci USA 86:2766-2770), denaturing gradient gel electrophoresis (DGGE) (Borresen et al. (1988) Mutat Res. 202:77-83.), heteroduplex analysis (Lessa et al. (1993) Mol Ecol. 2:119-129), mismatch cleavage detection (Grompe et al. (1989) Proc Natl Acad Sci USA. 86:5888-5892). Another method for determining the identity of the nucleotide present at a particular polymorphic site employs a specialized exonuclease-resistant nucleotide derivative as described in U.S. Pat. No. 4,656,127. Oligonucleotide microarrays or solid-phase capturable dideoxynucleotides and mass spectrometry may also be used (Wen et al. (2003) World J Gastroenterol. 9:1342-1346; Kim et al. (2003) Anal Biochem. 316:251-258). Preferred methods involve directly determining the identity of the nucleotide present at a biallelic marker site by sequencing assay, microsequencing assay, enzyme-based mismatch detection assay, or hybridization assay.

[0334] As used herein, the term “biological sample” refers to a sample comprising nucleic acids. Any source of nucleic acids, in purified or non-purified form, can be utilized as the starting nucleic acid, provided it contains or is suspected of containing the specific nucleic acid sequence desired. DNA or RNA may be extracted from cells, tissues, body fluids and the like.

[0335] Methods of genotyping find use in, e.g., in genotyping case-control populations in association studies as well as in genotyping individuals in the context of detection of alleles of biallelic markers which are known to be associated with a given trait. In the context of the present invention, a preferred trait is a mental disorder selected from the group of bipolar disorder, schizophrenia and depression, and most preferably bipolar disorder.

[0336] Methods of genotyping may be used not only for determining the genotype of an individual but also for determining the haplotype of an individual. When determining the haplotype of an individual, each single chromosome should be studied independently. Methods of determining the haplotype of an individual are well known in the art and include, e.g., asymmetric PCR amplification (Newton et al. (1989) Nucleic Acids Res. 17:2503-2516; Wu et al. (1989) Proc. Natl. Acad. Sci. USA. 86:2757-2760), isolation of single chromosome by limit dilution followed by PCR amplification (Ruano et al. (1990) Proc. Natl. Acad. Sci. USA. 87:6296-6300) and, for sufficiently close biallelic markers, double PCR amplification of specific alleles (Sarkar and Sommer, (1991) Biotechniques. 10:436-440).

[0337] Thus the present invention is further directed to the use of at least one PP2A/Bγ-related biallelic marker for determining the haplotype of an individual. For example, a method for determining a haplotype for a set of biallelic markers in an individual may comprise the steps of: a) genotyping said individual for at least one PP2A/Bγ-related biallelic marker, b) genotyping said individual for a second biallelic marker by determining the identity of the nucleotides at said second biallelic marker. Preferably, both markers are PP2A/Bγ-related biallelic markers. Methods of determining a haplotype for a combination of more than two biallelic markers comprising at least one PP2A/Bγ-related biallelic marker in an individual are also encompassed by the present invention. In such methods, step (b) is repeated for each of the additional markers of the combination. Such a combination may comprise, e.g., 3, 4 or 5 biallelic markers. These biallelic markers may all be PP2A/Bγ-related biallelic markers.

[0338] When estimating haplotype frequencies in a population, one may use methods without assigning haplotypes to each individual. Such methods use a statistical method of haplotype determination. Thus another aspect of the present invention encompasses methods of estimating the frequency of a haplotype for a set of biallelic markers in a population, comprising the steps of: a) genotyping each individual in said population for at least one PP2A/Bγ-related biallelic marker, b) genotyping each individual in said population for a second biallelic marker by determining the identity of the nucleotides at said second biallelic marker; and c) applying a haplotype determination method to the identities of the nucleotides determined in steps a) and b) to obtain an estimate of said frequency. Such a method may also be performed for a combination of more than 2 biallelic markers. Step (c) may be performed using any method known in the art to determine or to estimate the frequency of a haplotype in a population. Preferably, a method based on an expectation-maximization (EM) algorithm (Dempster et al. (1977) JRSSB, 39:1-38; Excoffier and Slatkin, (1995) Mol Biol Evol. 12:921-7) leading to maximum-likelihood estimates of haplotype frequencies under the assumption of Hardy-Weinberg proportions (random mating) is used for performing step (c).

[0339] A preferred aspect of the present invention is directed to a method of diagnosing a mental disorder in an individual comprising the step of genotyping at least one PP2A/Bγ-related biallelic marker using a method of genotyping comprising the step of determining the identity of a nucleotide at a PP2A/Bγ-related biallelic marker or the complement thereof in a biological sample derived from said individual. Such a diagnosing method may further comprise the step of correlating the result of the genotyping step with a risk of suffering from said mental disorder. Typically, the presence of the risk allele, risk genotype or risk haplotype of the genotyped PP2A/Bγ-related biallelic marker(s) is correlated with a risk of suffering from the mental disorder. The PP2A/Bγ-related biallelic marker may be selected from the group consisting of biallelic markers 99-24169/139, 24-257/320, 99-24175/218, 24-247/216 and the complements thereof. In one embodiment, the presence of a genotype “AA” at biallelic marker 99-24169/139 is indicative of a risk of suffering from said mental disorder. In another embodiment, the presence a haplotype “AG” at biallelic markers 24169/139 and 24-247/216 is indicative of a risk of suffering from said mental disorder. In still another embodiment, the presence of a haplotype “AA” at biallelic markers 24-257/320 and 99-24175/218 is indicative of a risk of suffering from said mental disorder.

[0340] In a further aspect, the present invention pertains to the use of a polynucleotide comprising a contiguous span of at least 12 nucleotides of SEQ ID NO: 37 or a polynucleotide complementary thereto in a microsequencing assay for determining the identity of the nucleotide at a PP2A/Bγ-related biallelic marker, wherein the 3′ end of said polynucleotide is located 1 nucleotide upstream of said PP2A/Bγ-related biallelic marker in said sequence. Such nucleotides may comprise a contiguous span of at least 12, 15, 18, 19 or 20 nucleotides of SEQ ID NO: 37 or a polynucleotide complementary thereto. They preferably comprise a contiguous span of about 19 nucleotides of SEQ ID NO: 37 or a polynucleotide complementary thereto. In one embodiment, said PP2A/Bγ-related biallelic marker is selected from the group consisting of 99-24169/139, 24-257/320, 99-24175/218, 24-247/216 and the complements thereof. In a preferred embodiment, the polynucleotide comprising a contiguous span of at least 12 nucleotides of SEQ ID NO: 37 or a polynucleotide complementary thereto is selected from the group consisting of the primers depicted in table 4A in Example 14.

EXAMPLES Example 1 Yeast Two-Hybrid Screening

[0341] 1. Construction of PGBKT7-PPP2R2C

[0342] The full-length coding region of the PPP2R2C gene, which encodes the PP2A/Bγ subunit, was first amplified from a Human foetal brain cDNA library (Marathon-Ready cDNA, Clontech) with the two gene-specific primers of SEQ ID NO: 8 and of SEQ ID NO: 9. This first PCR product was then amplified with a new combination of primers of SEQ ID NO:10 and of SEQ ID NO:11. The amplified fragment encompassed nucleotides 52-1540 of the full-length cDNA, genbank accession number AF086924 extended, respectively, with EcoRI and BamHI cloning sites. The resulting 1503-bp fragment was digested with EcoRI and BamHI, purified and inserted into EcoRI and BamHI cloning sites of the pGBKT7 vector (Clontech).

[0343] 2. Isolation of Novel Splice Variants Encoded by the PPP2R2C Gene

[0344] The full-length coding region of the PPP2R2C gene, which encodes the PP2A/Bγ subunit, was first amplified from a Human foetal brain cDNA library (Marathon-Ready cDNA, Clontech) with the two gene-specific primers of SEQ ID NO: 8 and of SEQ ID NO: 9. This first PCR product was then amplified with a new combination of primers of SEQ ID NO: 10 and of SEQ ID NO: 11. The fragments were digested with EcoRI and BamHI, purified and inserted into EcoRI and BamHI cloning sites of the pGBKT7 vector (Clontech). Eight different clones were obtained, and the inserted cDNAs were sequenced using primers of SEQ ID Nos. 64-69.

[0345] The sequence of the cDNAs is shown as SEQ ID Nos. 48, 50, 52, 54, 56, 58, 60 and 62. These cDNAs encode polypeptides of SEQ ID Nos. 49, 51, 53, 55, 57, 59, 61 and 63 respectively. The alignment between SEQ ID Nos. 38, 49, 51, 53, 55, 57, 59, 61 and 63 is shown on FIGS. 7A and 7B. These polypeptides correspond to novel splice variants of the PP2A/Bγ subunit, the structure of which is shown in table 0. TABLE 0 Exons present in the PP2A/Bγ Position on subunit of SEQ ID NO: Exon No. SEQ ID NO: 37 38 49 51 53 55 57 59 61 63 1  1-124 X X X X X X X X X 1bis 125-200 X X 2 91147-91244 X X 3 93669-93834 X X X 4 96310-96422 X X X 5 99546-99723 X X X 5bis 124705-124802 X 6 125441-125605 X X X X X 7 141176-141345 X X X X X X X 8 145556-145647 X X X X X X X X 9 151316-151829 X X X X X X X X X

[0346] SEQ ID Nos. 53 and 59 comprise a novel exon, exon 1bis. Exon 1bis encodes amino acids 25 to 9 of SEQ ID NO: 53.

[0347] SEQ ID Nos. 51 comprises a novel exon, exon 5bis. Exon 5bis encodes amino acids 25 to 47 of SEQ ID NO: 51.

[0348] SEQ ID Nos. 55 comprises exons 1, 6, 7, 8 and 9. The 23 amino-terminal amino acids and the 238 carboxy-terminal amino acids of SEQ ID NO: 55 are identical to the 23 amino-terminal amino acids and to the 238 carboxy-terminal amino acids of SEQ ID NO: 38 (the wild-type PP2A/Bγ subunit). SEQ ID NO: 55 lacks amino acids 24 to 209 of SEQ ID NO: 38.

[0349] SEQ ID Nos. 57 comprises exons 1, 7, 8 and 9. The 23 amino-terminal amino acids and the 183 carboxy-terminal amino acids of SEQ ID NO: 57 are identical to the 23 amino-terminal amino acids and to the 183 carboxy-terminal amino acids of SEQ ID NO: 38. SEQ ID NO: 57 lacks amino acids 24 to 264 of SEQ ID NO: 38.

[0350] 3. The Yeast Two-Hybrid Screening

[0351] A yeast two-hybrid screening was performed to find polypeptides interacting with the PP2A/Bγ subunit. The Saccharomyces cerevisiae strain AH109 (MATa, trp1-901, leu2-3, 112ura3-52, his3-200, gal4Δ, gal80Δ, LYS2:: GAL1_(UAS)-GAL1_(TATA)-HIS3, GAL2_(UAS)-GAL2_(TATA)-ADE2, URA3:: MEL1_(UAS)-MEL1_(TATA)-lacZ) was transformed with the pGBKT7-PPP2R2C construction. A lithium acetate transformation procedure was done according to the manufacturer's instructions (Matchmaker Two-Hybrid system, Clontech). The MATa transformed cells expressing the bait were then mixed with a pretransformed Matchmaker Human brain cDNA library in the Y187 strain (MATα, ura3-52, his3-200, ade2-101, trp1-901, leu2-3, 112, gal4Δ, met, gal80Δ, URA3:: GAL1_(UAS)-GAL1_(TATA)-lacZ). Three independent mating were performed with respectively 5.10⁶, 5.10⁶ and 2.10⁵ clones of the Human brain cDNA library. The resulting diploid cells able to grow on SD/-Leu/-Trp medium containing plates were further selected onto the medium-stringency SD/-Leu/-Trp/-His selective medium for the identification of bait-prey interactions. Positive colonies were then picked up and plated onto the high-stringency SD/-Leu/-Trp/-His/-Ade selective medium. Only cDNA of colonies able to grow at the same time on SD/-Leu/-Trp and SD/-Leu/-Trp/-His/-Ade media was retained for sequencing and further studies.

[0352] 4. Results of the he Yeast Two-Hybrid Screening

[0353] 494 clones were obtained, sequenced and analyzed. Among these clones, the 2E11 and 1D3 clones comprised partial cDNAs encoding a novel splice variant of the KCNQ2 potassium channel. 2E11 comprised a cDNA encoding amino acids 433 to 643 of SEQ ID NO: 2, and 1D3 comprised a cDNA encoding amino acids 454 to 643 of SEQ ID NO: 2. The full-length splice variants were cloned and sequenced as described in Example 2.

Example 2 Cloning of the Full-Length KCNQ2 Splice Variants

[0354] 1. Cloning and Sequencing

[0355] Poly(A)+ mRNA from Human brain, thalamus (Clontech) were reversed transcribed (RT) using the murine Moloney leukemia virus reverse transcriptase (RT-PCR Advantage kit, Clontech) with a primer of SEQ ID NO: 12 hybridizing specifically with the novel splice variant cloned in 2E11. After a phenol-chloroform extraction and precipitation steps, the products obtained by the previous RT-PCR were directly PCR-amplified using the following gene-specific primers of SEQ ID NO: 13 and of SEQ ID NO: 14. The amplified fragment encompassed nucleotides 127-148 of the KCNQ2 full-length cDNA, genbank accession number AF033348. These primers were respectively extended with EcoRI and Bg/II cloning sites. The PCR products were digested with EcoRI and Bg/II restriction enzymes (New England Biolabs), purified and then ligated into the EcoRI and Bg/II cloning sites of the pCMV-Myc vector (Clontech). The two pCMV-Myc-3H9 and pCMV-Myc-3H2 clones were fully sequenced. The sequence of the insert in pCMV-Myc-3H2 comprises SEQ ID NO: 1, and the sequence of the insert in pCMV-Myc-3H9 comprises SEQ ID NO: 3.

[0356] Similarly, a cDNA was cloned from a poly(A)+ mRNA library from human foetal brain. One clone was obtained and fully sequenced. Its insert comprised SEQ ID NO: 5.

[0357]2. Description of the Novel Splice Variants

[0358] SEQ ID NO: 1 encodes the polypeptide of SEQ ID NO: 2 (KCNQ2-15bx). SEQ ID NO: 3 encodes the polypeptide of SEQ ID NO: 4 (KCNQ2-15by). SEQ ID NO: 5 encodes the polypeptide of SEQ ID NO: 6 (KCNQ2-15bz). SEQ ID NO: 7 corresponds to the full-length KCNQ2 polypeptide (KCNQ2-fl).

[0359] As shown on the alignment between SEQ ID NO: 7, SEQ ID NO: 2, SEQ ID NO: 4 and SEQ ID NO: 6 (FIG. 1), the three splice variants display a novel carboxyl-terminal extremity compared to KCNQ2. The 55 carboxyl-terminal amino acids of SEQ ID NO: 2, SEQ ID NO: 4 and SEQ ID NO: 6 are unique to these three splice variants. These 55 amino acids correspond to the amino acids at position 589 to 643 of SEQ ID NO: 2.

[0360] The genomic structure of the KCNQ2 gene is shown on FIG. 2 and in table 1. The KCNQ2 gene is comprised of 17 exons. All novel splice variants display a novel exon, exon 15b, which encodes the amino acids at position 545 to 643 of SEQ ID NO: 2. Since the primers used for reversed transcription specifically reversed mRNAs displaying exon 15b, none of the novel splice variants displays the exons corresponding to exons 15, 16 and 17 of the KCNQ2 gene.

[0361] The 44 first amino acids encoded by exons 15 and 15b are identical (amino acids at position 545 to 588 of SEQ ID NO: 2). The 55 last amino acids encoded by exon 15b are unique to exon 15b (amino acids at position 589 to 643 of SEQ ID NO: 2). Furthermore, the novel splice variants do not display exons 16 and 17 of KCNQ2-fl. The most carboxyl-terminal exon of these splice variants is exon 15b. SEQ ID NO: 2 further comprises exon 1 to exon 14 of KCNQ2. Exon 12 of KCNQ2 is lacking in SEQ ID NO: 4. Exons 9 and 12 of KCNQ2 are lacking in SEQ ID NO: 6.

[0362] The insert of the 2E11 clone, which corresponds to a partial cDNA, comprises exons 13,14 and 15b. TABLE 1 Encodes Encodes Encodes Encodes Exon SEQ ID AA of SEQ SEQ ID AA of SEQ SEQ ID AA of SEQ AA of SEQ No. NO: 1 ID NO: 2 NO: 3 ID NO: 4 NO: 5 ID NO: 6 ID NO: 7  1  1-296  1-98  1-296  1-98  1-296  -98  1-98  2 297-387 100-129 297-387 100-129 297-387 100-129 100-129  3 388-514 130-171 388-514 130-171 388-514 130-171 130-171  4 515-690 173-230 515-690 173-230 515-690 173-230 173-230  5 691-816 231-272 691-816 231-272 691-816 231-272 231-272  6 817-927 273-309 817-927 273-309 817-927 273-309 273-309  7  928-1023 310-341  928-1023 310-341  928-1023 310-341 310-341  8 1024-1118 342-372 1024-1118 342-372 1024-1118 342-372 342-372  9 1119-1148 374-382 1119-1148 374-382 / / 374-382 10 1149-1217 384-405 1149-1217 384-405 1119-1187 374-395 384-405 11 1218-1247 407-415 1218-1247 407-415 1188-1217 397-405 407-415 12 1248-1301 417-433 / / / / 417-433 13 1302-1525 435-508 1248-1471 417-490 1218-1441 407-480 435-508 14 1526-1631 510-543 1472-1577 492-525 1442-1547 482-515 510-543 15 / / / / / / 545-587  15b 1632-1929 545-643 1578-1875 527-625 1548-1845 517-615 / 16 / / / / / / 588-629 17 / / / / / / 630-872

Example 3 Yeast Mating Test

[0363] 1. Construction of Vectors

[0364] 1.1. EX13-17, Which Comprises Exons 13, 14, 15, 16 and 17.

[0365] The pGADT7-EX13-17 plasmid was constructed as follows: a 1414-bp fragment was first PCR-amplified from a Human total brain cDNA library (Marathon-Ready cDNA, Clontech) with two gene-specific primers of SEQ ID NO: 15 and of SEQ ID NO 16. This first PCR product was then amplified with a second set of gene-specific primers of SEQ ID NO: 17 and 5′of SEQ ID NO: 18. These primers are extended, respectively, with EcoRI and BamHI cloning sites. After digestion with EcoRI and BamHI restriction enzymes, the 1338-bp purified fragment was ligated to the same cloning sites of pGADT7 (Clontech).

[0366] 1.2. EX13-15, Which Comprises Exons 13, 14 and 15.

[0367] The pGADT7-EX13-15 plasmid was obtained as follows: a 484-bp fragment was PCR-amplified with primers of SEQ ID NO: 19 and of SEQ ID NO: 20, which are respectively extended with EcoRI and BamHI cloning sites, from the first PCR product of the pGADT7-EX13-17 construction. The resulting fragment was then digested with EcoRI and BamHI purified, and ligated to the same cloning sites of pGADT7 (Clontech).

[0368] 1.3. EX16-17, Which Comprises Exons 16 and 17.

[0369] The pGADT7-EX16,17 plasmid was obtained as follows: a 883-bp fragment was PCR-amplified with primers of SEQ ID NO: 21 and of SEQ ID NO: 22, which are respectively extended with EcoRI and BamHI cloning sites, from the first PCR product of the pGADT7-EX13-17 construction. The resulting fragment was then digested with EcoRI and BamHI, purified, and ligated to the same cloning sites of pGADT7 (Clontech).

[0370] 1.4. EXsp15b, Which Comprises the Region Unique to Exon 15b.

[0371] The pGADT7-EXsp15b plasmid was constructed as follows: a 400-bp fragment was PCR-amplified with a primer of SEQ ID NO: 23 extended with EcoRI cloning site, and with a primer of SEQ ID NO: 24 from the pACT2-2E11 plasmid (see example 1). The resulting fragment was then digested with EcoRI and XhoI, purified, and ligated to the same cloning sites of pGADT7 (Clontech).

[0372] 1.5. EXco15, Which Comprises the Region Common to Exon 15 and exon 15b.

[0373] The pGADT7-EXco15 domain plasmid was constructed as follows: a 146-bp fragment was PCR-amplified with primers of SEQ ID NO: 25 and of SEQ ID NO: 26, which are respectively extended with EcoRI and BamHI cloning sites, from the pACT2-2E11 plasmid. The resulting fragment was then digested with EcoRI and BamHI, purified, and ligated to the same cloning sites of pGADT7 (Clontech).

[0374] 1.6. EX13-14, Which Comprises Exons 13 and 14.

[0375] The pGADT7-EX13-14 plasmid was constructed as follows: a 300-bp fragment was PCR-amplified with primers of SEQ ID NO: 27 and of SEQ ID NO: 28, which are respectively extended with EcoRI and BamHI cloning sites, from the pACT2-2E11 plasmid. The resulting fragment was then digested with EcoRI and BamHI, purified, and ligated to the same cloning sites of pGADT7 (Clontech).

[0376] 2. Protocol of the Yeast Mating Test

[0377] Yeast mating tests were performed to map the interaction domains between the different partners. The chosen Saccharomyces cerevisiae mating partner strains (AH109 and Y184) were transformed separately with the plasmids to be tested in combination with the plasmid of interest. The lithium acetate transformation procedure was done according to the manufacturer's instructions (Matchmaker Two-Hybrid system, Clontech). Transformants were selected on the appropriate SD dropout medium (Clontech). One fresh colony of each type to use was picked from the working stock plates and both placed in one 1.5 ml microcentrifuge tube containing 0.5 ml of YPD medium (Clontech). Cells were then incubated for 24 hr at 30° C. with shaking at 200 rpm. 100 μl of a 1:100 dilution of the mating culture were then spread on the appropriate SD medium: SD/-Leu/-Trp, and SD/-Leu/-Trp/-His/-Ade. After 7 to 15 days of growth on selective medium positive colonies were counted.

[0378] 3. Results of the Direct Mating Tests Between KCNQ2 Polypeptides and PP2A/Bγ

[0379] Mating tests between each of the above constructions and the pGBKT7-PPP2R2C construction described in example 1 were performed. The results are shown on FIG. 2. The sign “+” indicates that colonies grew, thus indicating that the tested polypeptide is capable of interacting with PP2A/Bγ. The sign “−” indicates that no colony grew, thus indicating that the tested polypeptide does not interact with PP2A/Bγ.

[0380] EX13-17, EX16-17, EX13-14 and EXsp15b do not interact with PP2A/Bγ. EX13-15b, EX13-15 and EXco15 interact with PP2A/Bγ. Since EX13-15b interacts with PP2A/Bγ, this shows that KCNQ2-15b polypeptides are capable of interacting with PP2A/Bγ. Since EX13-15b, EX13-15 and EXco15 but not EXsp15b interact with PP2A/Bγ, the common region between exon 15 and exon 15b plays a role in this interaction. Furthermore, since EX13-17 does not interact with PP2A/Bγ, the fact that exon 15 or that exon 15b is located at the most carboxyl extremity of the KCNQ2 polypeptide is of importance for efficient interaction with PP2A/Bγ.

[0381] 4. Results of the Direct Mating Tests Between Different KCNQ2 Polypeptides

[0382] Mating tests between the different above constructions were performed, and the results are shown on FIG. 4. 4 mating tests were performed for each pair of constructs and the results are shown on FIG. 3. The sign “++” indicates that all 4 colonies grew. The sign “+” indicates that 3 colonies out of 4 grew. The sign “−/+” indicates that 1 colony out of 4 grew. The sign “−” indicates that no colony grew.

[0383] This experiment shows that KCNQ2-15b polypeptides can associate and form homodimers. KCNQ2-15b polypeptides can also associate and form heterodimers with KCNQ2 polypeptides comprising exon 15 at their carboxyl-terminal extremity. KCNQ2-15b polypeptides only associate poorly with KCNQ2-fl polypeptides.

Example 4 Expression and Purification of Glutathione S-Transferase Fusion Proteins

[0384] 1. Construction of Plasmids

[0385] 1.1. pGBKT7-2E11

[0386] The pACT2-2E11 plasmid rescued from yeast two-hybrid screening was digested with EcoRI and Bg/II and the resulting 687-bp fragment inserted after purification into EcoRI and BamHI cloning sites of the pGBKT7 vector (Clontech).

[0387] 2.2. pGEX-2TK-2E11

[0388] A partial cDNA of the KCNQ2 splice variants was PCR-amplified from the pACT2-2E11 plasmid rescued from yeast two-hybrid screening using a gene-specific primer of SEQ ID NO: 29 and a primer in the pACT2 vector of SEQ ID NO: 30. These primers were respectively extended with BamHI and EcoRI cloning sites. The 892-bp PCR product was digested with BamHI and EcoRI, purified and inserted into BamHI and EcoRI sites of pGEX-2TK vector (Amersham Pharmacia Biotech). The pACT2 plasmid used for this construction was recovered from diploid cells as follows: a fresh colony of diploid cells was inoculated into 5 ml of SD/-Leu/-Trp (Clontech) and let to grow overnight at 30° C. with shacking at 200-250 rpm. Cells corresponding to 2 ml of the overnight culture were spun down by centrifuging at 4300 rpm for 10 min. The pellet was resuspended in 100 μl of zymolyase (1U/μl) (Seikagaku Corporation) and incubated 1 hr at 30° C. Then 100 μl of a proteinase K mix (100 mM NaCl, 10 mM Tris-HCl pH [pH 8.0], 25 mM EDTA, 0.5% SDS, 0.1 mg/ml proteinase K) were added for 2.5 hr at 40° C. DNA was extracted by two successive phenol:chloroform steps and precipitated with 0.3 M sodium acetate and 2.5 volumes of ethanol. DH10B ElectroMAX competent cells (Invitrogen) were transformed with DNA and selected on agar plates supplemented with 120 μg/ml Ampicillin. The protein encoded by pGEX-2TK-2E11 was named GST-2E11.

[0389] 1.3. pGEX-2TK-PPP2R2C

[0390] A 1485-bp fragment of PPP2R2C encompassing nucleotides 55-1540 of the full-length cDNA of PP2A/Bγ (genbank accession number AF086924) was PCR-amplified from the pGBKT7-PPP2R2C plasmid using gene-specific primers of SEQ ID NO: 31 and of SEQ ID NO: 32, which are respectively extended with BamHI and EcoRI cloning sites. The fragment was digested by BamHI and EcoRI, purified and ligated to the same cloning sites of pGEX-2TK vector (Amersham Pharmacia Biotech). The protein encoded by pGEX-2TK-2E11 is named GST-PPP2R2C.

[0391] 1.4. pGEX-2TK-KCNQ2-Cter

[0392] A 1393-bp fragment of a KCNQ2-fl encompassing nucleotides 1544-2924 of the full-length cDNA (genbank accession number AF033348) was PCR-amplified from the pCMV-HA-KCNQ2-iso1 construction using gene-specific primers: of SEQ ID NO: 33 and of SEQ ID NO: 34, which are respectively extended with XhoI and EcoRI cloning sites. This PCR product was digested with XhoI and EcoRI, purified and substituted at the same sites for a 767-bp XhoI-EcoRI fragment of the pGEX-2TK-2E11 plasmid. The pCMV-HA-KCNQ2-iso1 plasmid used for the construction of pGEX-2TK-KCNQ2-Cter was obtained as follows: the full-length coding region for KCNQ2-fl (encompassing nucleotides 126-2924 of the full-length cDNA, genbank accession number AF033348) was first amplified from a Human brain cDNA library (Marathon-Ready cDNA, Clontech) using gene specific primers of SEQ ID NO: 35 and of SEQ ID NO: 36, which are respectively extended with EcoRI and Bg/II cloning sites. The PCR product was digested with EcoRI and Bg/II, purified and ligated to the same cloning sites of the pCMV-HA vector (Clontech). The protein encoded by pGEX-2TK-2E11 is named GST-KCNQ2-Cter.

[0393] 2. Expression and Purification

[0394] Glutathione S-transferase fusion protein expression and purification by adapting the method described by Kaelin et al. (1991, Cell, 64:521-532). Overnight cultures of MAX Efficiency DH5αF′IQ competents cells (Invitrogen) transformed with either the pGEX2TK plasmid or the pGEX2TK-2E11, pGEX2TK-KCNQ2-Cter, and pGEX2TK-PPP2R2C recombinants were diluted 1:10 in LB medium containing ampicillin (100 μg/ml) and incubated for 1 hr at 37° C. Isopropyl-β-D-thiogalactopyranoside (IPTG, Promega) was then added to a final concentration of 0.1 mM and bacteria let to grow for 3 additional hours at 37° C. For fusion proteins recovery using the glutathione-Sepharose 4B beads (Amersham Biosciences), bacterial cultures were pelleted by centrifugation at 5000×g for 15 min at 4° C. and resuspended in 1/10 vol NETN (20 mM Tris-HCl [pH 8.0], 120 mM NaCl, 1 mM EDTA, 0.5% Nonidet P-40) supplemented with 1 mM phenylmethylsulfonyl fluoride (PMSF, Sigma) and one tablet of protease inhibitors cocktail (Complete™ mini, Roche) for 7 ml of buffer. The bacteria were then lysed on ice by mild sonication and centrifuged at 10,000×g for 10 min at 4° C. Aliquots (1 ml) of bacterial clear lysates were then rocked for 1 hr at 4° C. with 50 μl of glutathione-Sepharose 4B beads, which had been previously washed four times in NETN containing 1% Albumin Bovine (BSA fraction V, Sigma) and resuspended (final concentration 1:1 [v/v]) in NETN. The glutathione-Sepharose 4B beads were then washed three times with NETN. For recovery of the bound recombinants proteins, beads were washed two more times with 100 mM Tris-HCl [pH 8.0], 120 mM NaCl and elution was performed in the same buffer containing 20 mM glutathione (Sigma). Quantification of the eluted fusion proteins was performed by the standard Bradford's method (Biorad Protein Assay).

Example 5 In Vitro Labeling of the GST Fusion Proteins

[0395] Beads with bound GST fusion proteins corresponding to 1 ml of bacterial clear lysate were washed three times in NETN and one time with HMK buffer without DTT (20 mM Tris-HCl [pH 7.5], 120 mM NaCl, 12 mM MgCl₂). Beads were then resuspended in 30 μl of reaction mix (3 μl of 10×HMK Buffer with 20 mM DTT, 10 units of Protein Kinase A Catalytic Subunit [PKA from bovine heart, 250 units/vial, Sigma] in 40 mM DTT, 2 μl of [³²P]-γATP 6000 Ci/mMole and 24 μl of distilled water) and incubated at 4° C. for 30 min. During incubation beads were resuspended time to time by flicking. Reaction was stopped by adding 1 ml of HMK stop buffer (10 mM Sodium Phosphate [pH 8.0], 10 mM Sodium Pyrophosphate, 10 mM EDTA, 1 mg/ml BSA) and beads washed five times with NETN buffer. Elution of radiolabeled fusion proteins was carried out with 1 ml of freshly prepared 20 mM glutathione in 100 mM Tris-HCl [pH 8.0], 120 mM NaCl as previously described.

Example 6 Solid Phase Overlay Assay

[0396] 1. Protocol of the Solid Phase Overlay Assay

[0397] Solid phase overlay assays were performed by adapting the method described by Kaelin and collaborators (Kaelin et al., 1992, Cell, 70:351-364). 100 ng, 10 ng and 0.1 ng of GST and GST-2E11 recombinant proteins were resolved by 9% SDS-PAGE and were transferred by electroblotting onto nitrocellulose membrane (nitrocellulose transfer membrane Protran BA 83, Schleicher and Schuell). The membrane were then blocked in HBB buffer (25 mM Hepes-KOH [pH 7.7], 25 mM NaCl, 5 mM MgCl₂) with 5% (w/v) non-fat dry milk, 1 mM DTT, 0.05% Nonidet P-40 for 1 hr at room temperature. The binding reaction was carried out at room temperature in Hyb75 buffer (20 mM Hepes [pH 7.7], 75 mM KCl, 2.5 mM MgCl₂, 0.1 mM EDTA, 0.05% Nonidet P-40) with 1% (w/v) non-fat dry milk, 1 mM DTT, 1 mM PMSF and 3.5 10⁵ dpm of a [³²P]-γATP GST-PPP2R2C radiolabeled recombinant protein used as a probe. After 4.5 hr of incubation, the membrane was washed with Hyb75 buffer, 1 mM DTT, 1% (w/v) non-fat dry milk three times for 15 min at room temperature. The blots were analyzed by autoradiography.

[0398] 2. Results

[0399] This experiment was performed to validate the interaction between KCNQ-15b polypeptides and PP2A/Bγ. In this experiment, the PP2A/Bγ subunit was radiolabeled but not the proteins present on the nitrocellulose membrane. Thus, a signal appears when visualized by autoradiography only if the loaded protein interacts with PP2A/Bγ. GST-2E11 corresponds to a fusion protein between a KCNQ2-15b polypeptide comprising exons 13, 14 and 15b and GST. GST corresponds to the negative control. In the three lines loaded with the GST-2E11 recombinant protein, bands located at a position corresponding to a protein of a size of about 45 kD appeared. This corresponds to the protein size expected for the GST-2E11 protein. Furthermore, the intensity of the bands was proportional to the quantity of loaded GST-2E11. Thus GST-2E11 interacts with PP2A/Bγ. In the three lines loaded with the GST protein, no band appeared, showing that PP2A/Bγ does not interact with the GST protein. Thus the interaction between PP2A/Bγ and the GST-2E11 fusion protein is due to the part of the protein encoding 2E11 and not to the part of the protein encoding GST. This experiment indicates that KCNQ-15b polypeptides can interact with PP2A/Bγ in vitro. Furthermore, this shows that KCNQ-15b polypeptides can interact with PP2A/Bγ without a third binding partner, a hypothesis that can not be excluded by a yeast-two hybrid assay.

Example 7 In vitro Phosphorylation Assay With Recombinant GSK-3β Kinase and In Vitro Dephosphorylation With HTB-14 Whole Cell Extracts.

[0400] 1. Phosphorylation Assays

[0401] Phosphorylation assays were performed to determine whether the phsophorylation state of KCNQ2-15b is modulated by GSK3β, a kinase that plays an important role in the central nervous system by regulating various cytoskeletal processes through its effects on MAP1B, tau and synapsin 1. GSK3β is known to be inhibited by two mood stabilizing agents used in treatment of bipolar disorder, lithium and valporate.

[0402] 1.1. Protocol

[0403] Expression and purification of the GST-2E11 fusion protein were performed as described above. Beads with bound fusion protein corresponding to 1 ml of bacterial clear lysate were washed three times in NETN and one time with HMK buffer without DTT (20 mM Tris-HCl [pH 7.5], 120 mM NaCl, 12 mM MgCl₂). Beads were resuspended in 240 μl of reaction mix (24 μl of 10×HMK Buffer with 20 mM DTT, 40 units of Protein Kinase A Catalytic Subunit [PKA from bovine heart, 250 units/vial, Sigma] in 40 mM DTT, 5 μl of 24 mM ATP and 207 μl of distilled water) and incubated for 30 min at room temperature. Beads were then washed three times in NETN buffer and one time in GSK-3β reaction buffer (20 mM Tris-HCl [pH 7.5], 10 mM MgCl₂, 5 mM DTT) (New England Biolabs). Beads were then resuspended in 50 μl of reaction mix (5 μl of 10×GSK-3β reaction buffer, 1 μl of [³²P]γATP 10mCi/ml, 50 U of recombinant GSK-3β[New England Biolabs], and distilled water for a final volume of 50 μl) and incubated at room temperature for 30 min. After three washes in NETN buffer, phosphorylated proteins were boiled in 2× Sample Buffer (125 mM Tris-HCl [pH 6.8], 4% SDS, 20% glycerol, 1.4 M β-Mercapto ethanol), resolved by 10% SDS-PAGE, and visualized by autoradiography.

[0404] 1.2. Results

[0405] In this phosphorylation assay, non-radiolabeled polypeptides to be tested are incubated in the presence of GSK-3β, PKA and radioactive ATP. The proteins are then resolved by a 10% SDS-PAGE migration and visualized by autoradiography. A signal is visualized by autography only if the protein to be tested is phosphorylated by GSK-3β and PKA during incubation. In the line loaded with the GST-2E11 protein, which corresponds to the fusion protein between a KCNQ2-15b polypeptide comprising exons 13, 14 and 15b and the GST polypeptide, a band located at a position corresponding to a protein of a size of about 45 kD did appear. This is the size expected for the GST-2E11 protein. Thus the GST-2E11 protein is phosphorylated by GSK-3β and PKA in vitro. Three experiments corresponding to negative controls were performed in parallel. One experiment was performed without adding the GSK-3β kinase during incubation, one was performed without adding the PKA kinase during incubation, and one was performed with a GST protein instead of a GST-2E11 protein. No bands appeared in the three lines corresponding to the negative controls. Accordingly, this experiment shows that KCNQ2-15b polypeptides are synergistically phosphorylated by the GSK-3β and PKA kinases in vitro.

[0406] This result was confirmed by a competition experiment in which CREB phosphopeptides, which are known to be phosphorylated by GSK-3β and PKA, were added during incubation. In this competition experiment, 5 μg of CREB phosphopeptides (New England Biolabs) was added to the kination mix. A band did still appear at a position corresponding to the size of GST-2E11, but the intensity of the band was very significantly lower.

[0407] The influence of LiCl on the phosphorylation state of GST-2E11 was further studied by adding LiCl to the kination mix at a final concentration of 0, 8.3, 25, 75 and 225 mM respectively. The intensity of the band appearing at a position of about 45 kD decreased in the presence of LiCl, and the intensity of the signal was negatively correlated with the concentration of LiCl added to the kination mix. In the presence of about 50 mM LiCl, the phosphorylation state of GST-2E11 was reduced by 50%. This shows that LiCl, a well-known mood-stabilizing agent used in the treatment of bipolar disorder, inhibits phosphorylation of KCNQ2-15b polypeptides in vitro.

[0408] 2. Dephosphorylation Assays

[0409] Dephosphorylation assays were performed to determine whether the phophorylation state of KCNQ2-15b polypeptides is modulated by PP2A.

[0410] 2.1. Protocol

[0411] In vitro phosphorylated GST-2E11 fusion protein was incubated at room temperature for 30 min with 500 μg of whole cell extracts of Human glioblastoma, astrocytoma cell line (ATCC number: HTB-14) with or without 400 μM of the PP2A phosphatase inhibitor okadaic acid (Sigma). HTB-14 whole cell extracts were prepared as follow: cells were washed three times with ice-cold TBS buffer (10 mM Tris-HCl [pH 8.0], 120 mM NaCl) and lysed at 4° C. for 30 min in EBC buffer (50 mM Tris-HCl [pH 8.0], 120 mM NaCl, 0.5% Nonidet P-40). Then the lysate was centrifugated for 10 min at 13.000×g at 4° C. to pellet cell debris. Proteins present in the supernatant were quantified by the standard Bradford's method (Bio-Rad Protein Assay). The proteins were then resolved by 10% SDS-PAGE, and visualized by autoradiography.

[0412] 2.2. Results

[0413] The phosphorylated radiolabeled GST-2E11 proteins obtained from the previous assay were incubated in the presence of HTB-14 cell extracts containing the PP2A phosphatase to determine whether PP2A is capable of dephosphorylating GST-2E11 proteins. In this experiment, a protein that is dephosphorylated by PP2A is not radioactive after incubation in the presence of HTB-14 cell extracts any more. Thus dephosphorylation of the GST-2E11 protein is monitored by disappearance of the signal visualized by autoradiography. One line of the 10% SDS-PAGE gel was loaded with phosphorylated GST-2E11 fusion proteins incubated in the absence of HTB-14 cell extracts, as reference for the intensity of the band appearing for phosphorylated GST-2E11 proteins. In the line loaded with GST-2E11 fusion proteins incubated in the presence of HTB-14 cell extracts, the band had an extremely weaker intensity. Thus GST-2E11 fusion proteins are dephosphorylated when incubated in the presence of HTB-14 cell extracts. When the GST-2E11 fusion protein was incubated in the presence of HTB-14 cell extracts and okadaic acid, a known PP2A phosphatase inhibitor, the intensity of the band was only slightly weaker than the intensity of the band corresponding to phosphorylated GST-2E11. Thus the PP2A phosphatase is responsible of the dephosphorylation observed for GST-2E11 fusion proteins incubated in the presence of HTB-14 cell extracts. Accordingly, this experiment shows that KCNQ-15b polypeptides are dephosphorylated by the PP2A phosphatase in vitro.

Example 8 Cell Culture, Transfection, Immunoprecipitation and Western Blot Analysis

[0414] 1. Cell Cultures

[0415] HEK293-H cells (Gibco Invitrogen Corporation) were grown in DMEM medium (Gibco Invitrogen Corporation) supplemented with 0.1 mM Non-Essential Amino Acids and 10% Fetal Bovine Serum (Gibco Invitrogen Corporation), and transiently transfected with 20 μg of the pCMV-Myc-3H9 or pCMV-Myc-3H2 plasmids per 60 mm dish using the Invitrogen calcium phosphate transfection kit and protocols. 48 hr after transfection cells were washed three times with ice-cold phosphate buffer (PBS, Gibco Invitrogen Corporation), scraped and solubilized for 2 hr at 4° C. in solubilization buffer containing 150 mM NaCl, 5 mM EDTA, 1% Triton X-100, 0.1% sodium deoxycholate, 10 mM Tris-HCl [pH 8.0] and supplemented with protease inhibitors (1 mM phenylmethylsulfonyl fluoride, one tablet of Complete™ mini protease inhibitors cocktail [Roche]) and phosphatase inhibitors (1 mM Na₃VO₄ and 1 mM NaF). The lysate was then centrifugated for 10 min at 13.000×g at 4° C. to pellet cell debris. Proteins present in the supernatant were quantified by the standard Bradford's method (Bio-Rad Protein Assay).

[0416] 2. Immunoprecipitation

[0417] 500 μg (final volume: 500 μl) of the clear cell lysate were incubated for 2 hr at 4° C. with 1 μl of rabbit preimmune serum and 50 μl of protein A Sepharose CL-4B beads (Amersham Pharmacia Biotech) saturated with 1% Albumin Bovine (BSA fraction V, Sigma). Depleted supernatants were then incubated overnight at 4° C. with 1 μg of anti-Myc monoclonal antibody (Myc-Tag 9B11 monoclonal antibody, Cell Signaling). Protein A Sepharose CL-4B beads saturated with 1% Albumin Bovine were then added and the mixture incubated at 4° C. for 2 addtional hours. After five washes with ice-cold solubilization buffer immuno-complexes were boiled in 2× Sample Buffer (125 mM Tris-HCl [pH 6.8], 4% SDS, 20% glycerol, 1.4 M β-Mercapto ethanol), resolved by 8% SDS-PAGE and subjected to

[0418] 3. Western Blot

[0419] Proteins were transferred onto nitrocellulose membrane (nitrocellulose transfer membrane Protran BA 83, Schleicher and Schuell) using Towbin buffer (Towbin et al., 1979, PNAS, 76:4350-4354) and an electrotransfer device. After transfer, membranes were blocked, in 5% non-fat dried milk in TBST (10 mM Tris-HCl [pH 8.0], 150 mM NaCl, 0.05% Tween 20) supplemented with sodium azide (0.1%) for 2 hr, and then incubated for 16 hr at room temperature with the anti-Myc monoclonal antibody (Myc-Tag 9B11 monoclonal antibody, Cell Signaling) diluted 1:1000 in the same buffer. After several washes with TBST, the blot was incubated with a horseradish peroxidase-conjugated secondary antibody (Anti-mouse IgG, Fab specific, peroxidase conjugate, Sigma) diluted 1:5000 and developed using ECL Western blotting detection reagents (Amersham Biosciences).

Example 9 Electrophysiological Analysis

[0420] 1. Protocols

[0421] 1.1. cDNA Injection in Xenopus laevis Oocytes

[0422] The animal was anesthetized and pieces of the ovary were surgically removed and individual oocytes were dissected away in a saline solution (ND96) containinng 96 mM NaCl, 2 mM KCl, 2 mM CaCl2, 2 mM MgCl2 and 5 mM HEPES at pH 7.4. Stage V and VI oocytes were treated at room temperanre for 2h with collagenase type 1A (1 mg/ml) in the presence of 0.2 mg/ml trypsin inhibitor in saline solution to discard follicular cells. The concentrations were determined by measuring the absorbance at 260 nm. DNA corresponding to KCNQ2, 3H2 and 3H9 K+ channels were subcloned in PEKO vector in order to generate the respective cRNAS. cRNA concentrations were measured by absorbance at 260 nM. cRNA solutions were injected (about 50 nL/oocyte) using a pressure microinjector (Inject+matic, Geneve). Oocytes were then kept for 2-6 days in ND96 solution supplemented wirn 50U/mL penicillin and 50 U/mL streptomycin.

[0423] 1.2. Electrophysiological Measurements

[0424] In a 0.3 rmL perfusion chamber, a single oocyte was impaled with two standard glass microelectrode (0.5-2 Mohm resistance) filled with 3M KCl and maintained under voltage clamp using a Dagan TEV2OO amplifier system, USA. Electrical stimulations, data acquisition and analyses were performed using pClamp software (Axon Instruments, USA). Current to voltage relationships were obtained applying incremental depolarizing voltage steps (10 mV increment) from a holding potential of −80 mV (equilibrium potential for K+ ions) Repolarizations to −60 mV allowed K+ channel deactivation measurements from the “tail currents”.

[0425] 2. Results

[0426] The activity of KCNQ2-15bx and of KCNQ-15by homotetrameric potassium channels was tested and compared to the activity of KCNQ2-fl homotetrameric potassium channels. 0.2 ng or 0.4 ng of DNA were injected to the oocytes. The results are shown on FIG. 5, on which the intensity of the M-current generated by the potassium channels is indicated. An intensity of about 1 μA is found for the current generated by a of KCNQ2-fl homotetrameric potassium channel when 0.4 ng of DNA is injected. This value is similar to the value reported by scientific literature. A KCNQ2-15bx homotetrameric potassium channel yields a current of about 800 nA when 0.4 ng of DNA is injected, and a KCNQ2-15by homotetrameric potassium channel yields a courant of about 700 nA when 0.4 ng of DNA is injected. Thus the KCNQ2-15bx and KCNQ-15by splice variants can associate as functional homomeric potassium channels in vivo.

[0427]FIG. 6A and FIG. 6B show the voltage clamp traces corresponding to the currents generated at different voltages by KCNQ2-15bx (FIG. 6A) and by KCNQ2-15by (FIG. 6B) homotetrameric potassium channels. The slow activation that is observed on the traces is a characteristic feature of members of the KCNQ potassium channel family.

Example 10 Collection Of DNA Samples From Affected and Non-Affected Individuals.

[0428] Donors were unrelated and healthy. The DNA from 100 individuals was extracted and tested for the detection of the biallelic markers.

[0429] 30 ml of peripheral venous blood were taken from each donor in the presence of EDTA. Cells (pellet) were collected after centrifugation for 10 minutes at 2000 rpm. Red cells were lysed by a lysis solution (50 ml final volume: 10 mM Tris pH7.6; 5 mM MgCl₂; 10 mM NaCl). The solution was centrifuged (10 minutes, 2000 rpm) as many times as necessary to eliminate the residual red cells present in the supernatant, after resuspension of the pellet in the lysis solution.

[0430] The pellet of white cells was lysed overnight at 42° C. with 3.7 ml of lysis solution composed of:

[0431] 3 ml TE 10-2 (Tris-HCl 10 mM, EDTA 2 mM)/NaCl 0 4 M

[0432] 200 μl SDS 10%

[0433] 500 μl K-proteinase (2 mg K-proteinase in TE 10-2/NaCl 0.4 M).

[0434] For the extraction of proteins, 1 ml saturated NaCl (6M) (1/3.5 v/v) was added. After vigorous agitation, the solution was centrifuged for 20 minutes at 10000 rpm.

[0435] For the precipitation of DNA, 2 to 3 volumes of 100% ethanol were added to the previous supernatant, and the solution was centrifuged for 30 minutes at 2000 rpm. The DNA solution was rinsed three times with 70% ethanol to eliminate salts, and centrifuged for 20 minutes at 2000 rpm. The pellet was dried at 37° C., and resuspended in 1 ml TE 10-1 or 1 ml water. The DNA concentration was evaluated by measuring the OD at 260 nm (1 unit OD=50 μg/ml DNA). To determine the presence of proteins in the DNA solution, the OD 260/OD 280 ratio was determined. Only DNA preparations having a OD 260/OD 280 ratio between 1.8 and 2 were used in the subsequent examples described below.

[0436] The pool was constituted by mixing equivalent quantities of DNA from each individual.

Example 11 Amplification of Genomic DNA by PCR

[0437] The amplification of specific genomic sequences of the DNA samples of Example 10 was carried out on the pool of DNA obtained previously. In addition, 50 individual samples were similarly amplified.

[0438] PCR assays were performed using the following protocol: Final volume 25 μl DNA 2 ng/μl MgCl₂ 2 mM dNTP (each) 200 μM primer (each) 2.9 ng/μl Ampli Taq Gold DNA polymerase 0.05 unit/μl PCR buffer (10x = 0.1 M TrisHCl pH8.3 0.5 M KCl) 1x

[0439] Each pair of first primers was designed using the sequence information of genomic DNA sequences and the OSP software (Hillier & Green, 1991).

[0440] Primers Biallelic Markers Located in PPP2R2C

[0441] The genomic sequence of PPP2R2C that is shown as SEQ ID NO: 37 was constructed upon bioinformatic analysis based on (i) BAC clones constructed at Genset S.A.; (ii) BAC clones corresponding to EMBL Accesion Nos. AC114815.5, AC004599.6, AC122939.3 and AC004689.5; and (iii) RefseqN Accession No. NT_(—)006051. The polymorphisms were identified as described in examples 12 and 13, and validated as described in example 14.

[0442] Biallelic Markers Located in the KCNQ2 Gene

[0443] The biallelic markers located in the KCNQ2 gene were found using data provided by Celera. Each of these markers were further validated as described in example 14.

[0444] Table 2A indicates the position on SEQ ID NO: 37 of pairs of primers that were used to amplify specific regions of PPP2R2C. Table 2B indicates the position of the primers on SEQ ID Nos 42 to 47, which were used to amplify specific regions of KCNQ2. The orientation of the primer is indicated in the third column. The sign (+1) indicates that the sequence of the primer is identical to the corresponding region of SEQ ID Nos. 37 and 42 to 47. The sign (−1) indicates that the sequence of the primer is complementary to the corresponding region of SEQ ID Nos. 37 and 42 to 47. TABLE 2A Primer location in PPP2R2C Name of the Position on amplified region SEQ ID NO: 37 Orientation 24-257  109495 to 109512 (+1) 109963 to 109982 (−1) 99-24169 83709 to 83729 (+1) 84146 to 84164 (−1) 99-24175 117228 to 117248 (+1) 117659 to 117677 (−1) 24-247  99290 to 99309 (+1) 99719 to 99738 (−1)

[0445] TABLE 2B Primer location in the KCNQ2 gene Name of the amplified region SEQ ID No. Position Orientation 30-4  SEQ ID NO: 42 244 to 263 (+1) 324 to 343 (−1) 30-2  SEQ ID NO: 43 240 to 258 (+1) 319 to 338 (−1) 30-17 SEQ ID NO: 44 265 to 284 (+1) 345 to 364 (−1) 30-7  SEQ ID NO: 45 272 to 291 (+1) 315 to 333 (−1) 30-84 SEQ ID NO: 46 265 to 284 (+1) 334 to 353 (−1) 30-15 SEQ ID NO: 47 248 to 267 (+1) 312 to 331 (−1)

[0446] Preferably, the primers contained a common oligonucleotide tail upstream of the specific bases targeted for amplification which was useful for sequencing.

[0447] The synthesis of these primers was performed following the phosphoramidite method, on a GENSET UFPS 24.1 synthesizer.

[0448] DNA amplification was performed on a Genius II thermocycler. After heating at 95° C. for 10 min, 40 cycles were performed. Each cycle comprised: 30 sec at 95° C., 54° C. for 1 min, and 30 sec at 72° C. For final elongation, 10 min at 72° C. ended the amplification. The quantities of the amplification products obtained were determined on 96-well microtiter plates, using a fluorometer and Picogreen as intercalant agent (Molecular Probes).

Example 12 Identification of Biallelic Markers from Amplified Genomic DNA

[0449] The sequencing of the amplified DNA obtained in Example 11 was carried out on ABI 377 sequencers. The sequences of the amplification products were determined using automated dideoxy terminator sequencing reactions with a dye terminator cycle sequencing protocol. The products of the sequencing reactions were run on sequencing gels and the sequences were determined using gel image analysis (ABI Prism DNA Sequencing Analysis software (2.1.2 version)).

[0450] The sequence data were further evaluated to detect the presence of biallelic markers within the amplified fragments. The polymorphism search was based on the presence of superimposed peaks in the electrophoresis pattern resulting from different bases occurring at the same position as described previously.

[0451] The locations of the biallelic markers detected in the fragments of amplification are as shown below in Tables 3A and 3B. TABLE 3A Biallelic Markers in the PPP2R2C gene BM position on amplified polymorphism SEQ ID region BM name Strand All 1 All 2 NO: 37 24-257 24-257/320 (−) A G 109663  99-24169 99-24169/139 (−) A G 84026  99-24175 99-24175/218 (−) A G 117460 24-247 24-247/216 (+) A G 99505

[0452] TABLE 3B Biallelic Markers in the KCNQ2 gene BM position on indi- am- poly- cated plified morphism SEQ ID SEQ region BM name Strand All 1 All 2 No. ID No. 30-4  30-4/58 (+) A G SEQ ID NO: 42 301 30-2  30-2/62 (+) A G SEQ ID NO: 43 301 30-17 30-17/37 (+) A G SEQ ID NO: 44 301 30-7  30-7/30 (+) C T SEQ ID NO: 45 301 30-84 30-84/37 (+) A G SEQ ID NO: 46 301 30-15 30-15/54 (+) A C SEQ ID NO: 47 301

[0453] BM refers to “biallelic marker”. All 1 and All 2 refer respectively to allele 1 and allele 2 of the biallelic marker. The (+) or (−) sign in the column “strand of BM” indicates the strand on which the indicated alternative alleles are found. SEQ ID Nos. 37 and 42 to 47 correspond to strands (+). As a matter of example, the biallelic marker 24-257/320 corresponds to a polymorphism “a or g” at position 109663 on strand (−). Thus the nucleotide at position 109663 of SEQ ID NO: 37 will be “y”, which corresponds to “t or c” according to the standard PCT nomenclature. The biallelic marker 24-247/216 corresponds to a polymorphism “a or g” at position 99505 on strand (+). Thus the nucleotide at position 99505 of SEQ ID NO: 37 will be “r”, which corresponds to “a or g” according to the standard PCT nomenclature.

Example 13 Identification of Polymorphisms by Comparison of Genomic DNA from Overlapping BACs

[0454] Genomic DNA from multiple BAC clones derived from the same DNA donor sample and overlapping in regions of genomic DNA of SEQ ID NO: 37 was sequenced. Sequencing was carried out on ABI 377 sequencers. The sequences of the amplification products were determined using automated dideoxy terminator sequencing reactions with a dye terminator cycle sequencing protocol. The products of the sequencing reactions were run on sequencing gels and the sequences were determined using gel image analysis (ABI Prism DNA Sequencing Analysis software (2.1.2 version)).

Example 14 Validation Of The Polymorphisms Through Microsequencing

[0455] The biallelic markers identified in Examples 12 and 13 were further confirmed and their respective frequencies were determined through microsequencing. Microsequencing was carried out for each individual DNA sample described in Example 11.

[0456] Amplification from genomic DNA of individuals was performed by PCR as described above for the detection of the biallelic markers with the same set of PCR primers described in tables 1A and 1B.

[0457] The preferred primers used in microsequencing were about 19 nucleotides in length and hybridized just upstream of the considered polymorphic base. According to the invention, the primers used for microsequencing are detailed in tables 4A and 4B. TABLE 4A Primers in the PPP2R2C gene Orien- tation Position of the amplified of the primer on SEQ ID SEQ ID No. region Marker name primer NO: 37 of the primer 24-257   24-257/320 (+1) 109644 to 109662 SEQ ID NO: 40 99-24169 99-24169/139 (+1) 84007 to 84025 SEQ ID NO: 39 99-24175 99-24175/218 (+1) 117441 to 117459 SEQ ID NO: 41 24-247   24-247/216 (+1) 99486 to 99504 —

[0458] TABLE 4B Primers in the KCNQ2 gene Position of Orientation the primer amplified of the on indicated region Marker name primer SEQ ID No. SEQ ID No. 30-4   30-4/58 (−1) SEQ ID NO: 42 302 to 319 (primer B18) 30-4   30-4/58 (+1) SEQ ID NO: 42 282 to 300 (primer A19) 30-2   30-2/62 (−1) SEQ ID NO: 43 302 to 320 30-17 30-17/37 (−1) SEQ ID NO: 44 302 to 324 30-7   30-7/30 (+1) SEQ ID NO: 45 280 to 300 30-84 30-84/37 (−1) SEQ ID NO: 46 302 to 318 30-15 30-15/54 (−1) SEQ ID NO: 47 302 to 323

[0459] As for the primers in tables 2A and 2B, the sign (+1) in the column “orientation” indicates that the sequence of the primer is identical to the corresponding region of SEQ ID Nos. 37 and 42 to 47, and the sign (−1) indicates that the sequence of the primer is complementary to the corresponding region of SEQ ID Nos. 37 and 42 to 47.

[0460] The microsequencing reaction performed as follows. After purification of the amplification products, the microsequencing reaction mixture was prepared by adding, in a 20 μl final volume: 10 pmol microsequencing oligonucleotide, 1 U Thermosequenase (Amersham E79000G), 1.25 μl Thermosequenase buffer (260 mM Tris HCl pH 9.5, 65 mM MgCl₂), and the two appropriate fluorescent ddNTPs (Perkin Elmer, Dye Terminator Set 401095) complementary to the nucleotides at the polymorphic site of each biallelic marker tested, following the manufacturer's recommendations. After 4 minutes at 94° C., 20 PCR cycles of 15 sec at 55° C., 5 sec at 72° C., and 10 sec at 94° C. were carried out in a Tetrad PTC-225 thermocycler (MJ Research). The unincorporated dye terminators were then removed by ethanol precipitation. Samples were finally resuspended in formamide-EDTA loading buffer and heated for 2 min at 95° C. before being loaded on a polyacrylamide sequencing gel. The data were collected by an ABI PRISM 377 DNA sequencer and processed using the GENESCAN software (Perkin Elmer).

[0461] Following gel analysis, data were automatically processed with software that allows the determination of the alleles of biallelic markers present in each amplified fragment.

[0462] The software evaluates such factors as whether the intensities of the signals resulting from the above microsequencing procedures are weak, normal, or saturated, or whether the signals are ambiguous. In addition, the software identifies significant peaks (according to shape and height criteria). Among the significant peaks, peaks corresponding to the targeted site are identified based on their position. When two significant peaks are detected for the same position, each sample is categorized classification as homozygous or heterozygous type based on the height ratio.

Example 15 Association Study Between Bipolar Disorder and the Biallelic Markers Of the Invention

[0463] 5.1. Collection of DNA Samples From Affected And Non-Affected Individuals

[0464] The association studies were performed on two different populations. One collection of samples was provided by Hospital Pinero, Buenos-Aires, Argentina (the “Labimo” collection). The other collection of samples was provided by the University College of London (the “UCL” collection). Both collections are constituted by individuals that are affected or not by bipolar disease.

[0465] A) The Labimo Collection

[0466] a) Affected Population

[0467] 206 DNA samples from patients suffering from bipolar disorder (cases) were collected for genotyping analysis.

[0468] All patients fulfilled DSM-IV and ICD-10 criteria for bipolar type I (ICD-10: F30.x, F31.x) or bipolar type II (ICD-10: F31.8). All patients were of Caucasian ethnic origin up to the 2^(nd) generation.

[0469] All potential patients suffering from a medical disorder or from a drug abuse were excluded. According to DSM-IV criteria, 115 cases were classified as bipolar type I, 69 were bipolar type II, 22 were unclassified, and information concerning the type of bipolar disease was lacking in 20 cases (8.5%)

[0470] The main phenotypic data of the cases were as follows:

[0471] Mean age at first symptoms: 25.6 years (SD, 11; range, 8-58)

[0472] Mean age at inclusion: 43.3 years (SD, 13.8; range, 17-76)

[0473] Gender: 142 females and 84 males (ratio, 1.7)

[0474] Ethnic origin: 213 were European Caucasian, 7 were non-European Caucasians, and information was lacking in 6 cases (2.5%)

[0475] Family history of bipolar disease was found in 18.5%, whereas schizophrenia was found in 0.9%.

[0476] b) Unaffected Population

[0477] 201 DNA samples from individuals not suffering from bipolar disorder (controls) were collected for genotyping analysis.

[0478] All controls were individuals lacking personal or familial history of psychiatric disease.

[0479] The main phenotypic data of the controls were as follows:

[0480] Mean age: 43.8 years (SD, 12; range, 21-72)

[0481] Gender: 118 females and 83 males (ratio, 1.4) 180 controls were European Caucasian, and 21 had mixed ethnic origin

[0482] c) Cases and Control Populations Selected for the Association Study

[0483] The case control populations were matched for ethnicity and sex which resulted in 159 cases and 159 control individuals. Among the cases, 96 cases suffered from type I bipolar disease, 56 cases suffered from type II bipolar disease, and 7 cases suffered from an undetermined type of bipolar disease. 33.8% of the cases were males. The mean age of the cases was of 43 and the median age was of 44. 41.4% of the controls were males. The mean age of the controls was of 44 and the median age was of 46.

[0484] The presence of population structure can result in spurious association, which is an association between phenotypes and markers that is not linked to any causative loci but due to a different ethnic origin. The Fst test is a general statistical tool for analyzing variances and that can be used to verify that a collection is homogeneous, i.e., that found associations are not linked to the structure of the population. The Fst value is calculated using random markers that are (i) unlinked and (ii) not associated with the trait to be studied. An Fst value close to 0 indicates that the collection is homogeneous and that any significant associations that are found are due to the trait under investigation (see, e.g., Bruce S. Weir, Genetic Data Analysis II, Edition Sinauer, San Francisco and Hartl and Clark, Populations genetics, Edition Sinauer, San Francisco). 66 random markers that were (i) unlinked and (ii) not associated with bipolar disorder were used to calculate the Fst value. An Fst value of 1.68e-01 was found for the found in the Labimo collection, indicating that this collection is homogeneous.

[0485] B) The UCL Collection

[0486] a) Affected Population

[0487] 315 samples from patients suffering from bipolar disorder (cases) were collected for genotyping analysis.

[0488] All patients fulfilled DSM-IV criteria for bipolar type I (ICD-10: F30.x, F31.x) or bipolar type II (ICD-10: F31.8). All patients were unrelated individuals of Caucasian origins from the British Isles (including English, Welsh, Scottish and Irish) up to the 2^(nd) generation.

[0489] b) Unaffected Population

[0490] 300 samples fromunaffected control individuals (not suffering from bipolar disorder) were collected for genotyping analysis.

[0491] All control individuals showed (i) absence of personal history of psychiatric disease; and (ii) absence of familial history of psychiatric disease in first-degree relatives. All controls individuals of Caucasian origins from the British Isles (including English, Welsh, Scottish and Irish) up to the 2^(nd) generation.

[0492] c) Cases and Control Populations Selected for the Association Study

[0493] The population retained for the study was composed of 315 cases and 295 controls. Among the cases, 256 cases suffered from type I bipolar disease, 26 cases suffered from type II bipolar disease, and 33 cases suffered from an undetermined type of bipolar disease. About 36% of the cases were males. The mean age of the cases was of 46 and the median age was of 46. 48% of the controls were males. The mean age of the controls was of 37 and the median age was of 32.

[0494] 59 random markers that were (i) unlinked; and (ii) not associated with bipolar disorder were used to calculate the Fst value. A Fst value of 3.41e-01 was found for the UCL collection, indicating that this collection is homogeneous.

[0495] 5.2. Association Studies

[0496] A) Genotyping of Affected and Control Individuals

[0497] The general strategy to perform the association studies was to individually scan the DNA samples from all individuals in each of the populations described above in order to establish the allele frequencies of biallelic markers, and among them the biallelic markers of the invention, in the diploid genome of the tested individuals belonging to each of these populations.

[0498] Frequencies of every biallelic marker in each population (cases and controls) were determined by performing microsequencing reactions on amplified fragments obtained by genomic PCR performed on the DNA samples from each individual. Genomic PCR and microsequencing were performed as detailed above in Examples 11 to 13 using the described PCR primers and microsequencing primers.

[0499] B) Single biallelic Marker Frequency Analysis

[0500] The difference between the allelic frequencies in the unaffected population and in the population affected by bipolar disorder was calculated for all five markers located in the KCNQ2 gene, and for all four markers located in the PPP2R2C gene. The allelic frequency of markers between cases and controls were investigated using the Pearson Chi squared test for allelic frequency and genotypic frequency distributions. A significant difference between observed and expected alleles/genotypes of a specific marker between case and control populations implies an association between the gene harboring this particular biallelic marker and bipolar disease. Both allelic and genotypic p-values were calculated for all markers. The p-values in tables 5A and 5B indicate the probability of no association between a biallelic marker and bipolar disorder considering the frequency. A p-value under 5e-02 indicates a significant association between the biallelic marker and bipolar disorder.

[0501] Odds ratio determination is a way of comparing the probability of having the disease when carrying a given allele versus when not carrying the allele. An odds ratio higher than 1 indicates that the probability of having bipolar disease is higher when carrying one of the alternative alleles, haplotypes or genotypes than when carrying the other ones. The odds ratio allows the identification of the “risk” allele, haplotype or genotype for an associated biallelic marker. The genotypic odds ratio was calculated for one biallelic marker located in PPP2R2C and for two markers located in the KCNQ2 gene (tables 6A and 6B). TABLE 5A p-values for biallelic markers located in PPP2R2C Marker Location in Chosen All. Freq All. Odds Allelic Genotypic Name PPP2R2C Collection allele Diff. Ratio p-value p-value 99- Intron 1d UCL A 0.095 1.733 2.19e−04 3.61e−04 24169/139 Labimo A 0.002 1.012 9.46e−01 5.98e−01 24- Intron 4 UCL G 0.047 1.275 7.75e−02 2.29e−02 247/216 Labimo G 0.024 1.125 4.86e−01 7.65e−01 24- Intron 5 UCL A 0.018 1.079 5.52e−01 8.22e−01 257/320 Labimo A 0.102 1.557 4.04e−03 1.19e−02 99- Intron 5 UCL G 0.035 1.162 2.62e−01 3.99e−03 24175/218 Labimo A 0.096 1.546 6.69e−03 2.34e−02

[0502] TABLE 5B p-values for biallelic markers in the KCNQ2 gene Location in the KCNQ2 Chosen All. Freq All. Odds Allelic Genotypic Marker Name gene Collection allele Diff. Ratio p-value p-value 30-4/58  5′ of the UCL — — — — — gene Labimo G 0.03 1.24 3.03e−01 5.85e−01 30-2/62  intron 1 UCL A 0.05 1.23 7.76e−02 5.20e−03 Labimo A 0.03 1.13 4.42e−01 1.15e−01 30-17/37 intron 4 UCL A 0.01 1.03 7.77e−01 9.12e−01 Labimo G 0.03 1.13 4.70e−01 7.10e−01 30-7/30  intron 12 UCL C 0.05 1.21 1.05e−01 3.02e−02 Labimo C 0.02 1.06 7.03e−01 5.32e−01 30-84/37 3′ of UCL A 0.02 1.20 3.06e−01 3.69e−01 gene Labimo — — — — — 30-15/54 3′ of UCL A 0.01 1.06 6.92e−01 7.68e−01 gene Labimo — — — — —

[0503] TABLE 6A genotypic odds ratios for a biallelic marker located in PPP2R2C Biallelic marker collection genotype odds ratio p-value 99-24169/139 UCL AA vs GG 1.9 8.50e−02 AA vs AG 2.06 7.20e−05 AA vs 2.04 4.60e−05 (AG + GG)

[0504] TABLE 6B genotypic odds ratios for biallelic markers located in the KCNQ2 gene Biallelic marker collection genotype odds ratio p-value 30-2/62 UCL (AG + GG) vs AA 1.05 4.60E−01 AG vs AA 1.28 1.70E−01 AA vs GG 1.51 8.00E−02 AG vs (GG + AA) 1.62 3.00e−03 (AG + AA) vs GG 1.82 1.50e−03 30-7/30 UCL (CC + CT) vs TT 1.04 4.40E−01 TT vs CT 1.14 2.90E−01 (CC + TT) vs CT 1.37 3.80e−02 CC vs TT 1.58 3.80e−02 CC vs (TT + CT) 1.71 7.00e−03

[0505] Biallelic Markers in PPP2R2C

[0506] Thus the four studied biallelic markers located in the PPP2R2C gene are found to be significantly associated with bipolar disease. More specifically, 99-24169/139 is found to be highly associated with bipolar disorder in the UCL collection (significant allelic and genotypic p-values). 24-257/320 and 99-24175/218 are highly associated with bipolar disorder in the Labimo collection (significant allelic p-values). In addition, 99-24175/218 is also associated with bipolar disorder in the UCL collection (significant genotypic p-value). 24-247/216 is associated with bipolar disorder in the UCL collection (significant genotypic p-value).

[0507] The risk allele for the 99-24169/139 biallelic marker is “A”. The risk alleles for the 24-257/320 biallelic marker and for the 99-24175/218 biallelic marker are also “A”.

[0508] The risk genotype for the 99-24169/139 biallelic marker is “AA”. Thus an individual carrying the genotype “AA” at biallelic marker 99-24169/13 is at risk of developing bipolar disorder.

[0509] Biallelic Markers in the KCNQ2 Gene

[0510] Two biallelic markers located in the KCNQ2 gene, 30-2/62 and 30-7/30, are significantly associated with bipolar disease. More specifically, 30-2/62 is found to be highly associated with bipolar disorder in the UCL collection (significant allelic and genotypic p-values). 30-7/30 is associated with bipolar disorder in the UCL collection (significant genotypic p-value).

[0511] The risk genotype for 30-2/62 is “AG”. The risk genotype for 30-7/30 is “CC”. Thus individuals carrying the genotype “AG” at biallelic marker 30-2/62 and individuals carrying the genotype “CC” at biallelic marker 30-7/30 are at risk of developing bipolar disorder.

[0512] The association results of the single biallelic marker frequency analysis show that both the PPP2R2C gene and the KCNQ2 gene are associated with bipolar disorder. Accordingly, deregulation and/or dysfunction of KCNQ2 polypeptides and PP2A phosphatases comprising the PP2A/Bγ regulatory subunit contribute to the onset and to the development of bipolar disease.

[0513] C) Haplotype Frequency Analysis

[0514] One way of increasing the statistical power of individual markers is to perform haplotype association analysis. The analysis of haplotype frequencies cannot readily be derived from observed genotypic data. The EM (Expectation-Maximization) algorithm (Excoffier L & Slatkin M, 1995) allows the estimation of haplotypes for the population under investigation. Haplotype frequency estimations were performed by applying the OMNIBUS likelihood ratio test (PCT publication WO 01/091026)

[0515] The haplotype analysis was performed for two sets of markers located in PPP2R2C. The haplotype analysis for biallelic markers 24-257/320 and 99-24175/218 was performed in the Labimo collection. The haplotype analysis for biallelic markers 99-24169/139 and 24-247/216 was performed in the UCL collection. The results are shown in tables 7 (p-values) and 7B (odds ratios). TABLE 7A Ave SD Max markers Samples Haplotype Chi-S Chi-S Chi-S Chi-S p-value 24-257/320 Labimo AA 7.78 0.96 1.34 14.02  3.9e−03 and AG 0.02 1.02 1.40 11.19 8.79e−01 99-24175/218 GA 0.14 0.96 1.35 11.62 6.77e−01 GG 7.35 0.98 1.35 14.31  5.5e−03 99-24169/139 UCL AA 1,49641 1,03501 1,46687 14,67815 2.28e−01 and AG 5,19606 1,0854 1,52336 14,42852 2.73e−02 24-247/216 GA 13,91081 1,29859 1,81182 16,01507   5e−04 GG 0,42926 1,57482 2,19562 23,4845 6.03e−01

[0516] TABLE 7B markers haplotype overall cases controls odds ratio 24-257/320 AA 60.9% 65.9% 55.5% 1.55 and AG  2.8%  2.7%  2.9% 0.93 99-24175/218 GA  5.9%  5.5%  6.2% 0.88 GG 30.4% 25.8% 35.4% 0.64 99-24169/139 and AA 60.0% 62.0% 58.2% 1.17 24-247/216 AG 17.4% 20.0% 14.5% 1.47 GA 13.6%  9.5% 17.6% 0.49 GG  8.9%  8.5%  9.7% 0.86

[0517] The risk haplotype for 24-257/320 and 99-24175/218 is “AA”. The risk haplotype for 99-24169/139 and 24-247/216 is “AG”. Thus an individual carrying the haplotype “AA” at biallelic markers 24-257/320 and 99-24175/218 is at risk of developing bipolar disorder, and an individual carrying the haplotype “AG” at biallelic markers 99-24169/139 and 24-247/216 is also at risk of developing bipolar disorder.

REFERENCES

[0518] 1. Agostinis et al. (1996) Eur J Biochem. 236:548-557

[0519] 2. Altschul et al. (1990) J Mol Biol, 215:403-410

[0520] 3. Altschul et al., (1997) Nucleic Acids Res., 25:389-402

[0521] 4. Andrieux et al. (2002) Genes Dev., 16:2350-2364

[0522] 5. Borresen et al. (1988) Mutat Res. 202:77-83

[0523] 6. Dempster et al. (1977) JRSSB, 39:1-38

[0524] 7. Detera-Wadleigh et al. (1999) Proc Natl Acad Sci USA, A96(10):5604-5609

[0525] 8. Devereux et al. (1984) Nucleic Acids Res., 12:387-395

[0526] 9. Elbashir et al. (2001) Genes Dev. 15:188-200

[0527] 10. Ellington and Szostak (1990) Nature 346:818-822

[0528] 11. Excoffier and Slatkin, (1995) Mol Biol Evol. 12:921-7

[0529] 12. Grantham (1974) Science, 185:862-864

[0530] 13. Grompe et al. (1989) Proc Natl Acad Sci USA. 86:5888-5892

[0531] 14. Hu et al. (2000) Genomics., 67:83-86

[0532] 15. Janssens and Goris (2001) Biochem J. 353:417-439

[0533] 16. Kaelin et al. (1991) Cell, 64:521-532

[0534] 17. Kaelin et al. (1992) Cell, 70:351-364

[0535] 18. Kamibayashi et al. (1994) J Biol. Chem. 269:20139-20148

[0536] 19. Kim et al. (2003) Anal Biochem. 316:251-258

[0537] 20. Lessa et al. (1993) Mol Ecol. 2:119-129

[0538] 21. Newton et al. (1989) Nucleic Acids Res. 17:2503-2516

[0539] 22. Orita et al. (1989) Proc Natl Acad Sci USA 86:2766-2770

[0540] 23. Pan et al. (2001) J. Physiol., 531:347-358

[0541] 24. Pearson (1990) Methods in Enzymology, 183:63-99

[0542] 25. Pearson and Lipman (1988) Proc Nat Acad Sci USA, 85:2444-2448

[0543] 26. Price et al. (2000) Biochemistry. 39:11312-11318

[0544] 27. Ruano et al. (1990) Proc. Natl. Acad. Sci. USA. 87:6296-6300

[0545] 28. Sarkar and Sommer, (1991) Biotechniques. 10:436-440

[0546] 29. Schwake et al. (2000) J. Biol. Chem., 275:13343-13348

[0547] 30. Smith and Waterman (1981) Advances in Applied Mathematics, 2:482-489

[0548] 31. Strack et al. (1998) J Comp Neurol. 1998 392:515-527.

[0549] 32. Towbin et al. (1979) Proc Nat Acad Sci USA, 76:4350-4354

[0550] 33. Usui et al. (1988) J Biol. Chem. 263:3752-3761

[0551] 34. Wen et al. (2003) World J Gastroenterol. 9:1342-1346

[0552] 35. Wu et al. (1989) Proc. Natl. Acad. Sci. USA. 86:2757-2760

1 69 1 1932 DNA Homo sapiens CDS (1)..(1932) 1 atg gtg cag aag tcg cgc aac ggc ggc gta tac ccc ggc ccg agc ggg 48 Met Val Gln Lys Ser Arg Asn Gly Gly Val Tyr Pro Gly Pro Ser Gly 1 5 10 15 gag aag aag ctg aag gtg ggc ttc gtg ggg ctg gac ccc ggc gcg ccc 96 Glu Lys Lys Leu Lys Val Gly Phe Val Gly Leu Asp Pro Gly Ala Pro 20 25 30 gac tcc acc cgg gac ggg gcg ctg ctg atc gcc ggc tcc gag gcc ccc 144 Asp Ser Thr Arg Asp Gly Ala Leu Leu Ile Ala Gly Ser Glu Ala Pro 35 40 45 aag cgc ggc agc atc ctc agc aaa cct cgc gcg ggc ggc gcg ggc gcc 192 Lys Arg Gly Ser Ile Leu Ser Lys Pro Arg Ala Gly Gly Ala Gly Ala 50 55 60 ggg aag ccc ccc aag cgc aac gcc ttc tac cgc aag ctg cag aat ttc 240 Gly Lys Pro Pro Lys Arg Asn Ala Phe Tyr Arg Lys Leu Gln Asn Phe 65 70 75 80 ctc tac aac gtg ctg gag cgg ccg cgc ggc tgg gcg ttc atc tac cac 288 Leu Tyr Asn Val Leu Glu Arg Pro Arg Gly Trp Ala Phe Ile Tyr His 85 90 95 gcc tac gtg ttc ctc ctg gtt ttc tcc tgc ctc gtg ctg tct gtg ttt 336 Ala Tyr Val Phe Leu Leu Val Phe Ser Cys Leu Val Leu Ser Val Phe 100 105 110 tcc acc atc aag gag tat gag aag agc tcg gag ggg gcc ctc tac atc 384 Ser Thr Ile Lys Glu Tyr Glu Lys Ser Ser Glu Gly Ala Leu Tyr Ile 115 120 125 ctg gaa atc gtg act atc gtg gtg ttt ggc gtg gag tac ttc gtg cgg 432 Leu Glu Ile Val Thr Ile Val Val Phe Gly Val Glu Tyr Phe Val Arg 130 135 140 atc tgg gcc gca ggc tgc tgc tgc cgg tac cgt ggc tgg agg ggg cgg 480 Ile Trp Ala Ala Gly Cys Cys Cys Arg Tyr Arg Gly Trp Arg Gly Arg 145 150 155 160 ctc aag ttt gcc cgg aaa ccg ttc tgt gtg att gac atc atg gtg ctc 528 Leu Lys Phe Ala Arg Lys Pro Phe Cys Val Ile Asp Ile Met Val Leu 165 170 175 atc gcc tcc att gcg gtg ctg gcc gcc ggc tcc cag ggc aac gtc ttt 576 Ile Ala Ser Ile Ala Val Leu Ala Ala Gly Ser Gln Gly Asn Val Phe 180 185 190 gcc aca tct gcg ctc cgg agc ctg cgc ttc ctg cag att ctg cgg atg 624 Ala Thr Ser Ala Leu Arg Ser Leu Arg Phe Leu Gln Ile Leu Arg Met 195 200 205 atc cgc atg gac cgg cgg gga ggc acc tgg aag ctg ctg ggc tct gtg 672 Ile Arg Met Asp Arg Arg Gly Gly Thr Trp Lys Leu Leu Gly Ser Val 210 215 220 gtc tat gcc cac agc aag gag ctg gtc act gcc tgg tac atc ggc ttc 720 Val Tyr Ala His Ser Lys Glu Leu Val Thr Ala Trp Tyr Ile Gly Phe 225 230 235 240 ctt tgt ctc atc ctg gcc tcg ttc ctg gtg tac ttg gca gag aag ggg 768 Leu Cys Leu Ile Leu Ala Ser Phe Leu Val Tyr Leu Ala Glu Lys Gly 245 250 255 gag aac gac cac ttt gac acc tac gcg gat gca ctc tgg tgg ggc ctg 816 Glu Asn Asp His Phe Asp Thr Tyr Ala Asp Ala Leu Trp Trp Gly Leu 260 265 270 atc acg ctg acc acc att ggc tac ggg gac aag tac ccc cag acc tgg 864 Ile Thr Leu Thr Thr Ile Gly Tyr Gly Asp Lys Tyr Pro Gln Thr Trp 275 280 285 aac ggc agg ctc ctt gcg gca acc ttc acc ctc atc ggt gtc tcc ttc 912 Asn Gly Arg Leu Leu Ala Ala Thr Phe Thr Leu Ile Gly Val Ser Phe 290 295 300 ttc gcg ctg cct gca ggc atc ttg ggg tct ggg ttt gcc ctg aag gtt 960 Phe Ala Leu Pro Ala Gly Ile Leu Gly Ser Gly Phe Ala Leu Lys Val 305 310 315 320 cag gag cag cac agg cag aag cac ttt gag aag agg cgg aac ccg gca 1008 Gln Glu Gln His Arg Gln Lys His Phe Glu Lys Arg Arg Asn Pro Ala 325 330 335 gca ggc ctg atc cag tcg gcc tgg aga ttc tac gcc acc aac ctc tcg 1056 Ala Gly Leu Ile Gln Ser Ala Trp Arg Phe Tyr Ala Thr Asn Leu Ser 340 345 350 cgc aca gac ctg cac tcc acg tgg cag tac tac gag cga acg gtc acc 1104 Arg Thr Asp Leu His Ser Thr Trp Gln Tyr Tyr Glu Arg Thr Val Thr 355 360 365 gtg ccc atg tac agt tcg caa act caa acc tac ggg gcc tcc aga ctt 1152 Val Pro Met Tyr Ser Ser Gln Thr Gln Thr Tyr Gly Ala Ser Arg Leu 370 375 380 atc ccc ccg ctg aac cag ctg gag ctg ctg agg aac ctc aag agt aaa 1200 Ile Pro Pro Leu Asn Gln Leu Glu Leu Leu Arg Asn Leu Lys Ser Lys 385 390 395 400 tct gga ctc gct ttc agg aag gac ccc ccg ccg gag ccg tct cca agt 1248 Ser Gly Leu Ala Phe Arg Lys Asp Pro Pro Pro Glu Pro Ser Pro Ser 405 410 415 aaa ggc agc ccg tgc aga ggg ccc ctg tgt gga tgc tgc ccc gga cgc 1296 Lys Gly Ser Pro Cys Arg Gly Pro Leu Cys Gly Cys Cys Pro Gly Arg 420 425 430 tct agc cag aag gtc agt ttg aaa gat cgt gtc ttc tcc agc ccc cga 1344 Ser Ser Gln Lys Val Ser Leu Lys Asp Arg Val Phe Ser Ser Pro Arg 435 440 445 ggc gtg gct gcc aag ggg aag ggg tcc ccg cag gcc cag act gtg agg 1392 Gly Val Ala Ala Lys Gly Lys Gly Ser Pro Gln Ala Gln Thr Val Arg 450 455 460 cgg tca ccc agc gcc gac cag agc ctc gag gac agc ccc agc aag gtg 1440 Arg Ser Pro Ser Ala Asp Gln Ser Leu Glu Asp Ser Pro Ser Lys Val 465 470 475 480 ccc aag agc tgg agc ttc ggg gac cgc agc cgg gca cgc cag gct ttc 1488 Pro Lys Ser Trp Ser Phe Gly Asp Arg Ser Arg Ala Arg Gln Ala Phe 485 490 495 cgc atc aag ggt gcc gcg tca cgg cag aac tca gaa gaa gca agc ctc 1536 Arg Ile Lys Gly Ala Ala Ser Arg Gln Asn Ser Glu Glu Ala Ser Leu 500 505 510 ccc gga gag gac att gtg gat gac aag agc tgc ccc tgc gag ttt gtg 1584 Pro Gly Glu Asp Ile Val Asp Asp Lys Ser Cys Pro Cys Glu Phe Val 515 520 525 acc gag gac ctg acc ccg ggc ctc aaa gtc agc atc aga gcc gtg tgt 1632 Thr Glu Asp Leu Thr Pro Gly Leu Lys Val Ser Ile Arg Ala Val Cys 530 535 540 gtc atg cgg ttc ctg gtg tcc aag cgg aag ttc aag gag agc ctg cgg 1680 Val Met Arg Phe Leu Val Ser Lys Arg Lys Phe Lys Glu Ser Leu Arg 545 550 555 560 ccc tac gac gtg atg gac gtc atc gag cag tac tca gcc ggc cac ctg 1728 Pro Tyr Asp Val Met Asp Val Ile Glu Gln Tyr Ser Ala Gly His Leu 565 570 575 gac atg ctg tcc cga att aag agc ctg cag tcc agg caa gag ccc cgc 1776 Asp Met Leu Ser Arg Ile Lys Ser Leu Gln Ser Arg Gln Glu Pro Arg 580 585 590 ctg cct gtc cag cag ggg aca aga acg ggg tgg gct tct ggg aca aag 1824 Leu Pro Val Gln Gln Gly Thr Arg Thr Gly Trp Ala Ser Gly Thr Lys 595 600 605 ccc act gtg gcc cat ggt ggg agt gca ggg ggt gtg tgg gcg ggg cct 1872 Pro Thr Val Ala His Gly Gly Ser Ala Gly Gly Val Trp Ala Gly Pro 610 615 620 cct ccc cac cca cgt cgg cct ctg tca gct tct gtt gtg tct tca caa 1920 Pro Pro His Pro Arg Arg Pro Leu Ser Ala Ser Val Val Ser Ser Gln 625 630 635 640 agt ctg ttt taa 1932 Ser Leu Phe 2 643 PRT Homo sapiens 2 Met Val Gln Lys Ser Arg Asn Gly Gly Val Tyr Pro Gly Pro Ser Gly 1 5 10 15 Glu Lys Lys Leu Lys Val Gly Phe Val Gly Leu Asp Pro Gly Ala Pro 20 25 30 Asp Ser Thr Arg Asp Gly Ala Leu Leu Ile Ala Gly Ser Glu Ala Pro 35 40 45 Lys Arg Gly Ser Ile Leu Ser Lys Pro Arg Ala Gly Gly Ala Gly Ala 50 55 60 Gly Lys Pro Pro Lys Arg Asn Ala Phe Tyr Arg Lys Leu Gln Asn Phe 65 70 75 80 Leu Tyr Asn Val Leu Glu Arg Pro Arg Gly Trp Ala Phe Ile Tyr His 85 90 95 Ala Tyr Val Phe Leu Leu Val Phe Ser Cys Leu Val Leu Ser Val Phe 100 105 110 Ser Thr Ile Lys Glu Tyr Glu Lys Ser Ser Glu Gly Ala Leu Tyr Ile 115 120 125 Leu Glu Ile Val Thr Ile Val Val Phe Gly Val Glu Tyr Phe Val Arg 130 135 140 Ile Trp Ala Ala Gly Cys Cys Cys Arg Tyr Arg Gly Trp Arg Gly Arg 145 150 155 160 Leu Lys Phe Ala Arg Lys Pro Phe Cys Val Ile Asp Ile Met Val Leu 165 170 175 Ile Ala Ser Ile Ala Val Leu Ala Ala Gly Ser Gln Gly Asn Val Phe 180 185 190 Ala Thr Ser Ala Leu Arg Ser Leu Arg Phe Leu Gln Ile Leu Arg Met 195 200 205 Ile Arg Met Asp Arg Arg Gly Gly Thr Trp Lys Leu Leu Gly Ser Val 210 215 220 Val Tyr Ala His Ser Lys Glu Leu Val Thr Ala Trp Tyr Ile Gly Phe 225 230 235 240 Leu Cys Leu Ile Leu Ala Ser Phe Leu Val Tyr Leu Ala Glu Lys Gly 245 250 255 Glu Asn Asp His Phe Asp Thr Tyr Ala Asp Ala Leu Trp Trp Gly Leu 260 265 270 Ile Thr Leu Thr Thr Ile Gly Tyr Gly Asp Lys Tyr Pro Gln Thr Trp 275 280 285 Asn Gly Arg Leu Leu Ala Ala Thr Phe Thr Leu Ile Gly Val Ser Phe 290 295 300 Phe Ala Leu Pro Ala Gly Ile Leu Gly Ser Gly Phe Ala Leu Lys Val 305 310 315 320 Gln Glu Gln His Arg Gln Lys His Phe Glu Lys Arg Arg Asn Pro Ala 325 330 335 Ala Gly Leu Ile Gln Ser Ala Trp Arg Phe Tyr Ala Thr Asn Leu Ser 340 345 350 Arg Thr Asp Leu His Ser Thr Trp Gln Tyr Tyr Glu Arg Thr Val Thr 355 360 365 Val Pro Met Tyr Ser Ser Gln Thr Gln Thr Tyr Gly Ala Ser Arg Leu 370 375 380 Ile Pro Pro Leu Asn Gln Leu Glu Leu Leu Arg Asn Leu Lys Ser Lys 385 390 395 400 Ser Gly Leu Ala Phe Arg Lys Asp Pro Pro Pro Glu Pro Ser Pro Ser 405 410 415 Lys Gly Ser Pro Cys Arg Gly Pro Leu Cys Gly Cys Cys Pro Gly Arg 420 425 430 Ser Ser Gln Lys Val Ser Leu Lys Asp Arg Val Phe Ser Ser Pro Arg 435 440 445 Gly Val Ala Ala Lys Gly Lys Gly Ser Pro Gln Ala Gln Thr Val Arg 450 455 460 Arg Ser Pro Ser Ala Asp Gln Ser Leu Glu Asp Ser Pro Ser Lys Val 465 470 475 480 Pro Lys Ser Trp Ser Phe Gly Asp Arg Ser Arg Ala Arg Gln Ala Phe 485 490 495 Arg Ile Lys Gly Ala Ala Ser Arg Gln Asn Ser Glu Glu Ala Ser Leu 500 505 510 Pro Gly Glu Asp Ile Val Asp Asp Lys Ser Cys Pro Cys Glu Phe Val 515 520 525 Thr Glu Asp Leu Thr Pro Gly Leu Lys Val Ser Ile Arg Ala Val Cys 530 535 540 Val Met Arg Phe Leu Val Ser Lys Arg Lys Phe Lys Glu Ser Leu Arg 545 550 555 560 Pro Tyr Asp Val Met Asp Val Ile Glu Gln Tyr Ser Ala Gly His Leu 565 570 575 Asp Met Leu Ser Arg Ile Lys Ser Leu Gln Ser Arg Gln Glu Pro Arg 580 585 590 Leu Pro Val Gln Gln Gly Thr Arg Thr Gly Trp Ala Ser Gly Thr Lys 595 600 605 Pro Thr Val Ala His Gly Gly Ser Ala Gly Gly Val Trp Ala Gly Pro 610 615 620 Pro Pro His Pro Arg Arg Pro Leu Ser Ala Ser Val Val Ser Ser Gln 625 630 635 640 Ser Leu Phe 3 1878 DNA Homo sapiens CDS (1)..(1878) 3 atg gtg cag aag tcg cgc aac ggc ggc gta tac ccc ggc ccg agc ggg 48 Met Val Gln Lys Ser Arg Asn Gly Gly Val Tyr Pro Gly Pro Ser Gly 1 5 10 15 gag aag aag ctg aag gtg ggc ttc gtg ggg ctg gac ccc ggc gcg ccc 96 Glu Lys Lys Leu Lys Val Gly Phe Val Gly Leu Asp Pro Gly Ala Pro 20 25 30 gac tcc acc cgg gac ggg gcg ctg ctg atc gcc ggc tcc gag gcc ccc 144 Asp Ser Thr Arg Asp Gly Ala Leu Leu Ile Ala Gly Ser Glu Ala Pro 35 40 45 aag cgc ggc agc atc ctc agc aaa cct cgc gcg ggc ggc gcg ggc gcc 192 Lys Arg Gly Ser Ile Leu Ser Lys Pro Arg Ala Gly Gly Ala Gly Ala 50 55 60 ggg aag ccc ccc aag cgc aac gcc ttc tac cgc aag ctg cag aat ttc 240 Gly Lys Pro Pro Lys Arg Asn Ala Phe Tyr Arg Lys Leu Gln Asn Phe 65 70 75 80 ctc tac aac gtg ctg gag cgg ccg cgc ggc tgg gcg ttc atc tac cac 288 Leu Tyr Asn Val Leu Glu Arg Pro Arg Gly Trp Ala Phe Ile Tyr His 85 90 95 gcc tac gtg ttc ctc ctg gtt ttc tcc tgc ctc gtg ctg tct gtg ttt 336 Ala Tyr Val Phe Leu Leu Val Phe Ser Cys Leu Val Leu Ser Val Phe 100 105 110 tcc acc atc aag gag tat gag aag agc tcg gag ggg gcc ctc tac atc 384 Ser Thr Ile Lys Glu Tyr Glu Lys Ser Ser Glu Gly Ala Leu Tyr Ile 115 120 125 ctg gaa atc gtg act atc gtg gtg ttt ggc gtg gag tac ttc gtg cgg 432 Leu Glu Ile Val Thr Ile Val Val Phe Gly Val Glu Tyr Phe Val Arg 130 135 140 atc tgg gcc gca ggc tgc tgc tgc cgg tac cgt ggc tgg agg ggg cgg 480 Ile Trp Ala Ala Gly Cys Cys Cys Arg Tyr Arg Gly Trp Arg Gly Arg 145 150 155 160 ctc aag ttt gcc cgg aaa ccg ttc tgt gtg att gac atc atg gtg ctc 528 Leu Lys Phe Ala Arg Lys Pro Phe Cys Val Ile Asp Ile Met Val Leu 165 170 175 atc gcc tcc att gcg gtg ctg gcc gcc ggc tcc cag ggc aac gtc ttt 576 Ile Ala Ser Ile Ala Val Leu Ala Ala Gly Ser Gln Gly Asn Val Phe 180 185 190 gcc aca tct gcg ctc cgg agc ctg cgc ttc ctg cag att ctg cgg atg 624 Ala Thr Ser Ala Leu Arg Ser Leu Arg Phe Leu Gln Ile Leu Arg Met 195 200 205 atc cgc atg gac cgg cgg gga ggc acc tgg aag ctg ctg ggc tct gtg 672 Ile Arg Met Asp Arg Arg Gly Gly Thr Trp Lys Leu Leu Gly Ser Val 210 215 220 gtc tat gcc cac agc aag gag ctg gtc act gcc tgg tac atc ggc ttc 720 Val Tyr Ala His Ser Lys Glu Leu Val Thr Ala Trp Tyr Ile Gly Phe 225 230 235 240 ctt tgt ctc atc ctg gcc tcg ttc ctg gtg tac ttg gca gag aag ggg 768 Leu Cys Leu Ile Leu Ala Ser Phe Leu Val Tyr Leu Ala Glu Lys Gly 245 250 255 gag aac gac cac ttt gac acc tac gcg gat gca ctc tgg tgg ggc ctg 816 Glu Asn Asp His Phe Asp Thr Tyr Ala Asp Ala Leu Trp Trp Gly Leu 260 265 270 atc acg ctg acc acc att ggc tac ggg gac aag tac ccc cag acc tgg 864 Ile Thr Leu Thr Thr Ile Gly Tyr Gly Asp Lys Tyr Pro Gln Thr Trp 275 280 285 aac ggc agg ctc ctt gcg gca acc ttc acc ctc atc ggt gtc tcc ttc 912 Asn Gly Arg Leu Leu Ala Ala Thr Phe Thr Leu Ile Gly Val Ser Phe 290 295 300 ttc gcg ctg cct gca ggc atc ttg ggg tct ggg ttt gcc ctg aag gtt 960 Phe Ala Leu Pro Ala Gly Ile Leu Gly Ser Gly Phe Ala Leu Lys Val 305 310 315 320 cag gag cag cac agg cag aag cac ttt gag aag agg cgg aac ccg gca 1008 Gln Glu Gln His Arg Gln Lys His Phe Glu Lys Arg Arg Asn Pro Ala 325 330 335 gca ggc ctg atc cag tcg gcc tgg aga ttc tac gcc acc aac ctc tcg 1056 Ala Gly Leu Ile Gln Ser Ala Trp Arg Phe Tyr Ala Thr Asn Leu Ser 340 345 350 cgc aca gac ctg cac tcc acg tgg cag tac tac gag cga acg gtc acc 1104 Arg Thr Asp Leu His Ser Thr Trp Gln Tyr Tyr Glu Arg Thr Val Thr 355 360 365 gtg ccc atg tac agt tcg caa act caa acc tac ggg gcc tcc aga ctt 1152 Val Pro Met Tyr Ser Ser Gln Thr Gln Thr Tyr Gly Ala Ser Arg Leu 370 375 380 atc ccc ccg ctg aac cag ctg gag ctg ctg agg aac ctc aag agt aaa 1200 Ile Pro Pro Leu Asn Gln Leu Glu Leu Leu Arg Asn Leu Lys Ser Lys 385 390 395 400 tct gga ctc gct ttc agg aag gac ccc ccg ccg gag ccg tct cca agc 1248 Ser Gly Leu Ala Phe Arg Lys Asp Pro Pro Pro Glu Pro Ser Pro Ser 405 410 415 cag aag gtc agt ttg aaa gat cgt gtc ttc tcc agc ccc cga ggc gtg 1296 Gln Lys Val Ser Leu Lys Asp Arg Val Phe Ser Ser Pro Arg Gly Val 420 425 430 gct gcc aag ggg aag ggg tcc ccg cag gcc cag act gtg agg cgg tca 1344 Ala Ala Lys Gly Lys Gly Ser Pro Gln Ala Gln Thr Val Arg Arg Ser 435 440 445 ccc agc gcc gac cag agc ctc gag gac agc ccc agc aag gtg ccc aag 1392 Pro Ser Ala Asp Gln Ser Leu Glu Asp Ser Pro Ser Lys Val Pro Lys 450 455 460 agc tgg agc ttc ggg gac cgc agc cgg gca cgc cag gct ttc cgc atc 1440 Ser Trp Ser Phe Gly Asp Arg Ser Arg Ala Arg Gln Ala Phe Arg Ile 465 470 475 480 aag ggt gcc gcg tca cgg cag aac tca gaa gaa gca agc ctc ccc gga 1488 Lys Gly Ala Ala Ser Arg Gln Asn Ser Glu Glu Ala Ser Leu Pro Gly 485 490 495 gag gac att gtg gat gac aag agc tgc ccc tgc gag ttt gtg acc gag 1536 Glu Asp Ile Val Asp Asp Lys Ser Cys Pro Cys Glu Phe Val Thr Glu 500 505 510 gac ctg acc ccg ggc ctc aaa gtc agc atc aga gcc gtg tgt gtc atg 1584 Asp Leu Thr Pro Gly Leu Lys Val Ser Ile Arg Ala Val Cys Val Met 515 520 525 cgg ttc ctg gtg tcc aag cgg aag ttc aag gag agc ctg cgg ccc tac 1632 Arg Phe Leu Val Ser Lys Arg Lys Phe Lys Glu Ser Leu Arg Pro Tyr 530 535 540 gac gtg atg gac gtc atc gag cag tac tca gcc ggc cac ctg gac atg 1680 Asp Val Met Asp Val Ile Glu Gln Tyr Ser Ala Gly His Leu Asp Met 545 550 555 560 ctg tcc cga att aag agc ctg cag tcc agg caa gag ccc cgc ctg cct 1728 Leu Ser Arg Ile Lys Ser Leu Gln Ser Arg Gln Glu Pro Arg Leu Pro 565 570 575 gtc cag cag ggg aca aga acg ggg tgg gct tct ggg aca aag ccc act 1776 Val Gln Gln Gly Thr Arg Thr Gly Trp Ala Ser Gly Thr Lys Pro Thr 580 585 590 gtg gcc cat ggt ggg agt gca ggg ggt gtg tgg gcg ggg cct cct ccc 1824 Val Ala His Gly Gly Ser Ala Gly Gly Val Trp Ala Gly Pro Pro Pro 595 600 605 cac cca cgt cgg cct ctg tca gct tct gtt gtg tct tca caa agt ctg 1872 His Pro Arg Arg Pro Leu Ser Ala Ser Val Val Ser Ser Gln Ser Leu 610 615 620 ttt taa 1878 Phe 625 4 625 PRT Homo sapiens 4 Met Val Gln Lys Ser Arg Asn Gly Gly Val Tyr Pro Gly Pro Ser Gly 1 5 10 15 Glu Lys Lys Leu Lys Val Gly Phe Val Gly Leu Asp Pro Gly Ala Pro 20 25 30 Asp Ser Thr Arg Asp Gly Ala Leu Leu Ile Ala Gly Ser Glu Ala Pro 35 40 45 Lys Arg Gly Ser Ile Leu Ser Lys Pro Arg Ala Gly Gly Ala Gly Ala 50 55 60 Gly Lys Pro Pro Lys Arg Asn Ala Phe Tyr Arg Lys Leu Gln Asn Phe 65 70 75 80 Leu Tyr Asn Val Leu Glu Arg Pro Arg Gly Trp Ala Phe Ile Tyr His 85 90 95 Ala Tyr Val Phe Leu Leu Val Phe Ser Cys Leu Val Leu Ser Val Phe 100 105 110 Ser Thr Ile Lys Glu Tyr Glu Lys Ser Ser Glu Gly Ala Leu Tyr Ile 115 120 125 Leu Glu Ile Val Thr Ile Val Val Phe Gly Val Glu Tyr Phe Val Arg 130 135 140 Ile Trp Ala Ala Gly Cys Cys Cys Arg Tyr Arg Gly Trp Arg Gly Arg 145 150 155 160 Leu Lys Phe Ala Arg Lys Pro Phe Cys Val Ile Asp Ile Met Val Leu 165 170 175 Ile Ala Ser Ile Ala Val Leu Ala Ala Gly Ser Gln Gly Asn Val Phe 180 185 190 Ala Thr Ser Ala Leu Arg Ser Leu Arg Phe Leu Gln Ile Leu Arg Met 195 200 205 Ile Arg Met Asp Arg Arg Gly Gly Thr Trp Lys Leu Leu Gly Ser Val 210 215 220 Val Tyr Ala His Ser Lys Glu Leu Val Thr Ala Trp Tyr Ile Gly Phe 225 230 235 240 Leu Cys Leu Ile Leu Ala Ser Phe Leu Val Tyr Leu Ala Glu Lys Gly 245 250 255 Glu Asn Asp His Phe Asp Thr Tyr Ala Asp Ala Leu Trp Trp Gly Leu 260 265 270 Ile Thr Leu Thr Thr Ile Gly Tyr Gly Asp Lys Tyr Pro Gln Thr Trp 275 280 285 Asn Gly Arg Leu Leu Ala Ala Thr Phe Thr Leu Ile Gly Val Ser Phe 290 295 300 Phe Ala Leu Pro Ala Gly Ile Leu Gly Ser Gly Phe Ala Leu Lys Val 305 310 315 320 Gln Glu Gln His Arg Gln Lys His Phe Glu Lys Arg Arg Asn Pro Ala 325 330 335 Ala Gly Leu Ile Gln Ser Ala Trp Arg Phe Tyr Ala Thr Asn Leu Ser 340 345 350 Arg Thr Asp Leu His Ser Thr Trp Gln Tyr Tyr Glu Arg Thr Val Thr 355 360 365 Val Pro Met Tyr Ser Ser Gln Thr Gln Thr Tyr Gly Ala Ser Arg Leu 370 375 380 Ile Pro Pro Leu Asn Gln Leu Glu Leu Leu Arg Asn Leu Lys Ser Lys 385 390 395 400 Ser Gly Leu Ala Phe Arg Lys Asp Pro Pro Pro Glu Pro Ser Pro Ser 405 410 415 Gln Lys Val Ser Leu Lys Asp Arg Val Phe Ser Ser Pro Arg Gly Val 420 425 430 Ala Ala Lys Gly Lys Gly Ser Pro Gln Ala Gln Thr Val Arg Arg Ser 435 440 445 Pro Ser Ala Asp Gln Ser Leu Glu Asp Ser Pro Ser Lys Val Pro Lys 450 455 460 Ser Trp Ser Phe Gly Asp Arg Ser Arg Ala Arg Gln Ala Phe Arg Ile 465 470 475 480 Lys Gly Ala Ala Ser Arg Gln Asn Ser Glu Glu Ala Ser Leu Pro Gly 485 490 495 Glu Asp Ile Val Asp Asp Lys Ser Cys Pro Cys Glu Phe Val Thr Glu 500 505 510 Asp Leu Thr Pro Gly Leu Lys Val Ser Ile Arg Ala Val Cys Val Met 515 520 525 Arg Phe Leu Val Ser Lys Arg Lys Phe Lys Glu Ser Leu Arg Pro Tyr 530 535 540 Asp Val Met Asp Val Ile Glu Gln Tyr Ser Ala Gly His Leu Asp Met 545 550 555 560 Leu Ser Arg Ile Lys Ser Leu Gln Ser Arg Gln Glu Pro Arg Leu Pro 565 570 575 Val Gln Gln Gly Thr Arg Thr Gly Trp Ala Ser Gly Thr Lys Pro Thr 580 585 590 Val Ala His Gly Gly Ser Ala Gly Gly Val Trp Ala Gly Pro Pro Pro 595 600 605 His Pro Arg Arg Pro Leu Ser Ala Ser Val Val Ser Ser Gln Ser Leu 610 615 620 Phe 625 5 1848 DNA Homo sapiens CDS (1)..(1848) 5 atg gtg cag aag tcg cgc aac ggc ggc gta tac ccc ggc ccg agc ggg 48 Met Val Gln Lys Ser Arg Asn Gly Gly Val Tyr Pro Gly Pro Ser Gly 1 5 10 15 gag aag aag ctg aag gtg ggc ttc gtg ggg ctg gac ccc ggc gcg ccc 96 Glu Lys Lys Leu Lys Val Gly Phe Val Gly Leu Asp Pro Gly Ala Pro 20 25 30 gac tcc acc cgg gac ggg gcg ctg ctg atc gcc ggc tcc gag gcc ccc 144 Asp Ser Thr Arg Asp Gly Ala Leu Leu Ile Ala Gly Ser Glu Ala Pro 35 40 45 aag cgc ggc agc atc ctc agc aaa cct cgc gcg ggc ggc gcg ggc gcc 192 Lys Arg Gly Ser Ile Leu Ser Lys Pro Arg Ala Gly Gly Ala Gly Ala 50 55 60 ggg aag ccc ccc aag cgc aac gcc ttc tac cgc aag ctg cag aat ttc 240 Gly Lys Pro Pro Lys Arg Asn Ala Phe Tyr Arg Lys Leu Gln Asn Phe 65 70 75 80 ctc tac aac gtg ctg gag cgg ccg cgc ggc tgg gcg ttc atc tac cac 288 Leu Tyr Asn Val Leu Glu Arg Pro Arg Gly Trp Ala Phe Ile Tyr His 85 90 95 gcc tac gtg ttc ctc ctg gtt ttc tcc tgc ctc gtg ctg tct gtg ttt 336 Ala Tyr Val Phe Leu Leu Val Phe Ser Cys Leu Val Leu Ser Val Phe 100 105 110 tcc acc atc aag gag tat gag aag agc tcg gag ggg gcc ctc tac atc 384 Ser Thr Ile Lys Glu Tyr Glu Lys Ser Ser Glu Gly Ala Leu Tyr Ile 115 120 125 ctg gaa atc gtg act atc gtg gtg ttt ggc gtg gag tac ttc gtg cgg 432 Leu Glu Ile Val Thr Ile Val Val Phe Gly Val Glu Tyr Phe Val Arg 130 135 140 atc tgg gcc gca ggc tgc tgc tgc cgg tac cgt ggc tgg agg ggg cgg 480 Ile Trp Ala Ala Gly Cys Cys Cys Arg Tyr Arg Gly Trp Arg Gly Arg 145 150 155 160 ctc aag ttt gcc cgg aaa ccg ttc tgt gtg att gac atc atg gtg ctc 528 Leu Lys Phe Ala Arg Lys Pro Phe Cys Val Ile Asp Ile Met Val Leu 165 170 175 atc gcc tcc att gcg gtg ctg gcc gcc ggc tcc cag ggc aac gtc ttt 576 Ile Ala Ser Ile Ala Val Leu Ala Ala Gly Ser Gln Gly Asn Val Phe 180 185 190 gcc aca tct gcg ctc cgg agc ctg cgc ttc ctg cag att ctg cgg atg 624 Ala Thr Ser Ala Leu Arg Ser Leu Arg Phe Leu Gln Ile Leu Arg Met 195 200 205 atc cgc atg gac cgg cgg gga ggc acc tgg aag ctg ctg ggc tct gtg 672 Ile Arg Met Asp Arg Arg Gly Gly Thr Trp Lys Leu Leu Gly Ser Val 210 215 220 gtc tat gcc cac agc aag gag ctg gtc act gcc tgg tac atc ggc ttc 720 Val Tyr Ala His Ser Lys Glu Leu Val Thr Ala Trp Tyr Ile Gly Phe 225 230 235 240 ctt tgt ctc atc ctg gcc tcg ttc ctg gtg tac ttg gca gag aag ggg 768 Leu Cys Leu Ile Leu Ala Ser Phe Leu Val Tyr Leu Ala Glu Lys Gly 245 250 255 gag aac gac cac ttt gac acc tac gcg gat gca ctc tgg tgg ggc ctg 816 Glu Asn Asp His Phe Asp Thr Tyr Ala Asp Ala Leu Trp Trp Gly Leu 260 265 270 atc acg ctg acc acc att ggc tac ggg gac aag tac ccc cag acc tgg 864 Ile Thr Leu Thr Thr Ile Gly Tyr Gly Asp Lys Tyr Pro Gln Thr Trp 275 280 285 aac ggc agg ctc ctt gcg gca acc ttc acc ctc atc ggt gtc tcc ttc 912 Asn Gly Arg Leu Leu Ala Ala Thr Phe Thr Leu Ile Gly Val Ser Phe 290 295 300 ttc gcg ctg cct gca ggc atc ttg ggg tct ggg ttt gcc ctg aag gtt 960 Phe Ala Leu Pro Ala Gly Ile Leu Gly Ser Gly Phe Ala Leu Lys Val 305 310 315 320 cag gag cag cac agg cag aag cac ttt gag aag agg cgg aac ccg gca 1008 Gln Glu Gln His Arg Gln Lys His Phe Glu Lys Arg Arg Asn Pro Ala 325 330 335 gca ggc ctg atc cag tcg gcc tgg aga ttc tac gcc acc aac ctc tcg 1056 Ala Gly Leu Ile Gln Ser Ala Trp Arg Phe Tyr Ala Thr Asn Leu Ser 340 345 350 cgc aca gac ctg cac tcc acg tgg cag tac tac gag cga acg gtc acc 1104 Arg Thr Asp Leu His Ser Thr Trp Gln Tyr Tyr Glu Arg Thr Val Thr 355 360 365 gtg ccc atg tac aga ctt atc ccc ccg ctg aac cag ctg gag ctg ctg 1152 Val Pro Met Tyr Arg Leu Ile Pro Pro Leu Asn Gln Leu Glu Leu Leu 370 375 380 agg aac ctc aag agt aaa tct gga ctc gct ttc agg aag gac ccc ccg 1200 Arg Asn Leu Lys Ser Lys Ser Gly Leu Ala Phe Arg Lys Asp Pro Pro 385 390 395 400 ccg gag ccg tct cca agc cag aag gtc agt ttg aaa gat cgt gtc ttc 1248 Pro Glu Pro Ser Pro Ser Gln Lys Val Ser Leu Lys Asp Arg Val Phe 405 410 415 tcc agc ccc cga ggc gtg gct gcc aag ggg aag ggg tcc ccg cag gcc 1296 Ser Ser Pro Arg Gly Val Ala Ala Lys Gly Lys Gly Ser Pro Gln Ala 420 425 430 cag act gtg agg cgg tca ccc agc gcc gac cag agc ctc gag gac agc 1344 Gln Thr Val Arg Arg Ser Pro Ser Ala Asp Gln Ser Leu Glu Asp Ser 435 440 445 ccc agc aag gtg ccc aag agc tgg agc ttc ggg gac cgc agc cgg gca 1392 Pro Ser Lys Val Pro Lys Ser Trp Ser Phe Gly Asp Arg Ser Arg Ala 450 455 460 cgc cag gct ttc cgc atc aag ggt gcc gcg tca cgg cag aac tca gaa 1440 Arg Gln Ala Phe Arg Ile Lys Gly Ala Ala Ser Arg Gln Asn Ser Glu 465 470 475 480 gaa gca agc ctc ccc gga gag gac att gtg gat gac aag agc tgc ccc 1488 Glu Ala Ser Leu Pro Gly Glu Asp Ile Val Asp Asp Lys Ser Cys Pro 485 490 495 tgc gag ttt gtg acc gag gac ctg acc ccg ggc ctc aaa gtc agc atc 1536 Cys Glu Phe Val Thr Glu Asp Leu Thr Pro Gly Leu Lys Val Ser Ile 500 505 510 aga gcc gtg tgt gtc atg cgg ttc ctg gtg tcc aag cgg aag ttc aag 1584 Arg Ala Val Cys Val Met Arg Phe Leu Val Ser Lys Arg Lys Phe Lys 515 520 525 gag agc ctg cgg ccc tac gac gtg atg gac gtc atc gag cag tac tca 1632 Glu Ser Leu Arg Pro Tyr Asp Val Met Asp Val Ile Glu Gln Tyr Ser 530 535 540 gcc ggc cac ctg gac atg ctg tcc cga att aag agc ctg cag tcc agg 1680 Ala Gly His Leu Asp Met Leu Ser Arg Ile Lys Ser Leu Gln Ser Arg 545 550 555 560 caa gag ccc cgc ctg cct gtc cag cag ggg aca aga acg ggg tgg gct 1728 Gln Glu Pro Arg Leu Pro Val Gln Gln Gly Thr Arg Thr Gly Trp Ala 565 570 575 tct ggg aca aag ccc act gtg gcc cat ggt ggg agt gca ggg ggt gtg 1776 Ser Gly Thr Lys Pro Thr Val Ala His Gly Gly Ser Ala Gly Gly Val 580 585 590 tgg gcg ggg cct cct ccc cac cca cgt cgg cct ctg tca gct tct gtt 1824 Trp Ala Gly Pro Pro Pro His Pro Arg Arg Pro Leu Ser Ala Ser Val 595 600 605 gtg tct tca caa agt ctg ttt taa 1848 Val Ser Ser Gln Ser Leu Phe 610 615 6 615 PRT Homo sapiens 6 Met Val Gln Lys Ser Arg Asn Gly Gly Val Tyr Pro Gly Pro Ser Gly 1 5 10 15 Glu Lys Lys Leu Lys Val Gly Phe Val Gly Leu Asp Pro Gly Ala Pro 20 25 30 Asp Ser Thr Arg Asp Gly Ala Leu Leu Ile Ala Gly Ser Glu Ala Pro 35 40 45 Lys Arg Gly Ser Ile Leu Ser Lys Pro Arg Ala Gly Gly Ala Gly Ala 50 55 60 Gly Lys Pro Pro Lys Arg Asn Ala Phe Tyr Arg Lys Leu Gln Asn Phe 65 70 75 80 Leu Tyr Asn Val Leu Glu Arg Pro Arg Gly Trp Ala Phe Ile Tyr His 85 90 95 Ala Tyr Val Phe Leu Leu Val Phe Ser Cys Leu Val Leu Ser Val Phe 100 105 110 Ser Thr Ile Lys Glu Tyr Glu Lys Ser Ser Glu Gly Ala Leu Tyr Ile 115 120 125 Leu Glu Ile Val Thr Ile Val Val Phe Gly Val Glu Tyr Phe Val Arg 130 135 140 Ile Trp Ala Ala Gly Cys Cys Cys Arg Tyr Arg Gly Trp Arg Gly Arg 145 150 155 160 Leu Lys Phe Ala Arg Lys Pro Phe Cys Val Ile Asp Ile Met Val Leu 165 170 175 Ile Ala Ser Ile Ala Val Leu Ala Ala Gly Ser Gln Gly Asn Val Phe 180 185 190 Ala Thr Ser Ala Leu Arg Ser Leu Arg Phe Leu Gln Ile Leu Arg Met 195 200 205 Ile Arg Met Asp Arg Arg Gly Gly Thr Trp Lys Leu Leu Gly Ser Val 210 215 220 Val Tyr Ala His Ser Lys Glu Leu Val Thr Ala Trp Tyr Ile Gly Phe 225 230 235 240 Leu Cys Leu Ile Leu Ala Ser Phe Leu Val Tyr Leu Ala Glu Lys Gly 245 250 255 Glu Asn Asp His Phe Asp Thr Tyr Ala Asp Ala Leu Trp Trp Gly Leu 260 265 270 Ile Thr Leu Thr Thr Ile Gly Tyr Gly Asp Lys Tyr Pro Gln Thr Trp 275 280 285 Asn Gly Arg Leu Leu Ala Ala Thr Phe Thr Leu Ile Gly Val Ser Phe 290 295 300 Phe Ala Leu Pro Ala Gly Ile Leu Gly Ser Gly Phe Ala Leu Lys Val 305 310 315 320 Gln Glu Gln His Arg Gln Lys His Phe Glu Lys Arg Arg Asn Pro Ala 325 330 335 Ala Gly Leu Ile Gln Ser Ala Trp Arg Phe Tyr Ala Thr Asn Leu Ser 340 345 350 Arg Thr Asp Leu His Ser Thr Trp Gln Tyr Tyr Glu Arg Thr Val Thr 355 360 365 Val Pro Met Tyr Arg Leu Ile Pro Pro Leu Asn Gln Leu Glu Leu Leu 370 375 380 Arg Asn Leu Lys Ser Lys Ser Gly Leu Ala Phe Arg Lys Asp Pro Pro 385 390 395 400 Pro Glu Pro Ser Pro Ser Gln Lys Val Ser Leu Lys Asp Arg Val Phe 405 410 415 Ser Ser Pro Arg Gly Val Ala Ala Lys Gly Lys Gly Ser Pro Gln Ala 420 425 430 Gln Thr Val Arg Arg Ser Pro Ser Ala Asp Gln Ser Leu Glu Asp Ser 435 440 445 Pro Ser Lys Val Pro Lys Ser Trp Ser Phe Gly Asp Arg Ser Arg Ala 450 455 460 Arg Gln Ala Phe Arg Ile Lys Gly Ala Ala Ser Arg Gln Asn Ser Glu 465 470 475 480 Glu Ala Ser Leu Pro Gly Glu Asp Ile Val Asp Asp Lys Ser Cys Pro 485 490 495 Cys Glu Phe Val Thr Glu Asp Leu Thr Pro Gly Leu Lys Val Ser Ile 500 505 510 Arg Ala Val Cys Val Met Arg Phe Leu Val Ser Lys Arg Lys Phe Lys 515 520 525 Glu Ser Leu Arg Pro Tyr Asp Val Met Asp Val Ile Glu Gln Tyr Ser 530 535 540 Ala Gly His Leu Asp Met Leu Ser Arg Ile Lys Ser Leu Gln Ser Arg 545 550 555 560 Gln Glu Pro Arg Leu Pro Val Gln Gln Gly Thr Arg Thr Gly Trp Ala 565 570 575 Ser Gly Thr Lys Pro Thr Val Ala His Gly Gly Ser Ala Gly Gly Val 580 585 590 Trp Ala Gly Pro Pro Pro His Pro Arg Arg Pro Leu Ser Ala Ser Val 595 600 605 Val Ser Ser Gln Ser Leu Phe 610 615 7 872 PRT Homo sapiens 7 Met Val Gln Lys Ser Arg Asn Gly Gly Val Tyr Pro Gly Pro Ser Gly 1 5 10 15 Glu Lys Lys Leu Lys Val Gly Phe Val Gly Leu Asp Pro Gly Ala Pro 20 25 30 Asp Ser Thr Arg Asp Gly Ala Leu Leu Ile Ala Gly Ser Glu Ala Pro 35 40 45 Lys Arg Gly Ser Ile Leu Ser Lys Pro Arg Ala Gly Gly Ala Gly Ala 50 55 60 Gly Lys Pro Pro Lys Arg Asn Ala Phe Tyr Arg Lys Leu Gln Asn Phe 65 70 75 80 Leu Tyr Asn Val Leu Glu Arg Pro Arg Gly Trp Ala Phe Ile Tyr His 85 90 95 Ala Tyr Val Phe Leu Leu Val Phe Ser Cys Leu Val Leu Ser Val Phe 100 105 110 Ser Thr Ile Lys Glu Tyr Glu Lys Ser Ser Glu Gly Ala Leu Tyr Ile 115 120 125 Leu Glu Ile Val Thr Ile Val Val Phe Gly Val Glu Tyr Phe Val Arg 130 135 140 Ile Trp Ala Ala Gly Cys Cys Cys Arg Tyr Arg Gly Trp Arg Gly Arg 145 150 155 160 Leu Lys Phe Ala Arg Lys Pro Phe Cys Val Ile Asp Ile Met Val Leu 165 170 175 Ile Ala Ser Ile Ala Val Leu Ala Ala Gly Ser Gln Gly Asn Val Phe 180 185 190 Ala Thr Ser Ala Leu Arg Ser Leu Arg Phe Leu Gln Ile Leu Arg Met 195 200 205 Ile Arg Met Asp Arg Arg Gly Gly Thr Trp Lys Leu Leu Gly Ser Val 210 215 220 Val Tyr Ala His Ser Lys Glu Leu Val Thr Ala Trp Tyr Ile Gly Phe 225 230 235 240 Leu Cys Leu Ile Leu Ala Ser Phe Leu Val Tyr Leu Ala Glu Lys Gly 245 250 255 Glu Asn Asp His Phe Asp Thr Tyr Ala Asp Ala Leu Trp Trp Gly Leu 260 265 270 Ile Thr Leu Thr Thr Ile Gly Tyr Gly Asp Lys Tyr Pro Gln Thr Trp 275 280 285 Asn Gly Arg Leu Leu Ala Ala Thr Phe Thr Leu Ile Gly Val Ser Phe 290 295 300 Phe Ala Leu Pro Ala Gly Ile Leu Gly Ser Gly Phe Ala Leu Lys Val 305 310 315 320 Gln Glu Gln His Arg Gln Lys His Phe Glu Lys Arg Arg Asn Pro Ala 325 330 335 Ala Gly Leu Ile Gln Ser Ala Trp Arg Phe Tyr Ala Thr Asn Leu Ser 340 345 350 Arg Thr Asp Leu His Ser Thr Trp Gln Tyr Tyr Glu Arg Thr Val Thr 355 360 365 Val Pro Met Tyr Ser Ser Gln Thr Gln Thr Tyr Gly Ala Ser Arg Leu 370 375 380 Ile Pro Pro Leu Asn Gln Leu Glu Leu Leu Arg Asn Leu Lys Ser Lys 385 390 395 400 Ser Gly Leu Ala Phe Arg Lys Asp Pro Pro Pro Glu Pro Ser Pro Ser 405 410 415 Lys Gly Ser Pro Cys Arg Gly Pro Leu Cys Gly Cys Cys Pro Gly Arg 420 425 430 Ser Ser Gln Lys Val Ser Leu Lys Asp Arg Val Phe Ser Ser Pro Arg 435 440 445 Gly Val Ala Ala Lys Gly Lys Gly Ser Pro Gln Ala Gln Thr Val Arg 450 455 460 Arg Ser Pro Ser Ala Asp Gln Ser Leu Glu Asp Ser Pro Ser Lys Val 465 470 475 480 Pro Lys Ser Trp Ser Phe Gly Asp Arg Ser Arg Ala Arg Gln Ala Phe 485 490 495 Arg Ile Lys Gly Ala Ala Ser Arg Gln Asn Ser Glu Glu Ala Ser Leu 500 505 510 Pro Gly Glu Asp Ile Val Asp Asp Lys Ser Cys Pro Cys Glu Phe Val 515 520 525 Thr Glu Asp Leu Thr Pro Gly Leu Lys Val Ser Ile Arg Ala Val Cys 530 535 540 Val Met Arg Phe Leu Val Ser Lys Arg Lys Phe Lys Glu Ser Leu Arg 545 550 555 560 Pro Tyr Asp Val Met Asp Val Ile Glu Gln Tyr Ser Ala Gly His Leu 565 570 575 Asp Met Leu Ser Arg Ile Lys Ser Leu Gln Ser Arg Val Asp Gln Ile 580 585 590 Val Gly Arg Gly Pro Ala Ile Thr Asp Lys Asp Arg Thr Lys Gly Pro 595 600 605 Ala Glu Ala Glu Leu Pro Glu Asp Pro Ser Met Met Gly Arg Leu Gly 610 615 620 Lys Val Glu Lys Gln Val Leu Ser Met Glu Lys Lys Leu Asp Phe Leu 625 630 635 640 Val Asn Ile Tyr Met Gln Arg Met Gly Ile Pro Pro Thr Glu Thr Glu 645 650 655 Ala Tyr Phe Gly Ala Lys Glu Pro Glu Pro Ala Pro Pro Tyr His Ser 660 665 670 Pro Glu Asp Ser Arg Glu His Val Asp Arg His Gly Cys Ile Val Lys 675 680 685 Ile Val Arg Ser Ser Ser Ser Thr Gly Gln Lys Asn Phe Ser Ala Pro 690 695 700 Pro Ala Ala Pro Pro Val Gln Cys Pro Pro Ser Thr Ser Trp Gln Pro 705 710 715 720 Gln Ser His Pro Arg Gln Gly His Gly Thr Ser Pro Val Gly Asp His 725 730 735 Gly Ser Leu Val Arg Ile Pro Pro Pro Pro Ala His Glu Arg Ser Leu 740 745 750 Ser Ala Tyr Gly Gly Gly Asn Arg Ala Ser Met Glu Phe Leu Arg Gln 755 760 765 Glu Asp Thr Pro Gly Cys Arg Pro Pro Glu Gly Asn Leu Arg Asp Ser 770 775 780 Asp Thr Ser Ile Ser Ile Pro Ser Val Asp His Glu Glu Leu Glu Arg 785 790 795 800 Ser Phe Ser Gly Phe Ser Ile Ser Gln Ser Lys Glu Asn Leu Asp Ala 805 810 815 Leu Asn Ser Cys Tyr Ala Ala Val Ala Pro Cys Ala Lys Val Arg Pro 820 825 830 Tyr Ile Ala Glu Gly Glu Ser Asp Thr Asp Ser Asp Leu Cys Thr Pro 835 840 845 Cys Gly Pro Pro Pro Arg Ser Ala Thr Gly Glu Gly Pro Phe Gly Asp 850 855 860 Val Gly Trp Ala Gly Pro Arg Lys 865 870 8 27 DNA Artificial oligonucleotide 8 acctctgcgg attgcatcgg tgtgtgg 27 9 25 DNA Artificial oligonucleotide 9 ggatgacttg catgaggctg ggtgg 25 10 35 DNA Artificial oligonucleotide 10 agcgaattct caatgggcga ggacacggac acgcg 35 11 34 DNA Artificial oligonucleotide 11 tccggatcct cctgtgtcca cacactgcca cctc 34 12 35 DNA Artificial oligonucleotide 12 aatattaaaa cagactttgt gaagacacaa cagaa 35 13 33 DNA Artificial oligonucleotide 13 atcagaattc acatggtgca gaagtcgcgc aac 33 14 42 DNA Artificial oligonucleotide 14 tgacagatct taaaacagac tttgtgaaga cacaacagaa gc 42 15 17 DNA Artificial oligonucleotide 15 gtgtggatgc tgccccg 17 16 18 DNA Artificial oligonucleotide 16 tcccgcctca aaacctcg 18 17 35 DNA Artificial oligonucleotide 17 actagaattc agccagaagg tcagtttgaa agatc 35 18 27 DNA Artificial oligonucleotide 18 atcaggatcc gcgccgcctc acttcct 27 19 35 DNA Artificial oligonucleotide 19 actagaattc agccagaagg tcagtttgaa agatc 35 20 36 DNA Artificial oligonucleotide 20 actaggatcc ctactggact gcaggctctt aattcg 36 21 31 DNA Artificial oligonucleotide 21 aactagaatt cgtggaccag atcgtggggc g 31 22 27 DNA Artificial oligonucleotide 22 atcaggatcc gcgccgcctc acttcct 27 23 28 DNA Artificial oligonucleotide 23 aatcagaatt ccaagagccc cgcctgcc 28 24 22 DNA Artificial oligonucleotide 24 gcacgatgca cagttgaagt ga 22 25 29 DNA Artificial oligonucleotide 25 tactgaattc ttcctggtgt ccaagcgga 29 26 37 DNA Artificial oligonucleotide 26 acatggatcc tcacctggac tgcaggctct taattcg 37 27 37 DNA Artificial oligonucleotide 27 acatgaattc cagaaggtca gtttgaaaga tcgtgtc 37 28 31 DNA Artificial oligonucleotide 28 tgatggatcc tcaccgcatg acacacacgg c 31 29 30 DNA Artificial oligonucleotide 29 cacggatcca gcagccagaa ggtcagtttg 30 30 31 DNA Artificial oligonucleotide 30 cacgaattct ggacggacca aactgcgtat a 31 31 32 DNA Artificial oligonucleotide 31 agcggatcca tgggcgagga cacggacacg cg 32 32 34 DNA Artificial oligonucleotide 32 tccgaattct cctgtgtcca cacactgcca cctc 34 33 25 DNA Artificial oligonucleotide 33 gagcctcgag gacagcccca gcaag 25 34 35 DNA Artificial oligonucleotide 34 aagaattctg taaaaggtca ctgccaggag ccccc 35 35 31 DNA Artificial oligonucleotide 35 cggaattccc atggtgcaga agtcgcgcaa c 31 36 32 DNA Artificial oligonucleotide 36 ccagatcttg taaaaggtca ctgccaggag cc 32 37 151830 DNA Homo sapiens misc_feature (10)..(10) n = a or c or g or t 37 attgcatcgn tgtgtggcgg cggggcatgc ccagagcacc gggcacggcc ttca atg 57 Met 1 ggc gag gac acg gac acg cgg aaa att aac cac agc ttc ctg cgg gac 105 Gly Glu Asp Thr Asp Thr Arg Lys Ile Asn His Ser Phe Leu Arg Asp 5 10 15 cac agc tat gtg act gaa g gtaacgtacg tgttgtctga gacccctccg 154 His Ser Tyr Val Thr Glu 20 gccggccgcg gcgtggggat gccgtcgcac cgaatgccct ccgaaggttt ggaccgcgcg 214 atgtgtgtcg tgtccccccg ccccacccca ccccacccca tcccacccca ccccacccca 274 tcccatccca ccctgcccgg ggcccaggag ggagggagcc cgagggtacc ggcctccgct 334 gcccagcgcc ggcacagggc agcgccctcc tccgcgccgc cctccgggag gcagctttcc 394 tctcccaagc caggtggcat cctgattcgg ccctgaccat aattttttaa aaggccacgg 454 ctgtggctaa tctggtgaag aaatctcggg gaaatttaat ggtttaaatc ctggatttgc 514 catttcagcc ctgcccaaag cccgcagaat tttctaggct gccctctccc tggagaagaa 574 gagggacccg gggggaaaaa aacataatcc attgccagat cctcctggga ggcccgcctg 634 cccgggcccc tccctgtcct ccagaggcag ggtccctgag tgggagggag aaggcggctg 694 gtttggggct ggccttttta ttcctggtga gttatattga gacaggagca gctgggctaa 754 ctgtcgggat tttccaaaaa agtgggacat gccatcccaa acaggccctg tttaaaatcc 814 cctaagttgg ccctacaagc ccaaccccca cccccaccct acccccgagg ctggtgggtc 874 agcgcccctc tcttacaggc ctggaacttc cgggggcccc ctggtctgcc tcgctagggg 934 aacagtgggg acagcttccg tgcgcaggca gggcccgcgg agtgaccccg atggaggatg 994 gggaccggga ggtctgggct cggggccgcc tgtgctggag ccctgcccga gtgcggggac 1054 tgtcagccgc taacccacgg gctggcggcc cggccgcaga agtgtgcgcg gattccccgg 1114 gtgggtgccc cagtgggagg ggccctgggc acgggtcccg cggggcaggt gcgcgtgggt 1174 gcctgtgtca gggagaccga gtgggccagg cggcggagac cgggctcctg cggctgggtc 1234 cgcctcctcg aagcctggct ctgccggaaa tgaggccgag cggagccgga gccccgcgga 1294 ggcccgggga gcgcagcgcg agcgcgggcg cgggcgggct cggggcgccc tggcccggga 1354 ggcagaggct gggcgtggga cctgggcgga gggaggctgc gggggccgcg cccgctcccg 1414 gcgggagaac cgctgagtca cgcacgcttc gccgccgggt gtgtgcgaga gaggggcagg 1474 gctgcccggg cctccgggcc ggtggggctc tgacccggcc gcggctttgg gaggcccggg 1534 gagctgagag cggtcctttg tcgcctgctt cggcgaggct gagtcgggat cagcgtgggt 1594 ccgggatgtg gtttctgctc gcagcctgca gcgacagagg gttggaggaa gccgccgggt 1654 tgctggcccg tgcctcggtg gcctggctcg ggccgagagc ggatcttggc aggttgcccc 1714 gctgctccca ggctcgctgt ggtctggctt cctggagcaa gcctctgttt gctcatctct 1774 acgttgggga tgacggtggg atggggcgca gggctcgttg tgggaccagg cgtaaaaagc 1834 gccatggtgg acattttcaa acattaattc cctctgcacc ctgcccgtcc ccttttcttt 1894 cataaattca ccagccctca gcagggcaca ggaacgggga cggcacagtt ctggaggtca 1954 gagcagtgct atccaatcct tcatccagac acgagatatt taccgagcac ctgctgcatg 2014 ccgggcactg ttttatccct ggggactgga caaagactcc ctgcccttgt gcggcctgaa 2074 ttctatcagg gagctatatg accttgaggt ctgtcttctc accagggctc agtctcccca 2134 tctgtaaaat gggagtgaat cctgcctaca gggtctggag gtttctgtga ggagcaggtg 2194 caacggtgtt gaaggagccg ttcagagcta tgcattgcta acgtgcagcc aaaggatgct 2254 gagcacctgc tgtgtgctgg gacctcatac gaaggctcac ctacgcctta tccccacctt 2314 gagatgaaca aaccaaggcc tggccttgtg cctggtccag accgagtgcc agtgtgtgca 2374 gggcataggg ctcaggtgct gcggatgcag agagcaggat cggaacaaga aacaataata 2434 atcattataa taggtagaat tctggcctcc ctaatgaaaa acacactttc acactgttgc 2494 atcctgacta tatttcatgc tcagagcaca gggaaggtca cagatttgaa tgtcagaatg 2554 tcagacttga atcatgttaa agtcctgcct ctgactcctg actgctgtgc agccttggac 2614 aagttactac accttcctga gcttcacttt ccctttgtaa agggagaaat aataacgacc 2674 tttcatacag ggttgctggg atgatcagtg attttgctaa tatcaaaagt gcccagcaca 2734 gtgcttgggt tgttggaggc attgaacaca cggcattgtt attatttata tgccttgtaa 2794 ctggaagagc ctgtgggcaa acagtggatg ctaaaattca gtttgtggaa gaaccaggtg 2854 cacaaactcc tgttctacct gtggttgagt ctacactccc ccaccacacc ccagctgctc 2914 tgatctacct cctgttcctt gagcaggcca ttttctttct tgcttcaggg catttgcaat 2974 ggctgttccc tggaataccc acctcctgcc tttctcacca ctgactcttt ctcatccttt 3034 gggccccatg tccaatgtca tctttgcccg tgggagccct gcttgggttc ctgagtctct 3094 tgtaaaatct caaacatctt aggaagagtt taggttttgt tagtcattca catcttggtg 3154 tgaattcgtc agagcaggtt ggattttttt tttttttttt tttttttttg gtggcagggc 3214 tgggtggctt actcttggct gggctcaact gcattgaggg ttatggtgat gattaggtgt 3274 acctgcaggc cacctggggg cacagagaac tttgcatgaa tggggtcagg gtgtggggag 3334 agcagtgtag ctgatagggc actgggccct ggaccctgga ccctggaggg tgctaggaag 3394 tctccatcta gttagacatt tctcaagagc tggatatggt tccaggaagg actcttcctg 3454 gctctgttct ttctcttttt gcggcaggcc tcagtactta gctttagagt gagttgaata 3514 agcacttcca gactagactg aacttacaaa acccatccat ccttcctttg cttagcacca 3574 tttgccaagc acatcctgcc ctgggcagca gtgatgacca agacacagga gctcagccaa 3634 ggggaggtag ttcaggctga ccaggtagat cctggcagtg actgggtctt tctggggagc 3694 aacagtcact ctcatgtgcc tgacaggtaa ggcacttccg gagcacactt ttcagctgag 3754 gccagaggca cagcttcccc ttgtttgagc atctcagcca tcacacactg ttggacactc 3814 atgctttttg catctgcata aaggatgtac ccatgttttc ctaactccca tccctggatg 3874 tcctgtgtga tttcagagta gtctgtttat tcccacagag ttgtcctgat tttatagttg 3934 aggaagtgaa gggtgcttgg gaattgctaa ggtcatcatg gggtcctgag gctgtctgaa 3994 cgcagcaggc aggcaggttt tcctgcatgg aattgtctgc aggttttgaa ctggttgtgc 4054 cctggatacc atctactttc tgcccaggaa accacactga agaggggatg ctgcttgtgg 4114 gagactcagc attcagtgaa atctgcaccc ttatggtgga cgttgcagct gatctccaca 4174 acagttagtc tctcttcttc caaggagaac acatatggtt cctagtaaga gatctcaggc 4234 catagctgga tgtgatcagt gcaaggatga tctcattccc cttgcagtga ctggttccag 4294 aatggatgtg ggagtcagtt ctggaggttg agtggaaagt agggagaacc acaggtagtt 4354 ggtccctctc ttgtgatggg aacagggaaa ccttgtggtg gctggcagcc atctgacacc 4414 atgaggggag caagtcttag gccaccaccg ttgatggcag ggcagagagt gagtgagatc 4474 caggacatag aggcctgatg tccaggccgc ctctgaactt ccagttacat gagctgttac 4534 ttttcctttt cgttgtgcac tttcaagtct ccgttacttg cagcccatag caccccaact 4594 cgtacagccc tgactgctta tcaagaaaac caggaggctg atctgtaacc cacagctaag 4654 actcgagata cataaaaccc agagggattt ttgtttgctt tctgttttga gaaccctctt 4714 tcatttcact caagtcaagg ttgccaattt ctggttttcc ctcctcagtc ctattgagga 4774 ggtatttttg gtcagataag agagcctgag atctggcatc gggagatctg ggttcctggt 4834 ggggtctgac cctgggtctg taatattggg caggtcacac ggtctctctg agcctcagtt 4894 tattcttaat agatcagtaa gtgatgatgt ctattcttta ggggccagag ttagactagc 4954 ccttagaact gtcatcagac tggctagcct aacttccacc ccaacctatg gggaaactga 5014 ggctaagagg ggggacatta gtggtggcac agagggagat tagggagagt cagcctttga 5074 cttttgaaaa tcaagatgtg gactgttcag attctgtgtt cctttcgctt ctgtttggaa 5134 acgccactta cataagcttc ccttgggctt cacagcgagt gtgggctcca tttcagtgct 5194 ggggtgccct ccatcaaatc acatcacttt ctgagcctca gtttccctgc actgcctggt 5254 gccctgggtt gtcatgaggc tgtaaggagc caagggcatg tggactctga agttctacac 5314 gtgtaaaagg cgactgctgt caatttcccc aaattgtagt gtaggccanc tcccacgccc 5374 ctgctgtaag caatgtgctc ctttcttttt aatcaacccg aacttaaagc ttggcgcagt 5434 cacagagcac ggtttttgtc attttctttc tggaagatga aaatcaaatt ctaataaaat 5494 ttttccactc catctcctga ctgttgtcat ttgctacact ttttagtgtt tatccttaaa 5554 gcttgcagag ctaagggatg tttggtaaga agtgtttagg ccttgagact ggaagagccg 5614 ctgtatgaag cgctaggctc catggagagt gtgatgggga gtaagagaag gagagtgaac 5674 tcctgtgagt ccaccaagca gagggacata ctctcagcaa ctggggtatt tccttccagt 5734 ctttttttaa tgcccatgtc tgtttttaat gaaaactgta atctgtctgt atcaacaatt 5794 ttgaaggcta cttttctagt ttggcatgag attataggaa ttttccaggg ctttgctcca 5854 gggctggctt catggatatg caacctgtgt ggtcatctag gtccccacac tcagaaggac 5914 ctgtgcttgg gttcatgttc tgctgttact atcttgaaat ttttaagaat ttcactttgg 5974 atcctgtgtt ttgtaagcga aatctgatgg gacgggggag cctgggaatg agcagagggg 6034 tacgtgcggc aggcgagtct gtggttacac acattggctc ccacagcacg ctaccctgtg 6094 ttcacttgag cgtctgagcc ccacgcacag tggacagctc atgcaccttc tcagtgcgtc 6154 tgtagtttca caggcagggg ccatgctttc aactgatgct ccaaggcatt gatgttctca 6214 tgcagtgact tctaagaaac atgaatgacg caggaaccct atggtgtcct ttcttaacgt 6274 gtgttacgtg cccatatttg ccaatcgctg acactgaaaa tgattacaca gaagggaagg 6334 gaaaaagagg gcacctatag ttccttttcc tcctagtcct tccttgttta ttattgaacc 6394 aagggtagag ggtgttggaa gaatgtacac atatccagaa atgaaataag aacagttaag 6454 ttagtttcct ctgctctggt aagaacaaaa tccatatgcg aaatataact tgtgcatttt 6514 ggtgagtcta cattccagtt acgtgctctt atgtttgcat ttaaaattgg aggtgcacac 6574 tagaatggtg agtgataaaa tgcacgctga gagtttaagc tttttttttt ttaaatttga 6634 attgacatta aatagcaaat aacaccatga caaaatatgg aaggcatgaa aaggctttgt 6694 atcttagcac ctttaatgat gcttttcctt tgctttttga ataagaggct ctgcattttc 6754 atttttccct gtgccccacg aattataggg ttggccctgc tttgctggaa ctctgggtag 6814 ggtgaactcc ttggccctgc cttctacctc cttggctttc gtgattggtg gaaatggtga 6874 gagcctgcca tccattgggc agctcttccc tatggggagg ggttacaata ttaaatgtcc 6934 gtgctcctct ctcacccatt gggtccatgg gcctctgact tccaggttgc tctacagggg 6994 agaggccaac agttatctta ttttacaagc tagaagttag acctacctct ccccgcagga 7054 ccaaggggtg gggaggtgaa gtaggggtcc atagctcttt tttttcctac aggtttacca 7114 ttaataaagc agattttttt attcctgtct tgcggccagt cttttctgtg taatcccaag 7174 tcccagcaag gaagaggggt gactggttac cttggccccg cccccaagtc acacagtaca 7234 cgtattgaca accatcattt cattggctgc atactattcc tgtgatacat gtgtcatcat 7294 tcagtagttc aattaatcat ttccttatgg ctggatattt agttccctcc cttccctccc 7354 tccctccctt cctcccttcc ttccttctct ctctctctgt ctctccccca cacactttct 7414 tattttcata actaacactg caggaatgaa caccatttgt gtgtgtgaag accccctact 7474 cccatcgttc ccccttaacc ttggaatgat gctcttcaga aggaattcca cacgtgctat 7534 ttcatataaa gatcactagc atttttaatg ttgttgacac acattggcag attattctcc 7594 agaaagtttt tctctttaac cacatgctga tcaacattag gtagtctaat ttgtttgacc 7654 tttgcaaata tcaaagatga aaaatatttg ttgtaattca cgtctgcata ccaatgaggt 7714 tgaacatttt ttccttttgt tcagcgggta ttggctgatc cctgttatgt gccagggtga 7774 cattagattc tagacataca aagttgaaga gcaaggctgt gtctgccttg aaatgtggac 7834 tctcctctcc cagtgtcttg ggtgccactg cgggacctag ctacttctca ggagagagtc 7894 tgaagctgct ggaggagtct gtacatccct cagcaccctg gggagtcctg ttagttacac 7954 agggccttgc aaagacaggc atctcaccat taagcccttg agcagaatga tccaagtgga 8014 ctttaggatg aaataattac aaaacaaaca caatagccat tattatgatt caccatttat 8074 tggctntgta ctataatact atatgctgga catgaggctg cgtgcatctc attggtgatg 8134 ccccagacct gatgttgtgt atattatttc cccattttac agaggagaaa actgaggctg 8194 aggtgcttgt tcaatgtcac atggtttgta agggacagag ctgagttttg aatgcagcct 8254 gccaaaccca cgctcctgac tgctacatta attggctggg acccacaggg cagggttagg 8314 tggcctgttc agttctgatt atgcaccaca cttaggaggt tttgggattt gaactagact 8374 acctggcttg gtgctcttgc tatctgtgtt gcgatgaaag gcaatcgaga ggggtcagca 8434 ggaggagaga cccccttcac ggcacaggta gatggcagtg gcagaggcca caagtggaca 8494 cgtggtccag ggactgaagg gcaggtggca tttccaggtt ggggggtgat gatgtgctgg 8554 gacatggtat tctagcgcat tctgggcagg aggaacggtg tgtgcaaagt ggcataacac 8614 ttgtcccctg acagtgtccg gctcctctgc ttgagaccag gaggcagtta gttagttgcc 8674 agccggcccg ggagcaggac acacctgggg gcccctgtgc tgcccaggac aggcactgcc 8734 ctccttgcac agtgggggcc attgtcctcc agaacccagg gctgaatgtc ccattgaggc 8794 agaacaaagg ctgctcagag gttcccagct ggggtgtggg ctgccccaag cagggatggg 8854 atctccaact gcaggccaag ggcctcctcc aggctggcct ggcctcctgc agccccaccc 8914 ccacccctcc tcaggaccag gactgttgct gctggaggct ggacctgggc ttgggctccc 8974 aggcctgtgc tctgggtctg gcacagctgc cgtgcccttg gcagcttctt catcccctgg 9034 gcaatttccc catctatgaa gcagagagag agcgagctcc caaccagcaa ggctttcagg 9094 cagaattgaa tgaaatagtg cacactctgt aggttaatct caataaaagg gagctctttc 9154 atgatcatga ttagcttctg aatgtttttt tacaatttca aaaaagtttt gatgcaaact 9214 ttcaaatttg tgccacttct gggccaaagt gtttaagaag ggagtgcacc ttcccccctc 9274 cctctgtccc agagaaggga gagatgccgc tccctggagc ccctcatcac tctgtggaag 9334 ggactgctgg ccaactgtta caagaggaga aacttctttg catttgtgag aaaatagtct 9394 attgaactgc ttccaatcta tcaagatctt gctgtacttc cttcatttac tctcccctgc 9454 ttttggctga agaattttta ggcaaatcca agactcctgt cgtttccccg ttccatctgc 9514 aggcatctct gagtgttgag ggcatttctt gtagcccagt gctgttatcc cacctcacaa 9574 aacatatcct gattctttgt tacctaaatt ctggtccatt ttatgaacgt ccccagttgt 9634 ctgagaaatg tctcttatgg ttgggtggtt tggcccagga tccaaagtcc tgcacctgcg 9694 tttggctgtt ctgtctcttg tcttttctga cctagactca gcctccatcc ccttttcagg 9754 ctaccaactt gttgaagaca tttgttatta ttttatttta ttttttttaa gacggagttt 9814 cactctgtcg cccaggctgg agtgcaatgg cgtgatcttg gctcactgaa acccccgcct 9874 cccgggttca agtgattctc ctgcctcagc atcctgagca gctgggacta catacaggtg 9934 cccaccacca cgcccgacta atttttgtat ttttagtaga gacggggttt caccatgttg 9994 gtcaggctgg tcttgaactc ctgacctcag ataatctgcc ttcattatta ttttagagat 10054 tacagtgtca ctcccactgt ccctaatttg tgcctggatt ccatttgccc tgtgggtctg 10114 gaaggctgag aggtggttgc tgggacctgg gcatcggcct tggggctgcc cctctctcct 10174 ccaggacccc tttctgcaga gtggtgccct cgccactccc tggctgagtg atcttgggca 10234 agttgtccag ccaggccgtg cctgggtgac cacatctgag ctgggggtga gcgtggctgc 10294 ancatcctct ctgggatgtg gtgggtgttg aatgagatgg tgcatgccac gtgctccgtg 10354 ggcctggtgc ctgtgggtcc ctgtcttacc cccatgatgg ggatgtggca ggaactgggg 10414 tagccaccgc ctgcccacac agtgctcact ttctgtaggg gagacacccc tcagctggtc 10474 actacataca gcaggaccag cactttctga gggaagaggg atgttctctt gggaagtctg 10534 gatgctgaag acagtttgtt actctgatta ataccagtta caaagaaatc cccacattcc 10594 aggggttgat gtcatagaag tttatccctt tgtaacagtt cattgtggat gatcccagtt 10654 ggcccaggag tctcttccac agagtgatgc ggggctccag acccttctca tctgtcagct 10714 cccatgtcct ctccattctc cggggaagag ggtatgggga aggtgcactc cctccttaaa 10774 cactttggcc cagacatggc acttgtgact tccctcacat tccattggcc agagctagtc 10834 acatggcccc acctaatgca aggggctcta ggaaatgtag tccctggctg ggcagcccag 10894 tggctactct gcagtgggaa gaacctgcat cttggtggat gtcttgccat ctttgccaca 10954 tgaccccaca aaacaaacct ttacattctc agtccaaaaa accctactaa gaatcctgtg 11014 ctggagacac cctcactcaa cccctgaccc tcccctctcc ctgcttcagt gtccacacgt 11074 gcacggtgct gtgagatgca gagtccagag tcatgcggtg gctaggaggt cagggacgcc 11134 ttcctgggag aggcgatgtc tgagctgagt ctgcaaagcc aaataggtgg tgcccaggtg 11194 gatcaggtag gagagggatt ccgggcttcg gctgcagcag gggtaaaggc tggtgtcttg 11254 ggagagggca tcctgtgtag agaggggtct gtgggccact gagatttaga ggatgtgtgt 11314 ggggtggggt ggagtgggag aggagctgga gcgggatggg aagtgggagg caggactgtt 11374 tgtgaaaggc ttcaaatgcc gagataagga gtttggattg tatcctattg acattgtgga 11434 accagatgga gatggggcat ttccctttgt ttgaaagtat tttgatttct attggctgtc 11494 ttactacaaa aaacatatgt agtcatagca aaaagttcag aaaatttaga aagagaaaag 11554 gaggaaaaga aaatcctacc actgaaaata ttttggtata tgtgtttttg cctatgggta 11614 tacatactat ctaggtatat atatattcct acattttttt attcactgaa agatggtttt 11674 tgagcatcta ctgtgtgcgt atcctatttt gtaatcttta aaattttctc ttaatgatat 11734 gggagctttc tagcttagaa aataacacag cccattttct tagcttgctg ggacttctat 11794 aacacagtgc cacataccgg gcagttgaaa caacagagac ttaccgcctc acagtgctag 11854 agcttgggag tccaagatca aggtgttggc agggttgatt ccttctgagg cccctctcct 11914 tggcttatag atgaacatct ccctactgtg tcttcacatg gtctttcctg tgtgtgtctg 11974 tgtccttaga gggacaccag gcatattgag ttagggctca tccatatgac tgcattttac 12034 cttcgtcacc ttgttaaagg tcctttttgt caaacacagt cacattttga ggttctaggg 12094 gttaggactt caacaaagga atcttgggga gggggcacat ttcagcccaa agcacccgtc 12154 atcattggta atatcagtca catgcttctt ctatgtattt taaagagttc catgctggtg 12214 ggtatcagaa gttatggttg gtttaggatc atgagcagtg ttgtgagggc atctttgcac 12274 ctttttgcgt gcatatttgg ttatttccct agggtgtgga atggctgctt ctgagagttt 12334 ggtctttctg aagtatcttc atctaatgtc aacttttcct gatgaccaaa cttggtacta 12394 acaactccct ttccccagag cattgctagt ggcgactaga tccaacatat ttaatatttg 12454 ccaatattat ggtaaaaatt gctgtttttt tttgtgtgtg tgacagaggc ttgctctgtt 12514 gctcaggctg gagtgcagtg tcgtgatctt ggctcactgc aacctctgcc tcccaggctc 12574 aagcaattct tgtctctcag tctcccaaga agctggcatt ataggctgtg ttcttttaaa 12634 gcatttttca gtgagattga acttccttta ttatatttat tgaccatggc atatattcaa 12694 ttgtaagttt ttttgtgcac cgttcttggc ctgtttctct actgtaattg tcatctctct 12754 tgcaaacact gacccttggt ttgttgtttc tggtagcatt gattttatgt ggttagatgt 12814 catgactctt gtcctgctga gcatggatct cccattccac aatcatgaga agaaccaaca 12874 atatggagga ggtgacaccg tgtagctttg gaggctaagt aaaaaatagg tcatgtgctt 12934 ctgccttgga gccagccacc atattgtgag gaagcccaag cagtttgtgg agaggcacat 12994 gcagagagga accaaggtcc tggttgagct gcctgcctaa tatccagcac caccttgcca 13054 gcaggtgagt gagccatctt acaggtagag cctccagccc tcaggcaagc catccatatg 13114 gaacagagat gagccattcc caccaagatc tacccaaact gcagattcat gaaccaaata 13174 aatggtttct gcttgaagcc attaagtttt gaagtgcttt gttacacagc agtgggtaac 13234 tggaagagtc atggattcct gacattgaat tcctggtcct cctccttctc aggctacttg 13294 tctagatgtt ctgttctctc catgattctg tggatccctc agagccttcc ggtaacttcc 13354 ttctttgctt gtgttagcct gggtcaatct ctgttgctta taactgacag acatgggaaa 13414 ccagccccag caatgagagg tgacccagct cagatcatga gacaggacag gaatccaggc 13474 ctttctgaaa catagcccag ggtcccatcc cacaacgtgt cagtagacac catgcctgct 13534 gggtcatgcc tgcttccgct gcaccctgca cccagctcag cacctgctat cttccaaagg 13594 ccattgctga ttgcttgtac acacctgtta gttcatgcac agacagcaaa gcacgtagtt 13654 gtgctgcctc cttgccttcc tgctatgatc tgaatgttta agtaccccct ccaaattcac 13714 aggttgaaat ccagaccccc aatgtgaggg tatttaaaag gtggggactt tgggagtgat 13774 gaggttgtga gggtggagcc ctcatgggtg ggattagtgc ccttataaaa gaccttagag 13834 agctcccttg cccttctgtc acgtgaggac gcagcgagaa ggcactgttt gtgagtcagg 13894 aagttggacc tcagtggaca ccaaatctgc tgtgccttga tcttggactt ccagcctcca 13954 gaattgtgag gaataaatgc ttgttgttta taagccaccc ggtctatgat attttgttat 14014 agcagcctga acagactaag ccactcccag tgatgagcct gcatgatgtt ttacacaaac 14074 agatcactga aagaaggaat tggccagcaa agatgatgct cagcagagat gtgaaagatg 14134 ttaatgctgg aagtgaaatt taaattggag gtaaatggag tcatagaaga aatccatgat 14194 cttgggaagc tgaagctacc cttcaagaag ctcttatatg cagccagagg agttgagtga 14254 aggtgaacac actgatgtaa accaggaaag gagttgtgcc ccaaagcatg gagatgtccc 14314 agaggaagcg aggctgggaa aaacgttaaa ggaactcttg aagatatttc acagtgttga 14374 aagtgcaaag gataaaatct tggaagctgg tctggagaaa gataattctg caaagcatag 14434 aaagggtgct tttttggtat cgtaaggtat acaataacag tagcgagcac tgtgcaaact 14494 ctctccatat gtcttttaca aagaaataaa gcanttgaca tctcaatgtt tctaatgctt 14554 taaattacat tgtaccaaat aaatattagt tgtactattt taaaaaaact ttcccggttg 14614 ggcattgtgg ctcacacctg taatccaagc actttgggag gctgaggtgg gaggatcgct 14674 tgagcccagg agttcgagac cagcctgggc aatatagtga gaccctgtct cttcaaaaaa 14734 taaaaaaaaa ttagccaagg atggtggcat gtacctgcag tcccagctac tcaggaggct 14794 gaggctggag gatcacttga acccaggagg ttgaggctgc agtgagctat gattgcacca 14854 ctgtactcca gcctgggtga cagagccaga ccctgtctca aaaagaaaaa aaaattccct 14914 gtgcattccc tatggacatt tgtaactgtc cataaaagac tttttaatgt cttgacaaaa 14974 aattttaaag gccacagaag aattgtaatt tcctcattga ttattaggat ggctttaaat 15034 ggttttagct ttcatgctct attttttttt tttttttttt gagatggagt ctcgctctgt 15094 cgcccaggtc ggggtacagt ggtgtcatgt cagctcactg caacttctgt ctcctggttc 15154 aagcaattct cctgcctcag cctcctgagt agctgggatt acaggtgcct gccacggcat 15214 ctggctaatt tttgtatttt tagtagagac ggaatttcaa ccatgttggt caagctgatc 15274 ttgaactcct gacctcaggt gatctgcccg ccttagcctc ccaaagtgct ggaattatag 15334 gngcaagcca ccgcacctgg ctcatgctca tttttatgga tccacaccac ccgtacagca 15394 aggactgcct gcactcattc caagtggtca gagtggtcac cgcatgggcc ctccacgtgg 15454 ccnggccaca gtgatgtttc aaaccctggc tgggggattg cattcaatat ccccttatta 15514 aaggcggcag ctcaagaata ttaaatcatg ggaattcctc actgtggaag tgggaaggca 15574 gcccgtggtt caccgtgagg ggcacccaga gctccccctc cactgcgttc agtgtgcagc 15634 cctccagcca gcctgtctgc ttcgggagca atccatcatg gaatgaactg accgaaggag 15694 cgaggggctg aatgatgtgg ttcctacgcc gactttcaat gtgaaaggtg ataaaaacag 15754 ccctgaatat tttatggccc caaggagagg taaggctctt tattgaagct gtgaaaatat 15814 aatccatcat gataatgtgt cccatatcgt cagactctgc gagctaagtt gtgtgtatgt 15874 taaggtgctc tttttgagaa gatcttaatt ttatttctct attttatttc attacagaaa 15934 cgtttgaacg tgtagacagt agaataaagg ggggggggga aataacatcc ttcatttcac 15994 tactccagaa acactgctca cattttgttg catttccttc taactacccc ctgcagattg 16054 tactatgttt tgtgtctttt aaaatattaa atgcactgtc aacattttcc cagatcatcc 16114 tgcactctga gttaacaatt tttattggct gcataatact tcacgatgta ggtattatta 16174 ttcattcaat aactatttat ggattcattg atccgattag tgttgattgt ctataacagg 16234 tgtgtgggtg gggtaggggg attcaggaag aaggaatagg gcgcagctcc cccnccccag 16294 gatttctgga annagggaga cntaacagat ggctgtgatc cggtgtgagg ggcagggatg 16354 cagtgggccc ggttgcagcc tgggagcagg tggtcagaga tgnaaggctg tgggcagcag 16414 tggttggtgg tccacagcag taggcagcag ggggaggggg cgacattcat ggcaggaggg 16474 acattatggg cacagcacgg cgtggtgtgt tcagggttgg tggagcgttc acttacagtc 16534 ttgcagatcc tggcaggtgt ggtggtgatc tgtccaggca ggggagggag agggaactga 16594 gagtcatcaa aagtctctgg gagtttggaa aggagagtag ggggctcaga gggagtgtga 16654 gcacttccag cagaggtgag aaagccccca gtcagttgcc cagggtgggc agtggaaggg 16714 aagtggaggt gaacgttgtg gggtggagag ggttttcagg caggctggga gctgcccagt 16774 gtgctggagg aaggctgggt ctccttgaat ggtgtttggt caatgcaaga ccacaggagt 16834 gtgactagaa ggctgggggt gcagatggtg gcaggtggag gatggagaga gctgctccca 16894 ctgctgaaca acgactgccc caactttatg ggatgagcat tcttatgaat gcccattgtc 16954 ctgtattcca gattattctt gtgtctgtcc aggtagggat gcaatttctt gatgtaaggc 17014 tataggtgtt tttaagggct tgcataaaga tttgaatatg atgttgtcta gtagagtaaa 17074 aatcaaattg ggcaaaacat ttttgtttgg gtgatttttg gaagagtaag tccacgaatg 17134 caacgcagct ctggagtcat ctgtagatta cagcaagccc atcagtctct atgtctcttg 17194 cttacaacaa aggattgatt tcagctccag cactaggtga cttgtgctgt gttcattatc 17254 tcttgatagg tgtctgacag gagatggggc ttgggctgtg ccagggagga gccgtgtggt 17314 gcaccaccta tctccgcagg cataactatt ttgtcttcat ggcaaaataa tagcgatgat 17374 ggtgatgagg agggaagcta ccatttcttg actgctcctg tgtaatgaca tgttggtgat 17434 cacattaggg ctttatgtcc actctgggag gtggtgagaa tgacatcgcg tttgcacatc 17494 aggacgctga gcctcagaga ggttgagtcc caggacgaag gccacacagt gagtgccaca 17554 ggtaccatta ccacctaaca aatgactctg gagctcagtg atgtgatgag aaccatttta 17614 ttctgtctcc tggattctgt gagtcaggaa tttgggcaga gcttggctgg gcaaaccttc 17674 tgctctaaat ggccacccat gagtcttcca agctggtggg tggactgatc tggagggact 17734 gagatggtct cactcacaca ttttctgcgg ggtggggaga gttggaaggc ggggctcccc 17794 tccccagcgt gcagtctcag ggcagttgga ctcctttgat ggcagctggc tttcccgaat 17854 caagtatccc cagataccca ggtggaagct gcttggccct tcctgacccc tgggacatct 17914 cagtgtcaat tgtgtcatct tcatttagtt caagcaagtc acaggccggc ccaggttgaa 17974 gggcagttgg actcaacctt tgcatgtggg aagggccagg ttacatggta gaaaagcaga 18034 tgggatagga gaccgtgctc tggccctccc tgggaaacac ggtgtgccac agacgccctg 18094 ggcagagcca agacccccac tgggctctgt ctgaccttgg agccactgcc ccgctcctga 18154 gcaacaccct cttgtccccc tgaacagtca caggaagaac gggtccctct ctccatgcca 18214 ttttcctgtt aaaaaatgca aaaacatccc atacttttgc tcatttaaac acagaggaaa 18274 ggaggtgagt gaaagctttc tttaggggta gattagatgt gaggcagacc ggtggccctg 18334 ggtgtgcacc gggtggaaat tattcttaca aacagggccg ggtgggggtg cagcctgcca 18394 ccgcccctct ggccgtctgc ctccacagga ggcttgcagg tgcccacatc agccaacgtg 18454 gccctcggtg gggctgtgct tgccttcttg ccagggccac tgcagtaggg aggagtgcag 18514 agcagaaaca ggtgagctgg gctgaatttt ctgcttggct aattcagtgt ggcttgactc 18574 caagaaggac acaccgacct ccccatcatc ttgtttgttc agccttgcag aagcagtttt 18634 atgagaaacc attacagccc cggtggtctg ggcccagacc cggtgcacac cacgtgcccg 18694 cactggtgcg gggggaccat tctcggtgaa tatgatggat gcacaggaag ccgccctgcc 18754 attcagtgag agctcaccat gtgtctgccc ctggggtggg gtggggtggg cagtttccag 18814 cctttgccca tgggatagag ctgctggaag tctccccgag ctgaggaggc agagctgggg 18874 tggctggggc tgggggttgc catggatact tcctgcaagt cctgacgccg ctccttcctc 18934 tttggggatc tgtctcccat actgtccctg ctgcctttac atcttcaggg tggagaggga 18994 ctctggccat cctggggcca accatcctgt gtcactgctg gtgtttgtga cctgcggtgg 19054 gccctccctc aactccgtat ctccagctct aagccagaga caagaatatc ctctgtgggg 19114 gggtcccttc aagggtggat ggagatgagg cgttaggtgt atccgatgct caggaacggc 19174 cccgcacctg ctcatcttta tgatgagcag tgggactgcg ggcagaggga gccacacgca 19234 tccatcctgg ctctcagcat cccagggaaa gatgttctgc tctatcctga tcagcctcgc 19294 cctttaacca accacaggct gcctgcagtg tggccgtggg gagctggagt caggcatggt 19354 ggcagccctt ctagacagta ggcagtaggt aagcctgctg atcacggagc cgagattctc 19414 tgtgggacag agctggtccc cagcatccct gtggcctttg ggccaagaac tcagtcggct 19474 actttgcttc caggcttggg aacactcagg gtaggctggg agtcccctgg tctcaccctg 19534 tgagccccac ataagcctgt ggatagcacc agctcagcag gtgaccccct catcaaaacc 19594 ccaaactggg atgcttctct ggctacatag gcatggccac atggggacag tgggaggaca 19654 tgtgataatt tggggcagcg gctgaaagcc taggggttag ggctactgtg tccttctaag 19714 gtggtgcagg gcgcacagcc ctctgggcct cagtttcctc ttctgtgaaa tggggactct 19774 atcttggggc cgcaaatgcc agtgtcttct ctggaagaaa gggcgactgc tgagggaagc 19834 agcacacagg tgtgagggtc caggccccag acgggatccc acaaagacct aggacagtga 19894 gccaagagtg gagagagggg acgagggtgg actggggtgg gccccaggag ctggaaagtg 19954 aggaaaatcc agctgtgtcc tgagggttag actccactgc cagtgttcac aggatctgga 20014 gctgatgggg acctgcggtg tcaccctgaa gggacagatg gcccccaggc tagcaggagg 20074 tggcagtgtc cgtttggcag caacatttga caagcagaag gcagttggtc cctcctgctt 20134 cctgtccagg ctcttggggc tgggacccca ctcccagccc tgtcctcccc aacctcccca 20194 cacttacaca ggccactctg gggcagagga ggggtgctgt gatttgtggg tttgggagaa 20254 gttggaagca taatgggtca ggcctgcagc tcggtccaca ctgcctgtgc caggtggagc 20314 aggtgagggc atccctggct ctggggtggt gtcactgttc acactttgtc ctatagccag 20374 gcccttcttg ggggtgaggg ttccgtggag ccctccatct gcctggctct gccgatccaa 20434 ctcttttctc tctcttgggg gtttcaaact tagacaggaa taggggtgtc atttattggg 20494 ccccagacaa cctgaccagg tccctcagag cactgaggcc gggaggagga gggtggaagg 20554 agatgggaag agtttccttt gtcctctctc cctggccatc cccaaacctc cacacaaacc 20614 tggggtggct gagcattcat tatgctttgt ctttgtaaat aggcagctat aaaaacctat 20674 cagcttgcag caccttctcc ataacacagg ctggatggat ttataaccca ggtcccctcc 20734 ccgagagaag ctggcaaagc agaccccagc ccgcgctggc tgccatcacc ctccctgccc 20794 ctgccccacc tcatgcaaga aacagaaggg aaagcacatt gagttgtaat atgttttcga 20854 tggaatttgt cacaataaga aactggattt tgttggggct catgggatgt ttaggaaaga 20914 gccagagagt ggtgcaagct gtgggccctg ccgagaagcc tgggctacag gagggcaggg 20974 gctggagtgt tggcagggtc gcacagtggc tcatctggac agtccacagc ggatccagcc 21034 cacactgtgt caggcacttt gctgggactg ggggatgtgg ctgtgggtac gattgacaag 21094 gtctgtgtcc tgaggagccc gcagagcaga tgagatggac atgtggtcag tgatggtacc 21154 gtgtcgggtg gaagagacaa taggctgagc tgcccagagc atcgcctgac cagcttgggt 21214 ggtggcacgt ccaggagggc ttcctggaag aagtgaattt attcaacaca tgttcactag 21274 agccagtgat gcttaggcac tgagagtgtt gccagggata caggagagaa tgggagagtc 21334 cctgagtcat tccagactgt ggggctgaag tgtccgccga tggaggtgtg ggaagggcac 21394 agcggcttcc cacgtgagca aggagctatg caatgtggca ggtggcaggg ccaggcggag 21454 gtgcctccac ctgtctccag accccacccc ctacccaggt atggaattgt tgtctccagt 21514 tggcagagaa ggaaactgaa atgggggttt cacctctcag gaatgggtag gccaggattt 21574 taacccaggc ctgcagacac caaatctatc cctcgctcag gcctgcactg acctccgtgc 21634 acctctgggg ctccaggcag ctgcctgggt gggtgctgtg tctggggtct ctcctggcgt 21694 tccttaggcc cctcccctat caccgtcctt cattattcac ttggatgcct tgatggtcgg 21754 ggctggaacc ccccgagctg acccaccatg cggctcatct tccttctcct tccagtgctt 21814 ggtgatcttg agagtgaggc tgaaccgttg cttgattttt ctgtgaccca gatgaagagc 21874 tgggtaacca tttgctcaat aaagtgagag accccatgtt ctggttaaag tggaggcact 21934 gaggaccagc gaggggaagg cagtacttgt atttgtcagc ctggaggaga cgccagatac 21994 cagccagagc accccagcct gtatctcgac caccacctgc agttggtgct gaacccccca 22054 ctccacccca tagatgagac aattgaagcc cagagaggcc aggcttcttg ccgagggctg 22114 cacagccggc agggatgctg gaattgggat ttggccccag ccttgtctga ctccaaagcc 22174 aatgctattt ccaccatacc cagtgtctcc cagagctaat tttgcggctg gaactgcaac 22234 ccgcaaagct atctaggaca ggcaactcga tgaaagagaa ttaggaggga atcctagaaa 22294 aatggggctc ggcagctccc ggggaagcct ggagaggagg tggcgccgaa gcctctgcca 22354 gcagattggg gtggggctgt tttcagtcct ctctggcgag gtgttttgaa gcctcctctg 22414 ggaaccgtgt gcctctgtcc aggactggct gtctctctgg aaatcatacc ctggcagcat 22474 ttggctttgg gtgaaaggag aagagaagat tctggccatt cagagcaggc ccttgtgcgg 22534 gatggaaccc attttccaga actcttggga cagggaccag ggtggcaggc aggggcccgt 22594 ggactgcctg ggggacctgg tgcttgggga cttagagatt tgttttcctg ctgaatatat 22654 tgctttctcg tgcctgcttt gtgcaaccac gtgaggatgt gggggtgagg atggccgaca 22714 ggacacggga gtccctcccg acaggggcca ggcggcggcg ggggtccgca tgtctcacgt 22774 cagcatggct ctgtgttttc actcctctcc agcacatatt tagtggaaat gaactcattt 22834 tattattaaa aattaaagtc atgcattcat agggtaaaca agattgagag catgtggagg 22894 tgcactgtga aagtgcagtt ctctcggaat gggcacttag agacgcgcct gttctctgca 22954 gctgccgcag gggtctcatc ttgttgggac agaacacggt tgattcatgc aattggctgt 23014 tgatcaacat caggttgtgt ctagttttgt ttttttcccg tttcgcacgg tgctgcgaat 23074 tcacagctgt gccagtgtat ctgaaggtaa atcccacgag tgggccttgg agagtcagag 23134 gatggggcct tctacgtgga cttggtgtgg ttgggtgtgt gatgcctgca tggggctatg 23194 tgtttttagc ccttccttct gacaggttct ggaggcctcc tctgtgcctg ccagccatgc 23254 agccgctgag ccgagcatca cccaaggctt gcctgaacct ggcctgggtc ccaaaggaac 23314 actgctctgg ggcatggagg ttggctggtt gagaactaaa gccacatcag caggggcact 23374 gcccccacct gctggggtca gcccccgccc ggagttcagc aggacctccg tgagccttcg 23434 tgcaggtggc tcattgcagc acgtcccctt ggggtggtgg ccattggctt gtggttcctt 23494 tgctcactgc ggggaggagg acagccaggc acaggtgaaa ggggcttgcg ggtgacgatt 23554 ctagtccttg gcccggggaa tgtccctggg cttctgaggc ctcacctccc tgggtagtca 23614 ggagggttac gagggtgggg cctggccctg gggactccag ggtgtggcag cggtgggagt 23674 gaggaaacag ccctgagacg gagggagaga agggcgatcc agatggcggt ggcctcctca 23734 cccctcggcc agtgatgcat ggtagtggtt ttgacgggct gacctcgagg gtctgcctgg 23794 gagccgcttg gaactctctg gaggtggggc cggccctggt gggggcagga aggtcccaga 23854 gcagcttgtt aagtgggctg aggacaagtg tcaggagacc tgggtctgga tcccgctcca 23914 atacccctct ccgtgtgacc tccaagggat ccacctgcct tggcctctca aagtgctggg 23974 attacaggtg tgagccactg tgcccagcct gtgcccagtg tacccatcag taaagcaggg 24034 atcaaacagt tcttaaatcc tgcagcggtg gtgagagcca cctgaggaaa cgatgcaaag 24094 ggctttgacg gagtctggca cagagaacgc acccaataaa tgactgccgt gacgatcttt 24154 cttctcgccc tcaggtggtc tctggaagct cctctgtgcg gggttttctc atttgccagc 24214 tgtgcatccc ccggtcgtag tgcggctccc acgggggtgt accaggagcc tctgctcctc 24274 ctatgcttcc tgaaaaaggg cccagagaat atttccatca ggaataactg agtgaatccc 24334 agaaacttcc tatcacattt agggtgatta ggcagatgca tacgattctc actgtgggaa 24394 aggagctggc gacctcgatg ggttgtggtt cccgcaggga tgtgcttgcg ctgctgttac 24454 tccagccgta gctgaggcac gggagaaaac ggagacccca agaagttcag aggcttgtgc 24514 aggtcacgct gttcctacga ggtagaccct gactttgacc ccaggctgtg tccctgccaa 24574 gcttggagcc tctttctcaa aagggcgacg gaaggatgtt gttacagatg tggttgccag 24634 tttcctcctt ttcattaaat caccagggaa atggtctctt gcaacccccc taaagcaggg 24694 ggaaggagga ggacaaaggt caggtcacca tctttgctgg catgtgagtg gggtgggggt 24754 gggggtgggg agctaggaga cctggcgctg ggcccttgaa atatccacat ttccacaaca 24814 ttctgggtgt cagtgagccc ctgccttcct ccctcacatt tatccggagc tcttcctccg 24874 cagggaagaa caacagcccg agatggggtt atttcaaggg gatttccatg gaaacgggag 24934 ggtgggaggt tcctcccagc acttgtataa tgggagttgg ctgaggtggc agcgtgtccc 24994 cacggaaggg tgcgagggac cttctctgca ccgcaggcct cctcagagtg ggaggcaccg 25054 acccgagagt ggctggctcc cctttcatgc tcccaccctc tctacccagc tcaagacccc 25114 ggggctcctt ggtgtgagtg agagccaggc cagctcccca gggaccccca aggcctggtc 25174 cttcccatgg tctcttttct ctagcaggtc tttgtcttgg gctgctgcca gccacagctt 25234 cctggcagga cctcctggca ggacctctgt gctttgagcc gctgttgctc tgccaagacc 25294 ttgccccgca ccgtggtctg aatcagccca gcaccccttc gcctctgttg cagtgctcac 25354 atttatccct cactcctcca tccagcatgt tttgtttttt ttttttttac aagcagacac 25414 tttgctttat aaaagaattc tgctgtgagc tgccgtatcc tctctgagcc tcccttttgt 25474 catctgctga atggtaacag cagcgcctgc catgcctgct tggtgaggat tccatcaagc 25534 agggagacag tgggccgttg gcggggagtc tgagcaggtg taccagtatt tccagtcagc 25594 tgatggctga tggacatgtt cttggaggca gggaactcgg aggcctgcag acgtgcccca 25654 ggatgacaag attcatcagt tcctacaagc cctgcctggg cctcatgctt ttcagtgtgt 25714 cctgggcttt cccgtgtgaa atcttacctg atttttatgc caccttgaga agagtgatat 25774 tcatctccgt tgtacagatg aggaaactga ggctcaggga ggcaacgtga tctttgcaag 25834 gatccgtctg ttccccccgt ggcctggctg cccctcctgg cagtgcaggt ggagttaaaa 25894 ccatacagga gttaaaatga gcctcgatgg gggtgggaag ctacgactgg aaaacgtccg 25954 atgctctccc aagtcaaatt gtgcttggtg tctgtgggtg tgtcggtgtg ggggagggaa 26014 gctcagccct tttgaaaagt ggggggtggt ttgacgacgc tgcaggggca gctccgagtt 26074 ctagagtctc agaacgtggt tctaggcggt tcatgtggat caagtgctgt tctgagcact 26134 ttaatatcca gcgtgaccat aaggataagt gccactgtta ctggcttttt cacagatgag 26194 gaaactgagg cacagaggga ttaggtaaag tgactggagt cactcagcca ggatgtgaat 26254 cacagcccac acccatgtgc accaggaagc cttggctttc agggtccttg gagggtgtgc 26314 cgggcagtcg cctaagctgg gaaaccttgg gcttgtctcc aggccatgtg gccatgtgag 26374 ataggagtcc tcctgtgtta tgttctgcga cactgtgggc agagggctga ggaccccagc 26434 cctcccttag aacatcatgt tggtgtgaga catttagagc caggcctccc tgcttagaaa 26494 gcacctcttg ggtcgcttgc attagtgaag ttatacattt gaaactccat ttatttattt 26554 atttatttag agacagggtc tctccttgtc acccagacta gagtaccgtg gtgccatcat 26614 agctcactgc agcctcaaac tcctagactc aagtgatccc cctgccgggg cctcccagag 26674 tgctggcatt acaggcatgg gccacagcac ctggctgaaa ctcccttttc atgaaaagaa 26734 acagcttcaa ctttgcaatc tcatctgtct gtctatgagg ctgtgccttt gtgtgagatg 26794 agagcagtca ctgtcacttg ctctttgaat atttgattaa caggtaaaca gcctgaaatc 26854 catttgacat cttatccttt tgcaaacttg gctaaattct cttaaattgg ttccagttgg 26914 attaattaaa tgcatggttg cttatacatg tgtgtggaaa tgattctggc aggtcatgtc 26974 ttagctagat agtgaacata agcgtctaga atattctcag ctgttgcaga gactgccagg 27034 aatgaccttg aaaaagtttg ggagagggtt tttttttttg tttttatttt gcttttgttg 27094 agacagggtc tcactctgtc acctaggctg gagtgcagtg atgtgatctc agctcactgt 27154 aacctctgcc tcccaggctc aagcggtcct cctgcctcag cctcccgagt agctgggact 27214 acaggcaggc accaacatac ccggctaatt tttgtatttt ttttttgtag agttggggtc 27274 tcaccatgtt gcccagactg atctggaacc cctaggctga agggatccac ctgccttggc 27334 ctctcaaagt gctgggatta taggcgtgag ccactgtgcc caggctggag aggtttttgg 27394 atgcactggg ccatggatgt gaaggtgaac acatggaaac gatccctgcc acctgcttgt 27454 gtgtccagtg gacatgtctc tgatctatcc agattgttac actgtcaaag tgaaaactgc 27514 tgagagtaga gccatctgcc tggccaggca tcgcttggaa gcgtgaagac actttgcctt 27574 tttgtctcat gattctctct ccatgtgcag cttcgttggc ttaaaagaaa ttaagaaact 27634 gggcccccgc ttaggacctg ctgaagtgca gagttactgt ctttgaagtg gtggggtagg 27694 gaaaaatagg aaataagggg tctgatcatt ttgagaaacc tcagggagat ttacacctgg 27754 gctgtgcgag gaccccggag agtggcagag tgtatttgga atttccagta gtcctcattc 27814 ctcccttaat atccagggga tctggggcct cagtcttctt atctgttaaa tgggacaagt 27874 aacgactagg ctttggggtt gtcaggaaga ctgaataaga aaatgggtat gaaaacagtg 27934 gtcacggtgc ctggccctcc atccctgtct ccaccaggcc tacctgtctg gcccaggcct 27994 ccctgatctc cgcgggagca gacctcctgt aatggtgtca aaggaccctt gttctattta 28054 tccatctgat ttccattttc ggggccactg cctctagcca tgttaggcac atggtgagtg 28114 tctgtcccat caatccttgt cgattctgtg gtcctgggtg ggccatagcg tttctaacct 28174 gtccactctc tcctaatcag gcatttggac ctgtttgggt tcccaaactc tgtcacgggc 28234 agagggctgc aggaggctac tcacgggcca gggttgtttg gacctggttg ggtttccaag 28294 ctctctcgca gtcagggggc tgcaagaggc tacacatggg ccagggttgg gctgctgggc 28354 tgctgggctg ctgctgtgtt ggagctgcct agcacttgct tcgttgctgc acctgagagg 28414 ctgtgtgggc tgagacagcc agaaaagatg caccgggagc catctgtttg cagcccttgg 28474 accagatgct ctgcaaggac tccggggggg cggtggggtg gggagggaat acatttgctg 28534 agcacccagc atctttcaga gcctcagcac agccctacaa gctgggcatt gccatcatgt 28594 ttatacggac caggaacacg aggctcagag tgactgagtc actggtgaca gtcacccagc 28654 caggaagtgg cataggtggg gcttgaaccc agggcttcct gagtcccagg ctagtgttct 28714 ttgcctcagg ctgctgaggt tccagctgaa tgttgcggca gagtgacttc tgagaagtac 28774 cacggaaggg ggtgactcac gccggggtgg tctggcttct ctgcccagtg cctgaggaca 28834 cccaggtccc tctgcggcct tggggcttta cccagcgtct gcatggcatc ccgcagcacc 28894 ctgcctctgg agcgcaccct gtgtgtatcc taaagtgcgc tttgcctaga aaacctttct 28954 aatgaaactg gtggaagatg gagaagccaa attcagtttt cagagatgac actaatccta 29014 ttaaggttga tggggccaga gcatgtgtgg aattagtcct gccaggcggc ggccgggcac 29074 ctgcctggaa ggctggaggg gatcctaaca agagtggtgc cgaggagaga gagggaaggg 29134 gcctcatctc tcccagaggt ttaaaaaaac tgaggccact gtagagcttg gttctcccag 29194 gttcctgggg tggaaaacag ggcttcccac agcagacgga aatgggaggt gggcagtagt 29254 caccgagcag ggaggctgtg aagtagtcat ttaggtcggg aaagtcacgc aagatctcca 29314 agcttcagtc tccttagctg tgatgggggg aatgggtgcc ccccttgggc gacttgtggg 29374 acccagaact catcacgcag agcgtcccac tgctgtgcag ccactagctg ctcggtgctg 29434 gggctgtggt atgagcatgg actctggagt cagaattcct gccttcaaag ccccactcct 29494 caccttgcta gctgtgtggc ctggggtgag ttgcgtaacc tctccatgcc tcagttcctt 29554 catctatgaa atggggagac tgaaactgta ccccacaccc taggggtgtt ggaacttaag 29614 tgagttaatt catataaaac acggagtgag tgcctggtac gcaggaagtg ctcagttcct 29674 cttggtgcct gtgattattc ccataatcat cactggtgtc accttgtcgc ctctcccagc 29734 ccttggggcc atgctatttg tggtaggaaa tggggcctga aaccatcaaa ctaaactgga 29794 ctgaatgatc agtccaccga ccaccacagt cacggcttgg tggccccacg gactgaagca 29854 cgtggccaag ggcagttttc ccttctctgt gtgggttcca ctgggtccaa gtacattgtt 29914 cctaagccca ggcctctggc cactcaccca cctcctgctg agagcgggca gagctgatgc 29974 ccctctctgg gcagaatcag cccacggctg ggaggggagg ccaggcctgc tgctgggggt 30034 gcagatagtg gggagctgca ggccagccac tggaaacctg gcctgtgtgc tgagacagca 30094 cattggacac agtctggtgg ccttcccata gatcaggcca cagagtcctc atcctgggtc 30154 cacccaaggc actggccatt tccagatcaa agagcaggtg gattccaggg tgagacggtc 30214 ctctctgctg gctgccttcc cccacccacg gacaccgttt ggctttgatg gggctgtgtc 30274 ctaggcttga cccaggtggt caggagcctt ccactatgca gtgggatatg ctgcaggagt 30334 agggcggaga aggaagggaa tggccggtgg tgaacagctg ccatgcccca ggcatttaat 30394 tttgaccgca gtgctggggg gccataccca gtaatacaga tgaaggactg agactcaagg 30454 gtcagtgctt gctcagagac ccacagtgaa gagtggggcc atcgtgttgc atgtgtgtgg 30514 ctgggcccca tcccctcctt tctacagcac cacccctcta ttccttatca agttcacctt 30574 taaggctcct ttgcccctca ctggggcagt catgagggga gcagaggcct cggatctggg 30634 catggatgag ggtagagccc tggctgtgtc ctgcaggtga cacgtacaga gcagaaggtg 30694 atgctggaac catccgccag ggaagggctg tccaggaaga ggtcacagcc tgaacagagg 30754 cgaggtggag agagagtgct cgtgtgtggg gactggtggc agctcaggag ggcaagactg 30814 tgacttgcag gctgggaacc agggaggctg caggtgatgg aggccccatg ggtctcatgg 30874 ggcgggctga ggagcgtggc tcctcccctg cagctggagg ggccaggaag ggctttaagc 30934 catggagtga gggaccagag ttgggtttac aagggtcact gtggtgtcgg tgtggagggg 30994 cttgaaggga ggagtttgga gggaggggct gtagcaatgt tgagattccc taatcacttt 31054 agtgttttca tgcatgaggg ccccgaggtg cttttttcca gagcctgcac tgaggttccc 31114 tgttggcggc ttccctcagg ctgctggaac ccccttttcc tgtgcacctg cagagctgga 31174 ggttactgga aactcatgtc ctctgccaga gtcagccctc acccagtcac tgacaggtgc 31234 agtggtataa ataccccagc tccctccctc ctgatcagga cactttgaga tgggacctac 31294 actgtcccca gagctcccat gggactgagc tcaagtcgca ctccttgaga tttttcctgt 31354 tatcacaccc cacttggcct ccttcatgtc ctggccccac ttccctacac ccttcctggc 31414 tttcccagca acacttccta atcacttcca gaaaaatgtt ggcctcaggg tctgcttctg 31474 gagaacccag cctagcagag ggcagcaaag gtgttgaggc actaggagaa acatggtgag 31534 atacagactc aggcggcgtc catcagctat gccaggaggc tctgagacgt gccagtcagg 31594 gagggaggtg ctgaggccac agcaaactgg gggccagaag taagcaccac agacagcacc 31654 aaggctgcca gggtccatca tcttgggtct cccaattggt tgggtccaga gaccagcctg 31714 ctggggttta cagagccagc atgttacatc tctctgtgtc cccactgctg aaagcctctg 31774 gtcagtgcca tggtgctgag ggagcttggg cctcccttag aggttgctaa gagcccccca 31834 cacctgccct gtgagttgtt ggccccaggg gactctgagt ttccctgttt ctggttttcc 31894 tgctcatggg attgggagtc tgacctgagc ttgctgagac agataactga tcattcagat 31954 acaaaactct aaaggttaga actcttttct gataacttaa atagaaaatg aattcatgca 32014 acatgtactc atctgtccat ctgcgcatgc atccaacatg tatgtatctc agttgatggt 32074 tgtttccatg ccaggccttg gggatctaga gatggcttgg tccctatggt catacccatg 32134 tgaagggaga tagaggtgga cagaaagaca accataatgt cattttgaca aattctggga 32194 aaagatgggc cacccagcct gtgagacctg tatgtagtga tggagggatg gggaacggtg 32254 gaggtgtcag ggaagctccc caggggagct gttccttgag gtggttttaa gagcttagca 32314 agagttttct acgcagtgaa gtgaagacgt agggcaggtg gagtggaggg ttggcaccta 32374 aaggtcctga aaaggaatgg tgttgcaaga ggcagcaaat agcatggggt gggctaagct 32434 ccagctggtt gagtttgggt cagaagtgtg gacttggttg gtaaggactc ctgagagtgt 32494 catgtccagg cacttggact tgatgctgaa aatacagcca ttcaacagag aagtatgtat 32554 gtctgagtgt gatgtggtta gatctttagt ttaggaagat ctctctgttc atggtgggga 32614 gagtggatga gatgggggtg gactggaggc agaagagcag aggagaagag cagactttct 32674 aggagacgaa gcgggagggg ctgctcccag ggcctggctg tgagtggtac tgaccagagc 32734 catccatcag cccagatcat gtctccctaa tttagaagaa aatgagagga aagagccttt 32794 tcatctctgc ctcttctggg atggaaatga gctattttga atcacgctaa agttagattt 32854 ctagttttcc ttttaatccg tgtctcattt agagcattag aaactggaaa agcacccccg 32914 tatgaatgta gtgtcataaa tcagtgcacg tcacaaactg cagaaggagt catttctaca 32974 agagtgtgca gccttgcatt tatgataaat ctaatgcttt atctttttgg gcttcagact 33034 agagtaatta gtcatttctg ctgatactgg caaaccattg catgtgcagt gttaatggag 33094 agcaaatgta tttgaactgc ttttgcaatt gcttgtgagc attgctgtgt atctcttcta 33154 cctgtttcta gaggggaaac atcctatata tttcattctt gcctattcta ggaataggtg 33214 tggtaatagt atcaggtaac acttactggg tttcttccac atctctggca ctgttcagag 33274 attcaataag aaaggatcct ttgtccaaat ggaagctgcc gtgtgtgtgt tgaggtcctt 33334 gggtcaatct gatcatgctc tgtctcctgc tctgtgcccg cactgtgtca gggaccacct 33394 ggataccact catgtattat tcacctaata ggtttcttta aatgttggcc ctctaccata 33454 aatggaaaac cagcaaatca ggccaaaaat agaagtaacc aaagacaagc acaggtgttt 33514 ctgctctaat gaaatagaga catcctgaga aacttctcat tctgcaaaat cccaaacaaa 33574 tgacatcaga gctgatggac agaatggggt tgggacagat gactggaagt ctatgcagtg 33634 tgtcaccaga cacccataaa aatattaagt tttagaaaaa tctggcacaa tgaaagaaaa 33694 acatattaat tcctgttaaa gaaacattcc aaccattata caatcttatc ttgaaggaaa 33754 aagtgaaggt catttaatgg aaggggctga aagggaggga gctgaattat ggctgggaca 33814 tggcctgggt acagagggag acccgtccac caaactcttc caaactgagc taagaggtag 33874 gtgcgcaggg aatgagtcta ttctcttggg ccacattcct ttgaggcttg atgttcagcc 33934 attagtgtat tttgcattca gttgcttcct ctggctggca caaaacatta acacactgag 33994 aaaggctgcg tttgaaccaa cctaactttt acattatact gacatcattc ccctatgtac 34054 aaattgcata cgacctactt tgcaaaggca atggtcatag taactgtacg atggtgagtg 34114 gggttgttaa atgcagacca gatactgctg taatagggct gtgactcagg actatcattc 34174 cagttgcctg atatgaaaaa ggacatgaag gagaaggttt tatgagaact ctggcaaaga 34234 cccatgaaac cactcttctt tgccctccag aaaacctggt aaaactgaaa gtaagccagc 34294 agccccacgg gtttgggatt gatccagaag actgaaggaa taaaaacaag ctaatatatt 34354 tctatcccct cccttctaag gcctgtagtt ggttccatta tgatgagaca gcagccgatg 34414 cacgtaaaaa cagaggccat gcatctacac aggggtgttg aggattgaat gagattaggt 34474 ctgaaagaac acacagtgga gacagtgttg tcattgtggg gacaaagatt tcttttcaca 34534 atttgagtga cacttgtcat ttctataggc agttaagaga caataactgc atactgttgg 34594 ccgctgtacc tttcctgtgc actgagtccc tgagcatatt cgtgagtctt taaaagtaca 34654 ttctagtcaa tgtagaaaac agatagtaag ggacatgact ctacctagat taagctcagt 34714 tttgaagcag ggcctagagg atttagaagt gacagagtcc tggattaggt gacatttgat 34774 aagagctcta tccctaactt cctcttaatt ctggacaagc cactccccgc tctggctgta 34834 gttcccccat ctttaaaatg aaacagttga atcagacaac tacaaaagga cttgccaggc 34894 cttctgtctc agatcctgtg ttgttgaagg gatgtctgag gccagagatg cagtttactt 34954 ctgagcaatt acagttgtat ttcttgtgtt cagcctagcc ctttaccaag ctttgttgaa 35014 gaaatggagc aagatccttg tcctttgctt cggtggtttt taaaacttgg atgcctaaag 35074 aaaccaggaa ggtcatatca gtgagcaaag tacaaaatgt ataagcaaga cacagtgcac 35134 catgacgctg agagtggcaa agtaacagtc caaccatgca tcagggagtg gtggggactg 35194 tggcgtgctg gcaagcatag ccttgtggga ttctgcattg gacagctctt acaatttctg 35254 gagagaaatc agaaattcag gtctacatgt tgaatctttt aatattgaaa tgttcacttg 35314 gcaatgtgta aacatcattt gggtcaaagc ccatctgtga accaagttag tcaaagacaa 35374 cttgggcatt tggacctcag ctttatagtc tatataaggg ttggtaaact atggcccaca 35434 tgctaatctg acccacctcc tgtttttgtg aataaagttt aaatgaagat gcagtcacac 35494 ctatgtgttt aggtattgcc tgtggctact ttcacactac aacagcaggg ttgagtagtt 35554 gtgacggtag ttgagacagt gtggccctgt atttattctc tggaccttta tggaaaaagg 35614 ttgctgaccc ttggttcatg tcaatgactc atatggagca gcaggaaaca ttctgaattt 35674 ggagctgaat gaccagggtt tgacgcctgg ctcagggaac tctagtaaca gagtagagag 35734 tgtttctctt ttctcctttt ggaaatgatc ctgaagcaac aaatggaaca aatggaaatg 35794 caaatgccat ctttgatgga accatagctt ctggaacctc atatgtgggg aagtgcagta 35854 aaggtcaaaa atgggtgcag gatgtctcca aagggaaata aaatgcccat ggctgtaaag 35914 ctcagacaga gcaaacaaag cagaattttc tacaccttct gtggtgggct cagatggcaa 35974 gacctatagt tcctctcatg gagcaataag aacaagtgca ttggctggtg tcttagtctg 36034 ttcatgctgc tatagcagaa taccatagat tgggtggctt gtaagcagca tacttttatc 36094 tctcacagtt ctggaggctg ggaagtctga tacccaggtg taacagattt ggtgtctgct 36154 gaggacctgt tttcttgttc atagatggtg ccttcttgct gtgtgcttgc gtggcagaag 36214 gggctaggga gctctctgag atctctttta taagggtact aatcccattc atgagcactc 36274 caccctctaa gacctaatca gttctgaaag acgttacttc ctaagaccat cacattgggg 36334 gctaagattt ctatatatga atttcggggg gacacacatt cagaccataa caactggtgt 36394 gggagccttc ccagatctag ttttgcacaa agtgaaatca gggaagtctg gggtgaacaa 36454 ggtctcacat ggacaagcta tattttcaaa aagcagtcta ctagagaggc aaagtggaga 36514 aaaggggctg tgttatgtgc cagcctgtgg catctgatct taacaagaaa gaagtaaagg 36574 ccaaaagaac tgactctcac tcacaagcct gttttctaag aactagatta ctcttttgga 36634 cactctggtg cacgaatctt gtataaatag atggttcagg aagaactcat cacattcaga 36694 gatgagtaat aattagtaag gaccagtgca agctctatct caagatcctc caaaaatgaa 36754 gaaagtaaca gatgaaaaat atgcgcaaga aaacatttgc cataaatcag atgaaaatgt 36814 caacagtaca taatgccttg gactaaggaa aaaaataatt gagcaatcac acctctaaac 36874 aagagtataa agttgagata caagaactca ggagaggtgg taacatgaca gaagagagtg 36934 aaacctgata tgatgagctc cacaaagtag atagattaac aaataaaccc atctaaaaag 36994 tgaagtatgc aatggaatga ttatgacagg gaacacagaa aacacagtaa gagatatgga 37054 agatgagatt gggaaaagca agataaatta atgtaaagag agagagagaa atattagaac 37114 atgatacaga ggacagataa ggggatccaa catacacata attggtgtcc ctggagataa 37174 gaatgaaaat aattaaataa aaaaaattta aggcacaatt ccagaacttt ctaaaaataa 37234 gatttgaatt tatggactga aaggaagtac agtgagtggc tgagaaaata ttgatatggt 37294 gaggtcaaca gaaagacata gagaagtact aatttcctca taaatcaaga acccccaaaa 37354 aaattcaata gaagaatgga taaaggatgt gatgaggaga tggtttacat aaaaggaaat 37414 agaaatatct tttaaacaca taaaaactca acctcactca taataagaaa actccaagtt 37474 aagatactgt tttttatcta tcgtataggc aaggactaaa atagctgata ttaccatgat 37534 ggtgcaggta tgagggaaac aagaactctc agaaacatgg ctatggattt cacttctaat 37594 ccttgtctga tggaagtaca caagtaagag gccaggtgtg gtggctcatg cctgtaatcc 37654 cagcactttg ggaggccgag attggcagat cacttgaggt gaggagtttg acaccagact 37714 ggccaacatc acgaaacccc atctctacta aaactacaaa aattagccag gcgtggtggt 37774 gcatgcctgt aattttaggt acttgggagg ctgaggcacg agaatcgctt gaacccagga 37834 ggtggaagtt gcagtgagcc gagatcacgc cactgcactc tagcctgggt gacagtgtga 37894 gactctgtct caaaaaaaaa aaaaaaaaaa agaaaagaaa aaagaaatac gcaggtgaga 37954 aatgacattt atccacattt gtcatagcat tgttggtaat gggaaagaat ggaaatatct 38014 gtaatggcca tcacagggga ctgtttacat aaattattcc agagcgtgat agtggatagc 38074 aatgaaaaga atgtgacagc tcagggtgcg ctgatgtaga atgatgttta agattcttta 38134 ggtgaaatga gcaaggtgca aaatagtgga tgatccatga catgctttat gattaaaaca 38194 tggtatctta tgactgcttg tgtgtagact ccttctggta ggatgatgca cctgaaagtg 38254 ctcatagtgg ttgccactag acaggagagc tgagtgagtg ggagaagggc ctaagggaga 38314 cttattttca ctgttagctt ttttgtgccc tttgcatttt atactcattt cttaaccaaa 38374 ggctgcacag cttaggttgt gaccataagc tctagagtca gctgttcgag ttcgaaccct 38434 gactgggctg cctactcgct gtgtgacctt ggacaagtta cttcacctct gtgggtctca 38494 gagttgtcag atggatgtaa caatggtgcc tatttcataa gttgttgagg atgaactgag 38554 tcaattcaag ggaaagaatg aggacagaac ctggcacaaa aaaatacagt caaattagct 38614 attatagtga ctgcatgtat agttgaaccc agggtctgga tttggaaccc gtatgcttat 38674 tggcccaatg ggggggatga cttggccaca gaacagccac agccaggcag taaagggcac 38734 agggaggggg ccttagcctg gggcttcagg gaagctgccc aggggaagtg atgctgctgg 38794 gtcttacaga atgatgggaa aacttggcgg caccgtttca ggcgacgcta cttagatctg 38854 caaaactgtt gatgtcttac aataccaagt gtagggcggg gctggagaaa tggaaactca 38914 tgccaccact ggaaatggat atgaaagcaa accatttgca aagtcatttg ccaatatcca 38974 gatatgtcca agcagcccct ctgttcccct tctaggtaaa tagcagggaa gccttcagct 39034 gtgcacagag agccattcag caacagagca gaccctcgaa caacacgggg ttgggggagc 39094 caaccccctg cacagtcaaa aacccacata caacttttga ctccccaaaa acttaactaa 39154 tagcctcctc ttgattggac ttccaaaaac atgaacagtt gataaacata cattttgtat 39214 gttatatgta ttatatactg tattctaata aagtaagcta gaggaaagaa aacatcatta 39274 agaaaatcat aaggaagagg aaatatattt tctgttcatt aagtggaagg ggatcactat 39334 aatctttatc ctcgttgtct tcatgttgag taggctgagg agaaggaaga ggacgggttg 39394 gtcttgcagt ctcaggggta gcagaggcga aagaaaatca tgtataagtg accctcacag 39454 ctcagctcat gtttgagggt caactgtgtt ctaaaatcca agaggctctg aaagcctaaa 39514 gattttttcc taacttattt ggcagtgaaa cccaacctaa attgatgtga aaccatttat 39574 agcccttctc tatccctgta gtgtgaagtt tcatatgtta tgtacagaaa tagaaatgcg 39634 tatgcgtgtt gtcccagaag cccttggggg tgacagatgt cctaggtgac ctgtgcacca 39694 tattactgta cagtccaaat cctctatcct gaaatactgg gcccaccctt tgggatttgg 39754 gagatgacag tgaagctggt gtgtgttcag ggaattccag gttgttgaag gtgctggagt 39814 agaggggaga gggggaaacg aggcagcagg cgctgggtcc cgacggtcct tggacaccta 39874 ctgaggatgt gggtacaaca cttctttcat ccctggggct cagagatgtc tgctgaatca 39934 gtcgaggggc cttcagtcca ctgtgagccc cagaaggcag agctgtggcc tcctccgact 39994 tgtttctcag aaaggtcact tgggcagcag gtgaacatgg ctcaggagag gcaagggagg 40054 gtggggacag gtaggaagca gaagccactt actgggcaaa gaccatagcc atgaggatgg 40114 ggagggactg agtagccaga gaggcgctca tcaaagccta ctgctgtcgt ctgaaggtct 40174 ggtttctccc aaattcgtat attgaaatta agccttaaga tgatgtgtta agaggtgggg 40234 cctttgggag gtggtcaggt catgaagatg gagccctcat ttatgggatc agtggcttta 40294 taaagggacc ccacagtgag aagatggcca tctatgaact atgaagaggc cctccccaga 40354 cactgaagct tctacacctc gatcttggac ttcccagcct ctagaactgt gagatgtaaa 40414 tggctgttgt tataagcccc ccgagtctgt agtattctgt gggagcagcc ccaaatgact 40474 aagtccacgg cccatcctcc acccactgag gccataccac tgggaagggt atcagaggca 40534 gggttggggt cttagaggtc cagggtctct tgtccaggct ccccagaggc aggccccgag 40594 gtgtggacta gagtataagt ggtttatcaa ggaagtgtac ccaggggagg tccagataca 40654 agtaggaggg gctcaagcac agaggagcca gggaaggggg ggctctggac cgaaaccatg 40714 tcccctccac ggctttggac ttagcccctt ggggacacag acgtggctgg ggatgggtca 40774 caaagtaacc agggtgactg ccagcctgaa ctctgggctc tccagacttc tggggaccgt 40834 agtctcagcc tgagcagctt tctccaagga gggtcctgga aacctggggc ctgcccctga 40894 ttttgtcctg ggagcagggc ccctccatgg tgttctggag cccctcatat tagcttttga 40954 ggttgattgc ttaattttca gtttggagag ccagcagaca tcttgttggt agtttgaaat 41014 tggccagggc aggggtattt ataccatgga agctggcagg ggctgccttc cagaacctct 41074 ctccctccag gtgcagggaa acacggacct gcacaccctg gtggctttca caccttcccc 41134 tcctcaggcg gctcgtcccc ttgctcagtt atactgatcc ttgggcttgc aggcagaacc 41194 atctctgtca tccagaatct ccctagtaac cccaacccca aaagtgggct gccggaagag 41254 gcagatggca gtgtcccagg gctatggaag ccactgataa acatcttcca acaaacagga 41314 tcagggatct gcaaagtttt ttttttttgt tgttgttgtt tttttgagac agagtcttgc 41374 tctgtcgccc aggctggagt gcagtggtgc gatcttggct cactgcaacc tctgcctcct 41434 gggttcaagt gattctcctg cctcagcctc acaagtagct gggattacag gtgcctacca 41494 ccacaactgg ctaatttttg tgtttttagt ggaggcggtg tttcaccatg ttggccaggc 41554 tggtctggaa ctcctgacct catgtgatcc acccgccttg gccccccaaa gtgctaggat 41614 tacaggtgtg agccaccgtg cccggctgga tctgcaaagc tgttgaaagg aggagtggat 41674 aggattacaa agttggcctg attctgctaa atgaacattt caacatgttt cccctcgtgc 41734 accgaggagg catgcactct cctctgaggg tctgaggctt tcttcacgga gactttgtaa 41794 accacttctc cccagcactc tggagtgggg gagtcacgta gggaagtcat ttctctcctc 41854 ttggacctct cagtcccctt tggcttctcg ctgataccag gcagtcaggt ggatcagaga 41914 agacatggac tctggagctg gatgtctggt gcaggcagtg tggcttcagg caacttgctt 41974 tgcctctctg ggcctcagct tcctcctgga aaatcatgat gctcatacct agggtttcat 42034 gggggtcagg caggacagtg caggtgcagg tatgagcacc atcccatcaa ggacatagtc 42094 ctggctgctt tcagtgatct tggtgctggg gaaaatgggg ctgattctca tggaagagga 42154 aatggattca tgtgcccact tcttaaatgg aaattcaagg ccttgatcgt ggcccactta 42214 tgaggtgggg actagtgagg cttcaggtgg tgtcctaaga ttagaaaact ggagcattca 42274 gttgggagtc agacctctgc tgatgtgctg tgtgacgttg ggcaaggtgt gtgacttctc 42334 tgggccttgt gttcagtaga agcaggtcat ctttcaatag acctccttcc cagaccctct 42394 cggatgctgt gggcatccag ctggccccca tgccacacct ggcttctcgg ggactggcct 42454 gcattctcac acccgttctt tctggcaacg atgggcattt gtttctcccc tgccagcaaa 42514 ctcctttgga ccaagaattg atgccatggt gttagcatac aataaagctt caaggagctg 42574 gtgaaacact ctgagacggt cataaaattg gcttttcatc cctgtcggag ctttcttatt 42634 acagacaaca agcagtgtca gggagcagca cggtagatgc tgcttaaccc agcagcaggc 42694 gagactgagg gggtctcgtg ctgtttgtca ccaccgcctc tctgagatca tccccaaccc 42754 atactgttga cattcactgg gatacctggc tacctgtttt gggtttcctt acaatttttt 42814 catttgttta atagttttta tttttcaaag tcttaaaaaa cacaagtcag tgaaagtttt 42874 ggtctttgtt actgtcttcc taccaggtac gagggcctga aagtcactgt taattgatta 42934 ttgattatct gattagaacc gtacatttac tttttaagga aatgtgaaaa ataagcctag 42994 aaatgaaatc aaaagtgcgg tgttgaagtt agaaatggca gcgtcacggt caggaattaa 43054 agctgctgct tctctgtcac atggtatacc acagggggtg gtagctacag cccatgggca 43114 aaacttggcc cagtgcctgt ctttgtaaat aaagtttgat tggaacagag tcatgcccat 43174 gtatctacac attgtctgtg gatgcctttc tgctataatg gcagagttgc agagttgcca 43234 aagaggacat atgtcccacg aagcctaaaa tattggctat ctggcccttt gcagaaagaa 43294 tttgctgacc cttggtatag aggaaagtta gtggcacaag tttagatcgc ctatagtgaa 43354 agaccttgca ggaccaggag tcaggcagac ctgggttcga aacccgctct gccacttcct 43414 ggttgtgact tcaagctgct tgccttttcc tctcagggtt ctgtttctgt ctctgtcaaa 43474 tgcagccaaa tactgcccag tttgcacagc tgtttttgga gacagagaca ctcagcaagg 43534 ggtccagccc ctggtgggtg gtatcccaat gtcactgttg gcatttgcag tgtcagtgat 43594 gtctggctta ttcatcaggc cctcttgagt ttgccccaaa cgagtcaacc ctccagggct 43654 gtgaaacttc tgctgccttg atacgatgtg atttccgaac cagaaaaatg gaggaggccc 43714 tggcccctaa tgcttaagtc acaggtgact ctgtgcaatt ggtttcttcc ctgtctcctg 43774 tccctctaaa aagaaccacc tgagctcccg gactgtgcta tatccaggcc taaaggctgg 43834 tggaccagga cacagtcacc agcaatcagc tttcatcgac ttggctggac cttggaaact 43894 taaggcttgc cctgccctgg cttcttgcgg tgagcaggtc ttatggagtt gctctaacca 43954 ctgtccatcc aggccggggt tagaggatcc aaacacagcc atgttgatgg gaacctggag 44014 gcaaatagag ggcatgagac cctcctctcc tgaaaccttt ctggccttct tattggatac 44074 ccaccaaaca gtcttgatct taaaactttg tgcaaagcaa taggatgaac ttgtaggaca 44134 tgcataaaga ggaaggtatg gattgtgaca tgaggctctt agggatgctc ctcctacagt 44194 gctgagtgac cctcctcaga ggcacaggtg tgggcacagc ttgttctttc aaatcctggc 44254 accccagctg ttctgctgtc tagctcgttc cctcattgac aaaacaggaa taacagtgcc 44314 cacctccttg ggctgttagg ggatcaactg agatgctaag tcatccagga gggggagcct 44374 ctttcccaga gtcctgcctg tgcccggtgg ctgtgcagac ctgatacccg cagccatcta 44434 cctctacacc tcatgtgtgt tagagaacac cactctgatt tcagcctctc agactggggg 44494 ttcagtcact ggctgctaaa agcttcctaa agccaaggcc tctccttgcc tccaggggct 44554 ccgtgtctgt tagatgtgta aacagatcca tcaccgagca tactgatgag tcctggccta 44614 gggacaagca tggccacaaa tgaggtgtct ggaaagggct cacaggggaa ggagccactg 44674 aggagggcaa gaagaaggct tggccaggaa gatggggtag ggctcattcc tggcaggtcc 44734 agcctatgtg aagcccagag acccagtgag gggcttgccc atcctttggc cttgctggag 44794 ccaagggtgt gaaatgggag ctgagagtag gatgttagta gcagtggctt cctgggaagg 44854 gcccccacat gggagcctct ggcctggttg caaatggcag gaccaaggag gtggttgttg 44914 agttagttgg aaggcactgt cctgccagga tttcccacgt cctcgtttga gcattgagat 44974 gctgaacgtt aaactgtcct tcattctcca gctcagttct tttattcatc caacaaacac 45034 agagtagcta ctgtgtacca gatactattc taggcactgg gcatacagtg gggcccccag 45094 ctcgtcctgg cctcccagcc cagtgggtgt ggagcagtga gcaggaggac ctcgagtgtc 45154 acacttgctc cccttggtac acattggcac atggcgttgc caggtcagat attctcttct 45214 tggggttcac cagcatcccc cttggatgtg ccctccgtgg tatgtggccg cttccatctc 45274 agtctcaggc cgatggaaga tattttcaaa attaacttag cttttggaat tggttcctcc 45334 ccatgttggt gctcaaagac tccccagtga gacagctgcc tccttgagct ctgtgtgcaa 45394 aacttgggga gcaagacttg cttgagccag tgtttggcct ggcccaagct gttgggcctg 45454 cagagcctca cctgcccctg tggctcaggg cttggtgtct gaagtggatg gaggcagctg 45514 aactggtttc tccagggccc catccagcct gcgtttccca ggctgctgtc ccagctctgc 45574 tccacccaag tctactctgc cgtcccctga tactgacact gagtgtgttt ctgaacactg 45634 cagggggtga ggaataaggt gggcatattg tagcttcagg aggtgatgct tgtgtctgaa 45694 atataaggac cacaattgcc atgcaggtgt aaatatctcc agtgattaca catttccctg 45754 caccgaccga gtggctgcac ccagtctggg gctctgtctc tcctggtcag tctgttcttc 45814 ctgaagccag gaacacagga gggcaagttt ctctccatcc ctagtcccac cctggagcca 45874 gcacacagta ggctgcagga agtgctcgtg gaacaaacac aggcagcaat ggaagaatcc 45934 ccaccactgg gattttcagc agctgatcgt agaagggagc tggactgcaa ggccgtctcc 45994 gaccgcctcc ctctcactgc ccagctggct agggtgatga gtatggacga ggatggaggc 46054 aggctgtggc tgctgtctca tccaagtagc cttttcctga caccccaagg ctgggcagag 46114 ggactgagtt ggtcccaggg cggagcctgc tgggaaggaa ggctgttagc cgctgccttg 46174 caggtgccat agcaatgcca ggcagcccac ctgctccttg gattagatgg gggatcagag 46234 ccgtgaggga agcaggcctg tacccaggaa caggctcatc ccgcccctgc cctggcccgg 46294 tactgatgga cctggagcca tagagtgcct ctccccgcaa cacacatgca catgcatgca 46354 cgtgtgcatg cacacacata caccacatac acaccacaca cacacacccc acacatacac 46414 acataacaca cacaccacac acacacacac acacacacag ccaagcatcg attctgggcc 46474 ctgttctgta tgcacaccaa ttttcctgaa cagactctcc ttgtcttcta gcacccggga 46534 ggattcagaa gtgtcctggc tgccctgtgg tgatggggat ggcagggacc tgcatttttg 46594 tgagttcctg cacgtgatga aggggaaatt gcaactgccc aggcagcctg tgcaaaaagg 46654 cagtgggttt caagtgtggt cataaaccaa aagcctcagg ttcacacgtc atgggggagg 46714 ctgaggggaa cacacagcct ctgagctgtg ctctcgggct gattctgagc tcgtgctggt 46774 ggggacaccc ccagacttcc agcagcactg gatgtccctg gatcctcaca tgactcatga 46834 ggaggggctg gcatgttcct gaacttcagg tgttgactct gcagtgaggc gatttggatc 46894 agagagactg tgcaggtgcc caggacacat agcaggtgag gtgcacagcc aggcttggct 46954 agcaattggg ctcttaatga tgctcacact ggacgtgtca gagtgcctgc tcctgggcgt 47014 gcacagcctt gtgggagggg ccgacaggtg gacagggaat tatagggtgg ggggacaggg 47074 agctgtgctg gctgttgtgg ggacaccaca gggaaggccc cctgactctc atgttccagc 47134 attgccactt cctgtcatcc tctcggcaac cctatatgaa tgggaatagg agtaagtgct 47194 ctgtaaagac tcctctggct gccaggcacg tgctaagctc tttgcccaca ccactcaggc 47254 attcttcatg atggccctaa aagtagagac tcttgtgtcc ccattttaca gagtaggaaa 47314 gtgaacccta aagaggctgc ctgctgttct gcggccacgc agctgggcag tggcggcatc 47374 gggatttgaa cccagaaact ctggctgtac ggtcttagcc ttggctcact ctcacctcca 47434 agaaatagac tctgagcagt gaggtgacgt gtcccaggtc tcatgggggc tgagggatct 47494 gggaagggtg atttgccccc acccctgcat ctcccacacg gtcccatccc tgaacccttg 47554 cacacacggc ccctctgcct ccatgccctt cccctcactt tgtcaaaccc cagcagctgt 47614 tcagcaggca caccacagcc gcctctggag gaggcattgg ctggtctcct gtgtcaatgt 47674 atcgacactg cctggcgagg tctggctctc cggcctccct gtgtatccac aggtctcccc 47734 agctctgcaa tccctttagg gcaggctcag gtcagtcatg ctatggtcac ccctcagtgc 47794 cccgacatgg ctcagcagtg tccggtggct tgaatggagg accacaaact gtcctctctc 47854 tgcagagggg ccccaggtca tatctgctga cttagcaccg cctataagat ttaaagacca 47914 ctctgttttc acctggagga accgtcagct cacgcaggat ggcaggtggt tttccagggc 47974 tccacagtga ggtctccagt tcatcttttg atgagggtga tgatgggaca gtggccctga 48034 aagcacatgg ctctagagtg cttaggagcc tggtgacctg ctgctgtgac ttcctctcca 48094 gagctggagc tccaggggct gaggttcccc ttccctgggc agccccttcc tcctaatccg 48154 gctttccctg tgaggaagag cctcctggcc ttaagccaca tccttagcag cttctgccgt 48214 ggcccttcct ccagccgggg accctggcag aatgcatggg caggaggagg tgccttggcc 48274 ccaggacagc caggtgggca gtgaatggac gaaatcagtc tgtgcaggag ggaaacacta 48334 acactaaccc taaccctaac cctaacccta acacattctc aaaacatttg attctaactt 48394 aaaacacaca agggcactcc tttccatggc cctactacat gatctggcct gacctgcctt 48454 tctggcctct gctcatacca ctacctccct gatctttcag ttcctcaaac acaccaagct 48514 ggttcctacc ctctagctcc ctcccactga ctcctcctca ccctgagatc ctcctcagct 48574 tatcaaaaaa agattccccc attttctcac ttcaaccctt tgttcatttc ctccaaagta 48634 ctgtattaca gttaatgatt attttttggg tctgtttacc tgtttgggct tcgcctcccc 48694 agtggtatgt aagatcttta agggcagggt gcatgtgtgt ttcttgcttt ccaaaatatc 48754 cctagtgggg gccgggtgtg gtggctaatg cctataatcc cagcactttg ggaggctgag 48814 gtgggtggat cacttgaggt caggggttcg agaccagcct ggccaatgtg gtgaaacctc 48874 gtctctacta aaaacacaaa aattagctgg gcgtggtggt gtgcacctgt agtcccagct 48934 acttgggagg ctgaggcagg agaactgctt gaatccggga ggcagaggtt gcagtgagcc 48994 gagattgcac cactgcactc cagcctgggt gacagagtga gactgtcttg aaacaaacaa 49054 acaaaaaact aaaacaagaa aacccccaaa atatctccag tgggtagcac agagcctgac 49114 acacagtagg tctgcatgaa tatttgttga aggaatgaaa cagtgcctgg atgagtgtat 49174 tgcagcccct tccaggtagg gcacagccat cggggagcca gcgtgacaga tgtgagtgct 49234 gtggccctgg gatgcgatga caaccccttc tcactggggt gtaccctgga ttggggtggt 49294 gcatgtagaa tatatggcat gctgctggca cttggcaggt gctctgtcaa ggttagttgt 49354 tgttacttaa aaactctaat caagtaagca tgacatatac tgaggtccta ctgtgttact 49414 gttatgggct gaattgtgtc tgctccaaaa ctcacatgtt gaagtcctaa cccccagcac 49474 ctcagaatgt gactgtgttt tgagacaggg ttttcacaga ggtacctaag gttaaactgg 49534 atcattaagg tgggccctga tccaatatga ctgtgtcctt ataagaagag gagattagga 49594 cagagacaca cacagaagga caactgtgtg aagacacagg gagaagacag ccatctgcaa 49654 gccaggagag aggcttcaga agaaaccatc ctgctgacac cttgatcttg gacttccagc 49714 tccagaactg tgaggaaata gatttctttt gtttaagtgg cacagtctgg ggcactttgt 49774 tatggtggca ctagaaatga atacagttac caaatttaat ttttcaagct ctctctagca 49834 gcaaagtatt tcccccatat aaaaaaatga ggacgctgag gctcagagag gtgaactcgt 49894 ttgccggagc cacagggctt gctggcgggc gttggcactg atagttgaac cctggtccac 49954 tagtgtgcct ccagagatgg tgcaggccac gccgtctgcc ttggtctcac gcaagtggcg 50014 gctaagccca gaggcacttg tctccatttc agtgccctgc tattggctgg ttagaaagtc 50074 aatattttat ggagcctcat caacctccca agtcttgggt ctcaattccc ccttttggtg 50134 tgagcctctg aagactggtt gagcatttgt gagaaacaaa gttttgacta ctcaagactc 50194 tagttaaaaa aaaaaaaaaa ttgcaccaat gtgccatccg gctgcagcgt ctcaggggca 50254 tgattcggtt tttgcaacag ggagtagctc ttcttgaaac attatgggat ttctttccta 50314 agttgacttc acttacattc tgctcagcac atgcaaagca tttggttatc gggaggcaga 50374 gtaagatgac aaccctatta ttgaaggtaa gcagacctgg cctgttcaca aagccctttt 50434 tacatcttgt ttcattctgt taccaacagg gtaactgtga agtgggtggg caggaactgt 50494 gacttctttt caagtctcag aagatgtcag tcccccaggg aggctggcct ccgagtgcca 50554 gtgcaggtgg ctccccctcg gccgtcctat gccacgtgcc ctctcctcgt cattctcagc 50614 cccctcgcgt ctggagtcac ctcgctggtt tatcgtcttg tggtccatct gcccgtgagc 50674 attccagcca ggtctgtggg cttcgttttc acggccgcca ttttggctgc ccgcagagtg 50734 cctggtgcaa agcggatgac actcagtatc tagagcggca cttccgggta atccacaaac 50794 atttatcaaa cacttaggtg tcacttgggg tgctcggaat tgcaaacatg aggacaaacc 50854 ctcactccat ttggggcctg cagattcagc aagagtggaa aaaccagctt tttaaaatgg 50914 cagcctggga atcccagaat taggaagcac aagcttgtct ttggcaggcc aggccagctg 50974 ctgacccgca cggccttcag gggccagcca gtgcgaccat gattgaatgc acagccctga 51034 ctcctttgtg gcattggctc ctgggtccag gtgggagcat ctgattggcc cccactggtc 51094 atgtgctaac caggaagtgg tgtgtgatgg gctgagccta gggctcatac ctgcatgtgt 51154 tttgggggaa acagagaraa aggtgtggcc tctccacttc tgtggacacc ccaratagga 51214 agaagggtgc acacaaagca ccgcttccyc cacgaagccc tcctcaggca catcgaggag 51274 aaccagctgc ccaagctctt ggctgctgcc cttctgaggc ctgcctggta ggtggcgtag 51334 gaggaggctt ggtaagcaga tgatgggaca tcatctacca catcccatca gtaacatcca 51394 acaagtgtgt gtgccagcac agacctgggc actggcatgt cccagccgtc attccatgtc 51454 aaatacttat ctgtgccgtc atcgtcgagg tctggtttcc aactctatgg ctccattgtc 51514 tcaggtttaa ccagtcctct tattgggcat cagcttttcc atttttgctc tgtgagaggt 51574 tgttgagtta gttggaggac caagcccata atttcctgga tgacagttcg tgtcccgcag 51634 atagagctta accaacagtg gttccctttc cagacctaag caggtgggag tcagagatga 51694 gcatagagaa agggtgaagg ggtgcctctg gattcccaag gcagggacat agctggggga 51754 gctgcctccg gactcgcaag gcgggggtgt ggcagacact ttgcagaaaa agtacatctg 51814 tccttggggc gagaggccgc acatgcagcc ccaagtccct ggacctgtga gatcctggct 51874 gcctgctgtt gatagaacgg gacaggtggg gggatgcttt tgattcatgt acggtgaatg 51934 atcttattct cacctttatc actggtggca cattctgatg gaaggagaca ttggcagtgg 51994 gactgggcaa gaaacaggtc atttgtcatg gctgtgtgcc agcctcctgt cgttgcacag 52054 cctgtccttg ggaagtcttg ctcacctgtc atgtggagta gttgtatgtg tgtgagtgtg 52114 tgtgtgactg agagagacat acacatatgc acacacacgc agaagtgtct gtacctctga 52174 gaatatagtt ctccagagga tgcagaaaaa ttggggattg cagactgtcg tgcgtttaaa 52234 tgtgtccttc tctcaagaat aatgtccact tggaacctca gaatgtgacc ttatttggaa 52294 atagggttct tgtgtatgtc actagttaag ttgaggtcat attggattcg agtgggcctc 52354 aagtccaatg gctggtgtcc ttctaaggag aggacacaca gagacacagg gagaggaagg 52414 ccgtgtgatg acagaggcag agattggggt gatttatcta cacaccagaa gccaggaggg 52474 agtcagggag cggctcctcc ctcagagctt ccagagggag ccaggcctgc ccacgctgtg 52534 atgtcacatt cctggcctcc agaactagga gaggataaag ttcgattgtt ttccagctgt 52594 ctgtgtgtag taatatgtta cagcagccac aggacactga tacccagaca catcccaggc 52654 cctaacatcc cagaagagga gtccctgata ctcctctttt gcaaaatgag gtgtgggctc 52714 agagcaagtt cgattttctg tgaagggcct gatagtagat attttagact ttgcaggctg 52774 tgtaaatctc tgttgcatat ttttcttttc ttttctcttc ttttcttttc ttttctttct 52834 ttttttagac agagtctcac tctgtcgcct aggagtgcag tggcagtggc accatctcag 52894 ctcactgcaa ccactgcctc ccgggttcaa gcgattctcc tgccttagcc tcccgagtag 52954 ctgggattac aggcacatgc caccacgctt gcctaatttt tgtgtgtgtg tgtttttagt 53014 agagatgggg tttcaccacg ttggccaggc tggtctcgaa ctccctacct caggtgatcc 53074 gcctgcctca gcctcccaaa gtgctaggat ctgttgcaca tttttctttg tttgttttgt 53134 tgtcatttgt ttgttgtttg tttcacaacc ctttgaaaat gcagaaaaca ttcttagctc 53194 ttgggctggg tgtcactgag tttgccctag gggaaccctc accgcatgcg aagctgagtg 53254 ggcacggttt cctccgctgt caacgggaat attgatggtt tccctgagtg aggacccagg 53314 ggaagcactg ggctggtgcc cgcctcctgt ctctgtgccc aggcctactg tctgcttcac 53374 actttactcc ccagaaccag gcatggcact tagtacaggg caggccgagc tcgggggaga 53434 tttgcttgaa gaatgaggaa cgtttctgga agcctctctg accacccagc aggcaggggc 53494 aggtcttcct ctgagaccca agtcctctat gcttccctcc atcctagcag tgacttccat 53554 gacacaccat tgtccctttg ggagcacagg actctggctg agtcatctct gaagtgaggt 53614 gaacccagca cagggactga tggcttggga agagcagctc agcctatgtg gggggtgttg 53674 agggtgccca ggcccagggg cgatttgatc ccaccctacc ctagcgcagc cagaatgctg 53734 gggccgaggt tcacctggga gatgcaggag tttagagaag aggaggagga tgtttaagcg 53794 tgcgagctgg tgataggagc gtggagttgg agctagaccc agacttgaat tctggctttg 53854 ctgcgtggca gcagctgtgt ggcccttgat gagtgtctta accttgctgg gctttggctt 53914 cctctccagg agggcatagc aagtcctgcc tgttagggcc atcctgagga tggggtgacc 53974 agagcatgag cagccgggtg cccagggcac ctgggcaaca gccctgtggg taggtgggtc 54034 tgaatggttg agccccacgt tttagtcaag accactctcc ttgcagagca gttcatgtcc 54094 acttgcccac atccttcctg tcccagcacc gtctgtaggt tgctatgatc accccatttt 54154 acagatgagg aagcacatgc ccaaagaagc aagtgacttc ccaaggcggc aaggcaaggt 54214 gaggggcaga atgaggaccc caacccagtt ctccccaccc cctccttccc ttccagagcc 54274 cctgcctgct ggaggcattg tcccagcggc agagggtcag gccacatctg ccagagctaa 54334 ggggagtctc cgtcatctca aatcattggg tcaaatgaca gaaatctgct ggcatgctgc 54394 cttttgaggc tcggcgactt ctctgaggct ttcctgatgg ctgctctggg tgtctggaat 54454 gagctgtgga cgagggccgt cctctgagtg accatgcccc ccacgcagcc gaggttcccc 54514 tctgcctggc tcagtgcggg ttctgagaaa gcctgcctgc cctcactgga ggcacctctg 54574 actcactgct gcaaggatgt ggccatggac tggggtcccc gggggccccc gaaagcctca 54634 gcaggagaac atgtttatcc agaagcctgg gcaacaccca gagggtcctg gcatgggtgt 54694 gccaggcaga ctgggcatgg aaacatgccc cgtgatgtct ttgggatcct gggagcctga 54754 ggcttgttct cagtgtgtag ggcaggggct gggtgccacc caaggggggc aaactgaggt 54814 cacagagagg gaggcagtac ccccagaaaa ggtgattctt ctcattggaa gattcccaag 54874 gcccaaggcc tgggtcagca gacagtggaa caagggtaat ggtcatgtcc ttaattcacg 54934 taaccccgag gtgggtccct gtgaaaatcc cgtggatggg gcctggtgat ggctacactt 54994 atattctcag aagcagcatt accacctgga cccttccctt ttctcttact ccctcctcct 55054 cgtggggtct gcaagggggt ctggtaaatg gcatccccct ccccgcccag gggctggacc 55114 cgtggagcat aagccaaaag gggcggcaaa gagagacacg gaacctcact gccactgccc 55174 agctgccggt gctgcaggac ctggcttagg ttcaggggcc cggtgggctt ccccagtgct 55234 ggaccccagc aggcaggtgt ggagggagca gggggtagtg gagcagagta cagtggcccc 55294 tggctgttct cccccaggaa gagaggagag gcggggctgg actctttccc atctccctcc 55354 ccaatactcc agcgtcagtc agtctccccc cgacaggggg aagggagaga ggccaggagc 55414 cttcccctgg ggcacacaca gagagcccag caggcttgga agaagtgtct ccctcctcct 55474 ccagccctgc cagatggtcc cagccctcct gcagggttcc cgaagtggaa ggatctggac 55534 tcagagccca gtgctgctgc ttggcatctg tggtcccggg ctggagggcg tgttggcagc 55594 tcatgcctgg ccagcgcatc ggggtggctg cagcagagga tgggggaggg gagcagggac 55654 aagaggagcc tgcaggctgc tgggtgcagc cagggcttct gcttcacccc gggggtcaca 55714 gctgctttct gttgggaaag ctcccactgg aggtatgggg taggcagtgc tggagaccct 55774 ggtggcaagt gctgagctgg ggcacaggtg aggatcagga ggagctggga gggacatccg 55834 caggttgtgc tgatggactg cctctgagta ttttcacggg atggtggaaa gaggctttga 55894 gtcagacctg ggttcgaatc ctggctccta ctcttggtag cagtgtgact ttatgtgacc 55954 tttctgaacc tcagttttct ctgttgtaaa atggggaaaa ccacacatcg tgggggcngt 56014 tgtgtgcacc taaggaagcc accccagggc tgggcacacg ggtagccgat tgtcatatcc 56074 ttgttatgga aggttgttat ccttgttagg ctggtgggca ggggtggtag aggagtaggt 56134 tgtttttgga aaatggtgga cttagtctta gacatgttgt gtttaaattg ctcatgagaa 56194 atccaaatag aaagacccag ggtgacagca gggactgcta ggaacttggg ataaaaaatt 56254 ggtcctgggg tgctggtcac tgatcctgtg gataaaggag ttggggtgct ctgtttgggt 56314 ccagctggca gagttggacc agttgagaga aacttctagg aggaaggttt agaagaagaa 56374 tgctttcacc atcagagcta tcttaatagc tgtgtaatgt ggtagtgagc tccccatcgt 56434 aggaggtatg tgagtcatgg ctggaggact acttggaggt ctgttgtaga aggattcaga 56494 caccagagag ggttagactg gatgaccttc agttcccctc ctgggtgacc acagctcttc 56554 aaagcccctc actgctgccc gcttctgcag gattcagggt tgaatgtcag aagtctgctg 56614 gaatgctgtc gattgaggca cggtgacttg gccaagcctt tcctggtggc tgctctggta 56674 tctggaatga gctatgggtg agggccgtcc tctgagtgac cgtgcccccc tcacagctga 56734 ggttcccctc ggcctggatc agcgtgggtt ctgagaaagc ctgcttgccc tgactggagg 56794 cacctggagg tggttttcaa agtgtcactg tcaccgtgac ccagacatgc ttgagcccca 56854 ggctgggaaa gctttttttc tttgctttaa aaaagcagaa acagtgaagc aagcataaat 56914 ttgcctttga aataagaggc tgaatgtctg ccaaatgcaa atggattgaa atggccggtg 56974 gtctgacctt gggatgttcc attggtagtt tcagaggggc tctgagcccc caggccggct 57034 gtaacagtgg acatgctggc gctggccagt ttgatccctt tgaaagcccc ccgatattca 57094 cctccaagag agaaggccct ggcaggtcct ccagcatgcg gacgaggcgc atgcactgtg 57154 aggcagcggc tctgtgggag gacggggcct tttgtccact gtcctggcat tccatggccc 57214 tgtgtcccca gatatccgca cctgttcctg acaccatccc ttcctgtcgt gtgagcgaga 57274 tgctcttctg tggaacctgg gttcctatgg tcactgggag ggtgaccctg agttcacaga 57334 gaaaggggag caggctgttc aggaaaacta agcacatgtg gtgagcatcc acaggcggct 57394 agggatggaa ggcttttcat ccgggctttc agatgaggcc cctgaagctc agaggggtta 57454 ggcaattggc ctgaggttgc acagccagga aggagtgatg gcgtagtgat tcccattggg 57514 ctctcccacc ccctgttcct ccctccatcc agcccagggc ctcgtggata cattaggagc 57574 ccaacaagag ttcccctccc ttctcccttg cttctctgag cctcggtttc cccatccata 57634 taccaggagg aaccccctgc ccatctcnta gggctctttg acatggtgaa atgagatcca 57694 gatactggct gtctgtgtca actgtaaagt gctgtcctga gtgaccagtt gttgttggtg 57754 cctgtagcca tccttgaggc taaaagagac tgctgcttgc ctgatgctcc tcccgccagc 57814 ctcctgcttt ctgcgtgact tccctcgccc cagcaatgaa ccctggagcc acctgcaaat 57874 gggaaagctc ttttgttagt ttccacagaa tgcccaccgt gcacatgatc agagagtttg 57934 cgagcctagc tcaggtcagt ggaactggtt cttttcgtac atgtaggaag taatgcaggg 57994 tgctgccgaa taaatccact gcctgcctgg cctctgatga acttaccagc tcacgccagt 58054 tctagctcca gccaggagga ggaaaaaggc atactaggcc gtattttgtt tctttcaatg 58114 tttatttacc tgtacacaca cacacacaca cacacacaca cacacacaca cacatacaca 58174 ggcaaaactt atgttactgt cccatgcata attctctaga tttgggccac atagatctgg 58234 ttttggccat tgactggcaa catggcagta gccaactgca gagccaccag ggagcagcct 58294 cattctgatt gagtataacg aagacrctga tgggaaagag agacacgggt gagcaggggc 58354 tgtggggcat catgagagtt gggagggtcc ccatcgtgga gctggccagc cctgagtggg 58414 agccccggca cagtcctctg ctagctgtgg cctttggcca gtctccactt ctcagagtct 58474 cagtgacccc agctgccacc accaggattg ttggggtgtc caagaatgaa aataggggtc 58534 atccctggcc ctcaggggat atgtgggctt tcccctcatc atgaatggaa caggtgagtg 58594 ctgtggtgca ggctgagagg cggcagggtg ttctctcaca gcagggtcgg gtcttgctct 58654 gataactgca ccaggacaaa catccccagc ctctgggatg cacacccacc agcatctgcc 58714 cggcaggttt aattaccggc tgagatgggt tgtgttgggc tcactaagta tgctccataa 58774 gtgatgaaat tgggcaagtt ctcacctctg gaggctctga ccccgagtag ctttgaccct 58834 gagtagctga aggaacaggc agttcagcct ctgcttatgg gctgtgtgtg cacacatgca 58894 cgagtatgag agtgtgtcag tgtgtatcgt gtgaatatgt gtgcaggtaa gtgtccatgc 58954 atatgtgtaa gtacatgaca atgtgtgtgc gagtacatga ctgtgtgttt gtatgtacaa 59014 ctgtgtgtgc acatgtatgt ccgagcacat tggcgtgtgt gtgaatgtga gtgtgagagc 59074 gtgtgatttc atgactgtac atgttcactc tgtttattct cgggggaaat agcaggcaat 59134 ctgtaagaaa atgactgtgt aagtttcatg ggtggaggct tatgatactg ttagagtcta 59194 tcttagtctg ttggtgctgc cataacaaag ataccataga ctgggtgatt cataaacaac 59254 agaaacattt ctaacagttc tagagctggg aagtccaaga tgaaggtgcc agcagtttcg 59314 gtgtctgttg aaggccctat gcctggttca caggtggcga cttcctgttg tgtcctcaca 59374 tgggggaagg ggcaagggag cttttgtagg cccttcttct aagggcacta atcccattca 59434 tgggggctcc accctcatga cctcatgacc tcccaaaggc cccacctcct aacaccatta 59494 tcttggggtt agggtttcaa catatgaatt tgaggggaca cagccattcc atctgtgacc 59554 gtcctcaatc agccttctcc ctgcagggct gcaaatgagg gtgctgccgg attcataaga 59614 gaagatacat tgtaacatcc acagcacaca ggcactaggt tgggagcctt ttccagcact 59674 cagatcaggg ttcaaaccct aactgtgccc ttcaggagct gtgtgacttg ggcattcctt 59734 cattttttat tcaagcacac agctggcatc tacatgcctg ctgtgtgtca gggagataga 59794 aatagagggg tgagcccctg tgatattagg caggcagctt tcccttccag ggtctcattt 59854 ttctcactgg tgaaatgagg gcaggggctc ctcccctggg gttactttga ggggtcagta 59914 aggtgaacag ttacagtctc ttgcacagcc cctgaacgtt gtttagaagt caatactctg 59974 ttccatccca tcagcttcct cttcccttgt tttgactggc aaatagtcat caccttctga 60034 agtcattaag agaaggtctt tttaaactat tatgatgcca tcaaaactga cttttgatcc 60094 aaaatatctt ttaaacaagc tgaccattca gtgaggattt gccaggctcc tttgtgatcc 60154 atccttttgg ggccagggtc tgtggggccc agagctggac atcatggaac tagctctgag 60214 gagctcatgt tcaggtggga cacagtctcc tggaatcaca gttctaagca ctttccaact 60274 attaactcat ttaatcgtta attactacca tttcccagat gatgcaccag ggatgttaag 60334 taaccaagga atatggcagg gccactggga tagtgggctg ttagaaaagt cagggtggag 60394 gccgggcncg gtggctcatg cctataatcc cagcactttg ggaggccgag gtgggcggat 60454 cacgaggtca ggagattgag accatcctgg ctaacacagt gaaaccccgt ctctactaaa 60514 aatacaaaaa attagccagg tgtggtggcg ggcgcctgta gtcccagcta ctcaggaggc 60574 tgaggcagga gaatggcgtg agcccaggag gcggagcttg cagtgagctg agattgcgcc 60634 actgcactcc agcctgggcc atagagcaag actccctctc aaaaaaaaaa aaaaaagaaa 60694 tgaaaagtca gggtggagta cagacacaaa ttagagaact taagaggcac caacaagagt 60754 atgggcagta tagggagaaa tggaattagc acggagcagg ggcttcctag ggaggaatga 60814 tgggaggaga cacctccttc ctgctgctcc tgctgtgtgc cagcctgggc tgggagcgtc 60874 acgccatcag ctccagtatt cattccagcc ctgtgaggct ggcagcaggg tcctcctagt 60934 ggggctgaaa ggtgcaatgg tgaggaggag gattgcaggg gctggagtcc tggccccacc 60994 acttcctggc tgtgtgactg tgggcacgtt actcaccctc tctggccctc catttattca 61054 tcattaaaat gggattaggg gccaggtact ggtggctcac acctgtaatc caagcncttt 61114 gggaggctga ggtgggtaga tcacttgagc tcaggagttc aagaccagcc tgggcaacat 61174 ggtgaaactc catctctaca aaaaatacac aaattagcca ggtgtggtgg catgcgcctg 61234 tagtcccagc tacttggtgg ggctgaggtg ggaggattgc ttgaacctgg gagggttgaa 61294 gctgcagtga gcagagatcg caccaccgca cttcatcctg ggtgacagag tgagactctg 61354 tctaataaat aaataaataa ataaataaat aaataaataa ataaaacagg gggaatagta 61414 gtccctactc catagggctg ttgtgaagat ctagtgagat caatgttcat gaaggacttt 61474 ggcgctgcac acgtttctga gaaagggtga cctggccagg ctcactgggg tggtaagtgg 61534 cagggatggg cttctccacg tctcccctgt gatattaggc aggtgtatgc agttgcttca 61594 cgtccagcca caccccctca cacacctgca gaccagccag catggcacac cagacacatt 61654 tctgctgcac ctttccccac acagtaccta ccacctggcg tgcctctctg cccatcccca 61714 tctttttgat attttacctt ccacctaaat ccgaactgaa atcccagacc tcactagctg 61774 gtgggtgcat ggggtctctg ctctgccact tctggagctg ctcctagtgc atgccccagt 61834 tactcactcg tggccaccac cccccgagtc aggggtcgag agtccccttt gtccatgatg 61894 ggtgacgagg gcatacccgg aacagagggc taattaaatc acacgctgag gtttgtagaa 61954 catgggacgc ttcattaggc tctgtgtgaa caagtgcgcc cagcctgctc ccactactcc 62014 agcagactcg agcctggtat aatcacagct cacactctgc ttcatcagct cgctgaggct 62074 gtggggaggg ctcacacctt tgggctctaa agagagtggg cctgaggtgt gggatcctgc 62134 ttctgagcag gggtgtctgc cccgagccag cttgcccagt ggtgtggagc tggagccccc 62194 tctgcttaag taaaggcctc tgagggacac atgtcatgca gatgatgaca ccagactggc 62254 tcctcacttt aaactctact tcctgagagc agaaggcagg gaaggcctca gttggaggtg 62314 aaaatggaac tttcatccac cagatgttag ataaaagata ggaagggtgt tccaggcaga 62374 ggggaaagtc tgggcaaagg cttggaggat aaaagggcac cgcatgtttg gggagcgggg 62434 catgttccct ggggccagag acctgagttc tcctcttggc tctatcccca gctccaccca 62494 tgacttgggg tgagtcctga accccgacca accttagtgt ctccagggct gggatatggg 62554 ggggtggcag cctctgatct gtggtcacag ggagtctcag ctgtggtgct cctgtgcctc 62614 cctcttgcta ctctctggcc agtgacgatg gcactttact ctcctgcaga gacctgtccc 62674 cagtgcctgc ctcctccagt cctcttcctc atgggctggc tgctctgggc acatctcagg 62734 gcagccccag aaggtgggct gagctgttat ttggggcgtg gggttctcgg ttcctccgct 62794 ccatgctggt gggcctggtg cctggcacca ctggcccgtc ttccaggaag ctcactgaca 62854 ccatcctgga tgggccttgt tttctctctg gcctgggagt cagctgcact ctcgcaggtc 62914 ctaggccaag gtgacctgct tgtttcattc ttgtctttct cctttgcttt atggtatatt 62974 tttaagcata agatatattt atttgtaaaa taaaagttca ttataaaatg atgccttaat 63034 taccttcctg caatataaca attatttggt tgtatagttc ctgttctccg tattttgtgt 63094 aataaaatgg acccaatggg tgctgcacaa tgctgggtgc cacagggaac acacactgct 63154 gttttctcct ggatttttaa aattttaatt ccagcatggt ccttttatat gtgctttcac 63214 tctagctgtt tgcctacatc tccacagttt tgattgtcca gggtggtgaa taaaatgcaa 63274 cacttggcat cttttaatgt ttaaaaaaat caacaagtat tttatttaaa ataaaatgtg 63334 aatatctgta atcctaaaaa aaaaaaaaaa aaagccacag gatccttgag aggccctctg 63394 agacagtgac acccctgacc agctgcagcc ccctgtccac tccccaggct ccattctctc 63454 tacccactgc ctctgcatcc tccgcccttg gagtttctca gggtgccccg cagatcacct 63514 gtggcccaag tgctcaggga cttgtttaaa attcagattc ccaggccccg cccaggcttg 63574 caggcagcca gggccaagga atccaaatac taatcaagcc cactgtaatt gccctgcatc 63634 tgaggtctga aatcactcgc ctgctctgga ttatctgtgc tccagggtgg cctcagttta 63694 caccatccta cctccccatt gaaaccttac tgctcacgat ggcccaggtt cccacccatc 63754 ctgggagaga aagatgattg gctcagttct ctgggaggcc tggtgattgg ctgcctctag 63814 gagggtgtgg ctacctcttg atccaatcag tggagggcag catggggatg tgatcatgca 63874 gtgaagaacc tgtaccgggg gtagttaggc gccagggaag gggaggagga gaaaccagtt 63934 ctactgttag tatcagctca tctaacattt ggcccctggt gggggttttt gcatcctttt 63994 gggggtctag gtctcttctg ccattttgtt ggcactttaa tttcttgtta acaaacccaa 64054 gagcacatac aacttaattt ttaaattccc aataatttcc agcatcctct aagttagtgc 64114 tgagcgatag aaatgtaacg gaagctgtac gtgtagtttt aaaacttctg atagccaggt 64174 tatgcacgta aaaagaaaca ggtgaaatta attgtaataa tttgtatatc caaaatagta 64234 taaactgtaa tcaatctaaa gtaattgaga cattttacat tctgtttttc atattaaatc 64294 tttaaaattc ggtgtgtgtt ttatgcttac catacatccc agctcagact agccacattt 64354 caagggttca ttagccaccc atggctggtg gtccctgtac tggatagcgc agcactaaat 64414 gatggcttta ctttgtatcc ttggggaagt atgtattttt gaatccattt tcctcacttt 64474 tgaatagttt aagaacttcc cagtccattt gtctaagggt atttgacttc taaatgttgg 64534 gtttcttggc cgggctcagt ggcttacacc tgtaatccca gcctttggga ggccgaggta 64594 tgcggatcac ttgaggtcag gagtttgaga ccagcctggc caacatggtg aaaccccgtc 64654 tctactaaaa atacaaaaaa aataattagc cgggtgtggt ggcgggtgcc tgttgtccca 64714 gctacttggg aggctgaagc tggagaatcg cttgaaccca gcaggcgagg ttgcagtgag 64774 ctgagatcgt gccaccgcac tccagcctgg gcagcagagt gagactccat ctgaaaaaca 64834 aacaaacaaa aaaaccagtt gggtttctag caataaatgc tcataaaatc tgctggagtt 64894 ttggaggatt agtccattca tcctgacttg tgtcctgttt ctgctgggtc attgttgact 64954 tcccccactt gcctcacact tgtaaggcca tgtggcacac catcaacatt catctctgat 65014 taaggagctt gtttcttgta gtggctgcca taacatatta tcacacgttt ggttgtttaa 65074 acagcagaaa cttacactct tcctgttcta cagtccagaa gtccaaaatc atggtgtccg 65134 taggcctacg ttccctctgt agcctgcagg ggtggatcct tccttctcta gaggctgcca 65194 gcatctcttg gctttatggc cacattactc taagttctgc ttcggttttt acatcacctc 65254 ctcctctttc ccccatgtct tctcctctgt gtgtctctta taaagccact tgccactgca 65314 tttagggctt actcagataa ttcagaatga tcttctcatc tcagaatcct taattatgtc 65374 ttcaaagacc ctttttccaa ataaggtcac attcacaagt tccagggatt agagtgtgga 65434 catacctttt gttttttatt ttattttatt taatgtattt atttattttt gagacagagt 65494 ttttccctgt ttccctggct ggagtgcagt ggtgcgatct cggctcactg cagcctccgc 65554 ctcccaggtt caatggattc tcctgcctca gcctcccgag tagctgagat tacaggtgcg 65614 tgccaccata cccagctatt ttttttttgg ctttttcttt agtagagaca gggttttcat 65674 ccaacagatg ttagataaaa tgttgcccag gctggtctcg aactcctggg ctcaagcgat 65734 ctacccgcat tgggctccca aagtgctggg attacaggcg tgagccctgc accctgccaa 65794 gagtgtgtac atatcttttg tggggcacca ttcaacccat tgcagtgagg tgtcagtgtt 65854 ttgacaggaa gaagcagcaa agaagacaaa tcagcacttt atttttctaa gctttgaaat 65914 tcttaaaatg atagtgggtt aagaaagacc aacttcccca tggaaggtgc tggtccacac 65974 tggctgggtt tagatccctt tggctgaggt ttagatccct ttggagggga gtcaatttga 66034 agaagaagca catcagacac attcaggaag gcaaacccaa agacagcaga aaggcaagaa 66094 tgtctcaaat tgttcaaaaa taaatacgtt agttcttgta acgtgctccg aatagggtga 66154 ggctcaacat gagcacttaa taaatgctca gtttaattgt ggtaattgta attctcattg 66214 gtatatattt atgtcctgat cctatacctc tgttattaat gagactgata ataggtaagt 66274 gaagggaaaa agagaccccc ctgctgccag gaaacaaaac aaagtatcga gccaaatgcc 66334 aaatccataa gtcaccaaga tgggttttga tgacaaaacc tttctttctg gactccccct 66394 gcccctccgc gaagccgttc cccatggcca cgcttgtccg tggctggctt tataggccca 66454 tccttctttt atatgatcat caagatggca ctaatttggg tttgcaaatg aggttttcgt 66514 gatgttgtca tgtcagcatc tggattcaag aggggctgct tcccagaccc tgaccctccc 66574 ctgtggcctg ggagcaggcc cagcccctcc ctccatctaa tcactcccca ggaacctggg 66634 ggatttgcta atgggcccag gaagccataa agagtaatga aagtgctgtg tgactgctct 66694 gcacggggtt gcccttgggg tcccttcctc ataattaaat tcggaatcct ccttctgcct 66754 ttgagctgga agagagggtt ttatcctccc tgtggtctgt tcatcccttc ttccccccat 66814 tcatttgttc agcacttatt atccagttat ttgtttatca agccacagtt gaatgcctgc 66874 tgagagccgg tttagggcac tgagcttcct gttctcaaca ggcagaggtg ggagcagcca 66934 ggctgctgtg ggaagagcag agtggctatg gagccgccct gagccagctc tgctgtgcgg 66994 gagttctgcg acctggggaa cccgctcgct tggcttcctc atctgtaaaa cggggagact 67054 aatataatag cagctacctt ccaggggggc tgtgagaatt aaaggggacg atggatataa 67114 actcccacac actgtcgggc acagggcgtt aatagcagcc ctcagtctca tgtcccactt 67174 attttgtgcc cgacacactt ctgagcatct tatgtctatt cactcattta atttgcccag 67234 taactctagg aaggaggtca cgtccatggt tcttattttg ctgatgaggc agttgaggta 67294 ggcagaggtg cggtgccttg ctcaagatgg cacagtggaa ggacacgggg cagggcggac 67354 ctgaccgcag ttggccctcc cttgcctgcc tcttagcacg catgcagccc cctcgcctgc 67414 tctgcccgtt gtgtctcaga atctccactg ccatttgcgg gtgccctgaa tccacctcgc 67474 ttttccgtgc ctccctgctt ttgtgcttgg tgcagacccc tgcttcctca tgggcacctg 67534 cctccttaga accccccttg gaatctgtta actacagctt cctgggccca caccagcatc 67594 cctctgcaac tcagaatttc cagggcccat aatttcctac aggcccctcg ggtgattgct 67654 ttctcagtag gcaacttagg gccgtccctc caaaccttta gagtgagaag cgtgctacct 67714 gggtgcttca taactgatgt tgcaaatgtt caaccaagtg taggaagtga acacactttg 67774 tatctgcaaa gtgctgtgca tacaagcgag gtcaggagca gctggcaccc gtccccaagg 67834 gtttccatgc ctctggcgag atagggtagg agtatctgca agtagctgcc ttcttggcca 67894 tggaagaaca agttcaacag ggcgcctctg tgtgcctgcc ccttgctgtg tacaaggacc 67954 ttgcacttca gggacatcaa ggcaccttca gccgggcttt ggggaacttg tgtatgggag 68014 ggggggacct ctaaggacct ttcctgtccc aaggagctcc ccagaagcct gttgcagtgc 68074 ccagcacccc agcctcatgg ttaaggtagg cagtccccag gagtcccctt cctgggacat 68134 caactctcct ggtgggaaca aatgctgagc acctcagcat gagatgggta cagtcaggga 68194 ctccacaggc aggtcatgtc acagacaagg tcacacagct aggtggtggc aggttggaga 68254 gagagggcag tcccctgact cccatcccag tgctcttttc tcccatgaca gtgacgggtg 68314 aaatggcaca gtgtatccct gtcaggcagg aggggatttg ttgtactttt tttttttttt 68374 ttctgaggcg gagtttcact ctgtcaccca ggctggagtg cagcggcgca atctctgcac 68434 actgcaacct ccgcctccca ggttcaagcg attctcctgc ctcagcctcc tgagtagctg 68494 ggattacagg cacccaccac cacgcccagc taacttttgt atttttagta gaggcggggt 68554 ttcaccatgt tggccaggct ggtcttgaac tcctgacctc aaatgatccc cctgcctcgt 68614 cctcccaggt tgtattttta atcctccaca actaaatact catgtcagtg gaaaggttcc 68674 aagctcttta aagacagcct ctgccagcgt gctcccaggg gaggccaggg aaggctttgg 68734 gaagcctccg tgggggtggg gacctcctgc aacccctggc gcacagcctc accccgctgt 68794 aaacagagct gggattgaag tgcgatttcg gtttcttttt ctttttttct aatcaaataa 68854 aaacacctag ggggcaggaa gcgaggagga agaggccagg gagtaattct tgttgccaaa 68914 ccagtttcta aggggctccg ctccgctccc agcatttctg tctctgaggc tccgacctct 68974 gagatgatca atcctcccat ttcagccaga tgagaattgc tgtgggccct gccttttctt 69034 aatattttgc atgagagcga cagcccggcc agcggcagta atctcccacc cacgtgggga 69094 ggcacccact gtcctgccat gtgcataatt gaagtcttca gactgctcag tggttctaat 69154 tagcccaaag tggccccttc tggcctcagt ggaaattact gccctcctgc cgcctggtct 69214 tactagctga tctttgaagg tgtgagtgag ccgggagacg tgcagagcct agcactccct 69274 ctgctgcatt ggtctttctt ggcaggcctt catggctttg cagagggcgg gcagttgagg 69334 cctctgtctg ccgttgaggt cctgcctccc tcctctctgc caccactctc catgggacag 69394 gtgctccagc tgggcgcatg catgcccctc tcacctgaat gcctcccact agcagtgtct 69454 ctgctctttc tgacccttca ggttatgcag tgcctcctcc tccaggaagt catccctgat 69514 ccccaggctg ggccctcaga atccccatgt ctccctccat cgcagccctg gccatgccat 69574 gtggtgcttg tttacatcca tgactgcccc atgagactgg gagcccctag ggggcagaag 69634 ccgctccatg tcccacctac tcctggccta gcgcggtccc ataggacatg tctacggaaa 69694 tggagggcgt gagggtggga ggaaggaagg aaggcaagaa ggaaagaagg aaggagaagg 69754 aaaaaggaga agagagaaaa gagggagggt gggcaggtag caccatgccc attttgcagg 69814 tgagaacact gaggagacat aaccgggaag tggcagggcc aagcacaccc ttggcagctc 69874 attatacttt cccttcagcc tagcaaagct actgttcgat ttggggaaat ggggccgctt 69934 gtatgaagag ccgcaggcaa agtggaaagt gccgagggct ggaagtcaga tgggtgtggg 69994 tgcgcagcct tcctgtgtac ctgtgggcac cacttacctg ctctgtgacc ctgagcaggg 70054 cacctttgcc ttcgaaactt gaagatcaca gtcgtccagg tggattcaag gcgatgaaca 70114 gcaacagcgc atgctcttcc caaacagtat tcttcttatc ctcactgaag ccccagaagg 70174 tagttgatcc ttaccacatc attaacctca atgcgcagat gaggatgcca aagcacagag 70234 aggttgagca actggcccaa agtcacacag tgcgtgagtg acagagccag gatttgcgcc 70294 tgggttcttg gctctgatat tagtgccatt gactccactc tgttgtgtga ggtatgaagg 70354 catccagtac agtgtctggc atcggcaggt agcttccatg gcagataccc cccctctccc 70414 accagattct gccctttgag cgacaggaag ataaatagcg ctgttctcca gtgtcacttg 70474 tgactttcct ctgtgagttc attgtcaggg tgctcctgag ctgagctgtg gccaccactc 70534 attggtgtgg tccctggaga cacttggata aaattgtgat gacagagggc tctcaggctc 70594 atgagatcac acagaggagg gtggagctca aagggctatc tcagaccggg atgctccaga 70654 ggttaggtct tggtgctgtg tttggccccc agctgctctt tcaggccttg gtcttgccct 70714 tgcccttggt ctctggaagg ctgaatagct gcatcttgtt catctggaaa ctctctggga 70774 tgagtgactt tagcatctcg gatgttgcca tcgtagccca tgtgcataac aacttattgt 70834 gcaagcatgt acagtcatat tgaaaataaa tgtagaagtg aaggaggcag tccaaagacg 70894 gttcctgaca atactcggaa acagcttcat taggtattgg ccagagcttc tatttgtggg 70954 ttgctttggc gaaactgctt ccttaccatt aaccatatcc aggagatgga ggggaaagtc 71014 ttcacctggg ttggtttttc tcagaggggc aggcaagctg aataacggga gtactaacat 71074 ttccaagaag attaatgatt aaaatgttga atacaatttg agacttgttt tcatgttcat 71134 attttatagt ccagaagttc tttctataat gtcctcataa atattttatt tggccttagg 71194 ttaaatgtca gtttccatgt cctgccacgt gccacttgac caacgtgtgt gggaacgtct 71254 ctactttgga cacactgtct atatgaatgg aggcccttct accccttgaa atgttcctca 71314 actcccagct cagtttccct tccgcatccc tttgactgca tgagcggaag cgaggcatta 71374 cagagaggtt tgaggagcca gccagcaagc tagcaacggc ttcagttcat ttctgagatg 71434 tttgcattca ggggtcccat tggccaacct taacttctcc tttgagctct aggcatcttg 71494 tgatgaatgg cataagcctt agaacatggg agaggcttgg atgggccagg agctccaaac 71554 actaaggaat gttgcttaca tcaatagacg ccttagttac ttaggtcaat agatacctta 71614 gttgcttaga tcaatagatg ccttagtaga tcaaacaccc aaatcaccca atgtactttt 71674 agggcaatgg ttgccaaact ttttggtctt aggacccctt tttacactct taaaaattat 71734 tgtggctccc aaagaggttt tgtgtatgtg ggctatatcc ttcaatattt gccaactttg 71794 aaattaaaac tcagacagtt aaaaagattt atatgaattc attgaaaaat aaaaagtgta 71854 aacccattac atgttaacgt aaataatatt ttttttggaa aataactgtg ttttgtttta 71914 aaaagtgaga agagtggcgt gtgtatcaat ctctttaatc tctagcttaa tagatgatgg 71974 ttggattctc acatcagctc ctgcattcag tctgttgtga tacattgttt ggttgaggta 72034 ttgtcgaaca tctatcctca aacagatatg tagttggaaa agggagaacc ccacaatccc 72094 ctgaaaacgt cttggggtcc cctggaggta cttagaccac agtcttagaa ctgctgattt 72154 aggtgatggg tgaaactcaa gatgaagaca aaagagaaaa catttcaacc ccaagagact 72214 tcaatgcatt cacatgcatt gactcaggat cattaaagct ctaactgaac ccaacatgga 72274 gacagagcag gaaacacagc catggctggc ttgacttcag cctcccatca aagaccccca 72334 tctttggctc aactgccccc agtggtttca atcagccaca gacttccctt gtccagctgg 72394 actggacgtt ctgcatttga ctgtctgtcg gctgcccact gattttcagg ctgctgaatt 72454 acccattagc tcacctgaac ccctaatgcc acatctaaac ggtcctcact ctgcctttct 72514 cagcatccga gaatgtccta taaaaggctt cttccatgga ggtgggcagc cttgggcctc 72574 tcctagggtc agctcaggct gcccacgctg gctatggctt cctgctggcc cctggaagct 72634 gtgtacacct gggagagtga ggtgaatgtt aatttattca gcatgcaatt aatgaattct 72694 accctgtgcc tggcacgact catttctcat gccaaagcta gggtggatca gaccaccttg 72754 gacaaatctg gatgggtgaa cttgtggatt gatcaatgat cttagttgat gaaaaatgca 72814 ccaaatgact gtttccttta atgcgattgc ttgggtggtg gactcgatta cgttgagggg 72874 attaaattag cagcttgctg ggtttcagat gagtgcaggt ggctgctggc acttcctctc 72934 ccctcttttc tttctttccc ttttactgca aacgaagact tttcaaagct ttactaagta 72994 caataaatgc catcccctta aagtgtagac ttccatattc ttagaattgg caagctatgt 73054 atatgtttgt gaaatcaccc ccataattaa gatttggagc atggccttca cccacaaaac 73114 gtttcctgtt ctctgtgtgg tccattccta tctctgccct gcaccctggg tagccagtga 73174 tttgcctttg gtcactgtag gatagtctgc actttcaaga atttcatatg aatagagtca 73234 tagatgcatg cattttttgg tctggcttct ttcactcagt gtgggtattt tgaacttccc 73294 cctggttgct gtgtgtgtca atgatttgtt cctttttctt tgaggagaat tctgttctgt 73354 gaatatgcca tgatttattt attccttccc ctgctgatga atatttgagt tttttctaat 73414 tctgagctac tgtgcagaaa gctgctatga acacgtacgt atgcaccttt gtgagtttgt 73474 gagctttcgt gactcttggt tacaaggatg gttggttcgc atggtagacc cgtgcttatt 73534 ttcacgcttt aagaaactgc cttgctgttt cccacggggc tctatcgttt ttcattcccc 73594 cagcagtgtg tgaggggctg tttgctccac ctcttcacca actccatatt attagtcttt 73654 ttaatgttcg ccactctgat gggtgtacac tggtatctcg ttgtgatttg catctgcgtc 73714 ttgtgatgac tgatgatgtt aagccccttg ccatgtgctt cctgaccatt cttgtatttt 73774 ggtttgggaa gtgtctgccc aaatcttttg cctattttaa atcaggttgc ttgtgtttat 73834 attattgagc tgtaagaggt ctttatacat ccgggctaca agaggtttac tagatacatg 73894 tactacgaat attttctctc attccatgcc ttgccatttt cttttcataa cagtttcttt 73954 cacatagcaa aggtttaagc tttgataaag ttcagtttgt ccattttttg ttgtttttca 74014 tgctttttgt gtcttgagaa atcgaagttg caaggagttt cttctataat gtctcctaga 74074 aggctcatgg ttttagcttt tatgtttagg tagatgatgc atttcaatgt cagtttgtca 74134 gatggtgtaa gagttgatat tcattttgcc cccagtcatt tattggaaag actgtgcttt 74194 cctcgtggaa tcacctgagt gcctttgatg acaatctgag ttcaccacag acttgtgggt 74254 ctagttctgg attctctgtt tagttgtatt gatccacatg tctgtccttt taccaggacc 74314 acactgtctg tatcactgta tctttatatc agctggggta aatcctccaa ctgtgttcct 74374 ttatttattt atttattgca aagtcatttt ggctattcta ggtcttgttc taacaggaac 74434 atattttcgc ttatttaatc cttaggaccc tctgaagcag gtgtgaatat taagcccatt 74494 ttatggataa ggaaactgag gttcggagag gatgagtaac tttcccaggt aactgaggag 74554 gaagtgagcc ttgcccctgg taggtctggc agctgcactt gcccttagcc tctaggcagg 74614 ctgcactgcc ctctctgtgg gttccaacca ttcctggtac acacccctag ccaagaactt 74674 gtgaggttct tggaacctca tgcaagaggc tcttgcatga ggcctctttt ccaacttctg 74734 tttatcctgt cccaaagagg tcagtgaggg acccccaggg ccgcctctgt tccctcaccc 74794 tgcaccttgg ccgggagacc cccgcagcgc agggagcatc cctccggatg tttcttccca 74854 ggcaacaata ttctgtttat caagccaggc cccgaggctg aggcctcccc ctggcctggg 74914 gtgatttttg gttggtggtg agaagcagca ggggtgcctg ggggcctggc tgtcatcgga 74974 gccagctccc tgtcctggtc tctgctgtgc gggatggcat gggtaggggc tttgtgcagg 75034 atgagggtcc tgccgactgg gacgtgggct ttggaagggc cacgcttctc ttacaggggt 75094 gcccttgtgg ctgtatgagg agtccaagct ctgaggttga acactgggat tgaaggattc 75154 ctgccagggt gcacttaggt ggctcacttg gcccagagtg agccagagct ggctcgcatc 75214 agtgcgcggg agtcaatagt tacattttta ggaatttttt gagccagttg ttaaactgtg 75274 ggtagcatgg aaatcagccc tggcttgagt aggctcgcat cagtgcgcgg gagtcaatag 75334 ttacattttt aggaatgttt tgagccagtt gttaaactgt gggtagcatg gaaatcagcc 75394 ctggcttgag tattcatgcc acggacttgg caaatgccgc aaatcagggc cttctctcta 75454 ccccctccca gccccaaccc gaagacctga ttgttaactg cactggcaaa cccctggctc 75514 tgcctcctgg agcctcaggt tccttatctg gaagcgggga gaataatgcc cacaccttaa 75574 ggcatcatca acacccttaa atgagatcat gggtatgaaa tgcttgtgaa tagttttgag 75634 tgtgatacgc aagtgtgagg ggtgctcacc accctggcca ttgccattgt cctcctcatg 75694 gcagcagctg gacaatgtgc ccaggctggg agttggtgtc tccaggaaaa actggaggaa 75754 aggagcccga taacccatgg gcagcagctg ggttagggag ggctccagac ctgcctatct 75814 ccgtcagccc tgctgaatgt gcctctgttt gctcatcttt ataatgggtg cactgatccc 75874 agctgagagg ggtgtggtgg gctttggggt acaggccaca aggtacaagg catggcctga 75934 ctgcagctcc gtcactctca tggctcaggt gcatggctgt cccacagtgg aaggaccagg 75994 ggctggcctg atctgcactt catggcatca agagcacagg ccctggagtc caccaggcac 76054 agagaagcag cctgctcctg ggtggagtac aagttcaacc ctcgggagtt gtggtttccc 76114 catgtggaag ctggcagcat gccacgcacc tgccagggct gccgcgaggg ttcgcacaca 76174 ctgtgtgtaa tgctcctgtg tgagttcccc ggtgacccag gtcccactgg ggtggccggc 76234 gtgtaaccag gacaggaaca tctccaaagc cactccttgt ttgctgcctg gtggctcaag 76294 cagaacatct gtgcctgcag ggggcccata agccttaatg ccctgcagag agggggcctg 76354 ggggaggctg ggactcacac cagctgggga acaaggcctg cagctggggg gctaccagga 76414 tgctccttgc cagtaaagag ggtcctcagg agatcagcca cagctcaatc aggagggtct 76474 gcccatttca caggggagga aagcgagcct ctggaggctg agctgccagc agtcacgggg 76534 ccagcgcaca gccagagctg accactctgt atgactggcg ggtctgcgcc cttggcatac 76594 cacagcagct ctcacaccaa cagaggctgg acctgctgat cagcccccgc tgtggggggt 76654 cccgcctctg cccacaccct accccacacc ttcacagggg tggactgtca ccctctagca 76714 gactgtcctc cagagaccga gacacggagc ctctccacaa ggagggagga aagggaggtg 76774 gaaaccagcc ttaccctgga caccgggtgg tccttgctgc atacccaacc ctcattggtc 76834 agactggtct gggagggcct ggacatgccc gcggggtccg tttctgaatt cccgttgcct 76894 ggcataagct ctggcactta gtaggtcctc agttaatact tgtcagataa ataaatggcc 76954 tcctttgggg aaatgaagaa tgtccaggct ggccacgggg aaggggcagt gttaggagtg 77014 gagagcgaga gggtgagcca ggcagatggg acctttattc aaagggcagt ggggagccat 77074 ggaaggtttt agggagggcc atcggatgag gttttcattt tagaaaagtc cttctggctg 77134 ctgggtggat ggggtcaaga tgaagacagg aaatccagag aggaggcggc tgcaggctcg 77194 cgggtgagag gtgaccatgg ccaggccagg gcggaggcag ggaggtgggc ggaggggggc 77254 tgctggctct gccaactgtg accccagcac ccagctcagg gaattatggc cagagacaaa 77314 gcagcttaga gcctgacccc tgccctggag cagataggcc tgggaagggg gctgatggac 77374 acgctgatgt gatgggacct gagaggtgtt cttgtcacca ggccagtttg gcccccatcg 77434 cccgcctgcc ggctggggtc taaaaggctg gctgtagccc cagcagagag gacagggcct 77494 gtgggacccc aggtgctggg agcacagaag ccagccaggc catctggccc ggctgagact 77554 caagtgatag gtccgcatca gtgtcaggcc tccatgcccc ccatcctggg atgggaacag 77614 cacatcacag tttgcagagc cctgcggcag gggtgactct tattgccatt ttgcaaatgg 77674 gaaaactgag acttagagtc tctctgactc acataagcag gacaggagac agtcgaacca 77734 ggtcccccag ctgcaattta ccacatctca aacccttttc ctctctctgt cattgattaa 77794 tctttgcttc aatgtccaca tagttctgtg atttgctttg ggtacatagt agcaataatt 77854 atagcaacaa tttctagcag tttcttggtg ccagacactt ctgtctttgt tgcctcgttg 77914 aatcttcacc atcaaccttg aatatgaaac ccattttaga gattaggaaa ctgaggctca 77974 gagactgttt ataacttact gagaatcagg cagccccact gaggtgcttt accagtctcc 78034 cctttaccag tggttctcaa accttggcac accacaggaa aacctgtcag aatgcagatt 78094 ctaggcccca gcaattctgg tcctgtccgt ctgggcagag ccttggcaag cttcgtcttt 78154 aggagagaag cccaggtgac tgggggtggg gctttccgga gcctgtgttg caagaaggaa 78214 ggcagggagc atgtgatctt ctctcggtct ccctcacctt gaccctgtcc caaggccagc 78274 tgctggcctc aggctgcctg gttgcctttg aaggtccatg gggatccgat ggagggttgg 78334 tcgtgctgaa gccaggctgg gtgtcatcct ggctctgagc acagtccagc ctggctagag 78394 tcaaacccag cagcttgacc ggatcctgct gaccacagac aaatccacaa ctaccccgtc 78454 cacctccccc aggcccatct gcctctgtgc cagccaggct ggcagacact ccatcgggcg 78514 ggccccacct ggcttggcca gggagaaact ggcagccaca gcccctggcc tccccgatcc 78574 ctgtcccttg tgcactgccc atgggagggg cagtggcctt ccacgctggg tctggctcct 78634 gcagtagcag agctgggtgc agacacgggt tggaggccgg ggccatgggg gcattcgtag 78694 gctcatgagt cccttctcac tctcttctgg ggactgggtt tctgctggaa gagaaaggga 78754 ccagccttaa aagacatcgt gattaaaatg gaattattat ttcagcctgg aaaaggaatg 78814 atgtactgat ctgtgtcaca acatggatga accttgaaaa cattctgcga agtggaagaa 78874 gccaggcaga ccccaaaggc cacgtgctgc tgtatgattc tatttatgca aaatatccag 78934 agtaggcaaa atccatagaa acaggaagta gatcagtgat ttccgggggc tggggagagg 78994 aggggatagg gaatggctgc cgacggatgt ggggtttctt tttggggtgg tgggaatgtt 79054 ctgagtttct ttttggggcg gtgggaatgt tctggcatta gactgtggtg atggttctag 79114 aattctgtga atctgttaaa atccaatcaa gtgtacattt aaaagtggtg aatttcatgt 79174 tatgtatatt gtacctcaac tttagaaatg ctaaaataga aacaacaaaa tcatcatgat 79234 gcaacgcctt tcctcataga cctggagcga ggcctgagag agaagccata taaggcagat 79294 gaggggtggg atggagagct tcctttcatt cgctgcctgc ccagtgaggg tctgcttcct 79354 ctggcactta cttaacaaac ccgagagtca cccatgtgtg aggcatgggc tgggcacaga 79414 agggtccacg cccacccctg aaagtgctcg tccatgctag aaagacagaa ggatggggtg 79474 gtcattgaac ctaagtcaga ccgtggcttc ccagctcatg cagaataaaa tgctcaggcc 79534 tctcccggcc tgctgggtgc aggaccccgg cccagcccac ctctctgagc tctgagctca 79594 tgtcctgccc catccctctc acacgcacac tggcctcctt gctggcctgc aacagatcaa 79654 actcacccta cctcagggcc tttgctcgtg ctggtcacct gatatctgtg aggctccctc 79714 tctcacatcc ttcaggtctc tgctcaaatg cgtctccccc aggaagtctt ccctggcctc 79774 cccagctaaa acagcccctc ccacccctcc catgccattt accatactat agttttcatc 79834 ttagccctta tatctccctc caagagctat ttattgacat gaaaatttgc ttattggctg 79894 tctctcccat tcgagagtgg gctttctctg gggagtgtgc actgctgaat ttccagtgta 79954 tgcaacagtg ctgaggagag ggtaggtgct cagttaatgc tttttaatta aattttctat 80014 tgtggtagaa tatacatgac atagaattta ccatctgaac catttttaaa tgtacaatca 80074 atgtcattaa gtatattcac gttgctgtgc acctgtcacc accatccatt tctgggactt 80134 tctcatcatc ccagacagag actctgtacc tgttaaacaa gaactcgcca ttcattaata 80194 ttcttttgaa tgactaattg aatgactaag tgtatttcct gtgtgtcggt cacaagctag 80254 gtgatgagcc agtaaacctg gcgcctcgga gggtgtgtgt tcccgtatct gtctcggaga 80314 tggacagatc gactcagaga ggtgtgaagg gctttgccca aggtcacaca gctggtcagg 80374 gtgggattca aacgcaggtc tttccccctt tccacacagt ggcagttctg ggggatcact 80434 gcatgcaaag ggcatagcca tggcacctcc aggcctccag ccccacccag ggcttcccct 80494 gctgccgctc ccccaagggt cactgtgtcg gccacatgtt cctggtgtcc tcggctctgg 80554 caggctgacc accagtcaca ggcacgtctt gggaccacac ttggaggttt cagcttccca 80614 tttcacctgg tgctcttggg gtggaggccg ggatcatgga atcctttttc catggccttt 80674 aacacaaatc aatactgtgc ccagtttaaa tgtttatgta actcatcatc tgccggctct 80734 gctattacgg tgtgcttttc tttttataaa ccaagctcag gggaggtgat attaagtcca 80794 ggacttgcct ggcgaggccc agcgcgtgtg cagaggattc aatgtggcaa taagggcgag 80854 ttccctgcac agcgcctgcc atggctcgtc ccagcctcct ccctcatctg cttgtgtcct 80914 ctacacggta gggaggaggg agaggtccag agaggggagg tggcttgccc agggtcacag 80974 ccacaatgag gtggaacagg gattgtttcc aaggtgtgtg tgggggtggg acccaggctc 81034 ctgccagagg ccagggcggc agagccctga caggcagatc ctgggttcct gggtgtccag 81094 gttacgtggg tgggcaggtg gcagctggca cccaccccat acagacactc tctgacaccc 81154 cccaaaaata ctcccaccag ccccttcaca ttttcctcca gccaagtgac caaagcacag 81214 ctcagggccc atttgccctg gccacactgt ccccactctc cccacccaac ctctgaccac 81274 aggcctggga gctgccccat ctccaccaag ttcaggctgc aggaggaaac gtctcaccag 81334 gcccgctgga aggtggggtg gtgatgaaat gtgggggttc ttcagcgaga gtggaattca 81394 gtaataaggt gatcatcact gccgggcggt gcctggactc atgatgagcc aggactaggt 81454 gagtgcagag ggctggtgag caggcctgat ctgtgacccc ggtggccctg cggctctcag 81514 acccctcaca taaaatccca tcagggatat tccgttccct ggcccggaat gaggtcttcg 81574 tctttctgat cgcccttgga gagcccaacg gccttccgtc actcactcag tgctgatgtc 81634 cagtcccggc aacagtctga ctccgcccag acttggcgct tcccctccca tgcgcccgcc 81694 gcccggcgtg ctccctgctg gagggtgaca tggggagggg cctggctgca gcccttttca 81754 ggcagctctt gttggctggg aagggagcct ggggatgggc cgccttctac ctgccggtgg 81814 ctgtgcccac tctgagtgtg cttggtgggt gattacagct gctcacagct gtcaggagtc 81874 cttcacaggg cagtctggaa gtttcctgta gagctgtctc ctgcagagtc cttacctagg 81934 gagaccccgc tgtatgtcct gtggccagta gcatcctgtg gctttgctca atcccccagg 81994 cacagtgtgt gcacccccag cctccctctg ctgtgttctc cacgcccctc tgggcagccg 82054 gcactcagga cctaaggtgg tcctaagcag ctctcccctg tcccctggaa gtacgtggag 82114 gtaaaagctg catccctggc agaatcagac cccaaactcc agaccctttt gctgtgagtc 82174 tcaggctagg gtctcccacc tgcaggaatc attttgggcc ttttgagggt ctctttcata 82234 gacgtgggtg gggcgtctgc tcagcacctg ctttctcctt caccaactcc tcagcctccc 82294 atctctgacc ccataaacgc tgagaggaga accaggcctg gggggcaagt tcaaggactc 82354 aggaggcaga ccgctggaat ccaatctctc ccctgccctt actagctgag cggctgttgg 82414 caagttgtct tctctgtgct tcagtttctt catctgtgca atgggggtga taacagcaca 82474 caagaacatc ttggagttgt taagaagatt cagtaatagg tgtaaaatgc taaagctggg 82534 gcctggctcc caggaagtgc ccagaaggtg tactgtgata accacagacg ccacgtcacc 82594 ccgctggacc tggactccgt gaggaggggg ctccccatct ccttatccca gtgtcagccc 82654 gctgctgggt aaattcgctc gccaagccca taccaggtgc taatggctgc aggagcctct 82714 tcctctccct gacatttccc ttcggcagca ggcggacccc tccttcctcg cccacctcca 82774 tccttagcag ccctgatacc tctgacaatg ctaattaaat gcaacaacct catcagaagg 82834 ctcgagctgg gcttgcctaa ggccccctct ctgccctgag ccctgatgga tcattaatgg 82894 tgtcagcagc acttatggtg atggacgagg ggagcaagtc ccccgacgtg ctggggagga 82954 agtccgtgac gagcatcttc atctcctgtc tgcaggcctc ggccagagtt tccagggaac 83014 gtcctagtcc acagaatcgt ttgaatttca catttaccct gggagaacca tggccaggca 83074 gggatgtcaa ttcccattgt atccatgagg cagtcagggc tcagagaggg caagagattt 83134 gggtgagggc acacagctgg taagtagtgg ggctgggact ggattaccac ggctttgatg 83194 aaagctgcag ggggcatctg taagatccaa gggcgatgtc tcccccaggt ggcacgtgga 83254 gaagaaagcc agcaagtgcc accggcttgg gggtagccca gttctcgggg gctggagcct 83314 gcacactctc atctcagctc tgtgtcagtt tcctagggaa gctgtgacaa agtgctacaa 83374 actgcgtggc ttaaaacaac cgaaatttgt tctctcacag ttctggaggc cagaagtctg 83434 caatcacgat gctggcaggg ctgggctccc tctgacggct ccagggagga ctctgttcca 83494 ggcctcccca ccagcttcta gtggtggctg gcaatccttg gcatttccgg gcatttccag 83554 gcattgggag gcccggctcg gccccccaaa gtgctgggat tacaggtgtg agccaccatg 83614 cccgtcctgc ccttcattct tgatgcctcc cttcagcctc tgcctctgtc tccccatggc 83674 ctcctccctg tatctgtgtg tgctgtgtct tcatatggac ttcttatcag gataccagtc 83734 cttagatcta gggcccacca taatccagta tgaccgcacc ttaacttgat catctgcaaa 83794 gactctattt ccaaataagt tcccattcat aggtaccagg ggttaggatt ttaacatctt 83854 tttgtgggat gcagttcaac ccacgatacc atctttgccc atctctggct ctggcgtgca 83914 gggacctgtt actgggcggg tcactaggga taccacctct cacctctctg ggcacccatt 83974 ggtaggcctg tgctgtgccc agcaccaggg ggctggctga ggcctccttg tycagtggct 84034 cctgtgtgcc tctccacttg ggggttgccc tagagctgcc caggaaggga ggaggcacct 84094 caggggggga aggacagcat gagtttccat gggcttctcg tcacccacac agagtgactt 84154 ggaataatgc acccagtggc tgatctgggg ccctgagctc gaggctgcag ccagtggcag 84214 ctccaggccc tgcagtgtgg ggacagcgat ggccaaaaag agcacatgcc aaaggccctg 84274 ccacttaggg gactttggga aagtttgacc aagtttcctt gtctctaagt aaggaatgat 84334 aattggtcga tgggattgtt ctgagatgaa agtgctggtc cttgggaaag cttcagctga 84394 aatgtctttt tattttgccc ttcactcttt tttttttttc ttcactgttg tcgcccaggc 84454 tggagtgcaa tggtgcaatc tcggctcatt gcaacctcca ccacctctca ggttcaagca 84514 attctcctgc ctcagcctcc cagatagctg ggattacagg cgcccgccac catgcccgga 84574 taattttttt gtatttttag tagagacagg gtttcatcat gttggctagg ctggtctcga 84634 tctcctgagc tcaggtgatc cacccggctt ggactcccaa agtgctggga ttacaggtgt 84694 gagccactgt gcccggcctg cccttcattc ttgacgaata tttcgactga attcagaatt 84754 ctgggtttcc aggttttaac attttctttc ggcacattaa aagagtcttc tgggtgccat 84814 tatttctgct gacaagtcag cagtctctga gtcctggtgt ctctgaatgt aatatgttgt 84874 ttttattcta gctgctttaa cattttctca ttatttcagt ttccagtagt ttgcagtttg 84934 accaggatgt acctgggtat aattttcctt gtgcttatcc tgcttggagt tagctaagct 84994 tcttaaattt gtaaattgat gtcttttacc aaattgagga atttttcggt cattattttt 85054 ttatgtgttc tttttagtat atcttctctc tcccctccct ctacaactcc aatcacatgt 85114 gtgttgaacc ttttgatatg caacaggtct ttgaggatct ttttcttttt aaaaaaattt 85174 tttttctctc tattcttcag actgggtaat ttctattgaa atcatcttca agttcactaa 85234 ctcttctatt ttctcagact ttctgttaag caatttctgt taaggtgtga ttttttttct 85294 gtctcagaca tggtattttt aagttataga attttcattt agttcttttt taaattgttt 85354 atatttctct gctgagattt attctttcat gaagtatgag ccaattttct ttacgtcttt 85414 taacacagtt atcatagcaa gtttaaaaat ctctatttgc taattgcagc ggccagcaca 85474 tttcaggtga gtttccactg actgtctttt atattaagta tggctggttt tcctatttct 85534 ttgtatatct tcatataatt ttggatgata tcctgggtgt tgtgaatgat agcataagag 85594 cgactctaga tttttgttac ttctccccaa agagcatttt tgttttgctt tgtatttgca 85654 agcagttaac ttggctgaaa gcaactgtaa accatctgca gtcgtgagtg gtgggcagtg 85714 gcaggagcct ctgttcactt cttctagccc tggctgggtt gcagctgctg gaagtctgtc 85774 ctgtgtgtgt gtggtttggg gtcagcccaa gacatgggca gagtttattt gccccctctg 85834 gggatctgtc ttggtggctc tcttcattcc agaatttact cccacatttt tccagctgct 85894 gcgagtgtct cagactctgt ttgctgctct atcaagccag tgagactctg gctttccgtc 85954 tgagttctgg cagccctatg acacaggctg ggacttgtcc tcaggctgtg aaagccatga 86014 gaccaggaaa gccaacgccg gctgttcctc ccaattgctg accgcctgca gcatctgctg 86074 cggcctcacc ctccgatgcc ttcagagtgt cattttgttg ttgttttttc aagggtttat 86134 agtctatagt tatctgtgag agagttgctg cactaggagc tactaggcta ttaccggaag 86194 catttagagc agggcctggc agacagtaat cacttaagaa atgtgagtta atgtggtcaa 86254 ccatagtgcg gcgctgtttc ctctggtcaa ggctagagac aacgtggaca cagacagcac 86314 catgcaggaa gtgtcagtac ctagtgaaga gcacacaatg gccttaagac tgcacttgta 86374 ggccgggcgc ggtggctcac acctgtaatc ccagcacttt gggaggtcga ggtgggcaga 86434 tcacttgagg tcaggagttt accaacctga ccaatatggt gaaaccccat ctctactaaa 86494 aatacaaaaa ttagctgggt gtggtggcag gtgcctgtaa tcccaactac tcgggaggct 86554 gaggcacgag aatcacttga acctaggagg tacaggttgc agtgggccaa gattgcaccg 86614 ctgcactcca tcctgggtga caaagtgaga ctctgtctca aaaaaataaa taaataaaat 86674 aaaagcctgc agttgtagga gagaccactt aactggggga gggggaaagg ggactatcca 86734 ggaaggcttc ctggaggagg tggtattgga gctggaaatg tcagataatc caagatgaga 86794 agatggactt tcttcacaga ggtggctgcc aaaacaacca attttatggc cttactgatg 86854 agaatttctg gcactcaaga gaggcaactt ttcctaaggc aaatcctgaa gacatttacc 86914 tataaaaatg agtagacatt aaacatccac tagctccttc atgggccaga ggaagcagtg 86974 ctcaggcaag aggggatctg aggtctggtg gtggttctgt agatgtttgc agggagcgac 87034 tggcgggact ggtaggcggg accatccaca gtgaggttgg gcgcccagat ccatcgccac 87094 attgcagagc ttgtggctgt caattctgtg gcagccagga gcacaggtga ccgggagctt 87154 tagtttctgt ccagtacatt ttggtgattc attattcctg gagtcctcgt cttctcttcc 87214 tccctcccag accctctcac ctccttgtct cacttgaacc tctaatcctg ggaaggctcc 87274 accataagca cactacagat aatgaaacca aggctcagag aagttgtgtg gcttacccaa 87334 gaccacacag ctgaagcact ggagccaaga ctccaaccag cacttctgtc tgcaaagagc 87394 tcatggcgta gtctctcatg gagggagcct ccatctcctc tgctgccaaa tggaaatcac 87454 agtagtgtct cccgcagggg ctggcgtgag gttaaaggag gtagcagata tgaaaatgac 87514 atataaattg taaattgccc acagacatta gtgtgtgttg cctggtaacc acccagcatt 87574 tgtggactgc atttacttgg gatagcaata gttatattgg cattttaatt taatagcatt 87634 gttatgttcc catcataaaa ataatataca ctgtgtgtat gcccaccctc atcaaattat 87694 atacattaag tatgtgcagc gttttatata ttgattgtac ctcaatacag ctattaaaaa 87754 atgatgtaac ttcattatag aaaatctaga aaatatggac aagttgaaag aggaggaaat 87814 attattttgt tccagctacc ctaaagctac ctccgttcac attttggaga attctcttcc 87874 agcttttttc cccactgccc agtttctttg cttatttcac atggctataa tcactgatgt 87934 agatcattac aagcatttta tacccaattt tatatcccgt tccttcaccc tcagggggtt 87994 ttaatatgaa atagcaagaa ccagcgcccc atcggggacc ctagcacagc tgggctgggt 88054 ggttctggct tctgcccaga tgtgtctggg tgtccctggg ccagggcagg ctgccccacg 88114 gagggacaat gtcaggacag ctgggacctg accctgttct gactccatgc ccggtgggcg 88174 tttccgtgtt cccacagagc tgcttttctt atcttgtctt tttaagttca gtgacatgtg 88234 catctgtctt gatggatgga tggatacgtc cagcccgtca tcccacttct aaccaccctc 88294 tctcaatctt ttctgttgcc tcaaagctgg cattgactca tggctcagaa ggccagggca 88354 ggccaggagc tgtcctaaaa ggcccagact ggaaaaagaa aaggcatttc ttggatagat 88414 atctctggcc tggctactgc atacaggcac catttgaagc cgtgaattaa gcctgaggct 88474 cctgccctca tgaagtttac gttctggcca ggaagagagc ctacagatga taaaagcctt 88534 tacagaaaga aaaacatcag attaggttgg ggcagggatg gtcagggtgt cctgtatgag 88594 ggtgctgggg tgcagacagc agtttcagca aggtgatcca agctgtgctc acgggaaggc 88654 agcagtgggg cagaattgga agaataggaa ggagccatgc tggtacccag ggaaagccac 88714 tgcaggccga gagagcaggt cttgggacag caggtggcca ggacttttgg gaaagggcaa 88774 ggagcctggt gtttggaggg gaataagcag gtggagagca gtagatgagg ctggggaagg 88834 ggaggaggta ccttttgctg agttaaaaac acgagacccc gtgcatacaa cagtaaatgt 88894 tttcatcatc ttgcatctgc gattctgtgg tctgggcttg gctgggcttg ccctgctctg 88954 tgggtcagtg gggccctgct ggaggctggg cttggccggg ggttgggggg gttcttctgc 89014 acccactctt cctcctcccc ctcaggggcc agtgggccag cctgcgcagg tcctgctcct 89074 ggtaccgcca gaggcgttga tggcaacccc cagtacctaa gcccctttgc atctctgttt 89134 gcggcttgtc gaattgccgt tctgcaggcc aaagcaaaac acagggacaa gcccagaatc 89194 aaggtggggg gcagagaaca ggtcacctgg cccaccatgg gaggggtgaa ggtttggctc 89254 cagatgcggc ccacctgggc ctcggcaggt gggggctgcc tttagaacac tctgtgcttt 89314 tctctgagta cacaatggga gccgctggag ggttttgagc aggggagtgc caggatcagt 89374 cctgggtgtt accagcctct ctgctgccag tctgttgagg ctacgtcata gccagggaga 89434 aagagctgtg gcagtcatcc agtgagaggt gggagagtgg ctggcatccc gatatgctgt 89494 gaaggctgag caggcaggat tggatgtggg gtgtgtgtgt gtgtgtgtgt gtgtgtgtgt 89554 gtgtgtgtgt gagagagaga gagagagaga gagagagaga gagagagaga gagagagaga 89614 gagaacgaga aactccaagg cttgggcctg agcaagtgaa caatagagct gtcatcacct 89674 gagactgggg aagctgcaga ggatgaggct gaggagggat cagaattcag ttatggtgac 89734 caatgaaggg ttttgaatag agggacacag ggatgcactg gctcaggagt ttggtcatca 89794 cgttggccgc cagagggaga acagaggctg ggacagggaa ccctgtggag tgtcctctct 89854 gtggctacag ggagcaacgg tcagatctgt ggctggtttg aaagtagatc cattttgcta 89914 aaggtggtat cacagatttt ggagactaca gaatccaggc caggagagca aagaacgaca 89974 gaggtcccat tcacagcagc gggccatccc gggctcctac tagcttttgc tgcttgggcc 90034 tatggggatg gtattctaga actttccatc ttccaagaca tactggaaat gtggattttt 90094 ataggaaatc ttctactttt caaatattaa gaatgacttc aaattaaaag taataatcat 90154 tttggggctg cagtaaaact tgttggtgga gcaggcctca ggcttcaggt tggtgagctg 90214 tcctccagtg ggggtttctc ttccaggcta gggccttgtc ctcccctgct ctcccccact 90274 cccagggctg gccacccaga atgtgcaggc cactcatctc tgtgactcgt agaacctgag 90334 aatgttggtg atggaagggg tgttccccta gttcccacat gcaaaaagtg gggcctggag 90394 atggggctgt cttttttctc caaacacttg cccatccagg aaggccagcc ctgggcattg 90454 aagactccag gtatgggggt gactccataa ggagaggttc ctgagtgacc tgaagaaaca 90514 tggttgggat gaagtgcagg gagggtcagg gcaggcaggg ctgagcttcg cttctgcgag 90574 cagagattag agagcgatcc cagaggcctg cctggaggtg gggccacaga gcaggagtct 90634 gaaggagagg gggtaattca cctctgtcct actgtgtggg aagccctgag tgggccccta 90694 gcagagggtt gccttgcgct tatctatgga gatattggga agggcttccc tgacccaggt 90754 tgctggagca tgggggcctg ggtggcaggg gtaggtgtgg gagattcaag acaggaggat 90814 gaggccacat ccaggtggct tcagatacca ccgtgagtcc catagagtgt ccagttacta 90874 taaagtctgc cagccactgt ggtcgcccca ggcctgtgcc aagtcccgag atctctgccc 90934 tgcagccagt gcagagggaa gaggagggca ggaggggaca ggttggtggc ccctcgccga 90994 tgctcctgac ccctcaggct ccctgctgcc tcctgcccag ggctgtgggg cctcggggag 91054 cggggagctc gccattgctg tggcactgtt gagcacccgg gagaggcggg ttctgacagc 91114 caccccttcc cgtcttgctg ttcccctccc ag ct gac atc atc tct acc gtt 91166 Ala Asp Ile Ile Ser Thr Val 25 30 gag ttc aac cac acg gga gag ctg ctg gcc aca ggt gac aag ggc ggc 91214 Glu Phe Asn His Thr Gly Glu Leu Leu Ala Thr Gly Asp Lys Gly Gly 35 40 45 cgg gtc gtc atc ttc cag cgg gaa cca gag gtgcgaagcc ctgggtctgg 91264 Arg Val Val Ile Phe Gln Arg Glu Pro Glu 50 55 tgggaggtgg gaggggtggg gagcagagtc aggtgggagg cgggcatggt gggaggggat 91324 aaggataagg gggataaggg gtgatgcggt gagaggtggg aggggactat actccaaccc 91384 acaagagggc ttttaactga caggaggtgt ggggtgtctt gcctggatca catctcccag 91444 gggcatggat tccaggggtg ggaatgggat gctttggaat gccgaggtgg gagtggcggg 91504 cggtggtagg gggagtgcac tgggtgggct ggcaaagcca ggttctgagc cccctgccct 91564 cagccgatgt ttgcggagag ctgcctgcat cccatgctct gtcctagacc ctggatgaat 91624 ggtcaggatg tggcacaggc agctgctgcc ccagcttgtg ccttcagtga aaccttcctc 91684 tgcctgggtg acctgcgttg tcctggccag actggggagc gggaggactc cactcttgcc 91744 cagctgtcac agccctcaga ctgagctagg tggtttttgc tcaggcctgg gcccttgtcc 91804 tcacccctgt cctcaccccc acccccgggg gcttgttgtc cagcagaact ctgggtaaga 91864 cagcagtggc ctggacaacc tgcccaggac cacgtttctg gaacactgaa agagcctcgg 91924 gacaaaagcc catttactga gaacacttgc taagtattct ggagttgctt ctggtttact 91984 ctgcactgct cacctccgag ggccagatcc acacccctgt gacagatgcg gaaactcaga 92044 gaagccaccc agctagtgaa cagcagacct ggctgcccga cgccaggaca gtggccagca 92104 acgtcacaca ccacccggcc tcagagaggg cgtctccccc cgcaaacacg gactgtgcct 92164 ggaattagat gcagaagaca tccaggaaac caaggaggag ggaggagggg atggagcagg 92224 agaggcaggg gaggggaggg gaggaggaga agagaaggtg gagaagggga ggtaggaggg 92284 aggggaggaa gccgggggtg aagagaggac ctgcggaatc atctttcccc cgattcactc 92344 ctgagcatgg cccacgaact gaggatcctt gagtctgact ttatcttggt ggctcacata 92404 accctcctca cggtgaccct gtgggtgtag tgcagtgcgg ctactcccct cattttacag 92464 aggaggagcc cagagtgcag agggttaaaa tagttgacaa ggggcacatc ctagctgcca 92524 atcagttcct caaacacagc actcggccag cacctgtggg cttcaccaga tgcacctgtg 92584 gggtgtccca ccaggcactg cgaagctcag ccttcttttt gccaagctgc agaaagagat 92644 cggattggtt gatgcgattt tcttcatttt gaatttttct cctttagtgt tttcttcctt 92704 ctagtcccac tgacctttgt catagcgagt gctcatggga agtgaagtga attagaggca 92764 aaaatattgg agaacttcta agcttttcaa aagcaagaca gggatagaaa tatagatact 92824 taaaaaaatt accaggaaat cttgaaattg ttctgggttg aatgtctccg tttctccctg 92884 gttggggttt cgtgttgtcg tatgagttga actctctcct gggaacgtgg tccctggcgc 92944 acacagtgga ctcaccacct gactatgctg ggagctccac ggtcaagggt ctttattaga 93004 aggagctctg ctgcctaaac caggccaagc actgctgagg aaagccgggg acagattcca 93064 atccaggtct gacattgcca gacattctgt cccaatgtta aagtctgctc ccaaattcat 93124 ttattcctca agtcaggcct gagttggaca cgtggaatcc aggagcaagt cagggcccaa 93184 gacacgaggg tggccagagc ctcaagcctt ggcgtcaggc aggcctcggc agaggggtgc 93244 tcgccggaga gtgacctcac ggctctggga agtcacttcc cctctgagtc tctgtttgct 93304 ggtctgtgaa atggggagag tcgtggtgct caagcagagg aggcctggag ggtagaatgc 93364 gatggtgcgg ggaggactta gtggggtgtc cagcttgtag caggcgctgg ggaacattcg 93424 cattagcaag ttagccggct cgggtgtgag tgtttcatgg gaccgcacgg gagcggggct 93484 tgtccctggc acactgcaag tcatgggccg gttaagctgc agagagtttc atttgaccct 93544 cgaattggat ccctggcacg gctcggcact tggtcccacg gccggccctg ctgggtcccc 93604 ggaggtccta gccgtcgccc tgcaggtcac ggtgctcagg ccccttctcc gggtttccct 93664 gcag agt aaa aat gcg ccc cac agc cag ggc gaa tac gac gtg tac agc 93713 Ser Lys Asn Ala Pro His Ser Gln Gly Glu Tyr Asp Val Tyr Ser 60 65 70 act ttc cag agc cac gag ccg gag ttt gac tat ctc aag agc ctg gag 93761 Thr Phe Gln Ser His Glu Pro Glu Phe Asp Tyr Leu Lys Ser Leu Glu 75 80 85 ata gag gag aag atc aac aag atc aag tgg ctc cca cag cag aac gcc 93809 Ile Glu Glu Lys Ile Asn Lys Ile Lys Trp Leu Pro Gln Gln Asn Ala 90 95 100 gcc cac tca ctc ctg tcc acc aac g gtgaggcgct gcccggcctc 93854 Ala His Ser Leu Leu Ser Thr Asn 105 110 gcttgcatgg gcacaggccg tagatgtttc taccaaatgc tggtttgtat ttcacttata 93914 ttgtgagcat ttttctatgt cttcagaacg cctagaaaat aatatccttt ttgagcagca 93974 tataaatccc atgagtgagt atgccagacc ccctcagacg ctccctgtgt ctggacacag 94034 ggctgccccc ctttttgagc agcatgtaaa tcccatgagt gagtatgcca gaccctctca 94094 gaagctcccc atggccagac acagggctgc cccctgctgt gaatagagcc atccgagcca 94154 tctttgtagg cctttgcttt ggggtgaggg agtgtgatgg acaaggatgc aggtcgcaga 94214 cacgggggat atttgacaca aagtgaaccc ctcctcccca cgccgaatcc agacccctag 94274 actggggctg tcaccgcggc cttgcggggc agtgggagga gccttggttt aggaccccgg 94334 ccggcctctt aatcctcttg cctcagggag gagcatgtac ccctcaggca ccggaggctc 94394 tcggcctgac gcctgcttcc caggctccac tctgagggag tggctggggc tgtcctgctt 94454 ggctcaccat gggcctgggt cccccactca cgccccctgc ccatcctcct tcacctgggc 94514 cccctgcgga cccaggcagc ctggggtcgg gtaggacaca cctggattct tttttttctt 94574 tttttgagag acaagagtct tgctctgtca cccaggctgg ggtagagtgg cgcgatctct 94634 gctcacggca acctccgcct cccgggttca agcaattttt ctgcctcagc ctcccgagta 94694 gctggaatta caggcgtcca acaccatgcc cagctaattt ttgtattttt tagtagagac 94754 ggggtttcac tacatgttgg ccaggttgat ctcgaactcc tgacctcggg tgatccgcct 94814 gcctcagcct cccaaagtgc tgggattaca ggcatgagcc actgtgccca gccaggacac 94874 acctggattc tgtccctgcc ctgcctccct tgggcagtga ccttgctttc ctgagcccca 94934 gcagggtgga cacatctccc ttctggggtc cgtgaaatgg tgcccactca accccctgag 94994 aacagtaacc gctgcacaag caccagccag gcttcgaggt gctgtcccca cgccttcccc 95054 gaggacgtcc acgctcctca gcggggcctc caaggctctc ccgaacatgg ctaggcgcag 95114 cttctgccag cccgcctgtg cctgaaggct atcctcgccc tgtacctggc caactccctc 95174 ctcatcccat aagccttgct gggtgcccgc cttttctgac ctctccactg agccaggcat 95234 ccctcctgtg acaccctggc tcctcttaac tccggttcac cccctctctg ggcacctgct 95294 gttctgatgg tgttctcccg ccatgcacct caaaggcagg atctgtgtcc cctaaggggc 95354 cctgcccagc aaatctgtca cctgagccag cagagcatga gagatcctcc cgaagggcag 95414 gccctggggg acaggagcct cgtcctgtcc ccatgcacct gctccttttg aaaatattta 95474 agaaggacgt gtcagccaca tgcggtggct catgcctgta atctcagcac tttgggaggc 95534 tgagatggat ggattacttg agcccagaag tttgagacca gcctgggcaa cgtggtgaga 95594 ctctatctct acaaaaaaat aaaatattag ccaggtgtgg tggtgagagc ctgtagtccc 95654 agctactcag gaggctgaga ttgaaggatc atctgagacc ggtaaagtca aggctgtagt 95714 gagctgagat ggtgccactg cactccagcc tgggtgatgt gagtgagacc ctgtctcaaa 95774 agaaaaaaaa aaaaagacat gtcactttct tcctgcctct ctacagaaaa ggtcatcttt 95834 cagcactccc tacactccgc tcccctcaaa gcttcccacc tgggtttgaa tcctggcttc 95894 actctttcct aatggcaggg ccttgggtac ctttcagatg ctccactgac cccagttctc 95954 agttctcttc ccagttcctt ctcatcaaca tggtgctatt tgttttgact cctgtagtag 96014 tcagggttct ccagagaaaa agaatcagta gggtatgaga gtgagaaaga gaaaggggga 96074 tttattttaa ggaagtggct cacctgactg cggaggctgg ccgttccgaa atctgcaggg 96134 aggccgaagg ctggaggcct cgagacagag ctgcagttct ggtccaaagc cgtctgttgg 96194 cagaaccccc tccttcccca ggaggtgcct catgatttca ccttctaaag tggatcttct 96254 cttccatccg gctgcttaat tatgtgactc gctttatttt gttctgtttt taaag at 96311 Asp aaa act atc aaa tta tgg aag att acc gaa cga gat aaa agg ccc gaa 96359 Lys Thr Ile Lys Leu Trp Lys Ile Thr Glu Arg Asp Lys Arg Pro Glu 115 120 125 gga tac aac ctg aag gat gaa gag ggg aaa ctt aag gac ctg tcc acg 96407 Gly Tyr Asn Leu Lys Asp Glu Glu Gly Lys Leu Lys Asp Leu Ser Thr 130 135 140 gtg acg tca ctg cag gtgagctccg gtgaggggga agcaggcaca cgcctcttta 96462 Val Thr Ser Leu Gln 145 ttacacctga ggattttagg gctggaaaag cctttgagat ttgagccaga gtcaggtgca 96522 gaccctggtt gggctgctgg ctgctgggcg gccacgggcg tcttcctgcc ccttgcctca 96582 gtttcctcac cagcagcata cagatgacca cgtttcttct aggcttcttg tgagcatgca 96642 ggggtggtgt atggctgtaa agtgcttttc acctatagct gagggtggag agcaaggcag 96702 ataatccctt gttataagaa gggggaaact gaggcccaga gagagacagc aactcaccta 96762 aaactgctca gctgagtgag taggcagagg cagaaagaga atgggtcagc agagctttgt 96822 ggctcctgag tcctttactg agggcagaag gaagcctgga ccgtgtgagg ccttcagcat 96882 ctacaaaggc ctgaaacaga cataccctga aacagacaca cacgtgccca gcatccagtg 96942 agccgccata aatataaagc agtagtcagt gctcttcctg agaagaagaa ataaatgttt 97002 aaatacattg gcctaaatga ctggcaaatt gcacaaataa attctgagga agtgggcagc 97062 cgattagctt cgatgttgag taatgagggt gctggtgccc cctgccccac cccccgtccc 97122 aagaaagttt atgagggttt catctagagg gaaggataca gcgatcacat cttgatcacc 97182 ctggtgtttg gggcagagcc agtggccttc ataaaaatcc tgtttatgtc cctcccagcg 97242 ttggagattt ttctctgtaa gtcacacaca tcccaagaca cttaactgtc actgagaacc 97302 tgggtgccct ggtctgtcct catcctgcct ctcaccttgt ttgcttccga tttcacccac 97362 gccacgccaa ccctgcacag cattctaccc accctgcgca gttcacactg gaggcagctg 97422 tttactgagg agctgctcca cgctaggccc cgggctagcc cttggggccc tagaggtgag 97482 caaggttcaa ctcagtacct gtccccaaag tgtccccagc ccccaaggaa acagacatgg 97542 aatcgccatc acactggcgc tcagtgcggt gacagaggaa cacagagagg ccgtgggcac 97602 cccaggaggc ctttctctac tttgtcaatt tggtgaactc ccatacatcc cataaaaccc 97662 tactggcctt cacctctgta aagcctttct gcgcaggcca gatgacaatt gtgatctttc 97722 ctgtgtcccc tcttgccttt tggatccgac actgtctgtc cttagtgtct gtatcttcct 97782 tgcccctcat cttgactaga ctgtggcttc tgcggaggca gcatgtttta ctcatgaaac 97842 ccccaaacct tcagggaagg tttcctttct ctcttcttct ctttactaaa aaactggttt 97902 tgagctctgg tttggtggat ggcagcaaat ggctggagca ctggatgaac tgggtcccaa 97962 ggccgcctgg agaaaacaga aagcaatgtt gccggaagga agcaggaggt ggactgagat 98022 gccaagactt tgctgggcca gtgatgctct gcccttctcc agagcagctg ggctccctct 98082 ctctcctgag agtccaggga tccccagggt gggcagtggc tgcaccccga aggaagggaa 98142 ggttagcagc atagctaaaa tatctgacac aggaatacgt gcagggagga tgccttggag 98202 gagtnnnnnc acactaacac caactcccag gcacacaacc tagaagcaaa gacacagagg 98262 caacaatgca agaaccaccc agagccaggc tgtcactcac accggtgctg cgtgcacaca 98322 cacacacaca cacacacaca catgcatgca catacacgta tactcagtca tgcatgcaca 98382 ctcacatgca cactcatatg cacacactca tacatgaact ctcagccatg cacactccca 98442 cacacacagg ctgggtgccc tggtgtgtgg gaaaatttaa cgtgggctgc agagctgcct 98502 ctgctccaaa ggagctcagt gcttgtcact ccgactgcag caccgaggct gtcacctccc 98562 atctcagctg ttccctgaga gctcagggac acagcccatt cattcattct ctcacacatt 98622 cactcattca ctggagagtc tctctgctag gccttggact gagcgctaga gagatggaga 98682 gataaacaag aggtgacgcc ttgctcccgt agctgatccc tagtccactg ggaaagctga 98742 tgggaccagt tgacagcctc agggttggtc agggctgtgc aagggacctt cagggctgtg 98802 aaagctcagt gtctgatgcc atggcaagga ctcctcgcac caactgtctg agatgaaagt 98862 tcgtatgagt caggctaact ccaccgctgt aacaaaacaa caccagcagt ccagggccga 98922 gcacggaaat gcatttctca ctatgggaag gttcgatgtg gatgtgctgg ttgggacaca 98982 gctctcctgc aggatccttc catccccatc ccatgagtct cagtccctaa ggcttgggtc 99042 ctcaccttcc aggtggggaa ggtgctcccg ctgcttagct gcatcagggc caggtatcac 99102 tttgctcaca tcccattggt cagaactagt catgtggcca tgtctgggca caaaggctgc 99162 tgggaaatgt agtccacatg tagacagctg tttcccagtg acagcactgc attgcaggag 99222 gaggtgagga ggcctggcag acaattggct ggctctgcca cagtatcttt ttgtttcatt 99282 ttagagttga ggaaattggg gtataggagg gttcagccac ttattcacag acccacagca 99342 ggtaagcatc catgcctctc ttgcagggct ggtgggcggc gggcatttgc catctgtcac 99402 tgcctatttc agaccacgga ggatcaggat ggacgcccac ccctgtgttc cagcctccgg 99462 ttgggatcac atgctcacgg catgctatgt cctgatgcca ccacctggcc ttcacctctt 99522 ccctgcctcc tcatcctctg cag gtg cca gtg ctg aag ccc atg gat ctg atg 99575 Val Pro Val Leu Lys Pro Met Asp Leu Met 150 155 gtg gag gtg agc cct cgg agg atc ttt gcc aat ggc cac acc tac cac 99623 Val Glu Val Ser Pro Arg Arg Ile Phe Ala Asn Gly His Thr Tyr His 160 165 170 175 atc aac tcc atc tcc gtc aac agt gac tgc gag acc tac atg tcg gcg 99671 Ile Asn Ser Ile Ser Val Asn Ser Asp Cys Glu Thr Tyr Met Ser Ala 180 185 190 gat gac ctg cgc atc aac ctc tgg cac ctg gcc atc acc gac agg agc 99719 Asp Asp Leu Arg Ile Asn Leu Trp His Leu Ala Ile Thr Asp Arg Ser 195 200 205 ttc a gtatccttca ctgtggcctn ggccagtgcc tcccacgggc agagtagctt 99773 Phe ccgttgggtg gtgggtttgg tttgattggc agacagctgg tttggggatg gctgcattgt 99833 ttaacttctt cagtgaggca cctctggctc ctagtatgcg tgtgaggccc agatacaaaa 99893 tcatgtcacg tctgtttctg aaaaccgcaa agtcgtggtt gctgagcatt gcacccatcg 99953 cctcctccag catggccatg atcccctcat cctagggcct cacaaggggc caggaaggag 100013 acagagttca gggttcagct gctctggacg agggactgct ggccttgctc agcgtccact 100073 gaaggcgcct cggggccctc cccactggga cccaaggcag gctgtgttag cataggagga 100133 ccagcactgg ggccccggcc agggcttcgg gtgacaacca gggtgtcaga agcccagctg 100193 ggttggggtc ctgagggccc cctgctcggt gttctcctgt gtcagggcaa gctaggggaa 100253 gcagcagcat tgacgattcc cgccgactgc tgggaagaga gctggtgatg acatgagcac 100313 cagcctgcag gcagggcgag gcttggcctg ccggggggct ggtgggcggg caggcaggtt 100373 gctgtgatgt cactattctg catacaacca atgataataa taattataat aacacacagt 100433 gagactctgt gtgccaggct ctgtgactaa catcaacaag cattcatttt aactcatttc 100493 accttcacaa caaccctatg aggtaggtac tattctaagt ctcctttaca gatgaggaaa 100553 ctgagtcaca gagcactcaa gttaacttgc tcaaagctca cagccagcaa gtgtcaaagc 100613 tgggcctgaa acccaggccc tcaggcccca gagtccccgc ttctaacctc cataccacac 100673 tgccctttgt ggaggatgcc acccaggtgt gtcttggaag gggtgggaag accctcctga 100733 gagcctccat gcaactggat ggcctcccga ctccaggcag cctgggcacc cagcagtggt 100793 caggagtggg ctgtgtccct cggagcagta gaagccggga tagctgtggg gagcagggga 100853 ggcagggagc attccaggaa gggtgaaaga gagtaacaaa tggcttttgt ggtctgagat 100913 ccaggcacag ccagagaccc ctgggcaggg agacccttgg aaaacagcgg gaagggaaca 100973 gagcaaagcg ttggatgtcc cctgagccag ccagagggtg cggggcacat gtgtgggctt 101033 cggaggcaga aagtctgttt gggtctgact gccaccttca agctttgtga ccctgggtga 101093 gtacactcac ctccctctcc gagactccgt cttttcaatc atgcctcctc atagacctgt 101153 ggggtgccgt cagtgagccc ctatgtgtga tgtgccgaac cctaagtcag cacttggtgg 101213 gtatcaggaa gcatcagcat ctctctccct tctcttgtcc caaaggcatg gagtgcccag 101273 agctgggagg ctggattggg ccagccagga aggttccagg aaggattggg acctgagctg 101333 ctttgaaggc ttgaagctca gatttctctg gacatagagg gctgggctgg acatctgtct 101393 gaccctccac tgaagccgaa aggacatcgg gccccaccag tccacagtgc tcatagcagc 101453 agttggttag actctttctg ctgcacgagc atgtttgatg tggataactg taagagagct 101513 gcgggccagg tggcttcagg ggctggagca tcgtgggtga tggctctctg ggctgattgc 101573 ctctgctgtc ttctgtgttt caatctcagg tgccagtagt tggggcccca ccctcccaga 101633 ataaagtcca ggagaaacga gaccagttct ctctgaactg tcccactagg accctaaatg 101693 gcatcttgtg ggctctaatt gggggtgaat gccttgttgt gattggccag gccggactcc 101753 tgtacctctc cctggtgctg gagggagtca gctccgcccc caacccctgg atgtggggga 101813 ggggcggtct cctagcagga gctccaggtc tgcaaatggg gagggtgtgg ggctcactga 101873 gcggcctgga ccgtaccgta cagtttacaa atcagcctgc cgttcgttgt ctcacttggt 101933 gctcagagac agtggtaatt tgatgatcac cccatttcac agatgaggaa acggaggctg 101993 ggggagatga gggactggcc cagagtcccc agttggcagg ggcagagcca gagctcatgc 102053 tcgggcctcc atgcctggtc cagggctttt gccctggcct cggcctgccc cctgcagccc 102113 tgggacagtg gcagccaccc ttctcgagca cctgcttcct tcctgccgga cttgggtggg 102173 gatggtaatt gctgctcggt tttcctgtct gggctgctgt gaggattccg tgacactatg 102233 gatgccgaaa ccctttctaa agaaccataa agccctagag tatggaaggg atgctgcttc 102293 atttcattta ttcaaccatt cattccccac gcctttctac tcccaggccc acactgagcc 102353 ctagggacat ggggatgaat gggagaaact caacccttcc ctggagggct caggggctgc 102413 tgggggacac agccccgcca tggcagtgga agtgagggag tcatccttgc tgtagcccag 102473 ggtctggaca agctgctgtg ggggccgcca aggaagccag agaaggaatt tcggtaggaa 102533 gctccctggg ctcgaggagg ctgcctgagg gcatgggtgt gcaggaggcg gatgcatgag 102593 gaggcagaag gtgccggagc tgtggcactg tggatggtgc aggcaggggg ctttctcttg 102653 gggtaggggc cccgaatgcc agtcattcac aaaacccccc acagctgtgc ctgcctccac 102713 atgccacgtg tgcttccctt tacttttccc atttaaaaaa aattgttttc tttaagtcaa 102773 gttgctttat ttttgccgaa gtaattttct tttgaaaggg aattgaattt caccatgata 102833 agttaaagta tcacatacca taaataggag gtagcctcaa ccataacggc tgtgcacaca 102893 aaatggtggg aataaaatac aggctcagcc ctgtctgttg gaactttctg tggtagtaga 102953 ctgcttcgtc tgcactcatg gggcggcagc caccagcccc atgtgcctgc tgagtgccta 103013 aaacgtggct tggtgactga ggagcgacat cgttaatttg atttagttcc agttaatcat 103073 acttcaaacg aaatagccac atgtggccag tggctactga acaaggacgc tgcagcctct 103133 ctccaggttg cccttagacc ctgaagctgg ttctctctga aaagatggag gtaaacatgt 103193 gcttcaatgt taagggggag agtgcaaaac agagacatcc cccttcattc atcagaagga 103253 ttgaatcctg tctccccgtc tgcatctata ttacattact ggaggctgtg ccgacttccc 103313 acctgcctgc ttccagggaa cgggaaacta tgaagctatt gatgtactgt aaacaggggc 103373 gtgtcactag ccagctttgg aggtgtgtat gtcgtgggtg tgtgtcgtgg gtggattgga 103433 ttccagcaga caaggctggc ggcttgggaa ccagcaagga gacccgggga gagagagtga 103493 gaggcagggc cagagcgtgg ccacgggtgg gaggcggtgg aggaatgaga ttgtaaggat 103553 ggaggtgtca tagatttgga ttgtatcata accagttttg gatcggggtg gccacaagac 103613 attcagacag gttggctgta aagaagaaaa gggggttggt tcatcccagg actgcaaagt 103673 cctccctggc cgttaccgtg agccttgcct cctgtcccgt cccgaacaca cagattgtgc 103733 cctgtccgca tgttgcagag cacaccattt accagcaggt atttattaag cacctactgt 103793 gtgccagccc tcttgggtga tgctggaact agataaagat tctgcctcca ggagtggaca 103853 cgtgataaac cattggtaaa atacccggca ttggagcagg tggtccgtgg gtgctacagg 103913 gagtcggtgg cccagccagc gcagccgtgt acatttctct ccagccacgc ctgctgctgg 103973 ctgcaggcct caggtcggtg gagggtaagc caggggtgtg gtttttgcca agtgaggatg 104033 tagacacgga gctgatggtg tgtgcaagag agtgaaaata atgattattg accaaagaat 104093 ctgagccagg tgagggacag tgacaaggga ggagtgtcag cagatcgggg gcccctgtgg 104153 atcctgggaa catccctggc cgcacaccct gccgtgtaac tcagtgtcag atctctgtgt 104213 aacttcccat tctgtgaaaa tgattattaa ttcatcaaaa cataaagcac cctggcctta 104273 gtgatagagg agtgtgtgtc tatagcatga acaagattct gagctgggct tgaggcagcc 104333 ctgatagggc aacttaggca tttggcagga gttgagtgga gtctccaggg gcacatggtg 104393 gccatggaaa cctccccgat tggatctatt cattggggaa cctcagtgca cctggtgctc 104453 cccatggcct gttgccgctt ggctccccat ggggtgctgc tgcagtgaca agacacagat 104513 ccagggctca caccacagag agaagcctta cttggcagag aaagtgtgag gactgtgggc 104573 tgcaggtgct gcgatgagga ctgatagcag ccgagtaatg agaggaggcg tttcatttct 104633 gacatgggag gaggccagaa aggcagctga gaccccatgc ggagctggga attgctctga 104693 atgtttgaga taccttctaa gcaagtctca gtggggtgga ttctggctgt cagagggtga 104753 cagttctgat gagtcctgac aagaaaaacc cagggtcagg aggcctgtgt ccgcgcagag 104813 ccaggggaag gcttgggctg gacttggggt ttgcatcctt ctgacccctg ctctctgggg 104873 tcctcactcg gcccgatgac actgttcagt cctccgtgcc cactggaggt tttccaccat 104933 gtcgcatctc ctaagtccaa tcactaacac ttcccgtctc agcaaaatgg acttttagta 104993 accatatcaa gagaaaggaa aatgtttctt agtaaaggag aaaaagaggg cattgctttg 105053 actattggac aatgagaaag gtgactcaga ggacatctct gctggaggga gggagcctgg 105113 tgatactgag gctctgtgac ctgtctcggt gtagtcacca aggttcaagg aagaggagcc 105173 ctcccagcct cctccctctc tctcaccctc agaatggaaa gaggtgccca gccctctcta 105233 ctctccccag acacttgcct gaatcccgcc ctgtcctgcc cagagccttc tgcacagctg 105293 tgaaattggc tcatcggaac ctctggtctg accatgtcag ccccccttaa aactctcacg 105353 ggttcccctc tggcttctgg aggaagcctg agcccctcca cagtgccctg tgcctttggt 105413 gaccagcccc tgcccacctc tcgggtcaca ctggctcact ccttcagctg ctgggtccct 105473 ggcatggggc agggtggggt ggagcactgc catccgccat cccttctcct gaccatgcca 105533 tctgcctctt tggcctggct gactcctgtt tgcccacttg cagcatctca cagcccatta 105593 tctgggacag cctctgacct gtccctgcca cacccctcct aggctggtca gagcccctct 105653 aagcctgcgg ctccttggct gcccccggtc acactgagtg ttttgttact gtgacagcct 105713 cctccatttt atggtggaag ccctgagatt aggaacccag ggtgaggcct ctctgcatcc 105773 cctgctccac ataggacttg gcgataggag gtacttatga acggttgtag gtggagtggg 105833 ctggaagttc accacttcca tgtggtctta ggatacagac acctcctttt tgatctgggc 105893 gcctggggaa tcagagaccc cagaccctaa agtgcaggag aaggagcccg ggctttgggc 105953 cctggcgggc ctgggctgag acccattgct cagcctgctg ggccatcagc ttccctgaat 106013 ataaaatcag aaaattccct tttataagga tatttgtaag gaataaagaa atctttcaca 106073 taaagagcct ggtgcctaat tggagcccag caagaggatg gtttattttg tctcttaaac 106133 aacagccctt caaacattta agattggttc tcataaaatc cctgcatctc tgatggttaa 106193 aactccgttt tccacggtgc agtttcaacg tctgtttaag caacctctcg cgtcctttaa 106253 taccaacatt ttgagactgt taacacagca ctgggtgatt tttcttgagt ctgatgcatc 106313 ttaaaggtaa caaattgcac aggaggtctc agcggatgga cctctgcttt atttttagca 106373 cccagagaat ttaaaagacg gttcgattga tttttctctc ccttagtgat ttctcacggt 106433 gggaactggc atcacaccaa gcctcggcct ggagaatttc taattcccat ttacagagca 106493 ggtccgcacg gccaggtggg ctggaggggg gtgcagccat tcaccgcagg aggctcagaa 106553 ccttcatcag cccatgcctg cctgaagact cagcttgtct tctgtgcaga gaacaaagga 106613 gggagcagac acagtccctc tgcatgcaga ctctgtgctg ggccaaggga ccctgagccc 106673 aggctctacc cctgcctctg ccactgaccc tgatcagtca ctcagtcttt ctgcaccccc 106733 tttatcccat gggagtgtgt ctcctttacc aggagctgta aaggtggaat ggccgatgag 106793 tatggggcct ggtgccgtgt agacaagcaa ccctcaccag cacatgaccc actgtcgggt 106853 accttacagg ccacctcttc ttcctgccct tggtgctaat ttacagagaa ggaaactggg 106913 atgccctgct cagaaatgct ctgttcacgg catgtcagat acataccact gatggctggg 106973 agtctggacc cctgggttct tactccagct ctgccactac ctgcccacgg ttctgtgcat 107033 tcattggttg attcagcagc attggccgag agtcttctct gtgttgagca ttggacttgg 107093 tgctagggaa gcagacaggg tctctgccag ggcctgcgag tacagttgta tgggttgtct 107153 gctgcccaaa agaggtgatg atccaagcca agcaccttgg gaagaaggga cttttttgtt 107213 tttcagttct gcaaggaaga gctgtctttt cataattggc acaaaggcac tttctgagtg 107273 aatggggatc ctgatgctat ccaggtgaac tttctaggtg agcaaaaaga tagtcttctt 107333 cttgctcaag cctcgatgag tcctgtgatc ccatcgtcca aatgcaccca gagcccacct 107393 gcctgtctgc ccccagcatg tgtttaggcc actgtctcac tctgatcatg atggtgacct 107453 gactggcctc ccttcttagg tctaggagcc agactgccag ggctcagacc ttggccccaa 107513 gacataggga ctccgcggcc tcgggcagct cacttgggtt ctctgtgcct cagctcctca 107573 cctgtaaagc gaggaaaagc ccctgctgac accatacggc tgcttgagga ctgggtgcta 107633 cgatgacatc tgggaagcct ttagggcagt gcctggcaaa tcaccgagct gcagcatcat 107693 tgcttcatta gctgtgtttc cccaggtgtc tccttacagt ctgttctcct acaacatgag 107753 aaaaaaaaaa acgacaagat catgtcactc cttgctcaga acccttcagc aacttctccc 107813 aactggaagt aactccgccc ctttctctgg cctccaaggc cctgcaggag ctggccctgg 107873 cccctccctg gcccacttcc tcctctctcc ctttgctccc tgggctcagc gttcccggcc 107933 ccctgctctt caccatattt ccagccatct cctgcagcag agccattttg cactggctgt 107993 tccctccgcc tgtgaagttt ctccatcctc atccactcag tggacacctt cttaaagagg 108053 cnttccttga ccagtctgtc ggaactagtc catcccctcc atgactccct cgagcccctt 108113 ccctagaggc ttggcctcta cctcgttccc tgttcatttc ccgcctctcc ctcctggact 108173 ggcagcttct tgagagcagg gaccttgttt gatctacctg gaataatgcc tggtccagag 108233 tagatgctca aataatggaa ctagtgtaat acagtgagat gggtgttagg ataaggtggg 108293 gaggaccccg gcctccttag aaagtccttg atggaaaggc attgacactg aggcttctgt 108353 tctggacctg ccacgtggtc ccctggcagt ttgcttcacc ttcctggaca ccagtttccc 108413 cttctcttgg ctggactggt gtcctgaaac tggctttcat ttagacagtt gggctatcct 108473 tgccgggtct cccttgatct ggctatgtgt gaccttgtgt cttgccagct gctagcatga 108533 cacaaggtca cacacagctt gtaacagcca ggtgtgcaca tctcttccca aatccatgtt 108593 catggacatc tctttggcag cttgaatttg gccatggtgg tagtatttct ttctttttct 108653 tttctttttt tttttgagat ggagactcac tgtgtcgccc aggctgaagt gcagtggctc 108713 aatctcggct cactgcaatc tctgcctccc aggttcacgc cattctcctg cctcagcctc 108773 ctgagtagct ggggctacag gtgcccgcca ccacgcccgg ctaatttttt gtatttttta 108833 gtagagacgg ggtttcaccg tgttagccag gatggtctcg atctcctgac ctcgtgatcc 108893 acctgccttg acctcccaaa gtgctgggtt tacaggcgtt agccaccgca cctggcctgg 108953 tggtagtatt tctacagata tctacaaaca ctacaaaatc aatctctccc ctccccagaa 109013 gagagggtat tgttcaagtt accagcacac aactgctctg gggccttcac aaggccaggc 109073 agttggtcag tcagcctcca ncatgactga gggcttcctg cgtgccatgg cnctgtccat 109133 ggtgctgacc ccgttgtgag ccattgcgtc gaggtcagca tctccacctc ccaccccact 109193 gtcactactt gctgtgtcac acggtgttct gagcacgctg ccgatgttaa ctggttgaat 109253 cctcccaaca acactatgtg gtaggcgtta ttaatatccc ccttttacag atgaggaaac 109313 aaagccacag taagtttcag taatctaccc aaagtcaaag gggaaagggg gtgcagggga 109373 aagggggtgc cagggctggg attcagattt aagctgtctg gatgcagaac catgcactta 109433 actgtcatgc tacaccgcct ctcagtcatg atggtaacaa ccccagttgc agcctgcctg 109493 gtgctggggt gaacaaatgc aagatgccgc tgttgcattt cagtctcatg accactcgcc 109553 aggtgggggc tgtcactgtc ccaactcagc agaagtggag atgggcactg agaggtgggc 109613 tcccttgccc aaggcccctc tgagccaagt gtccttctga tggcctgccy agctttgttg 109673 agacagccgt atttcttggt tcttgcttta ggtcctgtgg aaagacaggc ccaattgcag 109733 gatagatggg aggttgtttt gctatgagca tggctgtcag tagctgtatg gcagtcctca 109793 cgtttgccct gcaggtggca tggtagaggt gtgcgaccct ggcctgcctc ctgtcccttc 109853 ttgacagacc tccctggcat ttctagaact cgctccctgt taaaatcctc ttgaccccag 109913 gcctgagccc cagacctttg gcctgcttcc ctcttcagga tgggtcctgc cactcccagc 109973 cttatgtcag gacccctcca ccctcatagc tcatactcca tcaccctgga gcctctccct 110033 ccctcttaga actcctctcc ttttggacag agcctatgct ccctctgagt tctgctggcg 110093 ccgcatcctc tccagcctgg ctctcaccct ctctgcctcc ctccctcatg ctcagccacc 110153 cagcctctca cacctctgag ccttgcactc cccctcttca accccctcac cccctccaac 110213 acacacacac cccaaacatt ttcccaccca ctagctctgc cgggataatt cctactcacc 110273 atgggcttcg gagggccctt ccctgactct gcaccatctc agggcctcgt tataaatctc 110333 tgacatgagc acctgtgtct ctcttaggcc atcgatcgat catggagcta aatctgcttc 110393 cctgccaggc tgggagcccc agcagtcagg gcggggtctg gtctgctcct tctcagtgct 110453 gtgggggtac agctgcctgg gtgcacatcc cagctctgtc caaccttgga ttccccctct 110513 cagttcttgg aaaccaaggc atgccattca ccacagaccc tcctagtcct cccagggggt 110573 gacaagcact gtaccttttg catcctgctt agctgtatgc ttttttccca gagggagaga 110633 aagactctgg gagttctaat ttaactaaat tcaatttaac tgtagccatg tgctgggtct 110693 tttgacatat gtcatctggt gaaatcctca ttacagccct gcaaagcaga agttatcaac 110753 ccattctaca gataagaaaa gcagagcaca gaaaggctga gttttcaaga gatcacacag 110813 atgttaggca gtggggctgg actttcaagc tctgggtttt gtgattcaga agtcaggact 110873 ttcttccttt ttcatagctt ggttgattcc tttctaagca cttatgaatc acctgaggtg 110933 ggctatggca gagctgtgaa gatggactca ccacacagag agcgtgcagg gctcagtggc 110993 ttgtgcagtg agcggtgaaa tagaacagca cctttcctac ggttccagca agctgggttc 111053 tgctccctga gaggaattgc ataatcatta aggtgttccg agtggagaag gaaaggaggc 111113 tgttacaggc tagattgtgt ctcctccatc cccattcata tgttgaaacc ctaactccca 111173 gaacctcaga atgagactat atttggagac agggccttaa aggggtaatt aagttaaaat 111233 aaggctggca gggtagaccc taatccaatc tgactggtgt tcttataaga agaggtgatt 111293 agaacccaca gagagatgtt aagatgcagg aataagaatg tgaggacaca aggagaaggc 111353 agtcaccttc aagccgagga gacgggcctc agaaggagcc agccctgcta acaccgtgtt 111413 attggacttc ggacctccat agctatgaga aacacatact gtttaagcca ctcggtctgt 111473 agcattttgc tatggcagcc aggaatcctc ctgtaggatc tgacatgcct tggtctgagt 111533 gcttgcagct catgtttgta gtcaggtcat cttttggaga tttgctgaaa aagcagtttt 111593 tcaagatgaa ctccatgtgt gggaggcctt ctagggcacc tccgcatccg gcgtccctgg 111653 tgagctcatg cgtgagtcct tttgtggctc ttggcagggc tgcctccatc cctaactccg 111713 gtggctgctt ggttgccatg gcgacagctt cctccatcct gagagcaggc tcctgccgag 111773 acatctggat gagcctcact gtgctcggtg aaatcggtgg agcccaaggc tgcagccctc 111833 tttctcatgg atccctgctc tgcacccagc atcccccttg ctgaggacac aagccagtcc 111893 agccagcctg gcatcagggt ccttggggtg cccaccccat ggggaaagct gcagatggtg 111953 tggaaatgcg tttactccag aacagtggga ggaacgctga ctggaagtta gggagccagg 112013 atttcagtcc ttactctgcc agggctctgc atgtggccct gggcaaatca ctgcccaccc 112073 tgggcctccc tctcctcctg ggtggggttg gcacatgggc agttcctgcc tgcaggggtg 112133 gactatttga ctggtctgtg ctaggcatgg ctctctgggg ttattaccat gtctcaaagt 112193 tcaattactt gctgtggttt ttagattagc ttgtcgtggg atctccactg gggcccatca 112253 tgaggtgaac cagtatttgc acactgcttt tggcgtttgt ggagtgcttt gcatacttgc 112313 ttctctcttg agctccttgc cagaaccaac cagtgatgct tcttcatttc acatacctgg 112373 ctatatttcc agtcagcaga gatttgccct gtagaggagc gagcagccct tggttcctgt 112433 gcccacctta caggagagga cgaccggggg gcagactggt gcagcttagc tgccatggct 112493 cctggaggtg cagccacctc ctccagcctc acgtggggct ggtgtggctg agctcgcgtg 112553 gctgggctcc aggagagcag gctgtgcctc tggtagcagg agatgaagga gtttcttttt 112613 ttttttttta caggtgaaat aaattttaat gataaaatta ttttagtaat aaaaatctta 112673 ataataaaat gtatttaact aaatataccc gaaatattat catttcaaca ttggcactag 112733 ctacatttca agtgcttttt ttgttattta agttctaggg tacatgtgca caatgtgcat 112793 gtttgttaca taggtataca tgtgccatgt tggtgtgctg cacccatcaa ctcgtcattt 112853 acattaggta tttctcctaa tgctatccct cctccattcc cccactccat gacaggtcct 112913 ggtgtgtgat gttccccgcc ctgtgtccga gtgttctcat tgttcacttc ccacctatga 112973 gtgagaacat gtggagtttg attttctgtc cttggaatag tttgctcaga attatggttt 113033 ccagcttcat ccatgtccct acaaaggaca tgaactcatc cttttttatg gctgcatagt 113093 attcaatggt gtatatgtgc cacattttct taatccagtc tatcattgat ggacatttgg 113153 gttggttcca agtctttgct attgtgaata gcgccgcaat aaacatacat gtgcatgtgt 113213 ctttatagta gcatgattta taatcctttg ggtatatacc cagtaatggg attgctgggt 113273 caaatggtat ttctagttct agatccttga ggaatcacca cactgttttc cacaatggtt 113333 gaactagttt atagtcccac caacagtgta aaagcgttcc tatttctcca catcctctcc 113393 agcacctgtt gtttcctgac tttttaatga tcgccattgt agctggtttg agatggtatc 113453 tcattgtggt tttgatttgc atttctctga tgaccagtga tgatagcatc ttttcatgtg 113513 tctgttggct gcataaatgt cttcttttga aaagtatctc ttcatatcct ttgcccactt 113573 tttgatggtg ttgtttgatt ttttttttgt aaatttgttt aagttctttg tagattctgg 113633 atattagccc tttctcagat gagtagattg caaaaatttt ctcccattcc gtaggttgcc 113693 tgtttgctct gatggccatt tttttttttt ttttgctgtg cagaagctct ttagtttaat 113753 tagatcccat ttgtctattt tggcttttgt tgccattgct tttggtgttt tagtcatgaa 113813 gtccttgccc atgcctatgt cctgaatggt attgtctgga tttttttcta tggtttttct 113873 ggttttaggt ctaacattta agtctttact ccatcttgaa ttaatttttg tataaggtgt 113933 aagggaggga tccagtttca gctttctaca tatggctagc tggttttccc agcaccattt 113993 attaaatagg gaatcctttc cccatttctt gtttttgtca ggtttgtcaa agatcagatg 114053 gttgtagata tgtggtgtta tttctgaggc ctctgttctg ttccattggt ctatatctct 114113 gttttggtac cagtaccatg ctgttttggt tactgtagct ttgtagcata gtttgaagtc 114173 aggtagcgtg atgcctccag ctttgttctt ttgcttagga ttgtcttggg aatgcgggct 114233 cttttttggt tccatatgaa ttttaaagta gttttttcca gttctgtgaa gaaagtcatt 114293 agtagcttga tggggagatg aaggagtttc tataaaaacc tctgcatgcc cgaggactat 114353 acgggaggcc tgtgtggatc acacctcctg tgtcctcgga agggatggct gcagacttca 114413 ctcttgggtg gaagaaaccc cgctttgctg actcccccag gtgcaggttc tgagctcaca 114473 ggggtggtct gaacagctgg gggcacccag cacccctacc cccacccacc agggtgagga 114533 gctccttgta ctgtggatgg gggaccggga taggcccacc tgtccctcca gggctgcact 114593 tgctccatct gacattgaac ctgggcctgt gtgcagtaaa gaagggaggc tgtgtgaccc 114653 aagcaagact gcatcgcctc ctgtaggcct ggggctgtgg gcggcagggc aaatccactg 114713 tgcgtggggc tttctgtgca catagccatc ctttgtttag ctagcacctc tggctggttt 114773 tctgttacaa cagcagagtt gagtccttgc agtttcgata gaaatcctac gtctggctag 114833 gcctgaaata ttgactctct gactctttgc agaaaacact tgccaacacc tgtgaatgtt 114893 ggcactggaa ggaaaagggg gtccatttca agacatgggg ggctgaagcc agacaactgc 114953 caggtccccg ggcccctcca gggacctgac agcccctcct tgcccagcac ctcgctgtcc 115013 ctgtctcatg cccatgactg cagctgtgac tttctcctcc tgctccctga gcctcagatg 115073 acacagagtc cagagaggct gagactgacc cgaggtgcca cagcagatga aagggggatt 115133 tgaggctggg acccagggtc ccacctgaca gcctttccct gcccagcacc tcgctgtccc 115193 tgtctcatgc ccatgactgc agctgtgact ttctcctcct gctccctgag cctcagaaga 115253 cacagagtcc agagaggctg agactggccc gaggtgccac agcagatgaa agggggattt 115313 gaggctggga cccagggtcc cacctgacag cccctccctg cccagcacct cactgtccct 115373 gtctcatgcc ggtggctgca gctgtgactt tctcctcctg ctccctgagc ctcagatgac 115433 gcagagtcca gagaggctga gaggctagcc cgaggctcca cagcagatga aaggtggatt 115493 tgaggctgga acccagggtc cctggcagcc aggcagaaca ggccgcagac cttctcagca 115553 gctcacctac agagcgccca ctctgagcct ggtcctgttc tcagcgcttc acgtggacta 115613 ccttacccca tcctcatctg ggagctgcag agtgcaattg cccttctgaa gttggggaaa 115673 ccgaggcaca gagaggttca gaaacttgcc caaagacaca tagctagcaa gcggcagagc 115733 tggagccacc cccagatggt cagggggcaa ggattgcact ctggagccac ggagggcgta 115793 tggaagactc tggagcccaa ctgagtccca ggcctggtct gacccttctc tccttgtccc 115853 tgagcaattg gcttctcctc gccgagcctc tgtttccaat gtagaagggg cacacctcac 115913 tcatggaagg cagaggggat tggatgagct acagatgcga agctagtccc acccagccag 115973 ccggccgcac gtgttagctg cgacaggtac taggtgcttg gctggggttt gggggatata 116033 aacagtagaa caactttgcc tagtcaggtg aatgacacaa gcaggtcagc cagtatttgc 116093 aacctaaaaa gatctcgctc atgggccttg gagcaggtgc agtggagacc agaggaagca 116153 gtgtaggaac aagttcttcc tgatggactt cactggaccc gcagcacgtg tgacgtgctt 116213 cccagaccac agtgctcttt tttttttttt tttttttttc caggcagagt ctcactctgt 116273 cacccaggcc ggaatacgtg gcacgatctc agctcactgc aacctctgcc tcccaggttc 116333 aagtgattct cctgcctcag cctcctgagt agctgggatt acaggtgccc actaccacgc 116393 ccagctaatt ttttttgtat ttttagtaga gtcagggttt catcatgttg gctaggctgg 116453 tctcaaactc ctgacctcaa gtgatcctcc tgcctcagcc tcccaaagtg ctgggattac 116513 aggcgtgaac caccatgccc ggccagcaca gcactcttgc gtttgtaccg cagcagcaat 116573 actttcaaca cgctgcaggg ggacggctcc tttgaatggc ctttgtcagt gacgatccac 116633 tcctaaaaaa cccctcacac cctggggcct ccttgaccat gcctcttttt tttttttttt 116693 tgtgctttct gtggctttct tttttctttt ttttattata ctttaagttt tagggtacat 116753 gtgcacattg tacaggttag ttacatatgt atacatgtgc catgctggtg tgctgcaccc 116813 actaactcgt catctagcat taggtctatc tcccaatgct atccctcccc gggagttgaa 116873 caatgagatc acatggacac aggaagggga atatcacact ctggggactg ttgtgaccat 116933 gcctcttatc tcaactttaa cagctgcttc cccttgagat ggtttgcaac ctcctgcccc 116993 ctgagccctg atcagagggg accacaatgg gctgattcat tcattcagtc agcaactact 117053 tactaaacac ctactgtgtg ccaggcactg aaggtgcagc agcaatcctg acaggcaggt 117113 ccctgccctc gctggggaca gatagcaaca aacaggccaa taatgtaata agcagtgatt 117173 aatgcttgca aaaagagaaa gcagaaaatc tataattaaa caaggtaaaa taaatgttta 117233 ttttgagggg cagaggagat ttacaggagg ttactttgtt aaggagcatt gaggcaggga 117293 tctgaagggc atgagtgtga gggccctgca gtgggaatgt gcccaacacg acctgggttg 117353 attggacacc tcctccgtgc gcacaacctg cagcttcttc taaggggcaa tggggcctgg 117413 ctgtgggggg ctgtgggcgg aggaacccaa gctggattcg caatcaygca cccgggctca 117473 ggtatcagct ctgctgctca ctgactgtgg aaccctctga gcctgtctct ggacctaagg 117533 aaagcaaagt ggagcaccag ctgccttctg caccctgtta gtgtgtgttg gggtgggggt 117593 ggggggcaaa tgaccgtgaa cagagtttct aaattggaag ggctgttccc agggaaaggt 117653 tcagagtcgt ctccccatct aatatttgcc cacggatcag tcatgcagcg aacatgtccc 117713 aggcaccagc tctgggcagg tcgtgtgtga ggggtgtggg ggcacggagg tgaatcagga 117773 ggtggagctg gccctggagc cgactgcagg gcgggacaga tggtcacata cacagcacaa 117833 tggtcctgag gatgagcaga cgggtaaggc cttgccttgg tgttcaggca gagactagga 117893 atgctccggc aacttcgaac tgctggatat ggctggcggg tatggaggga gaagcggcca 117953 aggtgagact gaggaagagc aggcaggggc agcacgctgg gcaagtccga cctcctcggt 118013 ggggtgggag aggccaacac gcagggtggt ggggagtccc gcagctgttt gaggaagttc 118073 actctagctg agcttgggca cggaccccca tggggacaga gatgctgatg gcctgggctg 118133 aggggcatag cgcaaggggt tcagatggag gaaccccagg acctgaaggc tggctggaca 118193 agggaagggc ttataatgag gaataagccc cctgatgcct ggcttggtgc cccaaggctg 118253 gggatgagga aatgggagtt ctagagaagg agcggtgtgg gggctgttgg tgtggggggc 118313 tgtcggtgtg ggggggctgt cggtgttggg ggctgtcggt gttgggggct gtcggtgtgg 118373 gggggctgtc ggtgtggggc ggctgtcggt gttgggggct gtcggtgttg ggggctctcg 118433 gcgtggaggc gctgttgtct taacgccctt tcgttctaac cgcccttctg ttttcaccgc 118493 cctgggctct aacaccccta tctctccaac cccctctgga tccccccccc cactcttttc 118553 ctcgcccccc taggcaacgc cttcttaatg tgcccaaagc ccccggcccc cctgcttggt 118613 tccccacctc tttttatgag tcatatctta ttctcttctc tccaaccctc tctttctttt 118673 ttttctctgc ctccctccct cctcctccct cctactcctc tctcttcttc tctctccttt 118733 tctcttttcc tttcttttcc ctcttttcct ttctttctta ctcctctctt tcccctctcc 118793 ctcctttttt ttcccttccc ctttctccct ctatctcttt tttttccttc tttctttttc 118853 tcttccctct tcctttcttc ttctttttct cctttttccc ctctttnttt ctatctcttt 118913 ctctctctct tattatttct ttctctcctt cctcctccct ttctttcttt cctccatctc 118973 tccttctcct atccctctct ctcttctcca tcttcttctc attcttggct nnnnnnnnnn 119033 nnnnnnnnnn nnnnnnnnnn nnnnnnnnnn nnnnnnnnnn nnnnnnnnnn nnnnnnnnnn 119093 nnnnnnnnnn nnnnnnnnna cnnnnnnncn ggcgtaggtg gtagatagtt cttaggtcag 119153 tcgcatgtac tagcggtggt gtctagctgg tcgtggttgt gtcggaggga ggcgtcgtag 119213 atagtgttat gtatacgagg tcgaggtcgt cggtgctggt aggtgcgatg ttcgtgctcg 119273 ttgtgctagg gatcaagatg tattagtggt ctactggtgg gcggtagtac tagaggtgtc 119333 gcacggatgt gggttcgtgg tggatttgtg agaatgagac tggtgtgtgg cgggagttgg 119393 ttaagttgtg gggtgtgtaa tggataaggc gtctggctgt aggagtttgt gtgtcggttg 119453 cgtgggggcg tgtctggttg agggggcggg ctgtgcgtgt gtcaggggta gctgtggttt 119513 gtgtgggggt cagttctgtg tggggtgggt tgtcttgttt tgtgggtgat ctgtgcggta 119573 atagggggtg tgttgggttt tggtggactg ttggagtgga ggggcgtggt tggtgtgtgt 119633 gggggcttga gtgtatgggg gggcgtttgc tgttggggat ctgtcggttt gtgggactgt 119693 tgatgctgtg gagtgtacgg tgtgttggtg cacttggtgt tgggggggtg cctgtatggg 119753 ggggttgttg ggtttttggg gtctgatgcg tgttgggggc tgttggtgtg gggggtcggt 119813 cggtgtgaag ggctgtcagt ttggggggtc tgtcggtgtg gggcggctgt cggtttgggg 119873 gggccgtcgg tgtggggggc tgtcactgtg ggggggctgt tggtgtgtgg ggctgtcggt 119933 gtggggggct gtcggtgtgg ggggttgttg gtgtgggggg gctgttgggt gttgggggct 119993 gtcgggtgtt gggggctgtt ggtgtggggg ggctgtcggt gtggagggct gtcggtgtgg 120053 gggggctgtc agtgtggggg ctgttggttg gggggctgtc agtgttgggg ggctgtcggt 120113 gttggggtgc tgtcagtatg ggaaggctgt tgggtgttgg gggctgtcgg tgtgggggga 120173 ctgtcggtgt tggggggctg tcggtggctg cccatagcac tggcattgcg tctgctctta 120233 tttcccaact cccaggaagc accttgggtg ggttagtgtc ctgtggctgc tgtggcaaat 120293 tgccataacc ttcatggctt caaaatacag atatattctc accgtcctgg gggccacaag 120353 ttctcaatcc aggtgttggc agggccgtgc tctctctgaa ggttctaggg gaggaggctt 120413 ccttgtctcc tccagctccg gggctccaga tgttcctgta gccatcgctc ccatctctgc 120473 ctttgtctcc acatggcctt ctcctctggt gtctcctctt ctgtctctta gaatgtcact 120533 tgtcattgca tttagggccc acctgggtaa tccagggtga tctcatctca agatctttaa 120593 ctacatctgc aaagaccctt ttcccaaatg agatcacact ccacagtctc tggggatcag 120653 gatgttatgg acacatgcta tgctgatgta tttgtggggg ccattattca acccactgca 120713 gtggagaaaa atagtctgtg ctcagttgag gcatatggga ttgaagagcg attttacctt 120773 ctctcctttt catcctctct gcataacttg ctcctctctc tggaattcct acctgtgtct 120833 gacaaacttt tcttgcaggg aaaatgactc ttagatgcta gagtgtgatt ggaagggaaa 120893 caaatcccac cagacagttg gagtggaatt agatgggaaa acagaagatg aataattcaa 120953 gcagctttgc caggggaaag gggactctta aatgagccta attatgcttg ttcccaaggg 121013 aggccagtcc tgaaatgaac cttgtgaagc agtttttcaa gcaggattta ggcgggtatc 121073 atgaagctgg ggtggggcca cctgcggtta gtcctggaaa ggaaagggcc caggccctca 121133 ttttgcagat ggggaaagca aggcttgcag aatggaaatg atgttccagt aacagccaag 121193 accagacgcc cagccggggg ccccgagtga cagccaagac cagacgccca gccgggggcc 121253 ctcagcttct gacctggtgc tggtcctgcc taagttaaag ccaccgagtg tggtcactgg 121313 gccaaatgct tcaaagtcta cacacggggg agggcatggt gtggggcaga aagctgtgtt 121373 cacggtagct gagtttgggc ataattctcg tgctccggag gcttctccca cagctacttc 121433 ccttgtcagg agtccatctt cagggccctg tgttatgatg gattgaggga gcaccaacag 121493 gggccacccc acttggtaat taattccttt tgtaaagggc tgggctgcag gcccgggtag 121553 gtcctatggc cacctgagcc aaggtcttgg agaggcggtc gcacggacca ggtgaccatg 121613 gacccagccc ggtgcccaca ccgtgaaggg tgctgtgctg cccagaggtt ctgggcacgg 121673 ctctgggccc tgggattcag aggctcggga ctgcttgcct ccccacggag atcttaccgt 121733 ggggaccctg ttgtggaggg cctgccgcat tggccgtgac agtgattttt ctccttctgc 121793 agggtgatgt ggatgcaggg cctctgtgtc tcacatggtt gtttcacagc agccaccgta 121853 tccgaagaca gagagaaaga gcaggagaga ttcccctgtg atggctcccc catgggtcct 121913 gacccaggtt tgggagactt tatctcccca aagccaggcc ctcgatccct ttgcctttgg 121973 ggactctgtg tccccagcct atacatgggg tgctcgattg agtgtccgtg cccctcagcc 122033 ggccctgggt tgccgtggct cgggtgtgtt tgccacaggg ctacagacct aatggagccc 122093 tgcatacttt tattaattaa ttaattaatt tatttattta tttttgagat ggagtcttgc 122153 tctgtcaccc agtctggagt gcagtggcgc gatctcagct cactgcaacc tctgcctccc 122213 cagtcaagcg attctcctgc ctcagcctcc caagtagctg ggatttcagg catgtgccac 122273 cacgcctggc taattttttt ttatttttta tttttagtag agacggggtt ttggtatgtt 122333 ggtcaggctg gtctcgaact cctgagctca ggtgacctgc tcgccttgac ctcccaaagt 122393 gctgggatta caggtgtgag ctctggtgcc tggcctccta catactttga aaagttctga 122453 aacatcccca ggtgggaaag gaaagagcgt ttgggtggac actgaacctg tcagggggct 122513 cacgttttgc agtggtagca aacaacctga aggtctccaa ggcctcaaac acccacttca 122573 cacctcccac tcacgctgca agtgtggccg tcacaggctg gctttggtgc gatctcattg 122633 cggagggaac agtgtcacag cagaccacgt gctggctctc aaaacttcag cctggaggtg 122693 acatgcctca cttgtctatt cattggcaga agcaaccagc ctctggccac tctgggttct 122753 gaaaggccga aggagaggtc tccccttggg agagaacctg gaatgttcag agaaccccct 122813 gggtgtcagc atttgacttc atcccaccga gtcctcctgc acccactgcg ccccatgagt 122873 tataacccca ggaaatacaa cgagaatgag tgtcctgatg acgcaaacag aactcctgtg 122933 ggactcacgt tcctgggcgc ttctgttgcc accaagcctc ctgtggcttt tgtgtgtctc 122993 agggtgtgca gagagaatgt agcccctctc tgccctgcct ctctactgca cattatccat 123053 gggccgtcgc actaatgtgc gtgacatttc atcagtggcc gcactttttc tctggatccc 123113 actttagtga agttcagtaa ggacctgaga gctgctccga gcgggcagcg tgtcctggaa 123173 agccatggga ggcattcggc ctgggagggc tgggctgcca ggtggacgct ggagaaatca 123233 gcatggcagg aggagggctc ttttcttgct tggccttcag tatcattttt cattatttaa 123293 tcgctgcttc ttttcatact ggaaaactgt agtttcctgg gaaaccagcc aggcagtgat 123353 gccttaactc atttttccct ctctttctat ttttatgtga ttctcagttt gtggttaatg 123413 acgtgcttcc gggaagcaag atttgagcac gagcacagag acccttttag gtgctttctg 123473 actgcacaga tcagccattt ttttccctgg cattttataa accctcgggt ttagagaggt 123533 cagaaaatac tgcttgcttg cttttttttt gacagagtct tgccctgtca ccaggctgga 123593 atataatggt gcgatctcgg ctaactgcaa catccacctc ccaggttcac gtgattcccc 123653 tgcctcagcc tcctgattag ctgggactac aggcatacgc cactactaat ttttttttag 123713 tagagatggg gttttgcaat gttggtcagg cttgtctcca actaatttct ttttgtattt 123773 tagtagagac ggggttttac tgtgttggcc agaatggtct cgatctcctg acctcgtgat 123833 ccgcccgcct cggcctccca aagtgctggg attacaaata ctgctttctt actgagagag 123893 gcagcagctt gggtggagga agagggaggg cagatggatt tcagagtttc agtcagtatt 123953 ttccagatag aaaataataa aaatggaaac tgacattcat tgagctctgc aacgcatcag 124013 gcagtgtgtg aagggctttg cctctgatga tcttcacagc gaagtgataa ggctatactg 124073 ctgactcatt ttacagatga ggaagctgag gcatggatag ctgggaactc actcagggtc 124133 acacagccag gaggtgacag agctgggatt caaaccccag accttccaac tccagggctc 124193 acatgcacct gaagagtcag agggaacaga ccgtgcaaag ccccatgcag ggccggggag 124253 accggagcct gaggtcattg ctgtgagagg ggagagggcc tttctgtcag ggtgatgggt 124313 gggatctgaa gctggaaagc cggagagaag ctcgggggtg ccagtccttg catgctccaa 124373 gagattctga tctgctgctg ggcagcaggg aagggatagg aaaagagcag gtgctggggc 124433 cggggaggtt gtgaggctga atccagcctt accaatcaca cctgggccac cccggacgag 124493 ttgctcatct tctctgtgct ctagtgtaac agtcagggat actgcctttg caagcagcaa 124553 agttcttgac tctaaacaaa aaatggacat ttattggctc ccacatttag cagtctgggg 124613 ggaatggctt caggtgcagc ttgatccagg attccaatgg catcaccaga tctttctctg 124673 cactctttcc actgtctgcc ccaccctcaa gctccagggt ttctccttgt cctggcagca 124733 gatagaagct ccttctttct acaccaccca gcacagcagg ggtgaccaag ctgcatccca 124793 gccttttcag tattccaagt cctggggtct ggagagcaca gatcagagcc gaggtggggc 124853 cgacccagaa acccagaaga acctttgccc aaaggagaat ctccatactg tggtcagaag 124913 aaggggagca ggtgccgggg gcaggaaggg gagctcccag atgcccacac actcaattcc 124973 agacacaatt tgaaaaggga ccgggaagac ttgaaatcat tcaccaatag catccactgc 125033 ccagcatgca gtcggcacaa tataaatgct ctttttcttc tgcttggcaa ccaacagggg 125093 aaggaaggca gaggagaggg gctccacagg tcagtgctat gtgtggctgg aactgatgca 125153 ccctcactgg ggtggggtgc aggtgagggg ggccgcaggt caggagggaa gtggtgggtc 125213 cagcttcatg ggaacagggg acaggcacct agaaggggta gccagcaggc agttcaccat 125273 gcaggtctgc agctcagggg gacgcatttt gagggtctca ggaacagaga ggcagctcag 125333 acgcgagggt ggacggtttt gcctcgggag aggtgtcaga aacctccggg aaggcggagc 125393 attgagggcg cccttcactg ccccttcctt gaccgcactg cccccag ac atc gtg 125448 Asn Ile Val 210 gac atc aag ccg gcc aac atg gag gac ctt acg gag gtg atc aca gca 125496 Asp Ile Lys Pro Ala Asn Met Glu Asp Leu Thr Glu Val Ile Thr Ala 215 220 225 tct gag ttc cat ccg cac cac tgc aac ctc ttc gtc tac agc agc agc 125544 Ser Glu Phe His Pro His His Cys Asn Leu Phe Val Tyr Ser Ser Ser 230 235 240 aag ggc tcc ctg cgg ctc tgc gac atg cgg gca gct gcc ctg tgt gac 125592 Lys Gly Ser Leu Arg Leu Cys Asp Met Arg Ala Ala Ala Leu Cys Asp 245 250 255 aag cat tcc aag c gtaagtgccg gtgcctgggg gtggggggct gtgcattggg 125645 Lys His Ser Lys 260 caggcgggcg ggtgggatgt cctgtcctgg tgcagctgct gcaggggtgg tgggtgtggg 125705 atgagcatgt cctggactgg ccaaggtggg tgggcccatt gctgcttcag cgctggctgg 125765 tcggggagcc tggtcttgcc acctgctgcc ccccagagtc cctgcacagc caggaacagc 125825 ccagctttta gggttcaggg ctctagggcg agggtcaggg catccagaag gtaaggaggc 125885 accaaactta aatgtcacct cctgtaggaa agcttcccgg cctcctactt tagatctgga 125945 tcctcctctg tggccctgca gcccccaaag cttccctctt ccaaaactag ccacacccag 126005 caaacttgct gtgggctgcc catcttctcc ggctccttgg agcagggtct gtaacatgtc 126065 ccctcatcct agaacccacc acaggcctgc tgtgggggtc ccacaggggt atccgtggag 126125 gtctggggct gaacgagttc caggggacat tttgtgacac agcagccccc agcataacag 126185 ctcacactga acactcactc tgagcccagc ccttaccaag ggctttacct gtgaactcat 126245 cgaatcttca cacaagcccc aggagatgct gttcagaaga ggaaacagaa gctccagtta 126305 ttggcccaag gtcacccaaa ttcaatcgtg gcagagctgg gctgcctggc actgggttgt 126365 ggccatgggc tgcacactgc cacagccatc ccagaggccc ctgaaggcga gggatcaggc 126425 cacggcatcc tccttcccag acagccctgc agggctagca aggggccagg caggaggtgg 126485 ggtgtccccc aggcagaggg cagggacttt gcttatctgg ttcccctcac tgtctgtccc 126545 cagcacctac cacagtgtct ggaaataaac acttgttgaa taaaccccag aggaccctga 126605 ctgaagcctg ggtgccggcg gcagagggct gtttgggagc gatggggcca cactgttccc 126665 ttagggtgtc tggttttgct gggcagtcag agacagggtg cacaccagcc ccaggactca 126725 ggctcagggc ccaccaaaac ctccagcttc tgcctccttc cttggccaag ttctggcccc 126785 cacatccacc ccctcatctc ctctgggttt gtccacgctc cgtgtgtcac gctcagccat 126845 ccaggcattc agtaggcgcc tattcctggc atgggtgtgc agcagaggcc caccgtcggg 126905 agctggcgtc tgcgggggag acagacagtg aacacacacc tgacgcatgt cagggcatgg 126965 tgagcaatgg caccaacacc cacaaagtca ggtacaggga cagagggggt cagggagggc 127025 ctccctgaag agaccacagt ggaacggaca ccctgagggg gtgggtggtg ccgatctctg 127085 gggaagaatg ttcgagaagg agggcactgc agtggccgtg actccacaca ttgcctgtag 127145 gtcaagggag ggactgggtt ttgttctggc tgagctgaga atgagaagct gtgggttgtc 127205 acgagattgg gacttgagga ggaagaggag acgccgcaga gggtccccgg gggagcaggc 127265 gtcagaggtc gctgcagggt ctgcaggaag aaatggtgac cccactgagg gggttgttgg 127325 gaggtggggc agggctcacc tggctgcccc ctctggatgt tgcttggagg tcgagctttg 127385 ccttgtgggg cgtgactctg tggttggttt gagctgtggg tgaaggtggg gccgtggcct 127445 ggaacaacag ggggtgccag ggaccagcag gcaggtttca gacccgcgag cctgaggccc 127505 gtattgggtt ccaaggaaat gggtcgagta ggcagccaga tatccaggca gtaatgccac 127565 ctggagataa gtgtggagtt agtggccgtg gactgatggg aggctggaga ccagctgaga 127625 ttcccggggt gcagggggct cggggctgcg tcctgtgcgc cacaacaaag gaccacacac 127685 ttggtggctg aaaacagggc atatgtatag tctcagtccg cagtcccaca gccagctcac 127745 tggccataat gaaggtgcca cgggctggta ccttcgggag gctctgggga gcaccgtttt 127805 ccctgcctct tctggcttct agaggcgctg cgttccctgg cacgtggccc ctcccccatc 127865 ctcccagccc acagcggcca agcctctctc acgtctctga ccctcctgtc tgtctttcgc 127925 gtataaaggc ccttgtgatc gccttgttcc tgccacccct aatgatccag gatgacttcc 127985 tcatctcaag gttggctgag ttgcgtcctt gatttcatct ttggccttat tttgactttg 128045 ccgtgtagca taacatagtc acaggtgcta gggatcagga cgcagccgtc tctgggggcc 128105 gttccaccgc ctactacagg acactgcccc cccacctacg cctcccgccc attcactcag 128165 gccacatgtg cctccagctg tgcctgtgta cagccaggtc tgggtccgaa tggaatggga 128225 gaatattggg gaagagaggg ggttcttcct gctcctggtc cgctgctgac cccgtgtgag 128285 ccctgtggga aggaggatgg ggcttcattg gcaccctgtt gtttataggg gtggaaatcc 128345 agaaacatcc tcaatatccc aatcttaaat gctaagatta ttcaactctt ctgaaatgag 128405 tgaggcagct ttttgtttct ttttctggaa ccgttggtgt aatatatctg ctccttgaag 128465 tattaggaaa acttgtgtgc aaatctattc ggcgtccttt tgagggagag aaggaaaatt 128525 ttaagcaacc agtttaaaat gccgagaaaa tgatgtcgac agtgatgaca tccatgtact 128585 agaatattgt tcggtcatgt cagctattgt tttagaagaa tttttaatgc cacagggaag 128645 tgattatgtt gaaagattta ggggataaca aaataaggct atgaccacca gaaaagtgga 128705 aacagagaaa actctggaaa gaaatacact aagttgtccc tgagtggtga gctataagaa 128765 actgatggaa tattttcttt ttatttttct gtgtattttt actttcatga tggatttgaa 128825 ctttgaatca gaaaacacat gtgtgtgcag gaagggtgga atttagagag cacagagacg 128885 ggcataggac agttttgtgc acccctcaat gtttgtgtga catttttcag tgggctagag 128945 ggggcagtca gacccccttt ggctcccgaa gcctgtgcta tccggtttcc cagggcagaa 129005 gcagcggtca catatacctt gcacatttcg tgagtccaag cacagacaca tccatttcag 129065 ccacgtaatt tcatatgcct gatgatgtat gagccttgtg tgaatcagcc aatgaactca 129125 acagtgcgag aaatatgagt gttttcgatg actcaattca atttcattct tcacccccag 129185 ctcccagggc tgcagtgaac gttaactttt agggcctcgg cagattccac tcctctccgg 129245 attgcactga ggttccagaa ggctctggca ggccgaggtg cggagagagg gacatggtgt 129305 cttccaggcc actgaggact tttgattgtg cctgggcgac cttggggcca ggtccttgct 129365 gacaaatccc caagggcctg ttggctgtgc tcagtgactc acctgggagg ttggcaacat 129425 gctgacctct ggcggctctt gcccgcacca gtgatcccaa gtctgtagac agggtggggc 129485 tgcctgtgat gtactaaggt tttatgtatg ctttttgcac acacagtcat aggtgaagtt 129545 ggtttataat tttcttttct tatactctct ttgcccaatt ttaagattat tcaactctcc 129605 taaaatgaac tgggcagctt tttctttctt tttctggagc agttgatgta atatatctgc 129665 tccttgaaat cttaggaaaa cttgtgtgca aatctatttg gtgtcctttt gagggagaga 129725 agaatttttt tctttttttt tagacagaat ttggctccat caccctgaca cgatcttggc 129785 tcactgcagc ctccacctcc tgggttcaag ggattctctc acctcagcct ctggagtagc 129845 tgggattaca ggtgtgtgcc accatgcctg gctaattttt tttgtatttt tagtagagac 129905 agggttttgc tgtgttggcc aggctggtct cgaactcctg gcctccagtg ctgggattat 129965 aggcatgagc caccatacca ggccaagaga agaaaaattt taaacaacca gcttaatttc 130025 ttttttgatt attgatttat gcaaatttta tttaaaattt ttctagaata tttttcatta 130085 tcaaactcaa tatcctgtac ggaaactttc tctttcgtgc cagcaaaaag attgcgcagc 130145 agtttttagc atgcttttac agcttccatt tctcctcatt taatttgccg cacattgggg 130205 cgagtggctg aagtgtctgt ccttctgcat gccttgtccg ggctgtgttt ttgctctgtg 130265 gctctcatgg gaaatcaagc acgcagccgc tttccaatta gcaggtggcg gctgttttta 130325 atctgaacac aaatggctgt tatttgagct aattttttaa aagggatttg gggattagga 130385 ttagttcttc acctcccact tccatccatg tatccaatta ctgctcaaaa ctcagggagt 130445 ggctgatagt gacaccccag agatgtgctc acagcatcat tttcctaaca gaatcagacc 130505 gcgaatgaag agcgtcctgg atgcaggaag gtgagcattt ctgccattgg acagatgagg 130565 agaccgaggg tccgagaagc tctgtgactt ccctggaccc ctcctctatc agggcagagc 130625 tgggggcaca caggccactc tgttccctct gcagcttccc acctttctcc gaagcactgg 130685 aaatccgcgt cttgtgactg cttggcagtg tgacagggta accgtggaaa caaccgtaca 130745 tgagtcctca aaatagacag ttacttctgc ttatgacagc acagagcctg cggaaagaaa 130805 gggccgtgcc cggaacactg ggatttctta gaattggggg tgatgatggc tgagaccctg 130865 atttcttaga atcggggccg atgatggcca agacccttca taggccccca acgacgtgcc 130925 tggcccggtg ttgggtgaaa taataaccgc agctcattct ttgcacacct agtgcaaaca 130985 catgctgttt tcagtttata tctcattaaa tactcagcac ctatgatggg tgtgttatag 131045 tattcatcct acagatgagg aagttgaata cacttgaccc tggaatgatg tgggagttag 131105 gggttcagac agtgcctgaa tgcagttgaa agtacatgct taacttttga ctccctcaaa 131165 acttcactcc taatagtcgg ctgttggtgg ggagcattac cagtaacatc aacagctgat 131225 gaacatttga agagactgat gtctacgtgg attttatgca tttgtgacat acctaacttt 131285 ttcttttctt atatatatat gtatgtatat atatgtatgt gtgtgtgtgt gtgtgtgtgt 131345 gtgtgtgtgt gtgtgtgtgt gtgtatcgtg gcagatctcc aaaatgtttt cagtatattt 131405 actgggaaaa tcgcacatca ggggacctgc aggttcaagc ctgtgttgtg tgagggtcaa 131465 ggggcaactg tatacgcact tctcattgct gcgggaacaa ttgccatgag cttagtggct 131525 caaaacaaca caaaagactg ttgtacattc tggaactcgg gctaaaatga aggcgtcagc 131585 tggcctgtgt tatctctgga ggctgcaggg tggggctgtt ttctgatctt ttccagctac 131645 tagaggcttc tagaggctgc ctgcactcct cagctcatca ttccaacctc tgcttccatc 131705 atcccatctc tttcttccat ctttgacctt ccttcttcct cctatacaga cccttgtgat 131765 gacattgggc ccatccagat tatccagggt cacctccgta cctcaaggtc cttcacttaa 131825 tgacatctgc aaagcccctt ttgccatgtg agataacagg tgcacagatt ctagggtgga 131885 ggatgtagat agacgccttt aggggtcatt gttctctgct acattgaagc acagagagat 131945 taagacattt gcccaaggtc acacagctaa gtagagccaa gatagagcct cagagagtct 132005 catgccttca acctgcactc tttttccctt tctcatcaca gaagccttga gaactaaaac 132065 tcttacagga attgtgggtg agctgggttt tttttttttt tttttttgaa atggagtctc 132125 attctattgc ccaggctgga gtgcaatggc atgatcttgg ctcactgcaa cctccacctc 132185 ctgggttcaa gcaattctcc tgcctcagcc tcctcagtag atgggattgc aggtgccggc 132245 caccacaccc gactttttgt atttttagta gagacaaggt tttgccatgt tggccaggct 132305 ggtctcaaac tcctgacgtc aggtgatctg tccacttcgg cctcccaaag tgctgggatt 132365 acaggcgtga gccaccgccc cccacctgag tgggttcatt taaaagggct gtgtgggctc 132425 aactcccagg gctcactcta gtaatggatc tgctgcagaa agaccagcct cagcccagac 132485 cctgcagctc tccaggtgca ggaccagggc aaagctcccc aacagtggga acagcccatg 132545 tgagggccct gtggctggat acagaggctg gagagaggag gtgaggtcag agaggtgtgt 132605 ggctggagga ggcctcacag gccagagcaa gagcttcggg tttcctctga aagggacagg 132665 aaccacaagg ccgtctgagt agggagtggg ccagcctggc catgtgttca caggatccct 132725 ctggctgccc agtggggaat aagctgaggg gtgaggtaga agtgggggct ggctgggggc 132785 tagcgtgttc acgcaggtga gagacgctgg tgcgcagagt gagtggccgg tgcaggtggg 132845 gaaggtggtg ggccctgccc cccatggcag gtggggcctg ctggatttgc tgctggattg 132905 gatggagagg gagggagggt cggggatggc ttcaggctct gtacagagac caggctcccg 132965 tctgtgtgga gctttgtgga gggaccacag gaaggggact agtaaataag taggtgcatt 133025 ggagtgggaa ggtttccatg aagggcatca ggagccctct gatgcattgc acctcagggg 133085 tcaggagagg tgtccctgga tgagaaagag cctgggaatg ggggcggggg tgccccaccc 133145 cacagtagtg tctgagagga acctggctga cgtcaggacc cgtgtggctg gaacaggtgg 133205 aggggtgggc tcttgtgtgc aaagatgggt taaggggaga gcgtgccggg cctgggggcc 133265 acagctgggc ttgagttttt tgtttgatgg ggctcgatca catggtgctg ggcagggagt 133325 gacaactgtc atctcttcat cagtgagcat tcattgtgcc cacctgtgcc attgtaggaa 133385 ctccctgctc cctccccact gtgtacagcc tcagggatag ggaaagaggc cgaacaggag 133445 gcccctcccc aaacagtggc atcacctgga acccaggagc aagccagtgt ccaggggtgc 133505 tcggggatcc ataaccccca tcgtccttct tctgcttctc ggaccctcca agctcctcct 133565 ggagcgcggc ctgaggtgag gccagctggc ccaggccact ccaccctcgt ggatggcctt 133625 gtatcccatc agatcacagg agggacccgt ggccagggta gccaggggcg atcactgccc 133685 aggaccccat aggcccctcc ccctccaggc cacctcctcc catgtttccc acctccaccc 133745 acctgcaggt ccctcccacc ctcatctgtt tctctggagg cctcactgaa ctgcacttgt 133805 ccctgaatgc atggctcaag cccatgcatt tctactgtgt gaacccaatc ggcctccacc 133865 ccagccccag aggagtgtcg tccacacact gacaacgatg ggggtggggc acagcaggtg 133925 ctaccaagag ggccacagag caagtgccac gggcacacag gggccacccc caggctggct 133985 gaggcttctc tgccaggcct ggaaactgca gtggaaccac atcaggttgg ggaagaaaga 134045 tgtcagtgag gggctggagc agaaacggca ggcagctgca caagcttctc tctgctcagg 134105 gagcagggcg gggccatgag gcagggtctg tgctaggcag gggcgccaag atgatcagtg 134165 actaatgacc aaggcaggac ccctggccca agggagctta cagccccatg aggggaccct 134225 gccctcctgc cagtgccaca ggagaaggta cccagcggct tgggggcagc agagggtaag 134285 cacaggattt ctttagagag catgtgaaca atatgcacag aaagcagggt gtgagcctgg 134345 ggttctagag gatgtatagg agttggtaag aaagaccagc taaaaatggg aaagggatct 134405 cagggagaga aaatgatgtg aaaaataact ccaggaatcc ctccgtagtt ttattgagca 134465 gctactgcaa gccccacact gggccatcgc ctccaggcat gacctctgaa gatcccatcg 134525 tgctccttct ccagatgagg gaagctgggc tcagagagga ccaggccctt gcctgaggtc 134585 acacagagca cgatgcattc tgctctctgc ccagcacatg gcggggcagg ggctacggga 134645 ggcaggggga gatgcctagg gctcaacatt gaggagacac ccacccccag agcctttgag 134705 tggatgcagt gccctagggg cccagcagga agggggctgg agtgtgcggc agaggggaac 134765 ttgcgtgtgt gaggcagcag cagcaggctg gttgggaccc attgagaagg agctggtcag 134825 ctacaggtag gagcctaaac cttgatcctg tgggcactgg ggagccaagg agggcttcaa 134885 gcagaaggag gtgccgtcgg ctctgtgtga ggctggaaag gaaggtgggc acctgctctc 134945 aggcttcacc tcctgtttcc tttgattcac aggtccgtca gagccgcccc acaccttggt 135005 tgggctcccc aggtcccctc caccttggcc tgagccaggg atgggggtgg ggaaggctct 135065 ctgtggccac aacaccgtgc aacacccagg gaggaagagg atgtggttgt cagggaaccg 135125 gctcgagcca tgagagccct aattatgcaa aatcattaaa aagaaacagg atggagattt 135185 cggctgattg agagctctcc aacttttaaa taattagggt gtgggggagt gggtggagat 135245 gggactgggc ccatcacaag tgatgggggc tttgagacat gtttctttaa acccatggca 135305 ggaataatta ctgtgaaatg tccttagcga ttcagtcaat tagaggggag accccttatc 135365 tcttgttagc gctctgaagg tggtgcagcg gggtgtgtgt gtgtgtatgt gtgtgtgttt 135425 gcgtgcgtac tcgggggcag cgattgatat ggaatagtag attccactat cttttggaaa 135485 aaaatctatt gtatcaaaaa tttcatagaa acgtctaaaa agaaaaagag gaacttttag 135545 gaatggtttt tcaggcttat taatatccct tccgatctat cgtttgcatt cctgttcctt 135605 gtgtccttaa aaaccctcag aaatgcccga gtacagccag cagtggggcg acaagggcca 135665 gcgccgtttg gctttgtttc cactatcgat tcaattgttc tctcagcctt tgatctttgc 135725 ggtttttcct gctggaggct ggtaggatac ttggccactc gttctgccct gtgacaccca 135785 gcaccggtgc cccctgtgat tctggctgaa tccacccgca agtcctgctg ggaacctaga 135845 ccagccctca aggtctgggg gagtctggtc tgagagaccc ctgagcaggc gagggggtac 135905 taaggccact ccggaagtca gcctgtgaga ggccgccctg gctcagtttt ggactcacct 135965 ccgcctcacc tccaagtgac agaaagccta gttcaggcca gacagggttc ccgccactca 136025 cctgggcagg tgctgggggc caccaggtcc cgctgagatt ctcttccttg tttccatcca 136085 tttagccacc gggggtccct cttctctcaa gccctctccc tgcttctccc aaatatgagt 136145 ctctacccac tgctaatgga aaggcagcac aacatcaccc ctttagggaa tcaagcgttc 136205 gaagtgattt tctttacggt aggcatcaga gagaaaaggg aactgtggtt gatccttctt 136265 tggcttaaca aagaaaaact acaaatatat atatatatat atatatatat atatatatat 136325 atatatatat atacacacac acatacagaa acaaagatgc caatttaatt attattatcg 136385 gggcacaaaa cattatcatg tgagatgacc aattagaact cagaggttca gaagctcaag 136445 gtgactccca gggagatttt actaccccta ccgtacccat cctcctccac aggcagggag 136505 gggttggagg gctcacagga gggagcatta gggccagggc ctcctccatt tttatggttc 136565 ggaaatcaca tcgtatcaag gcagcataag tttgcacagc cctggagggt tgactcgttt 136625 ggggcaaact caagagggcc tgatgaataa gccagacatc actgactctg tgaatgccaa 136685 cagtgacatt gggataccac ccaccagggg ctggacccct tgctgagtgt ctctgtctcc 136745 aaaaacagct gcgcaaactg ggcagtattt ggctgcattt gacagagaca gaaacagaac 136805 cctgacagga aaaggcaagc atcttgaagt cacaaccagg aagtggcata gcgggtttcg 136865 aacccaagtc tgcctgactc ctggtcctgc aaggtctttc actataagcg atctaaactt 136925 gagccactta cttttctata taccaagggt catcaaattc tttctgcaaa gggccagata 136985 gcccattttt tatggtttcg tgggaacata tgttctcttt gggcaaagtt tgccaacttt 137045 gccattttta tccaaaaagg gttttcacat aacaatgtgt tggattcctt gggggatgac 137105 ttcttttccc aatcaatact tttttttaca aaaacctggc tcttgggcca aatttttgtc 137165 ccatggggcc tgttatctta ccctccccct tgtgggtttt accttgttgg aacaaaaaaa 137225 accatccatc tttgttattt ttttgccccg ttgacacctt ttctatttat ttaaatttta 137285 acaaaccgat ccttttggga attcatattt ttggggcttt ttgttttaac gattgtcgct 137345 ttaaaaattt aaattggtgc cggtggcttc catcctattt atatcaatca tattaatttt 137405 aagcaagctg atctttcgga ggcccttctg gtcccttggt tgtggaaata actgttttct 137465 actataccaa agtatctttt acttgggcgg gttggggttt tttaaaatgt tttgggaaaa 137525 atataaaatg agagagaaag agaaggagag agacgggaag aaagaagaaa ggagagagaa 137585 tagagaggga agaaggaaga gggggggata gtggagtagg ggggagggga agagagagag 137645 aagaagggag aggagagaaa agaagagagg agagcgagga agaggagaaa gagaaagaga 137705 gaggagggaa ggaaggagga gaaagaagag gaaaggggga gagaggagaa gagaaagaag 137765 agaagagagg aagaggagga gaaagggaaa gggaaaagaa agagagagag aaaagaaaga 137825 agagaagaag agaagaaaga gaaaggagag agggagggag gggagaaaga gaggagaagg 137885 aggaggaaaa gaggaggaag gaagaaggga gggggggggg gggaggaaga gagggaggaa 137945 ggaagaagga aaggggagag agaagatggg aggaggggga aaaaggaaga ggatagaaaa 138005 aaaaaaaaaa aaggggggga gagaggaagg gagtgtgtga agagggagag gagaagaagg 138065 gggaagagga aaggaaatga ggaagggaag aagaagagaa aagaggagag gagagagggg 138125 ggaggaagaa ggaaaagaga ggagggagga gagagagaga gagagggaga ggaggaagag 138185 ggagagagag gaggagaaaa aagaaaaaaa agggaggaaa ggagggagga gaaaaaagga 138245 gttcgttaag aagggaggga gggagggaag taagtcagta gggctgcagc actcatcgtg 138305 cactgggctc actctgtaca gcatctttgc tgcctgcggc cctgcctgta cccagggtgg 138365 tgccaggcct ggctgcaacc ccctcctcct gccccttcct gaaaagcgcc cttggctcct 138425 gttgtaggga ggagcaaggc cagggctcag ggaggtgaag gcgttcaagg ccacacgagg 138485 ggctcgggga ttgagaccct ggcagcctgt tctctcccag ctccctctgc gagcggcctc 138545 acccttcctt cccatggtgc tgattttctt tctggtcctc ccttcaatgt gcccttgtgg 138605 aaagaggaaa gctcgggcca ctgagaaggg cgcccctgtg aacgatggag ggagattgag 138665 gtcgcaggca ggcctgggga ctgggggcgt gtggaggggt gggttgggct cctggaaagg 138725 gaggcgccta ctgtcagttt tgagtttcgt taaacacctg ccagcctgat agcattctaa 138785 ttccaaaata tgacaccact tattagtgga taaactaggc tccctccctc cttcctgatc 138845 ttgacgccag gactggaagg agcgaccacc tgccctcagg atacccggtg cagtgccatg 138905 gctttgaggg cagaggtgtg gggttgaagg ctgccactgc tcaccagagg ctgtggagag 138965 gctaaggaca gggatataga tctcctgagc ttcaggggtc tgcttcagag acaggtgttt 139025 ggaggccttg ctctcaagag aggtgggggg gaccttcctc ctgctgcctg ctctgatttg 139085 gggggatacc agaggcatga acataaacgt gggagccttt tcctgccctg taagcagctt 139145 ccctccccct cctctcacct cccctcacct ccctgcatgc agtggcctgg gatcaggatg 139205 gtgacacctg ggctctgcag ccctggccca ccgggtgctg gaacttcctt cctccgtcgg 139265 gaggggactc cagcctcctg cctgcccctc cctacctcct tgactcagat ttcatcctcc 139325 ctgtctctga accctcagtg gctcccgttt ccctaatggt gacttcctca cccctctccg 139385 tggcccatga gatcctgcgt gggtggcccc ttgcgtccct gttccccctg ctcactcctt 139445 tctctgcctg cacggccctt ggcgtgtccc tgcctcaggg cccttgcgtg tgccgtccct 139505 tctgcccagc acacccctct ccaggcatcg ccaccaatct ctccccaact tcactcagac 139565 cttggtcaaa cagcacctcc cacggaggcc ctgttcacct aaactaccag cccccagcac 139625 ctatctgcct gctggctctt cctccccagc acttgctgct ccctggcggt ggagggcgcc 139685 acttagtttt attgtctgta tctgcaagga gaatgttggc tgcacaggaa cagtggcttt 139745 atgctggtca ctgcatcatc ccagggcctg gcacagagta ggtgctgttt gcattggttg 139805 actgagtgaa taaatgaatg aatgaatgaa tgagtccatc agggcatcca gtgggccctg 139865 cagaggggag ctggacagga gttgtatttc tggagaggca gtggccaggt acagtgtcca 139925 ccttggacag gagggagaat ggggtgctgc catttcccat gaggggataa ggggctggga 139985 cagacctggg aggcaggaca cgagcccttg tggctgagag gggccagcag ggaggggcct 140045 ctcgggagcc tcagggtgct gtgatcagct ctgcttccct gtttctgggg tagagaccag 140105 agcaggccag caggcaaggc tgccactcag ccggtttcca tggggacagc tggacaggtt 140165 gtcataggtt taggtatttc cagattggct ggtgaatggc tgtcaactcc accaccctgt 140225 tctcttccca tcgttccctg ggtctctctg tggcccaggt cctagggagt tagtgcctgg 140285 cccaacaggg gtcctagtcc ccacgctact tcagccccag ggtcactgct accagtgaga 140345 cagataccag cagaaatgag cttagagacc ttgtcccact ttgggaactt ctgcagctca 140405 ggaaggccag gttatggggg cagtggggag gggacactgt ctggggagtc ctcattgccc 140465 actctgtccc agtctataat tgtccaggtg ggcagcaaac cgttgccttt agggaccaga 140525 taagcaactt cctgtgcaga gcaggtgctc caagaaaaaa ggagatggtc agtggatggc 140585 atacaggaga ctgtaccaac tctgtggcag tcagatttga ttttgttaca aaccccatgg 140645 caatgaaaca aaacccacct ataagtaggg ctcagccatg cctgcccagg acaccatgaa 140705 cagagataac tactggccca aggtcccagg gccagttagt gccagagcca caagcagtgc 140765 ccagtctggt agaggacatt gtccagcaca tttgagaatg tcaggacacc tttgcaatct 140825 ggcattcagc atcaccagta gggggcagta gagggcagca catcaagtat agctttggct 140885 tcaaatcccg actctaccac cttcttccag cactgactcc ccaggcatgg gttttagcca 140945 gctgctcctc cattttcttg gctatgaatg gggatagtaa tggctatttc tgcacagcac 141005 agaatcttac caggcttgtt ccctggtaag tgtttagttc taggtttgag gaatgaatga 141065 atgactgaat aaacagagca tgggcccagg tgcaaaacag agtcatccgt cgtgccaacc 141125 ccatgggcgg gagcagcgca gtgacggcca ttgcttctct gtctccacag tc ttt 141180 Leu Phe 265 gaa gag cct gag gac ccc agt aac cgc tca ttc ttc tcg gaa atc atc 141228 Glu Glu Pro Glu Asp Pro Ser Asn Arg Ser Phe Phe Ser Glu Ile Ile 270 275 280 tcc tcc gtg tcc gac gtg aag ttc agc cac agc ggc cgc tac atg ctc 141276 Ser Ser Val Ser Asp Val Lys Phe Ser His Ser Gly Arg Tyr Met Leu 285 290 295 acc cgg gac tac ctt aca gtc aag gtc tgg gac ctg aac atg gag gca 141324 Thr Arg Asp Tyr Leu Thr Val Lys Val Trp Asp Leu Asn Met Glu Ala 300 305 310 aga ccc ata gag acc tac cag gtgggcacca cagcaggaga cccccaatcc 141375 Arg Pro Ile Glu Thr Tyr Gln 315 320 cgggtctttt ttccctatgc tgagatcccc atggaggggg ccttcctagc caggcgtggc 141435 tttcatatgc ccggtatgta ggtgaagaca cggaggctga agaaatccag caactcatcc 141495 ccacacgtag cttggcagag ggcaggagtg ctcagtcttg cctcacaggg agctttggat 141555 gtccctgagc aaggcctgca gtccagggcc caggggcctc aattccaggg aggaaagaga 141615 tgtgggaaca gagatgagcg tcaggctggg ccccagtgga gcatgtagac gatggcttnc 141675 cctccccact ccctgggagc ctgcatcgga gctgtaccat taaagagggt taagcgttgc 141735 cctcccaggg tgcatccgta agcagtgcac gcagaggtga actgagcaca tgtttccttt 141795 ccagatcctc agcacaggcc tataagcctg gagtctaggt gaagcctggg cccttcttgg 141855 acagtattat ttattatctt gctattatca tccattcaga tatgttaggg ggtagacaac 141915 aaaactcatg tgatgttaaa ataaaatgtg gacttgaaag aaatgtggga tggcttcaaa 141975 gctggttcca gttaggtggg gagatcaggg aggcttcttg gaggaggtgg catttgtgct 142035 gggccttgaa ggatgggtaa gatctggncc gtgcaaacat gggtgggaaa acaccccacc 142095 agaaacccca gccggttcct caccgtgtca ctcctcacac anggggtgcc acgtgcttga 142155 catctgtcac ctccattctt tactgtccgg tgacaaggag ccatcatcct atttggtgga 142215 aagggaactc gggcactgag aggtagggag atgagggagg tgtctctcgg ctgggcggtg 142275 acagattcag agcccaggct cagagcccta cgctttcctt tcctccgtgc gaagacctag 142335 taggaaagcg tcctgggtgg cgcaggcctc gctgggaact ggtgcagagc tcagagggtg 142395 ggctgctctg atctgacctg ggccccagag gaacagctca cgctcctgga agccacacac 142455 ccacaaggac cgctatgggg accgcctgtt tgtcagccac gtgtgtttac ttgagttctt 142515 gcgactgccc cagctcctcc ctcaggcccc ctcctcacac tgcacacccc aggcaggact 142575 cagccctcct ctgtccctgt gggaatggca gagaccccag actaggagag ggacaggata 142635 agcccggctc aagcctgcag gagcaactct ctggctccct ctggaggcag ctcagggaaa 142695 tgaacatttc caaccccctc cggccccttg tccggtcact tacctccatc cctgaggtca 142755 gcaaaggccc atgaacccct gaaactacgt ggaatgtgtt ctatgagcat tttcaggggg 142815 agggggacac agctttctga aattctcatg aaggacccca cgaaggaggg gaatgactgt 142875 tctggagcgt gaggccgtaa gctgggcact tggcatctgg cccagctgac ctattgatgc 142935 taaaataata gcaataacta cataaaagca gnacaacaac caacattttt tggtggcttg 142995 tgatgtgcta gaaattgtgt gtagcaggac tgcgttcggc tggtgtgcgg tgcttaacaa 143055 atcggggcta tttttctccc anaacaggga gtctggagag ggcagtccag gaaggtgggg 143115 gggctccatg accccggcag cgccacagtg gttccttctg tgatccagtc caccatcatt 143175 tgggcgttgg ttttccacct tcacatgtgg tacctcatgg tggcaaagtg gctgccacac 143235 ctccaagcac tttgcctaca ttccaggcag gaaataggaa atgcactaga tctcacccct 143295 ggggtctgtt gcgtgtttca ctgtgattgt aaaatcttcc ccagaatgct tctcagaaga 143355 cttcttacac ctcattgtct agaatgggtc cctggcagcc accatagtgg ctgggaagat 143415 taatggttta acagcctctg tggttgaaga aggcaagggt gaaggggctg gggacggttg 143475 ttgaatgagc cacactgagg taagtccata ntatgctttg cctcatctaa gcctcccagc 143535 tgtcctggga ggtggggccg gtattctccc catcccattt tattggaaga cnattgagtt 143595 aaatggcaaa tctgtgacag agccagcaag cagnggacct tagattgaca gtctttctcc 143655 agagctcttc ctcaccctgc cactagaggg caggagatgc ttagtgcacg gcagagagaa 143715 cagcatgcgc atttggacgc gtgcatcacc aaggctgctg ggagctgagt aaggaggaca 143775 cacaaaaatg cagagccggg ggtgggacac gaacactaaa acctgctgcc attcatcccc 143835 cttgatttta gttgttacac atactgagcc agtaccctgt gcccaacaca gtgctagacc 143895 ctggacccag agagaaggaa gaacctcggc ctcaccctcg agggtcccag acagacagga 143955 acacagtgac cctcagcttg gtggggctgc agcccagggg cccaagggga aggcaagggt 144015 caccaggagg acacgggggc tggggaggga tgagcagggc cccaggcggg agtcaggtag 144075 ccttgtctaa ccatcctgtg tgcagtgaat agcaggccct tcctcccaat cctgcttccc 144135 ctagtgccac tctgttttcc tgtgtagtcc ttgccaccat attagtcaga tggctcagag 144195 aaacagaacc aacaggatgg ggatagagac tgagaaagaa gggagatttg aaggaattag 144255 ctcacgtggc atgttctaaa tctgcagagc aggcgggcag gctggtgacc caggggagag 144315 tgactatgcg agcccacacg catctgttag cggaatcccc cggtcctcag ggaggtctgt 144375 ctttgttcta tcagggcctt cgactgattg gacaaggccc cccacatgat ggagggcagc 144435 ctgctttact cagtatatca gcttaaatgt taacctcccc tacaaaatgt cttcacagaa 144495 acaccaagta tctgggtacc ttggcccagc caagctgaca cacgaaattg acgttcacac 144555 cacccttcac attttctgtg ttcgttggag ttgttaattt caactcctgg gagttgaaac 144615 caggctccat ggcacccagt taccttccct tccgcaccca gagggcagag cccgtgccct 144675 gttgtcctgg cagctccagc ctcagcagag ggctggcact catgcggccc tccgggtaca 144735 gggcttgtag gaccggctgc agtcaggtgg atgcaggtcc tggggtgtca ccctctctcc 144795 tgtggggtac gggaatcctg gggaagggtc ctggtcagcc tcttagaggc tgtgtgaccc 144855 tgtgagcctc agtgcctcgt gctgtggatg gatgagaaac ctctgtgggt tccctcttcc 144915 cctttcttga tggccgccac cctgtgttct cggagatcat taccctcaaa aggcctgccc 144975 tgcacttaat gccagaacca ctgtgaggtt cgccctctta tcactttaag tttgaagaaa 145035 ctgaggctca gagagatgaa atcacttgtc caagatcaca cagctgggag ggcagagcca 145095 ggatctggac cccaggtggt cctggcccct gtgctgtgag cgttctgttt gtcacagtgg 145155 actctgctcc ctggtgctac tcccgtctct ggccacagct cagaggtcag ccgtgtgcct 145215 ggtcgtgggc ccccgataag atgagcaggg ctgtattggg ctgtgtcacg gtggaggtca 145275 gccgtgtgcc tggtcgtggg ccccccgata agatgagcag ggctgtattg ggctgtgtca 145335 cggtcggggt cagccgtgtg cctggtcatg ggcctcccga tgagatgagc agggctgtgt 145395 cgggctgtgt cagagcattc agaccctcgc tgagatgagc aggtctgcgc tgggccatgt 145455 cagggcatgc agaccctcgc tgctctttga gacccttctt gtggaagggc caggatggtc 145515 gggacgcccc gtccactcac ctcatccctt atcccaccag gtc cat gac tac ctt 145570 Val His Asp Tyr Leu 325 cgg agc aag ctc tgt tcc ctg tac gag aac gac tgc att ttc gac aag 145618 Arg Ser Lys Leu Cys Ser Leu Tyr Glu Asn Asp Cys Ile Phe Asp Lys 330 335 340 ttt gaa tgt gcc tgg aac ggg agc gac ag gtaagccctg acctcagccc 145667 Phe Glu Cys Ala Trp Asn Gly Ser Asp Ser 345 350 gcacctcacc tcaccgtagg gagggtttct gccctgcagg ggtctgggct gggattccgg 145727 tgacccgcag catggggcta ctcagcctca atgggtccag gtgtctgggt gaagcccacg 145787 ctttccagag caggtccaac tctcagcgct cagattcaag gggcaggaca tgaaattctt 145847 catcttctgt cactgaacct cacagccacg ttggcgcctg ccctatgggc agtagtggga 145907 acatgtttag ttaattcagg gtccccggtg atgtgctccc ctctcccagc ttgtcggggg 145967 cgagggctat agcccagcac ccggtcacca tcatccatcc acacctgtat gtcctgagac 146027 agccctgcac ccctgtggct ttgaccatcg gtctactcac ccctcctccc atcaccacta 146087 ctgtctccct ctcttcctgg tgacacccca ctcgggcccg ctgaggctca ggggcacctt 146147 ggagctccta caccctccag ggcttgtcac aatccacaag tccagccgtc tctcaacccc 146207 acctgcctgg aaagtggcgc cccagtgcca gaagtgagtt cctgtgtctc cctagcctgg 146267 gctcagccca gggcgggcat ggacaagggg gctgtggcag gggctcctga cctgacctct 146327 acccgtgggt ccttacctct gtgtctcttc tctgggattc ttcctccatt ctggaggtgg 146387 gaaaatccct cttctgccct cccaaatcac atcagctttg tgctcagggt cctgccaggc 146447 gtaagattct gaaatggaca agcctactct ccatctgtga gtttcgatct cagaagctga 146507 gaggtggcct ctcagtgtct cctacagctg cttcctcaag gacaggatgc ctctttgtcc 146567 agccgcccag attcagaagt gggtctccag atgatacaca gtgtggagat aaagactaca 146627 ctggctgcta gatcagaata ccacctgtca ggagcccatg tactgtcacc tcctccccgc 146687 agtcctgtcc agtgtggtgg gcaaggaggg tggagtgaga gccagcagcc ctgacttggg 146747 catcacctgg tggggggctg tccaccctgt ggatggcatc agtcaacatg acaggtctgg 146807 gctctcccag acctctgagg gtggctggca ctgtggtggt catgtgagag ctgccgcact 146867 atgactctct gtggctctgg gcatagggct gggaccatca gggttggtgt gtgggatgag 146927 gggagggctg gacatggcag agacaggacc aggagggagc cccctggaag cagggctgga 146987 tccaagtggg gggccaagtc attgtgtcca gggaaggaga tttctgagag agttgccaac 147047 atcctggagc tcccccagcc cgcaggggtc tctcagcaga gcccgagctc aggcaagggg 147107 ctggcatggt gatcacaggg ggccactaaa ggatgcttag aaaaccagga tggaggcccg 147167 acccggggct gggctggcac agctgggtca gcaggacaca ggaccttctc tctaggccct 147227 gcccccagat agatcccaga cacccccagc agacagggct cctcccatgc tgctgagctg 147287 catttggggt tccctggtgc agtgggtccc aagagggtct atccaaatcg gacgagaggg 147347 acctgcagct gtaacaagct gattccagct tttatgtgcg ttttgcgggg taggtccccg 147407 ctggctgcga cccactgccc gtccttcctt caagctgcca ccagggggca cccgcggcca 147467 ggtgatgcct gctcccagga ctggagaagc cgccaagcat ccccaggctg acagtggtgt 147527 ctaggcctgg gctctcctgt cctgcctccc acccgccact tcctgcgtgc actttacacg 147587 ccagccacgc cctgtcctag tggtccccca cccgcctcac tgtctctcgc tccacagctg 147647 gctctgctct gcccggctgg aacctctgtc cttgtttgcc tcccgcaatg ggtggggtgc 147707 cctggggggc tactatgact caacctgttc tgagcccttc actggggacc tcaggtgtgt 147767 ccagtggctg tgggtgtttc tagaaggcat agaggtgtgc cacctcccag ttcactttga 147827 gcactgttct gagaacaaca tgccccatgg tcaggggtcc caagataaac agaccctggg 147887 tcctgccttc cagggcctca gaggctcagg agagaagcaa ggattccccc caggttccca 147947 catccttgca gaccaaagca aactcgaatc ctggcaggct cccagttgct gccctcttat 148007 tcctggtgac cccctctgac agttggtccg gcccgcagag cgccgctgct gccgcgtggt 148067 ggctgcccga tggcccctgc cgtggggctt cctagcaccg gcagaacgca gatgggcagc 148127 gtgctgtgga gaggcagcag ctctcctgct ggactctctc agtctctggt ccacattcta 148187 ccctcgccac cgtgtgcttg aggaagcccc taagtcagct cggctggaaa gtggttctag 148247 gaaactggcc ttcgtggccg ctttggggat gagaccatgt gtgatgcctt cagcaagatc 148307 ccagttcgta tgcgcagggg tgccgcagtg atcctgcgtg gactatccta ttggcaggcc 148367 tgcccttccc caggttacct acccggagga atcccgcagg ccctcccaca acaggcttca 148427 acgccccctc ctccatgaag ttctccttga tctgtcctgc ctggggggag agatttgtgc 148487 cagccgagcg tgctcgggtg cgggagtcaa acacacctac acttgctctg aggagtcctg 148547 ggcaaggctc ccccaggggc ccatgctgta tccctagggc tgtttttttc tctccggccg 148607 ttttcttctc tccatgcttc cccatctccg ctcctccctg cttcttctta cacactggcc 148667 tcatcctctc cctcttcaga gatgaccccc aaatcattcc cctttccatt atcctcagcc 148727 agccaacccc tcccagggac tgtgtaaaac tctcatggaa ggatctgatt ggctctgtgt 148787 gggtcacttg cccacttttt gcaccaatca gcatggacag ggatatcaca tgcccaagtt 148847 ggccaggcca aggggcgagg agagcactgt gattgaccgc tcacagggat agggagtgca 148907 gtggcgccat ctcggctcgc tgcaacctcc gcctcctgga gtcaaacact tctcctgccg 148967 cagcctccca agtagctggg attacaggcg ccacgggtgg cgagggcagg agcctttctt 149027 tccccaaagg aaagaggagc ggagcactgg ggctgaaagc agccggcgtt gnggtcccac 149087 atgcagatga ggctaggaga ggtgaagcag ctcccctgcc cttttccctg ttaagggaac 149147 cttctggaat ttaagaaacc tgcctgaatg tgaggaatgg ctctcatggt ggtgcggcct 149207 ggtgctctag gatgagaggg gcccctccct ctcccccaga gcacgtgtca gctgaattcc 149267 acacccgaac agggggagga tcaggaactg tgtgggttgc aaatgacttt aattatgtcg 149327 ctctccttcc actaaatgga tcagaagaac cagcattgtg tgaaatcacc caggttcatt 149387 ctgtgaactg ttccctgaag aacaaagggg gctgcctccc cactgtgctg gcgcggggag 149447 ggtgtggcct cccccagtca gcctgtggcg cctgggcagg gcccttctgt gggactcgtt 149507 cacccggccc ccctcgcatg ctgcttccct tgtcccaggc tctgagtcac atataaagcg 149567 ggtgcggctt tggtcacatg gacgattagg atcgaggagt acctggtaaa taacaagaag 149627 caaagtgcct caagcccagc actgtgcggg gtgttcagcc tatgtcccct gattcacgct 149687 caccaggggc tgcgttccct tgttgatccc agttcttata gaaaactaag agagtgcgca 149747 tgtcagggta gggcagagct gggatccgga cccaggcgga ctggccagag cccaagcccc 149807 tgactgcagt gccggagctc acgtgtgagc ttttgtcctc tgtgcataac ccctggagac 149867 ccagggatcc acctggttct gtcacagagc agtgtcaccc tcaggaagcc cagctcagct 149927 tccaaaagga aacaggattt cctccctgaa gagccttcag caggacaact tctttatggt 149987 cgcttttcgt aacatcctct tcctccccag ttaccttgca cctcacagct gctccagggc 150047 cctgcagagg ccaaacccca aaaccctccc tctgggcgca ggcccacaga actgtgcttt 150107 ctctcctgcc tcttactatg tggatgaact tacccttcct cccaccggca ggaacccctt 150167 ctccttagga gcagggagag cagagaaatg gtgtggaatt ctctttagcg ggacggtgag 150227 ggcagcgagc ccctgcacgt cagcactgct cgccccgacc ctcatggcga tgcatgtttg 150287 tttattcgcc cgagtcctcg ggacaggcgg gcccctggag ggaagcaggg cctggtggtt 150347 ttctgtccca gctgcttcca tgtctacctc ctgctgtggt tgcacagtct gtttggaagg 150407 ccagagcttt ctctcctgga ctaacagaaa ttacaggagg gtcttttctt ttcttttctt 150467 ttcttttttc gagacggagt tttgctctta ttgcccaggc tggagtgcag tggcgcgatc 150527 ttggctcact acaaccttgc ctcctggatt caagcaactc tcctgcctca gcctcctgag 150587 tagctgggat tacaggtgcc caccaccatg tccagctaat ttttgtattt ttagtagaga 150647 cagggtttca tcatgttggc caggctggtc tcaaactcct aacctcaggt gatctgcccg 150707 ccttggcttc ccaaagtgct gggattacag gtgtgagcca ccacgcctgg ccaggagggt 150767 attttcatga tgattggggc agaggataaa aaggatctta gctcctggcc ccaaagtctg 150827 catgttggtg gcagctgaca tgtgaggggg tataagagac cccaagatac aggggaatag 150887 aggcaggtgt ggtttccctt tccagggagt gatggctctg taggctctgg gattgctttt 150947 tcatttgttt gttgttttgg gacagagttt tactctgtca cccaggctag actgcagtgg 151007 taaatcacag ctcactgcag tctctgcctc cccaggctca ggtgatcctc ctgcctcccc 151067 aggctcaggt gatcctcctg cctcaacctc ctgaatagct gggactacgg tcatttttaa 151127 tttttttttg tagaggtgga gtctcgctat gttgtccagg ctggtcttga actcctaggc 151187 tgaagcaatc ctcccaccgg ggcctcccaa agtcctggga ttatgggcgt gagcccccac 151247 acctgggctt atttctcgag aaggggcttg tgctcctcct cacctgatgc ctctccttct 151307 cccaccag c gtc atc atg acc ggg gcc tac aac aac ttc ttc cgc atg 151355 Val Ile Met Thr Gly Ala Tyr Asn Asn Phe Phe Arg Met 355 360 ttc gat cgg aac acc aag cgg gac gtg acc ctg gag gcc tcg agg gaa 151403 Phe Asp Arg Asn Thr Lys Arg Asp Val Thr Leu Glu Ala Ser Arg Glu 365 370 375 380 agc agc aag ccc cgg gct gtg ctc aag cca cgg cgc gtg tgc gtg ggg 151451 Ser Ser Lys Pro Arg Ala Val Leu Lys Pro Arg Arg Val Cys Val Gly 385 390 395 ggc aag cgc cgg cgt gat gac atc agt gtg gac agc ttg gac ttc acc 151499 Gly Lys Arg Arg Arg Asp Asp Ile Ser Val Asp Ser Leu Asp Phe Thr 400 405 410 aag aag atc ctg cac acg gcc tgg cac ccg gct gag aac atc att gcc 151547 Lys Lys Ile Leu His Thr Ala Trp His Pro Ala Glu Asn Ile Ile Ala 415 420 425 atc gcc gcc acc aac aac ctg tac atc ttc cag gac aag gta aac tct 151595 Ile Ala Ala Thr Asn Asn Leu Tyr Ile Phe Gln Asp Lys Val Asn Ser 430 435 440 gac atg cac tag g tatgtgcagt tcccggcccc tgccacccag cctcatgcaa 151648 Asp Met His 445 gtcatccccg acatgacctt cacgaccgca atgcaaggag gggaagaaag tcacagcact 151708 gatgaggaca gctgcagagg tggcagtgtg tggacacagg aagtttgggc cccctccctg 151768 ccccagcttt cctaggccag aattgtgttt ggcagtaatt gtctgtttaa aaaaataaaa 151828 ag 151830 38 447 PRT Homo sapiens 38 Met Gly Glu Asp Thr Asp Thr Arg Lys Ile Asn His Ser Phe Leu Arg 1 5 10 15 Asp His Ser Tyr Val Thr Glu Ala Asp Ile Ile Ser Thr Val Glu Phe 20 25 30 Asn His Thr Gly Glu Leu Leu Ala Thr Gly Asp Lys Gly Gly Arg Val 35 40 45 Val Ile Phe Gln Arg Glu Pro Glu Ser Lys Asn Ala Pro His Ser Gln 50 55 60 Gly Asp Tyr Asp Val Tyr Ser Thr Phe Gln Ser His Glu Pro Glu Phe 65 70 75 80 Asp Tyr Leu Lys Ser Leu Glu Ile Glu Glu Lys Ile Asn Lys Ile Lys 85 90 95 Trp Leu Pro Gln Gln Asn Ala Ala His Ser Leu Leu Ser Thr Asn Asp 100 105 110 Lys Thr Ile Lys Leu Trp Lys Ile Thr Glu Arg Asp Lys Arg Pro Glu 115 120 125 Gly Tyr Asn Leu Lys Asp Glu Glu Gly Lys Leu Lys Asp Leu Ser Thr 130 135 140 Val Thr Ser Leu Gln Val Pro Val Leu Lys Pro Met Asp Leu Met Val 145 150 155 160 Glu Val Ser Pro Arg Arg Ile Phe Ala Asn Gly His Thr Tyr His Ile 165 170 175 Asn Ser Ile Ser Val Asn Ser Asp Cys Glu Thr Tyr Met Ser Ala Asp 180 185 190 Asp Leu Arg Ile Asn Leu Trp His Leu Ala Ile Thr Asp Arg Ser Phe 195 200 205 Asn Ile Val Asp Ile Lys Pro Ala Asn Met Glu Asp Leu Thr Glu Val 210 215 220 Ile Thr Ala Ser Glu Phe His Pro His His Cys Asn Leu Phe Val Tyr 225 230 235 240 Ser Ser Ser Lys Gly Ser Leu Arg Leu Cys Asp Met Pro Ala Ala Ala 245 250 255 Leu Cys Asp Lys His Ser Lys Leu Phe Glu Glu Pro Glu Asp Pro Ser 260 265 270 Asn Arg Ser Phe Phe Ser Glu Ile Ile Ser Ser Val Ser Asp Val Lys 275 280 285 Phe Ser His Ser Asp Arg Tyr Met Leu Thr Arg Asp Tyr Leu Thr Val 290 295 300 Lys Val Trp Asp Leu Asn Met Glu Ala Arg Pro Ile Glu Thr Tyr Gln 305 310 315 320 Val His Asp Tyr Leu Arg Ser Lys Leu Cys Ser Leu Tyr Glu Asn Asp 325 330 335 Cys Ile Phe Asp Lys Phe Glu Cys Ala Trp Asn Gly Ser Asp Ser Val 340 345 350 Ile Met Thr Gly Ala Tyr Asn Asn Phe Phe Arg Met Phe Asp Arg Asn 355 360 365 Thr Lys Arg Asp Val Thr Leu Glu Ala Ser Arg Glu Ser Ser Lys Pro 370 375 380 Arg Ala Val Leu Lys Pro Arg Arg Val Cys Val Gly Gly Lys Arg Arg 385 390 395 400 Arg Asp Asp Ile Ser Val Asp Ser Leu Asp Phe Thr Lys Lys Ile Leu 405 410 415 His Thr Ala Trp His Pro Ala Glu Asn Ile Ile Ala Ile Ala Ala Thr 420 425 430 Asn Asn Leu Tyr Ile Phe Gln Asp Lys Val Asn Ser Asp Met His 435 440 445 39 19 DNA Artificial probe 99-24169/139 39 ctggctgagg cctccttgt 19 40 19 DNA Artificial probe 24-257/320 40 gtccttctga tggcctgcc 19 41 19 DNA Artificial probe 99-24175/218 41 caagctggat tcgcaatca 19 42 601 DNA Artificial amplicon 30-4 42 tgaagccgac gttgtcgccg ggcagagctt cgctcagagc ctcgtggtgc atctccactg 60 acttcacctc agtggtgatg ttcactggcg caaaggtcac caccatgccc ggccgcagga 120 tgccggtctc cacccggccc acgggcaccg tgccaatgcc tgcagagggg agggggtgtg 180 aggggaaggt ggggcccgag gggatgctgg ggcaggatat tcggggacag agcctggaaa 240 ccaacaaagc ctgggactgg atccccccga caggcctggg ggttggggcc acatgggcgg 300 rgtgcagggg aagggaggcc agggacaagg gcagacacag agattccaag ggaagtgggg 360 gctctcccac ccagctgggg aaataagagg ctgagcagca gagctcccag gaacccacgg 420 aaaagccaca gggacagaga agcgggagga tgggcagaga ggggctgtct gaacctgggg 480 tcccatcctt gcccccggag agcactttcc ctcaaaggag gcactatggg acccctcctt 540 tgtctgagga ctcctccctg tgagtgtggg cggggcgact gactgcttct gcctggggcc 600 t 601 43 601 DNA Artificial amplicon 30-2 43 gctaacagga gaaagcacct gcacactagc tccccgacgc tggaacaggg ccatggccct 60 gcgccccaca ctccagctcc actctccaca ggaaaaggct cccagaatcc agccactcag 120 tgtgtggggg caggggccct gctgacttag aaacaagtgg cacattgatc cgcattcaaa 180 cttgccagcc aatcaaccac agccccgcgc acagactctc ccaggtggga ctgagggggt 240 ctcccctgtc cttggcaggg gcgtctcccc cacgcacccc cagtcccgtc ctctccacag 300 rctccagatg cccacatccc cagaacactc aatgggacaa ctcagagcag gttacagaga 360 aagaaaagcc acacaagctc accaagggca cgctatttca gaagtgcctt ctcctcctgg 420 aaatgtcgac cccaaagctc tcactgggaa acctctggcc tggccccggg aagcgacagg 480 cgcaggtttg gggctgaggc cgtcccagca gctctgtggc ctgccagacc tcagagcact 540 cccatcaggg gccacaagag cagagagctc ttcagcccca tgttctcctg gacgaattaa 600 a 601 44 601 DNA Artificial amplicon 30-17 44 caccacccgc cacctgcctc caggagcact gcagcctcgc cagtcagccc actttgggct 60 ctgtctccag ggatataggg gctggatgga cccgtctcct gaggccagca gaggctccac 120 gccagggtcg gtggcagggc tggcacaggg gaaccaggag gcgccgctgg cttcaccatc 180 ttagctacgg cagcccattc ccctgagcct cctggcctgg gcaacagtgg ctcgcatggc 240 cagcccaccg tgccctccag ggtcagtagc gtctattctg gcggccagca gggctggaga 300 rtcttgggac tgttgagacc ctcccccaac ctccctgagc ctccgggcac agatgtgaaa 360 agggtgccca ctgcagtcag cactcaaccc ccacagcgtc cagggaggga gaggggccac 420 cgggggctga cccctgccca ttctgcagac aaagccacca ccctgccagg gctcaagagg 480 gaagaaaatg gggagggggc catttgagca aatgagccca cccgtgagca aggtggaggg 540 acagcacagt ctggcaggat ggggtctcgg tcactggggg gcctggggcc cctggaactc 600 a 601 45 601 DNA Artificial amplicon 30-7 45 gccgagatcc cccgagtccc gaggcgtcgc gtgcttgggg acgtcaggag ccgatggtac 60 aggctcgctc aggaccccag tcctgagtcc acacccctgc actgcctgag gccaacacac 120 cgtgcccatg ggggccaggg gtgctcagag tcctggtgct gtgggtgcct ctgtcccaac 180 ggcctctggt ccccatccca acaacaaaag cacaggtggt cggggagaac cggacggggg 240 ccaggggagc acatgggcac aggctcagcg ggactcctgg aatgttctct ctttctccac 300 ygcacgagcc atttcaaagg caagaatagg cccctcctga ccccgctcag gcaggcctca 360 gggcaagtgg gagtcactgg aagactcaat tcctctctct gcgtttccac ccgaggcagg 420 tccagtcacc agagagagaa gcagccacct cctttctcac ggcagctggc aaagcaccgg 480 gtggaggaca gagccggtcg gcccaactgt agcttcgggg ctgcccttgg ctggtctctg 540 ggcagagccc ggtgctgagg gcttgcagtg ggaaaggcac agcttgagga atgggcatca 600 g 601 46 601 DNA Artificial amplicon 30-84 46 tgtgctaaaa catagtggct taaaaataat gataaccatt tatcgtctca gtttctgcag 60 ctcaggagtc ggacggcacg cagccgatct ccactcccaa cgtgcagggc ctctgccata 120 agccttgaag gcactcattc actcacgcat cgggggctag tacaggctgt gacagaggcc 180 tgagctggaa ctgttgacca ggacacacac atggccatgt ggcctctggg cttcctcaca 240 gcatggtgtc tggattccag gagttggcat cctgagaaac aaccatgcag aagcagccct 300 rtggatcctg gcctggcctt ggagtcaggc agtgtcactc ctgtgccttc taacctgggc 360 ccccgggccc aaggggagga aatggagacc ccacctccca gtggagggaa ggcaaggtcc 420 cactgtgggg gtagcacatg ggatacaccc atgtggctgc cgctggagac gttagtttgc 480 cacacccgtt tcttctacgt gaacatttgc ctgcatctca ccttctaact cctgggtgct 540 gtttgtccat tttcactaca ccaggggccc ccacagtata tgcagaccag gtttcctggc 600 c 601 47 601 DNA Artificial amplicon 30-15 47 gatgctgaat aagccaggaa gaagatccgg ctaaatgttg gcacattcta aagtctacgt 60 gaggccagtc tgaccctggg aacctccatg aagacatggg cgtggagggt ctgccttttg 120 cagggcccac caggggctca caggaaaggt cgtggaaaat tacaagaaat cttccctctg 180 gcactagcgg gtgaggggaa tggaagccac cgccagacag caccatctcc tcaccctcct 240 gtgaagcaca agactcactt gcagagggaa gagcgcagaa accgtcaccc caggacgctg 300 mggttgaacg agaggaagcg agaatggaga agccctggcc ctggggaaca ggatggaaaa 360 cgcttggctc agctccgtgg ctgcgaagga accggcgcgc tcgcggaggc cacaccccga 420 gacccgagga cacagtgcct gcctgagatg gagccagaaa cattctccac cctttcacgc 480 aagactaaca agggctccat gaaaataaaa ctggaagagc tgaaagagaa gcattctccc 540 tgggtgtgaa accaagaaaa gacacaaagc caaggaaaag ccattgagaa aacacctggc 600 a 601 48 1522 DNA Homo sapiens CDS (55)..(126) 48 attgcatcgt tgtgtggcgg cggggcatgc ccagagcacc gggcacggcc ttca atg 57 Met 1 ggc gag gac acg gac acg cgg aaa att aac cac agc ttc ctg cgg gac 105 Gly Glu Asp Thr Asp Thr Arg Lys Ile Asn His Ser Phe Leu Arg Asp 5 10 15 cac agc tat gtg act gaa gag taaaaatgcg ccccacagcc agggcgaata 156 His Ser Tyr Val Thr Glu Glu 20 cgacgtgtac agcactttcc agagccacga gccggagttt gactatctca agagcctgga 216 gatagaggag aagatcaaca agatcaagtg gctcccacag cagaacgccg cccactcact 276 cctgtccacc aacgataaaa ctatcaaatt atggaagatt accgaacgag ataaaaggcc 336 cgaaggatac aacctgaagg atgaagaggg gaaacttaag gacctgtcca cggtgacgtc 396 actgcaggtg ccagtgctga agcccatgga tctgatggtg gaggtgagcc ctcggaggat 456 ctttgccaat ggccacacct accacatcaa ctccatctcc gtcaacagtg actgcgagac 516 ctacatgtcg gcggatgacc tgcgcatcaa cctctggcac ctggccatca ccgacaggag 576 cttcaacatc gtggacatca agccggccaa catggaggac cttacggagg tgatcacagc 636 atctgagttc catccgcacc actgcaacct cttcgtctac agcagcagca agggctccct 696 gcggctctgc gacatgcggg cagctgccct gtgtgacaag cattccaagc tctttgaaga 756 gcctgaggac cccagtaacc gctcattctt ctcggaaatc atctcctccg tgtccgacgt 816 gaagttcagc cacagcggcc gctacatgct cacccgggac taccttacag tcaaggtctg 876 ggacctgaac atggaggcaa gacccataga gacctaccag gtccatgact accttcggag 936 caagctctgt tccctgtacg agaacgactg cattttcgac aagtttgaat gtgcctggaa 996 cgggagcgac agcgtcatca tgaccggggc ctacaacaac ttcttccgca tgttcgatcg 1056 gaacaccaag cgggacgtga ccctggaggc ctcgagggaa agcagcaagc cccgggctgt 1116 gctcaagcca cggcgcgtgt gcgtgggggg caagcgccgg cgtgatgaca tcagtgtgga 1176 cagcttggac ttcaccaaga agatcctgca cacggcctgg cacccggctg agaacatcat 1236 tgccatcgcc gccaccaaca acctgtacat cttccaggac aaggtaaact ctgacatgca 1296 ctaggtatgt gcagttcccg gcccctgcca cccagcctca tgcaagtcat ccccgacatg 1356 accttcacga ccgcaatgca aggaggggaa gaaagtcaca gcactgatga ggacagctgc 1416 agaggtggca gtgtgtggac acaggaagtt tgggccccct ccctgcccca gctttcctag 1476 gccagaattg tgtttggcag taattgtctg tttaaaaaaa taaaaa 1522 49 24 PRT Homo sapiens 49 Met Gly Glu Asp Thr Asp Thr Arg Lys Ile Asn His Ser Phe Leu Arg 1 5 10 15 Asp His Ser Tyr Val Thr Glu Glu 20 50 1163 DNA Homo sapiens CDS (55)..(195) 50 attgcatcgt tgtgtggcgg cggggcatgc ccagagcacc gggcacggcc ttca atg 57 Met 1 ggc gag gac acg gac acg cgg aaa att aac cac agc ttc ctg cgg gac 105 Gly Glu Asp Thr Asp Thr Arg Lys Ile Asn His Ser Phe Leu Arg Asp 5 10 15 cac agc tat gtg act gaa gct cca ggg ttt ctc ctt gtc ctg gca gca 153 His Ser Tyr Val Thr Glu Ala Pro Gly Phe Leu Leu Val Leu Ala Ala 20 25 30 gat aga agc tcc ttc ttt cta cac cac cca gca cag cag ggg 195 Asp Arg Ser Ser Phe Phe Leu His His Pro Ala Gln Gln Gly 35 40 45 tgaccaagct gcatcccagc cttttcaaca tcgtggacat caagccggcc aacatggagg 255 accttacgga ggtgatcaca gcatctgagt tccatccgca ccactgcaac ctcttcgtct 315 acagcagcag caagggctcc ctgcggctct gcgacatgcg ggcagctgcc ctgtgtgaca 375 agcattccaa gctctttgaa gagcctgagg accccagtaa ccgctcattc ttctcggaaa 435 tcatctcctc cgtgtccgac gtgaagttca gccacagcgg ccgctacatg ctcacccggg 495 actaccttac agtcaaggtc tgggacctga acatggaggc aagacccata gagacctacc 555 aggtccatga ctaccttcgg agcaagctct gttccctgta cgagaacgac tgcattttcg 615 acaagtttga atgtgcctgg aacgggagcg acagcgtcat catgaccggg gcctacaaca 675 acttcttccg catgttcgat cggaacacca agcgggacgt gaccctggag gcctcgaggg 735 aaagcagcaa gccccgggct gtgctcaagc cacggcgcgt gtgcgtgggg ggcaagcgcc 795 ggcgtgatga catcagtgtg gacagcttgg acttcaccaa gaagatcctg cacacggcct 855 ggcacccggc tgagaacatc attgccatcg ccgccaccaa caacctgtac atcttccagg 915 acaaggtaaa ctctgacatg cactaggtat gtgcagttcc cggcccctgc cacccagcct 975 catgcaagtc atccccgaca tgaccttcac gaccgcaatg caaggagggg aagaaagtca 1035 cagcactgat gaggacagct gcagaggtgg cagtgtgtgg acacaggaag tttgggcccc 1095 ctccctgccc cagctttcct aggccagaat tgtgtttggc agtaattgtc tgtttaaaaa 1155 aataaaaa 1163 51 47 PRT Homo sapiens 51 Met Gly Glu Asp Thr Asp Thr Arg Lys Ile Asn His Ser Phe Leu Arg 1 5 10 15 Asp His Ser Tyr Val Thr Glu Ala Pro Gly Phe Leu Leu Val Leu Ala 20 25 30 Ala Asp Arg Ser Ser Phe Phe Leu His His Pro Ala Gln Gln Gly 35 40 45 52 1696 DNA Homo sapiens CDS (55)..(141) 52 attgcatcgt tgtgtggcgg cggggcatgc ccagagcacc gggcacggcc ttca atg 57 Met 1 ggc gag gac acg gac acg cgg aaa att aac cac agc ttc ctg cgg gac 105 Gly Glu Asp Thr Asp Thr Arg Lys Ile Asn His Ser Phe Leu Arg Asp 5 10 15 cac agc tat gtg act gaa ggt aac gta cgt gtt gtc tgagacccct 151 His Ser Tyr Val Thr Glu Gly Asn Val Arg Val Val 20 25 ccggccggcc gcggcgtggg gatgccgtcg caccgaatgc cctccgaagc tgacatcatc 211 tctaccgttg agttcaacca cacgggagag ctgctggcca caggtgacaa gggcggccgg 271 gtcgtcatct tccagcggga accagagagt aaaaatgcgc cccacagcca gggcgaatac 331 gacgtgtaca gcactttcca gagccacgag ccggagtttg actatctcaa gagcctggag 391 atagaggaga agatcaacaa gatcaagtgg ctcccacagc agaacgccgc ccactcactc 451 ctgtccacca acgataaaac tatcaaatta tggaagatta ccgaacgaga taaaaggccc 511 gaaggataca acctgaagga tgaagagggg aaacttaagg acctgtccac ggtgacgtca 571 ctgcaggtgc cagtgctgaa gcccatggat ctgatggtgg aggtgagccc tcggaggatc 631 tttgccaatg gccacaccta ccacatcaac tccatctccg tcaacagtga ctgcgagacc 691 tacatgtcgg cggatgacct gcgcatcaac ctctggcacc tggccatcac cgacaggagc 751 ttcaacatcg tggacatcaa gccggccaac atggaggacc ttacggaggt gatcacagca 811 tctgagttcc atccgcacca ctgcaacctc ttcgtctaca gcagcagcaa gggctccctg 871 cggctctgcg acatgcgggc agctgccctg tgtgacaagc attccaagct ctttgaagag 931 cctgaggacc ccagtaaccg ctcattcttc tcggaaatca tctcctccgt gtccgacgtg 991 aagttcagcc acagcggccg ctacatgctc acccgggact accttacagt caaggtctgg 1051 gacctgaaca tggaggcaag acccatagag acctaccagg tccatgacta ccttcggagc 1111 aagctctgtt ccctgtacga gaacgactgc attttcgaca agtttgaatg tgcctggaac 1171 gggagcgaca gcgtcatcat gaccggggcc tacaacaact tcttccgcat gttcgatcgg 1231 aacaccaagc gggacgtgac cctggaggcc tcgagggaaa gcagcaagcc ccgggctgtg 1291 ctcaagccac ggcgcgtgtg cgtggggggc aagcgccggc gtgatgacat cagtgtggac 1351 agcttggact tcaccaagaa gatcctgcac acggcctggc acccggctga gaacatcatt 1411 gccatcgccg ccaccaacaa cctgtacatc ttccaggaca aggtaaactc tgacatgcac 1471 taggtatgtg cagttcccgg cccctgccac ccagcctcat gcaagtcatc cccgacatga 1531 ccttcacgac cgcaatgcaa ggaggggaag aaagtcacag cactgatgag gacagctgca 1591 gaggtggcag tgtgtggaca caggaagttt gggccccctc cctgccccag ctttcctagg 1651 ccagaattgt gtttggcagt aattgtctgt ttaaaaaaat aaaaa 1696 53 29 PRT Homo sapiens 53 Met Gly Glu Asp Thr Asp Thr Arg Lys Ile Asn His Ser Phe Leu Arg 1 5 10 15 Asp His Ser Tyr Val Thr Glu Gly Asn Val Arg Val Val 20 25 54 1065 DNA Homo sapiens CDS (55)..(840) 54 attgcatcgt tgtgtggcgg cggggcatgc ccagagcacc gggcacggcc ttca atg 57 Met 1 ggc gag gac acg gac acg cgg aaa att aac cac agc ttc ctg cgg gac 105 Gly Glu Asp Thr Asp Thr Arg Lys Ile Asn His Ser Phe Leu Arg Asp 5 10 15 cac agc tat gtg act gaa gac atc gtg gac atc aag ccg gcc aac atg 153 His Ser Tyr Val Thr Glu Asp Ile Val Asp Ile Lys Pro Ala Asn Met 20 25 30 gag gac ctt acg gag gtg atc aca gca tct gag ttc cat ccg cac cac 201 Glu Asp Leu Thr Glu Val Ile Thr Ala Ser Glu Phe His Pro His His 35 40 45 tgc aac ctc ttc gtc tac agc agc agc aag ggc tcc ctg cgg ctc tgc 249 Cys Asn Leu Phe Val Tyr Ser Ser Ser Lys Gly Ser Leu Arg Leu Cys 50 55 60 65 gac atg cgg gca gct gcc ctg tgt gac aag cat tcc aag ctc ttt gaa 297 Asp Met Arg Ala Ala Ala Leu Cys Asp Lys His Ser Lys Leu Phe Glu 70 75 80 gag cct gag gac ccc agt aac cgc tca ttc ttc tcg gaa atc atc tcc 345 Glu Pro Glu Asp Pro Ser Asn Arg Ser Phe Phe Ser Glu Ile Ile Ser 85 90 95 tcc gtg tcc gac gtg aag ttc agc cac agc ggc cgc tac atg ctc acc 393 Ser Val Ser Asp Val Lys Phe Ser His Ser Gly Arg Tyr Met Leu Thr 100 105 110 cgg gac tac ctt aca gtc aag gtc tgg gac ctg aac atg gag gca aga 441 Arg Asp Tyr Leu Thr Val Lys Val Trp Asp Leu Asn Met Glu Ala Arg 115 120 125 ccc ata gag acc tac cag gtc cat gac tac ctt cgg agc aag ctc tgt 489 Pro Ile Glu Thr Tyr Gln Val His Asp Tyr Leu Arg Ser Lys Leu Cys 130 135 140 145 tcc ctg tac gag aac gac tgc att ttc gac aag ttt gaa tgt gcc tgg 537 Ser Leu Tyr Glu Asn Asp Cys Ile Phe Asp Lys Phe Glu Cys Ala Trp 150 155 160 aac ggg agc gac agc gtc atc atg acc ggg gcc tac aac aac ttc ttc 585 Asn Gly Ser Asp Ser Val Ile Met Thr Gly Ala Tyr Asn Asn Phe Phe 165 170 175 cgc atg ttc gat cgg aac acc aag cgg gac gtg acc ctg gag gcc tcg 633 Arg Met Phe Asp Arg Asn Thr Lys Arg Asp Val Thr Leu Glu Ala Ser 180 185 190 agg gaa agc agc aag ccc cgg gct gtg ctc aag cca cgg cgc gtg tgc 681 Arg Glu Ser Ser Lys Pro Arg Ala Val Leu Lys Pro Arg Arg Val Cys 195 200 205 gtg ggg ggc aag cgc cgg cgt gat gac atc agt gtg gac agc ttg gac 729 Val Gly Gly Lys Arg Arg Arg Asp Asp Ile Ser Val Asp Ser Leu Asp 210 215 220 225 ttc acc aag aag atc ctg cac acg gcc tgg cac ccg gct gag aac atc 777 Phe Thr Lys Lys Ile Leu His Thr Ala Trp His Pro Ala Glu Asn Ile 230 235 240 att gcc atc gcc gcc acc aac aac ctg tac atc ttc cag gac aag gta 825 Ile Ala Ile Ala Ala Thr Asn Asn Leu Tyr Ile Phe Gln Asp Lys Val 245 250 255 aac tct gac atg cac taggtatgtg cagttcccgg cccctgccac ccagcctcat 880 Asn Ser Asp Met His 260 gcaagtcatc cccgacatga ccttcacgac cgcaatgcaa ggaggggaag aaagtcacag 940 cactgatgag gacagctgca gaggtggcag tgtgtggaca caggaagttt gggccccctc 1000 cctgccccag ctttcctagg ccagaattgt gtttggcagt aattgtctgt ttaaaaaaat 1060 aaaaa 1065 55 262 PRT Homo sapiens 55 Met Gly Glu Asp Thr Asp Thr Arg Lys Ile Asn His Ser Phe Leu Arg 1 5 10 15 Asp His Ser Tyr Val Thr Glu Asp Ile Val Asp Ile Lys Pro Ala Asn 20 25 30 Met Glu Asp Leu Thr Glu Val Ile Thr Ala Ser Glu Phe His Pro His 35 40 45 His Cys Asn Leu Phe Val Tyr Ser Ser Ser Lys Gly Ser Leu Arg Leu 50 55 60 Cys Asp Met Arg Ala Ala Ala Leu Cys Asp Lys His Ser Lys Leu Phe 65 70 75 80 Glu Glu Pro Glu Asp Pro Ser Asn Arg Ser Phe Phe Ser Glu Ile Ile 85 90 95 Ser Ser Val Ser Asp Val Lys Phe Ser His Ser Gly Arg Tyr Met Leu 100 105 110 Thr Arg Asp Tyr Leu Thr Val Lys Val Trp Asp Leu Asn Met Glu Ala 115 120 125 Arg Pro Ile Glu Thr Tyr Gln Val His Asp Tyr Leu Arg Ser Lys Leu 130 135 140 Cys Ser Leu Tyr Glu Asn Asp Cys Ile Phe Asp Lys Phe Glu Cys Ala 145 150 155 160 Trp Asn Gly Ser Asp Ser Val Ile Met Thr Gly Ala Tyr Asn Asn Phe 165 170 175 Phe Arg Met Phe Asp Arg Asn Thr Lys Arg Asp Val Thr Leu Glu Ala 180 185 190 Ser Arg Glu Ser Ser Lys Pro Arg Ala Val Leu Lys Pro Arg Arg Val 195 200 205 Cys Val Gly Gly Lys Arg Arg Arg Asp Asp Ile Ser Val Asp Ser Leu 210 215 220 Asp Phe Thr Lys Lys Ile Leu His Thr Ala Trp His Pro Ala Glu Asn 225 230 235 240 Ile Ile Ala Ile Ala Ala Thr Asn Asn Leu Tyr Ile Phe Gln Asp Lys 245 250 255 Val Asn Ser Asp Met His 260 56 900 DNA Homo sapiens CDS (55)..(675) 56 attgcatcgt tgtgtggcgg cggggcatgc ccagagcacc gggcacggcc ttca atg 57 Met 1 ggc gag gac acg gac acg cgg aaa att aac cac agc ttc ctg cgg gac 105 Gly Glu Asp Thr Asp Thr Arg Lys Ile Asn His Ser Phe Leu Arg Asp 5 10 15 cac agc tat gtg act gaa gtc ttt gaa gag cct gag gac ccc agt aac 153 His Ser Tyr Val Thr Glu Val Phe Glu Glu Pro Glu Asp Pro Ser Asn 20 25 30 cgc tca ttc ttc tcg gaa atc atc tcc tcc gtg tcc gac gtg aag ttc 201 Arg Ser Phe Phe Ser Glu Ile Ile Ser Ser Val Ser Asp Val Lys Phe 35 40 45 agc cac agc ggc cgc tac atg ctc acc cgg gac tac ctt aca gtc aag 249 Ser His Ser Gly Arg Tyr Met Leu Thr Arg Asp Tyr Leu Thr Val Lys 50 55 60 65 gtc tgg gac ctg aac atg gag gca aga ccc ata gag acc tac cag gtc 297 Val Trp Asp Leu Asn Met Glu Ala Arg Pro Ile Glu Thr Tyr Gln Val 70 75 80 cat gac tac ctt cgg agc aag ctc tgt tcc ctg tac gag aac gac tgc 345 His Asp Tyr Leu Arg Ser Lys Leu Cys Ser Leu Tyr Glu Asn Asp Cys 85 90 95 att ttc gac aag ttt gaa tgt gcc tgg aac ggg agc gac agc gtc atc 393 Ile Phe Asp Lys Phe Glu Cys Ala Trp Asn Gly Ser Asp Ser Val Ile 100 105 110 atg acc ggg gcc tac aac aac ttc ttc cgc atg ttc gat cgg aac acc 441 Met Thr Gly Ala Tyr Asn Asn Phe Phe Arg Met Phe Asp Arg Asn Thr 115 120 125 aag cgg gac gtg acc ctg gag gcc tcg agg gaa agc agc aag ccc cgg 489 Lys Arg Asp Val Thr Leu Glu Ala Ser Arg Glu Ser Ser Lys Pro Arg 130 135 140 145 gct gtg ctc aag cca cgg cgc gtg tgc gtg ggg ggc aag cgc cgg cgt 537 Ala Val Leu Lys Pro Arg Arg Val Cys Val Gly Gly Lys Arg Arg Arg 150 155 160 gat gac atc agt gtg gac agc ttg gac ttc acc aag aag atc ctg cac 585 Asp Asp Ile Ser Val Asp Ser Leu Asp Phe Thr Lys Lys Ile Leu His 165 170 175 acg gcc tgg cac ccg gct gag aac atc att gcc atc gcc gcc acc aac 633 Thr Ala Trp His Pro Ala Glu Asn Ile Ile Ala Ile Ala Ala Thr Asn 180 185 190 aac ctg tac atc ttc cag gac aag gta aac tct gac atg cac 675 Asn Leu Tyr Ile Phe Gln Asp Lys Val Asn Ser Asp Met His 195 200 205 taggtatgtg cagttcccgg cccctgccac ccagcctcat gcaagtcatc cccgacatga 735 ccttcacgac cgcaatgcaa ggaggggaag aaagtcacag cactgatgag gacagctgca 795 gaggtggcag tgtgtggaca caggaagttt gggccccctc cctgccccag ctttcctagg 855 ccagaattgt gtttggcagt aattgtctgt ttaaaaaaat aaaaa 900 57 207 PRT Homo sapiens 57 Met Gly Glu Asp Thr Asp Thr Arg Lys Ile Asn His Ser Phe Leu Arg 1 5 10 15 Asp His Ser Tyr Val Thr Glu Val Phe Glu Glu Pro Glu Asp Pro Ser 20 25 30 Asn Arg Ser Phe Phe Ser Glu Ile Ile Ser Ser Val Ser Asp Val Lys 35 40 45 Phe Ser His Ser Gly Arg Tyr Met Leu Thr Arg Asp Tyr Leu Thr Val 50 55 60 Lys Val Trp Asp Leu Asn Met Glu Ala Arg Pro Ile Glu Thr Tyr Gln 65 70 75 80 Val His Asp Tyr Leu Arg Ser Lys Leu Cys Ser Leu Tyr Glu Asn Asp 85 90 95 Cys Ile Phe Asp Lys Phe Glu Cys Ala Trp Asn Gly Ser Asp Ser Val 100 105 110 Ile Met Thr Gly Ala Tyr Asn Asn Phe Phe Arg Met Phe Asp Arg Asn 115 120 125 Thr Lys Arg Asp Val Thr Leu Glu Ala Ser Arg Glu Ser Ser Lys Pro 130 135 140 Arg Ala Val Leu Lys Pro Arg Arg Val Cys Val Gly Gly Lys Arg Arg 145 150 155 160 Arg Asp Asp Ile Ser Val Asp Ser Leu Asp Phe Thr Lys Lys Ile Leu 165 170 175 His Thr Ala Trp His Pro Ala Glu Asn Ile Ile Ala Ile Ala Ala Thr 180 185 190 Asn Asn Leu Tyr Ile Phe Gln Asp Lys Val Asn Ser Asp Met His 195 200 205 58 976 DNA Homo sapiens CDS (55)..(141) 58 attgcatcgt tgtgtggcgg cggggcatgc ccagagcacc gggcacggcc ttca atg 57 Met 1 ggc gag gac acg gac acg cgg aaa att aac cac agc ttc ctg cgg gac 105 Gly Glu Asp Thr Asp Thr Arg Lys Ile Asn His Ser Phe Leu Arg Asp 5 10 15 cac agc tat gtg act gaa ggt aac gta cgt gtt gtc tgagacccct 151 His Ser Tyr Val Thr Glu Gly Asn Val Arg Val Val 20 25 ccggccggcc gcggcgtggg gatgccgtcg caccgaatgc cctccgaagt ctttgaagag 211 cctgaggacc ccagtaaccg ctcattcttc tcggaaatca tctcctccgt gtccgacgtg 271 aagttcagcc acagcggccg ctacatgctc acccgggact accttacagt caaggtctgg 331 gacctgaaca tggaggcaag acccatagag acctaccagg tccatgacta ccttcggagc 391 aagctctgtt ccctgtacga gaacgactgc attttcgaca agtttgaatg tgcctggaac 451 gggagcgaca gcgtcatcat gaccggggcc tacaacaact tcttccgcat gttcgatcgg 511 aacaccaagc gggacgtgac cctggaggcc tcgagggaaa gcagcaagcc ccgggctgtg 571 ctcaagccac ggcgcgtgtg cgtggggggc aagcgccggc gtgatgacat cagtgtggac 631 agcttggact tcaccaagaa gatcctgcac acggcctggc acccggctga gaacatcatt 691 gccatcgccg ccaccaacaa cctgtacatc ttccaggaca aggtaaactc tgacatgcac 751 taggtatgtg cagttcccgg cccctgccac ccagcctcat gcaagtcatc cccgacatga 811 ccttcacgac cgcaatgcaa ggaggggaag aaagtcacag cactgatgag gacagctgca 871 gaggtggcag tgtgtggaca caggaagttt gggccccctc cctgccccag ctttcctagg 931 ccagaattgt gtttggcagt aattgtctgt ttaaaaaaat aaaaa 976 59 29 PRT Homo sapiens 59 Met Gly Glu Asp Thr Asp Thr Arg Lys Ile Asn His Ser Phe Leu Arg 1 5 10 15 Asp His Ser Tyr Val Thr Glu Gly Asn Val Arg Val Val 20 25 60 638 DNA Homo sapiens CDS (55)..(132) 60 attgcatcgt tgtgtggcgg cggggcatgc ccagagcacc gggcacggcc ttca atg 57 Met 1 ggc gag gac acg gac acg cgg aaa att aac cac agc ttc ctg cgg gac 105 Gly Glu Asp Thr Asp Thr Arg Lys Ile Asn His Ser Phe Leu Arg Asp 5 10 15 cac agc tat gtg act gaa gcg tca tca tgaccggggc ctacaacaac 152 His Ser Tyr Val Thr Glu Ala Ser Ser 20 25 ttcttccgca tgttcgatcg gaacaccaag cgggacgtga ccctggaggc ctcgagggaa 212 agcagcaagc cccgggctgt gctcaagcca cggcgcgtgt gcgtgggggg caagcgccgg 272 cgtgatgaca tcagtgtgga cagcttggac ttcaccaaga agatcctgca cacggcctgg 332 cacccggctg agaacatcat tgccatcgcc gccaccaaca acctgtacat cttccaggac 392 aaggtaaact ctgacatgca ctaggtatgt gcagttcccg gcccctgcca cccagcctca 452 tgcaagtcat ccccgacatg accttcacga ccgcaatgca aggaggggaa gaaagtcaca 512 gcactgatga ggacagctgc agaggtggca gtgtgtggac acaggaagtt tgggccccct 572 ccctgcccca gctttcctag gccagaattg tgtttggcag taattgtctg tttaaaaaaa 632 taaaaa 638 61 26 PRT Homo sapiens 61 Met Gly Glu Asp Thr Asp Thr Arg Lys Ile Asn His Ser Phe Leu Arg 1 5 10 15 Asp His Ser Tyr Val Thr Glu Ala Ser Ser 20 25 62 730 DNA Homo sapiens CDS (55)..(129) 62 attgcatcgt tgtgtggcgg cggggcatgc ccagagcacc gggcacggcc ttca atg 57 Met 1 ggc gag gac acg gac acg cgg aaa att aac cac agc ttc ctg cgg gac 105 Gly Glu Asp Thr Asp Thr Arg Lys Ile Asn His Ser Phe Leu Arg Asp 5 10 15 cac agc tat gtg act gaa ggt cca tgactacctt cggagcaagc tctgttccct 159 His Ser Tyr Val Thr Glu Gly Pro 20 25 gtacgagaac gactgcattt tcgacaagtt tgaatgtgcc tggaacggga gcgacagcgt 219 catcatgacc ggggcctaca acaacttctt ccgcatgttc gatcggaaca ccaagcggga 279 cgtgaccctg gaggcctcga gggaaagcag caagccccgg gctgtgctca agccacggcg 339 cgtgtgcgtg gggggcaagc gccggcgtga tgacatcagt gtggacagct tggacttcac 399 caagaagatc ctgcacacgg cctggcaccc ggctgagaac atcattgcca tcgccgccac 459 caacaacctg tacatcttcc aggacaaggt aaactctgac atgcactagg tatgtgcagt 519 tcccggcccc tgccacccag cctcatgcaa gtcatccccg acatgacctt cacgaccgca 579 atgcaaggag gggaagaaag tcacagcact gatgaggaca gctgcagagg tggcagtgtg 639 tggacacagg aagtttgggc cccctccctg ccccagcttt cctaggccag aattgtgttt 699 ggcagtaatt gtctgtttaa aaaaataaaa a 730 63 25 PRT Homo sapiens 63 Met Gly Glu Asp Thr Asp Thr Arg Lys Ile Asn His Ser Phe Leu Arg 1 5 10 15 Asp His Ser Tyr Val Thr Glu Gly Pro 20 25 64 17 DNA Artificial primer 64 atcttccagc gggaacc 17 65 22 DNA Artificial primer 65 ccttttatct cgttcggtaa tc 22 66 18 DNA Artificial primer 66 cacatcaact ccatctcc 18 67 17 DNA Artificial primer 67 agcccttgct gctgctg 17 68 18 DNA Artificial primer 68 tgaacatgga ggcaagac 18 69 17 DNA Artificial primer 69 gcttgctgct ttccctc 17 

1. An isolated polypeptide selected from the group consisting of: a) a polypeptide comprising SEQ ID NO: 49; b) a polypeptide comprising SEQ ID NO: 51; c) a polypeptide comprising SEQ ID NO: 53; d) a polypeptide comprising SEQ ID NO: 55; e) a polypeptide comprising SEQ ID NO: 57; f) a polypeptide comprising SEQ ID NO: 61; g) a polypeptide comprising SEQ ID NO: 63; h) a polypeptide comprising amino acids 25 to 47 of SEQ ID NO: 51; i) a mutein of any of (a) to (h), wherein the amino acid sequence has at least 60% or 70% or 80% or 90% or 95% or 99% identity to at least one of the sequences in (a) to (h); j) a mutein of any of (a) to (h) which is encoded by a DNA sequence which hybridizes to the complement of the DNA sequence encoding any of (a) to (h) under moderately stringent conditions or under highly stringent conditions; and k) a mutein of any of (a) to (h) wherein any changes in the amino acid sequence are conservative amino acid substitutions to the amino acid sequences in (a) to (h).
 2. The polypeptide of claim 1, wherein said polypeptide is capable of binding a KCNQ2 polypeptide comprising exon 15b shown at position 545 to 643 of SEQ ID NO:
 2. 3. The polypeptide of claim 1 or 2, wherein said polypeptide is capable of binding a catalytic subunit or a scaffolding subunit of a PP2A phosphatase.
 4. A purified polynucleotide encoding the polypeptide of any of claims 1 to 3, or a polynucleotide complementary thereto.
 5. The polynucleotide of claim 4, wherein said polynucleotide is selected from the group consisting of: a) a polynucleotide comprising SEQ ID NO: 48; b) a polynucleotide comprising SEQ ID NO: 50; c) a polynucleotide comprising SEQ ID NO: 52; d) a polynucleotide comprising SEQ ID NO: 54; e) a polynucleotide comprising SEQ ID NO: 56; f) a polynucleotide comprising SEQ ID NO: 58; g) a polynucleotide comprising SEQ ID NO: 60; h) a polynucleotide comprising SEQ ID NO: 62; i) a polynucleotide complementary to any of the polynucleotides of (a) to (h); and j) a polynucleotide hybridizing to any of the polynucleotides of (a) to (h) under moderately stringent conditions or under highly stringent conditions.
 6. An expression vector comprising the polynucleotide of claims 4 or
 5. 7. The expression vector of claim 6, wherein said vector is a gene therapy vector.
 8. A host cell comprising the expression vector of claims 6 or
 7. 9. A method of making a polypeptide, said method comprising the steps of culturing a host cell according to claim 8 under conditions suitable for the production of a polypeptide of any of claims 1 to 3 within said host cell.
 10. The method of claim 9, further comprising the step of purifying said polypeptide from the culture.
 11. An antibody that specifically binds to a polypeptide of any of claims 1 to
 3. 12. Use of a PP2A/Bγ subunit as a target for screening candidate modulators.
 13. Use of a PP2A phosphatase comprising a PP2A/Bγ subunit as a target for screening candidate modulators.
 14. The use of claims 12 or 13, wherein said modulator specifically modulates a PP2A phosphatase comprising said PP2A/Bγ subunit.
 15. The use of any of claims 12 to 14, wherein said candidate modulator is selected from the group consisting of a natural ligand, a small molecule, an antibody, an antisense RNA, an aptamer and a short interfering RNA.
 16. The use of any of claims 12 to 15, wherein said modulator is a candidate drug for the treatment of a mental disorder.
 17. Use of modulator of a PP2A phosphatase comprising a PP2A/Bγ subunit for preparing a medicament for the treatment of a mental disorder.
 18. The use of claim 17, wherein said modulator specifically modulates a PP2A phosphatase comprising said PP2A/Bγ subunit.
 19. Use of a gene therapy vector comprising a polynucleotide encoding a PP2A/Bγ subunit for preparing a medicament for the treatment of a mental disorder.
 20. The use of any of claims 12 to 19, wherein said modulator is used in combination with a known drug for said treatment of said mental disorder.
 21. The use of any of claims 16 to 20, wherein said mental disorder is selected from the group consisting of bipolar disorder, schizophrenia and depression.
 22. The use of claim 21, wherein said mental disorder is bipolar disorder.
 23. Use of a PP2A/Bγ subunit as a target for screening for natural binding partners.
 24. The use of any of claims 12 to 23, wherein said PP2A/Bγ subunit is a polypeptide of SEQ ID NO:
 38. 25. The use of any of claims 12 to 23, wherein said PP2A/Bγ subunit is the polypeptide of any of claims 1 to
 3. 26. A method of assessing the efficiency of a modulator of a PP2A phosphatase comprising a PP2A/Bγ subunit for the treatment of a mental disorder, said method comprising administering said modulator to an animal model for said mental disorder; wherein a determination that said modulator ameliorates a representative characteristic of said mental disorder in said animal model indicates that said agonist is a drug for the treatment of said mental disorder.
 27. The method of claim 26, wherein said animal model is the STOP−/− mice with synaptic defects and severe behavioral disorders.
 28. The method of claims 26 or 27, wherein said modulator specifically modulates a PP2A phosphatase comprising the PP2A/Bγ subunit.
 29. The method of any of claims 26 to 28, wherein said mental disorder is selected from the group consisting of bipolar disorder, schizophrenia and depression.
 30. The method of claim 29, wherein said mental disorder is bipolar disorder.
 31. The method of any of 26 to 30, wherein said PP2A/Bγ subunit is a polypeptide of SEQ ID NO:
 38. 32. The method of any of 26 to 30, wherein said PP2A/Bγ subunit is a polypeptide of any of claims 1 to
 3. 33. Use of at least one PP2A/Bγ-related biallelic marker for diagnosing whether an individual suffers from or is at risk of suffering from a mental disorder.
 34. The use of claim 33, wherein said PP2A/Bγ-related biallelic marker is selected from the group consisting of 99-24169/139, 24-257/320, 99-24175/218 and 24-247/216 as depicted in table 3A and the complements thereof.
 35. The use of claim 34, wherein presence of a genotype “AA” at biallelic marker 99-24169/139 is indicative of said individual suffering from or being at risk of suffering from said mental disorder.
 36. The use of claim 34, wherein the presence a haplotype “AG” at biallelic markers 24169/139 and 24-247/216 is indicative of said individual suffering from or being at risk of suffering from said mental disorder.
 37. The use of claim 34, wherein presence of a haplotype “AA” at biallelic markers 24-257/320 and 99-24175/218 is indicative of said individual suffering from or being at risk of suffering from said mental disorder.
 38. Use of at least one PP2A/Bγ-related biallelic marker for determining whether there is a significant association between said marker and a mental disorder.
 39. The use of claim 38, wherein said PP2A/Bγ-related biallelic marker is selected from the group consisting of 99-24169/139, 24-257/320, 99-24175/218 and 24-247/216 as depicted in table 3A and the complements thereof.
 40. The use of any of claims 33 to 39, wherein said mental disorder is selected from the group consisting of bipolar disorder, schizophrenia and depression.
 41. The use of claim 40, wherein said mental disorder is bipolar disorder.
 42. A method of genotyping comprising the step of determining the identity of a nucleotide at a PP2A/Bγ-related biallelic marker or the complement thereof in a biological sample.
 43. The method of claim 42, wherein said biological sample is derived from a single subject.
 44. The method of claim 43, wherein the identity of the nucleotides at said biallelic marker is determined for both copies of said biallelic marker present in said individual's genome.
 45. The method of any of claims 42 to 44, wherein said determining is performed by a microsequencing assay.
 46. The method of any of claims 42 to 45, further comprising amplifying a portion of said sequence comprising the biallelic marker prior to said determining step.
 47. The method of claim 46, wherein said amplifying is performed by PCR.
 48. A method of diagnosing a mental disorder in an individual comprising the step of genotyping at least one PP2A/Bγ-related biallelic marker according to the method of any of claims 43 to
 47. 49. The method of claim 48 further comprising the step of correlating the result of the genotyping step with a risk of suffering from said mental disorder.
 50. The method of claim 48 or 49, wherein said PP2A/Bγ-related biallelic marker is selected from the group consisting of 99-24169/139, 24-257/320, 99-24175/218 and 24-247/216 as depicted in table 3A and the complements thereof.
 51. The method of claim 50, wherein presence of a genotype “AA” at biallelic marker 99-24169/139 is indicative of a risk of suffering from said mental disorder.
 52. The method of claim 50, wherein the presence a haplotype “AG” at biallelic markers 24169/139 and 24-247/216 is indicative of a risk of suffering from said mental disorder.
 53. The method of claim 50, wherein presence of a haplotype “AA” at biallelic markers 24-257/320 and 99-24175/218 is indicative of a risk of suffering from said mental disorder.
 54. The method of any of claims 48 to 53, wherein said mental disorder is selected from the group consisting of bipolar disorder, schizophrenia and depression.
 55. The method of claim 54, wherein said mental disorder is bipolar disorder.
 56. Use of a polynucleotide comprising a contiguous span of at least 12 nucleotides of SEQ ID NO: 37 or a polynucleotide complementary thereto in a microsequencing assay for determining the identity of the nucleotide at a PP2A/Bγ-related biallelic marker, wherein the 3′ end of said polynucleotide is located 1 nucleotide upstream of said PP2A/Bγ-related biallelic marker in said sequence.
 57. The use of claim 56, wherein said at least one PP2A/Bγ-related biallelic marker is selected from the group consisting of 99-24169/139, 24-257/320, 99-24175/218 and 24-247/216 as depicted in table 3A and the complements thereof. 